http://biotechdispatch.com.au/privacy-policy 2017-08-28T10:30:24+10:00 http://biotechdispatch.com.au/terms-of-service 2013-11-27T15:39:26+11:00 http://biotechdispatch.com.au/cookies 2014-06-17T00:38:51+10:00 http://biotechdispatch.com.au/about 2017-07-30T11:42:09+10:00 http://biotechdispatch.com.au/privacy-statement 2014-10-31T10:01:13+11:00 http://biotechdispatch.com.au/ads 2014-11-06T08:44:17+11:00 http://biotechdispatch.com.au/ads/300x250 2025-06-05T21:38:30+10:00 http://biotechdispatch.com.au/contact 2021-01-11T05:59:42+11:00 http://biotechdispatch.com.au/news 2017-05-19T06:00:59+10:00 http://biotechdispatch.com.au/ 2017-05-19T06:40:55+10:00 http://biotechdispatch.com.au/plan/product/1/premium-digital-access 2026-03-07T13:48:59+11:00 http://biotechdispatch.com.au/plan/product/3/premium-digital-access-group 2024-05-08T01:51:13+10:00 http://biotechdispatch.com.au/plan/product/4/conference 2022-08-04T01:57:38+10:00 http://biotechdispatch.com.au/news/paradigm-partners-with-london-researchers-to-deepen-understanding-of-osteoarthritis-treatment 2026-04-02T10:52:01+11:00 http://biotechdispatch.com.au/news/telix-strengthens-board-with-seasoned-life-sciences-executive-as-leadership-transition-takes-sha 2026-04-02T10:49:01+11:00 http://biotechdispatch.com.au/news/adalta-reports-positive-tumour-responses-in-advanced-mesothelioma-trial 2026-04-01T15:17:01+11:00 http://biotechdispatch.com.au/news/engineered-immune-cells-show-striking-durability-against-hard-to-treat-cancers 2026-04-01T15:15:01+11:00 http://biotechdispatch.com.au/news/clearing-the-path-for-neurons-as-new-data-strengthens-case-for-nuz-001 2026-04-01T15:15:01+11:00 http://biotechdispatch.com.au/news/cynata-reaches-crucial-milestone-as-phase-2-trial-moves-toward-results 2026-03-30T14:32:01+11:00 http://biotechdispatch.com.au/news/medical-research-powering-australias-health-and-economic-future 2026-03-30T14:20:01+11:00 http://biotechdispatch.com.au/news/alterity-therapeutics-updates-investors-on-key-meeting-with-us-regulator 2026-03-30T14:19:01+11:00 http://biotechdispatch.com.au/news/aroa-biosurgery-reports-promising-trial-milestone-for-advanced-wound-treatment 2026-03-30T14:18:01+11:00 http://biotechdispatch.com.au/news/genetic-signatures-reshapes-its-business-to-cut-costs-and-drive-growth 2026-03-30T14:17:01+11:00 http://biotechdispatch.com.au/news/ai-meets-oncology-as-algorae-advances-drug-discovery-collaboration 2026-03-30T14:16:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-strengthens-national-policy-engagement-at-science-meets-parliament-2026 2026-03-26T13:50:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-represents-life-sciences-sector-in-national-rd-reform-discussions 2026-03-26T13:49:01+11:00 http://biotechdispatch.com.au/news/bcal-expands-access-to-early-cancer-detection-tests-across-australia 2026-03-26T09:45:01+11:00 http://biotechdispatch.com.au/news/a-new-pill-that-slips-past-the-liver-could-transform-how-brain-medicines-are-delivered 2026-03-26T09:28:01+11:00 http://biotechdispatch.com.au/news/clarity-advances-us-manufacturing-strategy-with-major-copper-64-supply-agreement 2026-03-26T09:18:01+11:00 http://biotechdispatch.com.au/news/liberty-expands-into-asia-pacific-life-sciences-insurance-with-new-tailored-offering 2026-03-26T09:18:01+11:00 http://biotechdispatch.com.au/news/emyria-advances-toward-victorian-clinic-launch-as-workforce-and-funding-pathways-fall-into-place 2026-03-24T10:29:01+11:00 http://biotechdispatch.com.au/news/radiopharm-reports-strong-interim-results-for-brain-metastases-imaging-agent 2026-03-24T09:57:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-expands-us-footprint-with-major-multi-site-agreement-in-leading-academic-health-syste 2026-03-24T09:42:01+11:00 http://biotechdispatch.com.au/news/australian-biotech-surges-in-response-to-trial-suggesting-a-new-hope-in-the-fight-against-pancre 2026-03-24T09:32:01+11:00 http://biotechdispatch.com.au/news/first-patient-treated-in-australian-trial-targeting-core-als-disease-mechanism 2026-03-24T09:20:01+11:00 http://biotechdispatch.com.au/news/act-now-to-take-advantage-of-early-bird-pricing-for-ausmedtech-2026 2026-03-19T11:46:01+11:00 http://biotechdispatch.com.au/news/racura-advances-rc220-trial-as-hong-kong-patient-dosing-milestone-clears-path-for-next-phase 2026-03-19T09:52:01+11:00 http://biotechdispatch.com.au/news/monash-leader-calls-for-action-on-research-infrastructure-investment 2026-03-19T09:46:01+11:00 http://biotechdispatch.com.au/news/breakthrough-early-results-position-immuteps-novel-therapy-as-potential-autoimmune-disease-treat 2026-03-19T09:19:01+11:00 http://biotechdispatch.com.au/news/orthocell-device-aids-nerve-repair-in-ukrainian-war-casualties-as-real-world-use-expands 2026-03-19T09:12:01+11:00 http://biotechdispatch.com.au/news/adalta-bolsters-woard-with-the-appointment-of-investor-relations-specialist 2026-03-19T09:05:01+11:00 http://biotechdispatch.com.au/news/australia-stakes-a-claim-in-global-gene-therapy-manufacturing-through-new-partnership 2026-03-19T09:00:01+11:00 http://biotechdispatch.com.au/news/renewed-calls-for-major-investment-in-life-sciences-to-secure-nations-innovation-future 2026-03-17T12:23:01+11:00 http://biotechdispatch.com.au/news/implantable-sensor-approved-in-australia-could-transform-how-hydrocephalus-is-monitored 2026-03-17T09:16:01+11:00 http://biotechdispatch.com.au/news/oncosil-secures-full-subscription-entitlement-offer-to-advance-cancer-treatment-program 2026-03-17T09:12:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-recruits-global-dealmaker-to-accelerate-nasodine-expansion 2026-03-17T09:09:01+11:00 http://biotechdispatch.com.au/news/regulators-clear-path-for-pivotal-trial-of-pyc-vision-therapy-for-rare-blinding-disease 2026-03-17T09:05:01+11:00 http://biotechdispatch.com.au/news/scientists-identify-highly-specific-targets-that-could-transform-multiple-myeloma-treatment 2026-03-17T09:01:01+11:00 http://biotechdispatch.com.au/news/a-new-prostate-cancer-technology-moves-closer-to-global-trials-after-strong-early-results 2026-03-12T10:48:01+11:00 http://biotechdispatch.com.au/news/cell-therapy-company-mesoblast-names-executive-to-guide-clinical-development-and-medical-affairs 2026-03-12T10:35:01+11:00 http://biotechdispatch.com.au/news/patrys-moves-toward-first-human-trial-for-injectable-delirium-therapy 2026-03-12T09:47:01+11:00 http://biotechdispatch.com.au/news/imugene-launches-20-million-capital-raise-to-fund-expansion-of-azer-cel-trials 2026-03-12T09:39:01+11:00 http://biotechdispatch.com.au/news/csl-expands-us-manufacturing-with-15-billion-investment-to-boost-plasma-therapy-production 2026-03-10T10:58:01+11:00 http://biotechdispatch.com.au/news/telix-phase-3-cancer-study-shows-encouraging-safety-results-for-novel-radiotherapy 2026-03-10T10:51:01+11:00 http://biotechdispatch.com.au/news/imugene-reports-strong-early-results-in-azer-cel-cancer-clinical-trial 2026-03-10T10:43:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-expands-antiviral-program-through-burnet-institute-collaboration 2026-03-10T10:40:01+11:00 http://biotechdispatch.com.au/news/new-cancer-research-highlights-potential-of-narmafotinib-to-koost-kras-inhibitor-therapies 2026-03-10T10:39:01+11:00 http://biotechdispatch.com.au/news/nanosonics-achieves-key-fda-clearance-as-coris-endoscope-coverage-expands 2026-03-10T10:38:01+11:00 http://biotechdispatch.com.au/news/lateral-pharma-secures-key-us-patent-for-novel-neuropathic-pain-therapy 2026-03-10T10:38:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-targets-breakout-year-in-2026-as-nasodine-expansion-accelerates 2026-03-04T12:26:01+11:00 http://biotechdispatch.com.au/news/adalta-strengthens-clinical-push-for-breakthrough-solid-cancer-therapy 2026-03-04T12:25:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-secures-strong-backing-as-retail-offer-adds-47-million-to-capital-raise 2026-03-04T12:23:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-deepens-us-biodefence-ties-to-advance-marburg-treatment 2026-03-04T12:23:01+11:00 http://biotechdispatch.com.au/news/australian-medtech-innovators-move-closer-to-procurement-through-national-capability-program 2026-03-04T12:22:01+11:00 http://biotechdispatch.com.au/news/alterity-strengthens-clinical-leadership-with-appointment-of-neurologist-daniel-claassen 2026-03-04T12:22:01+11:00 http://biotechdispatch.com.au/news/australian-study-shows-natural-protein-can-offer-a-new-hope-against-sepsis 2026-03-03T11:48:01+11:00 http://biotechdispatch.com.au/news/entropy-neurodynamics-completes-first-cohort-enrolment-in-psilocin-trial-for-binge-eating-disord 2026-03-03T11:19:01+11:00 http://biotechdispatch.com.au/news/botanix-accelerates-sofdra-growth-as-fulfilment-platform-drives-revenue-growth 2026-03-03T10:40:01+11:00 http://biotechdispatch.com.au/news/avecho-biotechnology-sears-crucial-milestone-in-phase-3-insomnia-trial 2026-03-03T10:31:01+11:00 http://biotechdispatch.com.au/news/neuren-backs-european-re-examination-as-daybue-momentum-builds-and-cash-position-strengthens 2026-03-03T10:20:01+11:00 http://biotechdispatch.com.au/news/clinuvel-posts-record-half-year-revenue-as-expansion-strategy-accelerates 2026-02-26T10:56:01+11:00 http://biotechdispatch.com.au/news/eu-backs-vaxxas-led-consortium-with-up-to-250m-to-advance-next-generation-influenza-vaccines 2026-02-26T10:14:01+11:00 http://biotechdispatch.com.au/news/imugene-sharpens-focus-on-azer-cel-as-costs-fall-and-clinical-progress-builds 2026-02-25T13:07:01+11:00 http://biotechdispatch.com.au/news/neurizon-advances-als-drug-program-as-funding-trials-and-global-partnerships-gain-momentum 2026-02-25T11:41:01+11:00 http://biotechdispatch.com.au/news/immutep-strengthens-focus-on-late-stage-immunotherapy-trial-as-pipeline-momentum-builds 2026-02-25T11:40:01+11:00 http://biotechdispatch.com.au/news/acrux-returns-to-profit-as-product-launches-and-strategic-reset-drive-revenue-growth 2026-02-25T11:40:01+11:00 http://biotechdispatch.com.au/news/blood-test-discovery-may-help-predict-head-and-neck-cancer-relapse-risk 2026-02-25T11:39:01+11:00 http://biotechdispatch.com.au/news/tetratherix-reports-steady-progress-as-it-moves-toward-commercialisation 2026-02-24T11:54:01+11:00 http://biotechdispatch.com.au/news/radiopharm-reaches-clinical-milestone-as-first-patient-receives-novel-cancer-radiotherapy 2026-02-24T09:50:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-advances-rna-pipeline-amid-financial-discipline-and-strategic-expansion 2026-02-23T20:21:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-launches-new-funding-push-to-fast-track-breakthroughs-in-heart-disease-and-diabetes 2026-02-23T11:38:01+11:00 http://biotechdispatch.com.au/news/argent-biopharma-reaches-milestone-as-major-cannepil-shipment-lands-in-ireland 2026-02-23T11:37:01+11:00 http://biotechdispatch.com.au/news/ausmedtech-2026-unveiled-as-the-industry-gathers-in-perth-for-landmark-year 2026-02-19T12:36:01+11:00 http://biotechdispatch.com.au/news/medical-developments-builds-momentum-as-penthrox-growth-offsets-softer-respiratory-demand 2026-02-19T10:10:01+11:00 http://biotechdispatch.com.au/news/csl-in-new-strategic-deal-to-advance-promising-anti-inflammatory-therapy 2026-02-18T16:43:01+11:00 http://biotechdispatch.com.au/news/idt-signals-turnaround-as-revenue-rises-and-losses-narrow-under-strategic-reset 2026-02-18T16:42:01+11:00 http://biotechdispatch.com.au/news/nyrada-advances-lead-candidate-into-mid-stage-trial-as-momentum-builds-across-programs 2026-02-18T16:41:01+11:00 http://biotechdispatch.com.au/news/percheron-targets-next-wave-of-immunotherapy-with-novel-vista-checkpoint-candidate 2026-02-18T16:41:01+11:00 http://biotechdispatch.com.au/news/telix-files-for-european-approval-of-brain-cancer-imaging-candidate-tlx101-px 2026-02-18T16:40:01+11:00 http://biotechdispatch.com.au/news/ausbiotechproto-axiom-alliance-aims-to-fast-track-australias-next-wave-of-biotech-innovators 2026-02-18T16:39:01+11:00 http://biotechdispatch.com.au/news/botanix-raises-45-million-to-fuel-sofdra-growth-and-secure-global-supply-chain 2026-02-17T10:33:01+11:00 http://biotechdispatch.com.au/news/new-imaging-agent-shows-stronger-detection-of-recurrent-prostate-cancer-in-head-to-head-trial 2026-02-17T09:51:01+11:00 http://biotechdispatch.com.au/news/medibank-funding-expansion-signals-momentum-for-emyrias-mental-health-model 2026-02-17T09:49:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-names-experienced-biotech-leader-as-chair-in-board-and-executive-refresh 2026-02-17T09:48:01+11:00 http://biotechdispatch.com.au/news/director-pay-rises-across-asx-healthcare-sector-but-gender-balance-remains-uneven 2026-02-17T09:47:01+11:00 http://biotechdispatch.com.au/news/life-sciences-sector-unites-to-advance-womens-leadership-at-landmark-2026-events 2026-02-17T09:44:01+11:00 http://biotechdispatch.com.au/news/chimeric-escalates-cdh17-car-t-trial-to-highest-dose-after-strong-safety-and-early-activity-sign 2026-02-12T09:59:01+11:00 http://biotechdispatch.com.au/news/patrys-taps-experienced-biotech-executive-to-drive-clinical-expansion 2026-02-12T09:47:01+11:00 http://biotechdispatch.com.au/news/canine-osteoarthritis-study-offers-compelling-translational-evidence-for-pps 2026-02-12T09:44:01+11:00 http://biotechdispatch.com.au/news/amplia-expands-us-footprint-as-amplicity-pancreatic-cancer-trial-gains-momentum 2026-02-12T09:43:01+11:00 http://biotechdispatch.com.au/news/csl-presses-ahead-with-transformation-as-earnings-slip-and-leadership-changes 2026-02-12T09:42:01+11:00 http://biotechdispatch.com.au/news/immutep-reaches-midpoint-in-global-phase-3-lung-cancer-trial 2026-02-09T16:53:01+11:00 http://biotechdispatch.com.au/news/memphasys-fast-tracks-australian-market-entry-with-early-tga-approval-for-felix-system 2026-02-09T16:46:01+11:00 http://biotechdispatch.com.au/news/algorae-expands-commercial-footprint-with-new-licensing-deal 2026-02-09T16:41:01+11:00 http://biotechdispatch.com.au/news/arovella-enters-new-chapter-as-board-transitions-follow-clinical-milestone 2026-02-09T16:36:01+11:00 http://biotechdispatch.com.au/news/molecule2market-appoints-inaugural-ceo-to-lead-next-phase-of-growth 2026-02-09T16:29:01+11:00 http://biotechdispatch.com.au/news/nuclear-medicine-sector-argues-for-dedicated-scheme-to-unlock-cancer-therapies 2026-02-05T10:49:01+11:00 http://biotechdispatch.com.au/news/cleo-diagnostics-highlights-urgent-need-for-earlier-ovarian-cancer-detection-during-awareness-mo 2026-02-05T10:20:01+11:00 http://biotechdispatch.com.au/news/trajan-sees-momentum-return-in-fy26-as-second-quarter-rebound-offsets-soft-start 2026-02-05T10:08:01+11:00 http://biotechdispatch.com.au/news/arovella-enters-clinical-stage-as-fda-clears-first-car-inkt-therapy 2026-02-05T09:51:01+11:00 http://biotechdispatch.com.au/news/neuren-advances-nnz-2591-regulatory-pathway-as-european-uncertainty-weighs-on-rare-disease-strat 2026-02-05T09:42:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-medicines-australia-unite-to-accelerate-advanced-therapies 2026-02-03T13:42:01+11:00 http://biotechdispatch.com.au/news/lixa-and-gardp-to-collaborate-on-tackling-antimicrobial-resistance 2026-02-03T10:57:01+11:00 http://biotechdispatch.com.au/news/imagion-biosystems-advances-imaging-with-fda-filing-for-phase-2-trial 2026-02-03T10:53:01+11:00 http://biotechdispatch.com.au/news/genetic-signatures-appoints-seasoned-life-sciences-executive-as-ceo 2026-02-03T10:49:01+11:00 http://biotechdispatch.com.au/news/ema-decision-clears-regulatory-path-for-argenicas-lead-stroke-drug-in-europe 2026-02-03T10:48:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-delivers-record-revenue-as-us-emerges-as-growth-engine 2026-02-03T10:47:01+11:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-deepens-us-partnership-to-advance-burn-wound-treatment 2026-02-03T10:47:01+11:00 http://biotechdispatch.com.au/news/pycs-capital-raise-marks-one-of-the-largest-biotech-fundraisings-in-australian-market-history 2026-02-03T10:46:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-urges-adoption-of-national-life-sciences-strategy-as-global-competition-intensifies 2026-02-03T10:44:01+11:00 http://biotechdispatch.com.au/news/building-investor-readiness-in-australias-life-sciences-sector 2026-01-29T12:03:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-broadens-copd-treatment-horizons-with-ai-enabled-technegas-study 2026-01-29T10:30:01+11:00 http://biotechdispatch.com.au/news/cartherics-secures-key-china-patent-for-tag-72-car-gene-modified-stem-cell-therapy 2026-01-29T10:25:01+11:00 http://biotechdispatch.com.au/news/arovella-secures-fda-clearance-to-begin-first-in-human-trials-of-ala-101-cell-therapy 2026-01-29T10:08:01+11:00 http://biotechdispatch.com.au/news/peer-reviewed-validation-strengthens-paradigms-osteoarthritis-program 2026-01-29T10:02:01+11:00 http://biotechdispatch.com.au/news/patrys-completes-reliis-acquisition-expands-clinical-pipeline-and-strengthens-board 2026-01-29T10:01:01+11:00 http://biotechdispatch.com.au/news/technegas-named-preferred-ventilation-agent-in-major-us-and-international-lung-imaging-guideline 2026-01-27T11:15:01+11:00 http://biotechdispatch.com.au/news/new-study-highlights-effectiveness-and-cost-benefits-of-aroas-myriad-in-trauma-surgery 2026-01-27T10:55:01+11:00 http://biotechdispatch.com.au/news/bcal-appoints-healthcare-technology-leader-to-its-board 2026-01-27T10:49:01+11:00 http://biotechdispatch.com.au/news/oncosil-achieves-first-treatment-at-major-berlin-hospital-advancing-german-expansion 2026-01-27T10:45:01+11:00 http://biotechdispatch.com.au/news/nexsen-and-rmit-awarded-federal-funding-to-develop-rapid-gbs-test-for-newborns 2026-01-27T10:40:01+11:00 http://biotechdispatch.com.au/news/compumedics-achieves-record-first-half-sales-orders-and-strong-revenue-growth 2026-01-22T11:39:01+11:00 http://biotechdispatch.com.au/news/equipping-life-sciences-leaders-to-manage-foreign-interference-risks 2026-01-22T11:35:01+11:00 http://biotechdispatch.com.au/news/noxopharm-completes-heracles-trial-with-positive-safety-outcome-for-sof-skn 2026-01-22T11:35:01+11:00 http://biotechdispatch.com.au/news/telix-delivers-on-2025-revenue-targets-as-gozellix-fuels-next-phase-of-growth 2026-01-22T11:34:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-announces-new-advisory-groups-to-support-the-life-sciences-sector 2026-01-22T11:31:01+11:00 http://biotechdispatch.com.au/news/neurizon-secures-global-trademark-protection-across-major-pharmaceutical-markets 2026-01-20T11:43:01+11:00 http://biotechdispatch.com.au/news/us-regulator-signals-path-forward-for-mesoblasts-cell-therapy 2026-01-20T08:55:01+11:00 http://biotechdispatch.com.au/news/china-regulator-accepts-illuccix-filing-marking-telixs-first-application-in-the-market 2026-01-20T08:48:01+11:00 http://biotechdispatch.com.au/news/immuron-delivers-continued-sales-growth-across-key-global-markets 2026-01-20T08:45:01+11:00 http://biotechdispatch.com.au/news/zelira-secures-transformative-funding-to-advance-hope-1-autism-program 2026-01-20T08:44:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-reaches-paediatric-milestone-as-stanford-childrens-hospital-adopts-technegas 2026-01-15T11:44:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-joins-trade-diversification-network-to-boost-global-life-sciences-partnerships 2026-01-15T11:40:01+11:00 http://biotechdispatch.com.au/news/neurens-daybue-momentum-builds-as-global-sales-forecast-climbs-toward-us700-million 2026-01-15T11:34:01+11:00 http://biotechdispatch.com.au/news/haemalogix-appoints-chris-baldwin-to-lead-next-phase-of-growth 2026-01-15T11:29:01+11:00 http://biotechdispatch.com.au/news/radiopharm-increases-ownership-in-md-anderson-joint-venture 2026-01-13T13:41:01+11:00 http://biotechdispatch.com.au/news/clinuvel-begins-preclinical-evaluation-of-controlled-release-injectable-peptide-platform 2026-01-13T13:35:01+11:00 http://biotechdispatch.com.au/news/vaxxas-appoints-former-global-vaccines-leader-to-head-global-commercialisation-push 2026-01-13T13:31:01+11:00 http://biotechdispatch.com.au/news/adalta-and-shcell-launch-cancer-collaboration-to-progress-breakthrough-car-t-therapy 2026-01-13T13:31:01+11:00 http://biotechdispatch.com.au/news/neuren-expands-global-footprint-of-landmark-phase-3-trial-with-canadian-regulatory-approval 2025-12-22T10:50:01+11:00 http://biotechdispatch.com.au/news/inoviq-advances-exosome-based-cancer-therapy-with-promising-preclinical-results 2025-12-22T10:12:01+11:00 http://biotechdispatch.com.au/news/biomarins-acquisition-of-amicus-adds-momentum-to-dimerixs-phase-3-kidney-candidate 2025-12-22T10:06:01+11:00 http://biotechdispatch.com.au/news/clarity-moves-toward-phase-3-trial-for-cu-64-sartate-in-neuroendocrine-tumours 2025-12-22T09:57:01+11:00 http://biotechdispatch.com.au/news/telix-strengthens-precision-medicine-strategy-with-positive-illuccix-china-phase-3-results 2025-12-22T09:33:01+11:00 http://biotechdispatch.com.au/news/cleo-diagnostics-raises-funds-to-accelerate-us-launch-and-advance-ovarian-cancer-screening 2025-12-18T10:25:01+11:00 http://biotechdispatch.com.au/news/actinogen-crosses-key-milestone-as-pivotal-alzheimers-trial-fully-enrols 2025-12-18T09:38:01+11:00 http://biotechdispatch.com.au/news/oncosil-completes-first-production-run-at-new-sydney-manufacturing-facility 2025-12-18T09:33:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-secures-key-partnership-with-texas-biomed 2025-12-18T09:32:01+11:00 http://biotechdispatch.com.au/news/ferronova-secures-funding-to-advance-nanoparticle-technology-for-cancer-surgery 2025-12-18T09:31:01+11:00 http://biotechdispatch.com.au/news/antimalarial-candidate-under-wehi-msd-partnership-offers-fresh-hope-against-resistance 2025-12-18T09:29:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-reports-high-success-rate-in-phase-2b-imaging-trial 2025-12-15T16:21:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-opens-applications-for-2026-medtech-procurement-program 2025-12-15T16:20:01+11:00 http://biotechdispatch.com.au/news/amplia-reports-new-rumour-response-for-narmafotinib-in-pancreatic-cancer 2025-12-15T16:18:01+11:00 http://biotechdispatch.com.au/news/new-analysis-finds-mesoblasts-remestemcel-l-outperforms-ruxolitinib-in-severe-gvhd 2025-12-15T16:16:01+11:00 http://biotechdispatch.com.au/news/algorae-unveils-major-breakthrough-in-ai-driven-drug-combination-discovery 2025-12-15T16:15:01+11:00 http://biotechdispatch.com.au/news/neuren-wins-second-fda-approval-for-trofinetide-with-launch-of-formulation 2025-12-15T16:07:01+11:00 http://biotechdispatch.com.au/news/dimerix-completes-adult-recruitment-in-phase-3-trial-for-fsgs-treatment-dmx-200 2025-12-15T16:06:01+11:00 http://biotechdispatch.com.au/news/orthocell-lodges-european-and-uk-regulatory-application-for-remplir 2025-12-15T16:05:01+11:00 http://biotechdispatch.com.au/news/prescient-secures-european-approval-to-launch-ptx-100-trial-for-rare-lymphoma 2025-12-15T15:17:01+11:00 http://biotechdispatch.com.au/news/cynata-completes-patient-enrolment-in-phase-2-trial-for-agvhd-therapy 2025-12-15T15:16:01+11:00 http://biotechdispatch.com.au/news/ai-analysis-uncovers-strong-efficacy-for-argenicas-arg-007-in-severe-stroke-patients 2025-12-11T09:33:01+11:00 http://biotechdispatch.com.au/news/oncosil-announces-first-uk-patient-treated-with-its-pancreatic-cancer-treatment 2025-12-11T09:14:01+11:00 http://biotechdispatch.com.au/news/fda-clears-neurizons-nuz-001-to-join-the-healey-als-platform-trial 2025-12-11T09:08:01+11:00 http://biotechdispatch.com.au/news/tga-clears-the-way-for-ltr-pharmas-phase-2-study-of-spontan 2025-12-11T09:06:01+11:00 http://biotechdispatch.com.au/news/immutep-strikes-major-licensing-deal-with-dr-reddys-to-commercialise-novel-cancer-immunotherapy 2025-12-09T13:00:01+11:00 http://biotechdispatch.com.au/news/australian-breakthrough-uncovers-genetic-trigger-for-severe-macular-degeneration 2025-12-09T08:15:01+11:00 http://biotechdispatch.com.au/news/csls-haemophilia-therapy-shows-durable-five-year-benefits-in-landmark-trial-results 2025-12-08T13:39:01+11:00 http://biotechdispatch.com.au/news/telix-doses-first-patient-in-expanded-phase-3-prostate-cancer-trial 2025-12-08T11:56:01+11:00 http://biotechdispatch.com.au/news/imugene-secures-fda-support-for-azer-cel-registrational-pathway 2025-12-08T11:50:01+11:00 http://biotechdispatch.com.au/news/chimeric-secures-key-orphan-drug-designation-paving-the-way-for-accelerated-development 2025-12-08T11:42:01+11:00 http://biotechdispatch.com.au/news/algorae-pharmaceuticals-achieves-milestone-with-validation-of-ai-drug-combination-platform 2025-12-07T11:48:01+11:00 http://biotechdispatch.com.au/news/cmax-clinches-2025-australian-export-award-marking-major-milestone-for-australias-clinical-trial 2025-12-07T11:44:01+11:00 http://biotechdispatch.com.au/news/evinco-therapeutics-launches-to-pioneer-immune-based-treatments-for-alzheimers-disease 2025-12-04T10:10:01+11:00 http://biotechdispatch.com.au/news/ltr-pharma-advances-spontan-program-with-ethics-approval-for-phase-2-clinical-trial 2025-12-04T09:45:01+11:00 http://biotechdispatch.com.au/news/melbourne-scientists-discover-how-electrical-pulses-could-transform-tissue-and-organ-regeneratio 2025-12-04T09:44:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-secures-boost-as-directors-and-major-shareholders-exercise-options 2025-12-04T09:43:01+11:00 http://biotechdispatch.com.au/news/bcal-launches-national-registry-to-track-real-world-impact-of-breastestplus 2025-12-04T09:42:01+11:00 http://biotechdispatch.com.au/news/medtech-pipeline-accelerates-as-report-showcases-translation-success-of-mtpconnect-backed-innova 2025-12-04T09:40:01+11:00 http://biotechdispatch.com.au/news/noxopharm-advances-autoimmune-candidate-as-first-multiple-dose-cohort-clears-safety-review 2025-12-04T09:40:01+11:00 http://biotechdispatch.com.au/news/ceo-pay-rebounds-across-asx-health-and-biotech-as-boards-balance-pressure-and-retention 2025-12-03T10:18:01+11:00 http://biotechdispatch.com.au/news/clinuvel-advances-second-therapy-toward-market-with-planned-2026-european-filing 2025-12-02T11:27:01+11:00 http://biotechdispatch.com.au/news/imugene-reports-high-response-rate-in-trial-of-off-the-shelf-car-t-therapy 2025-12-02T10:35:01+11:00 http://biotechdispatch.com.au/news/tetratherix-joint-venture-secures-alcon-partnership-to-accelerate-ophthalmic-biomaterials 2025-12-02T10:34:01+11:00 http://biotechdispatch.com.au/news/melbourne-showcases-its-health-and-biomedical-strength-as-leaders-gather-for-national-precincts- 2025-12-02T10:33:01+11:00 http://biotechdispatch.com.au/news/cartherics-appoints-dr-ian-nisbet-as-ceo-as-the-company-accelerates-toward-clinical-trials 2025-12-02T10:32:01+11:00 http://biotechdispatch.com.au/news/immutep-unveils-strong-phase-2-data-ahead-of-san-antonio-breast-cancer-symposium 2025-12-02T10:31:01+11:00 http://biotechdispatch.com.au/news/first-patient-successfully-dosed-in-trp-8803-trial-to-treat-binge-eating-disorder 2025-12-02T10:30:01+11:00 http://biotechdispatch.com.au/news/chimeric-signals-board-refresh-and-shareholder-support-as-lead-trial-advances 2025-11-30T14:07:01+11:00 http://biotechdispatch.com.au/news/astrazeneca-global-search-and-evaluation-leaders-to-brief-australias-life-sciences-community 2025-11-28T12:57:01+11:00 http://biotechdispatch.com.au/news/imugene-and-jw-therapeutics-join-forces-on-first-in-class-combination-for-solid-tumours 2025-11-27T09:37:01+11:00 http://biotechdispatch.com.au/news/neurizon-therapeutics-entering-a-promising-new-horizon-as-als-program-advances 2025-11-26T15:18:01+11:00 http://biotechdispatch.com.au/news/us-medicare-sets-reimbursement-price-for-promarkerd-paving-way-for-major-commercial-rollout 2025-11-26T11:38:01+11:00 http://biotechdispatch.com.au/news/recce-reports-strong-preclinical-efficacy-for-inhaled-r327-in-hospital-acquired-pneumonia-model 2025-11-26T11:37:01+11:00 http://biotechdispatch.com.au/news/race-oncology-secures-human-ethics-approval-for-lung-cancer-trial-of-rc220 2025-11-26T11:35:01+11:00 http://biotechdispatch.com.au/news/adalta-chair-says-the-company-is-on-the-cusp-of-transformational-growth 2025-11-26T11:34:01+11:00 http://biotechdispatch.com.au/news/syntara-advances-next-generation-anti-fibrotic-cream-into-phase-1b-trial 2025-11-26T11:34:01+11:00 http://biotechdispatch.com.au/news/5qs-with-ausbiotechs-tamlyn-oconnor-strengthening-global-pathways-for-australias-life-sciences-s 2025-11-25T13:53:01+11:00 http://biotechdispatch.com.au/news/autoimmune-pioneer-wins-ausbiotechs-early-stage-innovation-forum-for-breakthrough-biologic 2025-11-25T13:47:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-anthea-stephenson-to-lead-national-industry-growth-program 2025-11-25T13:44:01+11:00 http://biotechdispatch.com.au/news/nsw-premier-opens-australias-first-large-scale-health-translation-hub-at-unsw 2025-11-24T13:29:01+11:00 http://biotechdispatch.com.au/news/sanofi-becomes-first-tenant-of-entri-marking-major-step-for-queenslands-translational-research-a 2025-11-24T13:27:01+11:00 http://biotechdispatch.com.au/news/race-oncology-signals-a-defining-year-ahead-as-rc220-advances-and-it-prepares-for-clinical-miles 2025-11-24T10:43:01+11:00 http://biotechdispatch.com.au/news/cynata-completes-final-patient-visits-in-pivotal-phase-3-osteoarthritis-trial 2025-11-24T10:24:01+11:00 http://biotechdispatch.com.au/news/mesoblast-to-launch-pivotal-adult-trial-for-cell-therapy-in-severe-steroid-refractory-gvhd 2025-11-24T09:21:01+11:00 http://biotechdispatch.com.au/news/syntara-launches-phase-2-trial-aiming-to-teduce-transfusion-burden-in-myelodysplastic-syndromes 2025-11-24T09:20:01+11:00 http://biotechdispatch.com.au/news/moderna-names-csiro-scientist-dr-anne-klein-as-2025-australian-fellow 2025-11-24T09:19:01+11:00 http://biotechdispatch.com.au/news/new-analysis-shows-telixs-tlx250-cdx-could-change-clinical-of-renal-disease 2025-11-20T12:32:01+11:00 http://biotechdispatch.com.au/news/amplia-secures-positive-fda-feedback-clearing-path-toward-late-2026-registration-trial 2025-11-20T10:29:01+11:00 http://biotechdispatch.com.au/news/tryp-advances-psilocin-trial-for-binge-eating-disorder-as-second-patient-enrolled 2025-11-19T15:05:01+11:00 http://biotechdispatch.com.au/news/nyrada-advances-toward-phase-2a-trial-of-cardioprotective-candidate 2025-11-19T15:04:01+11:00 http://biotechdispatch.com.au/news/dimerix-phase-3-kidney-trial-clears-seventh-safety-review 2025-11-19T15:03:01+11:00 http://biotechdispatch.com.au/news/bcal-advances-early-cancer-detection-portfolio-as-australian-launch-looms 2025-11-19T15:02:01+11:00 http://biotechdispatch.com.au/news/cleo-diagnostics-appoints-us-oncologist-as-first-key-opinion-leader 2025-11-19T15:01:01+11:00 http://biotechdispatch.com.au/news/oncosil-charts-a-new-growth-phase-as-chairman-outlines-progress-and-opportunities 2025-11-19T15:00:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-appoints-experienced-industry-executive-to-its-board 2025-11-19T14:59:01+11:00 http://biotechdispatch.com.au/news/idt-australia-resets-strategy-as-advanced-therapies-drive-new-phase-of-growth 2025-11-19T14:59:01+11:00 http://biotechdispatch.com.au/news/mesoblast-appoints-chief-financial-officer-as-it-evolves-into-fully-integrated-commercial-organi 2025-11-17T10:49:01+11:00 http://biotechdispatch.com.au/news/syntara-secures-positive-european-opinion-for-orphan-designation-of-amsulostat-in-myelofibrosis 2025-11-17T10:48:01+11:00 http://biotechdispatch.com.au/news/argent-biopharma-secures-significant-financing-facility-to-support-strategic-expansion 2025-11-17T10:47:01+11:00 http://biotechdispatch.com.au/news/race-oncology-launches-new-clinical-programs-in-aml-and-lung-cancer 2025-11-17T10:46:01+11:00 http://biotechdispatch.com.au/news/noxopharm-begins-daily-dosing-in-second-phase-of-heracles-trial 2025-11-17T10:45:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-reaches-enrollment-milestone-in-phase-2b-trial-for-rad101 2025-11-17T10:44:01+11:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-pays-tribute-to-founder-and-scientific-pioneer-dr-graham-melrose 2025-11-16T13:29:01+11:00 http://biotechdispatch.com.au/news/biotron-reports-promising-advances-in-hepatitis-b-program-as-lead-candidate-shows-strong-antivir 2025-11-16T12:15:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-reports-sustained-vision-gains-in-rp11-clinical-trial 2025-11-16T12:14:01+11:00 http://biotechdispatch.com.au/news/new-national-incubator-aims-to-supercharge-australian-vaccine-innovation 2025-11-16T12:11:01+11:00 http://biotechdispatch.com.au/news/immutep-posts-encouraging-phase-2-results-as-efti-spurs-robust-anti-tumour-activity 2025-11-13T15:33:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-appoints-peter-coleman-as-new-chair-as-part-of-board-renewal 2025-11-13T15:30:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-reports-strong-early-results-from-chm-cdh17-phase-12-trial 2025-11-13T11:54:01+11:00 http://biotechdispatch.com.au/news/rage-biotech-raises-29-million-and-appoints-new-leadership-to-advance-precision-rna-therapeutics 2025-11-13T09:50:01+11:00 http://biotechdispatch.com.au/news/nanosonics-names-new-north-american-president-ahead-of-coris-launch 2025-11-13T09:49:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-completes-sale-of-cyclotron-asset-to-strengthen-focus-on-technegas-expansion 2025-11-12T13:21:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-advances-phase-1-trial-of-177lu-rad204-in-pd-l1-positive-cancers 2025-11-12T13:18:01+11:00 http://biotechdispatch.com.au/news/arovella-appoints-former-csl-chief-scientific-officer-dr-andrew-nash-to-its-board 2025-11-12T13:17:01+11:00 http://biotechdispatch.com.au/news/microba-renews-board-with-new-appointment-as-long-serving-directors-retire 2025-11-12T13:16:01+11:00 http://biotechdispatch.com.au/news/pathkeyai-and-armstrong-clinical-partner-to-strengthen-early-phase-trial-success-through-ai 2025-11-12T13:15:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-invites-members-to-help-guide-the-future-of-australian-biotechnology 2025-11-11T12:22:01+11:00 http://biotechdispatch.com.au/news/neuroscientific-advances-stemsmart-therapy-with-fourth-patient-treated-in-crohns-disease-program 2025-11-11T09:50:01+11:00 http://biotechdispatch.com.au/news/monash-engineers-develop-first-tailored-heart-pump-for-under-treated-heart-failure-patients 2025-11-11T09:45:01+11:00 http://biotechdispatch.com.au/news/noxopharm-and-unsw-collaborate-on-gene-based-approach-to-reducing-implant-inflammation 2025-11-11T09:41:01+11:00 http://biotechdispatch.com.au/news/monash-leads-world-first-trial-of-cholesterol-lowering-gene-editing-therapy 2025-11-10T07:23:01+11:00 http://biotechdispatch.com.au/news/proteomics-international-secures-wa-government-grant-to-advance-world-first-blood-test-for-endom 2025-11-09T10:50:01+11:00 http://biotechdispatch.com.au/news/avita-medical-narrows-losses-and-secures-eu-approval-as-reimbursement-challenges-ease 2025-11-09T10:49:01+11:00 http://biotechdispatch.com.au/news/neuren-posts-record-royalties-as-daybue-sales-surpass-us100-million-in-third-quarter 2025-11-06T10:40:01+11:00 http://biotechdispatch.com.au/news/bionsw-opens-expressions-of-interest-for-november-bioinvest-catalyst-event 2025-11-05T14:38:01+11:00 http://biotechdispatch.com.au/news/rhythm-biosciences-appoints-gavin-fox-smith-as-chair 2025-11-05T13:47:01+11:00 http://biotechdispatch.com.au/news/national-vaccine-and-infectious-disease-incubator-to-launch-in-november 2025-11-05T11:13:01+11:00 http://biotechdispatch.com.au/news/nanosonics-announces-20-million-share-buy-back-as-confidence-in-growth-outlook-strengthens 2025-11-05T11:11:01+11:00 http://biotechdispatch.com.au/news/mesoblast-to-meet-with-us-fda-over-potential-non-opioid-treatment-for-chronic-back-pain 2025-11-05T11:11:01+11:00 http://biotechdispatch.com.au/news/imagion-biosystems-reports-positive-results-from-wayne-state-collaboration-as-phase-2-breast-can 2025-11-05T11:10:01+11:00 http://biotechdispatch.com.au/news/noxopharm-advances-autoimmune-drug-trial-as-heracles-enters-second-phase 2025-11-05T11:09:01+11:00 http://biotechdispatch.com.au/news/radium-capital-surpasses-1-billion-milestone-in-innovation-funding 2025-11-05T11:07:01+11:00 http://biotechdispatch.com.au/news/orthocell-expands-canadian-presence-with-full-national-coverage-for-nerve-repair-device 2025-11-05T11:07:01+11:00 http://biotechdispatch.com.au/news/hong-kong-positions-itself-as-a-global-bridge-for-biotech-and-life-sciences-innovation 2025-11-05T11:05:01+11:00 http://biotechdispatch.com.au/news/invex-reports-promising-new-data-on-exenatide-in-alzheimers-disease-model 2025-11-03T14:39:01+11:00 http://biotechdispatch.com.au/news/new-clinical-trial-offers-hope-for-australians-living-with-vitiligo 2025-11-03T12:54:01+11:00 http://biotechdispatch.com.au/news/resmed-delivers-strong-start-to-year-with-double-digit-profit-growth-and-margin-expansion 2025-11-03T11:54:01+11:00 http://biotechdispatch.com.au/news/orthocell-expands-asian-presence-with-first-remplir-surgical-case-in-hong-kong 2025-11-03T09:37:01+11:00 http://biotechdispatch.com.au/news/actinogen-medical-presents-alzheimers-and-depression-program-at-bio-europe-2025 2025-11-03T09:36:01+11:00 http://biotechdispatch.com.au/news/fda-approves-anteris-technologies-global-pivotal-trial-for-duravr-heart-valve 2025-11-03T09:35:01+11:00 http://biotechdispatch.com.au/news/aroa-biosurgery-appoints-paul-shearer-to-board-as-john-pinion-retires 2025-11-02T11:35:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-launches-new-nasodine-throat-spray-for-international-markets 2025-11-02T11:34:01+11:00 http://biotechdispatch.com.au/news/immuron-provides-update-on-us-clinical-trials-for-travelan-and-imm-529 2025-11-02T11:33:01+11:00 http://biotechdispatch.com.au/news/amplia-therapeutics-begins-trading-on-us-otcqb-venture-market 2025-11-02T11:32:01+11:00 http://biotechdispatch.com.au/news/australasian-journal-of-biotechnology-october-edition-out-now 2025-10-30T13:51:01+11:00 http://biotechdispatch.com.au/news/90-million-investment-marks-30-years-of-the-viertel-foundations-impact-on-medical-research 2025-10-30T09:20:01+11:00 http://biotechdispatch.com.au/news/csl-seqirus-partners-to-localise-advanced-influenza-vaccine-manufacturing-in-saudi-arabia 2025-10-30T09:09:01+11:00 http://biotechdispatch.com.au/news/csl-centenary-fellowships-awarded-to-australian-scientists-pioneering-lifelong-immunity-and-ai-d 2025-10-29T17:40:01+11:00 http://biotechdispatch.com.au/news/arovella-advances-ala-101-program-with-cro-appointment-and-phase-1-trial-preparations 2025-10-29T13:18:01+11:00 http://biotechdispatch.com.au/news/australian-based-world-first-rna-trial-offers-new-hope-for-lupus-patients 2025-10-29T11:45:01+11:00 http://biotechdispatch.com.au/news/duravr-delivers-strong-one-year-results-for-patients-with-small-aortic-annuli 2025-10-29T11:43:01+11:00 http://biotechdispatch.com.au/news/australia-launches-first-clinical-and-commercial-scale-viral-vector-manufacturing-facility 2025-10-29T11:40:01+11:00 http://biotechdispatch.com.au/news/uniseed-names-alastair-hick-as-new-ceo-to-lead-next-phase-of-growth 2025-10-29T11:39:01+11:00 http://biotechdispatch.com.au/news/advisory-committee-backs-avitas-burns-treatment-paving-the-way-for-expanded-access-in-australia 2025-10-29T11:39:01+11:00 http://biotechdispatch.com.au/news/myrio-therapeutics-partners-with-leading-us-research-institutions-to-advance-t-cell-immunotherap 2025-10-28T11:15:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-signs-cooperation-agreement-with-saudi-ministry-of-health-to-boost-life-sciences-coll 2025-10-28T11:11:01+11:00 http://biotechdispatch.com.au/news/snoretox-wins-global-innovation-award-for-breakthrough-canine-therapy 2025-10-27T17:13:01+11:00 http://biotechdispatch.com.au/news/pyc-reports-strong-clinical-momentum-and-cash-position-ahead-of-key-readouts 2025-10-27T14:34:01+11:00 http://biotechdispatch.com.au/news/cann-group-announces-major-debt-restructure-and-capital-raise-to-strengthen-balance-sheet 2025-10-27T14:30:01+11:00 http://biotechdispatch.com.au/news/leadership-change-at-polynovo-as-long-time-chair-steps-down 2025-10-27T14:30:01+11:00 http://biotechdispatch.com.au/news/immuron-launches-proibs-in-australia-to-support-people-living-with-ibs 2025-10-27T14:29:01+11:00 http://biotechdispatch.com.au/news/queensland-to-host-ausbiotech-international-conference-and-sector-leadership-strengthened-with-d 2025-10-27T14:28:01+11:00 http://biotechdispatch.com.au/news/global-focus-intensifies-as-ausbiotech-strengthens-trade-partnerships-and-international-engageme 2025-10-23T15:14:01+11:00 http://biotechdispatch.com.au/news/telix-doses-first-patient-in-solace-trial-for-metastatic-bone-pain-1 2025-10-23T11:22:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-invest-kicks-off-australias-biggest-week-in-biotech-innovation 2025-10-23T08:54:01+11:00 http://biotechdispatch.com.au/news/starpharma-receives-upfront-payment-from-genentech-launching-oncology-collaboration 2025-10-22T10:47:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-secures-fda-response-date-for-galidesivir-approval-pathway 2025-10-22T09:57:01+11:00 http://biotechdispatch.com.au/news/noxopharm-granted-first-us-patent-for-sofra-immune-modulation-platform 2025-10-22T09:14:01+11:00 http://biotechdispatch.com.au/news/4dmedical-secures-stanford-as-first-commercial-site-and-expands-astrazeneca-partnership-in-brazi 2025-10-22T08:54:01+11:00 http://biotechdispatch.com.au/news/impedimed-accelerates-growth-strategy-on-strong-results-and-expanding-market-reach 2025-10-22T08:45:01+11:00 http://biotechdispatch.com.au/news/idt-australia-sharpens-strategy-with-cost-savings-and-radiopharmaceutical-focus 2025-10-21T18:42:01+11:00 http://biotechdispatch.com.au/news/clarity-pharmaceuticals-copper-theranostics-platform-delivers-superior-prostate-cancer-imaging-r 2025-10-21T18:29:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-launches-global-repeat-dose-trial-for-potential-first-in-class-adoa-treatment 2025-10-21T18:21:01+11:00 http://biotechdispatch.com.au/news/neuren-secures-fda-fast-track-designation-for-nnz-2591-in-phelan-mcdermid-syndrome 2025-10-20T10:37:01+11:00 http://biotechdispatch.com.au/news/radiopharm-secures-funding-to-accelerate-radiopharmaceutical-pipeline-as-data-show-strong-moment 2025-10-20T10:30:01+11:00 http://biotechdispatch.com.au/news/monash-scientists-crack-genetic-code-behind-rna-splicing-opening-door-to-to-new-therapies 2025-10-20T10:25:01+11:00 http://biotechdispatch.com.au/news/algorae-partners-with-cadila-pharmaceuticals-to-launch-therapies-in-australia-and-new-zealand 2025-10-20T09:31:01+11:00 http://biotechdispatch.com.au/news/orthocell-expands-stake-in-marine-biomedical-secures-global-rights-to-regenerative-bone-technolo 2025-10-20T09:26:01+11:00 http://biotechdispatch.com.au/news/immutep-unveils-dual-breakthroughs-at-esmo-2025-strengthening-case-for-efti-across-multiple-tumo 2025-10-20T09:06:01+11:00 http://biotechdispatch.com.au/news/advancell-unveils-promising-first-clinical-results-for-212pb-advc001-in-prostate-cancer 2025-10-19T12:30:01+11:00 http://biotechdispatch.com.au/news/orthocell-boosts-balance-sheet-with-capital-raise-to-drive-nerve-repair-product-growth 2025-10-19T12:29:01+11:00 http://biotechdispatch.com.au/news/amplia-targets-us-market-expansion-as-fak-inhibitor-shows-promise-in-pancreatic-cancer 2025-10-19T12:29:01+11:00 http://biotechdispatch.com.au/news/chimeric-and-viral-vector-manufacturing-facility-sign-advanced-manufacturing-agreement 2025-10-15T14:25:01+11:00 http://biotechdispatch.com.au/news/medibank-backs-expansion-of-emyrias-trauma-and-depression-programs-to-queensland 2025-10-15T14:24:01+11:00 http://biotechdispatch.com.au/news/vicki-robinson-joins-proteomics-international-board-as-independent-non-executive-director 2025-10-15T14:23:01+11:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-lifts-revenue-guidance-after-strong-third-quarter-performance 2025-10-15T14:22:01+11:00 http://biotechdispatch.com.au/news/intranasal-insulin-delivers-new-hope-for-delirium-treatment 2025-10-15T14:21:01+11:00 http://biotechdispatch.com.au/news/victorian-government-ministers-to-headline-australias-biggest-biotech-week 2025-10-14T13:11:01+11:00 http://biotechdispatch.com.au/news/claritys-co-psma-trial-delivers-breakthrough-in-early-prostate-cancer-detection 2025-10-14T11:18:01+11:00 http://biotechdispatch.com.au/news/nexsen-to-list-on-asx-with-rapid-cross-sector-diagnostic-platform 2025-10-13T11:56:01+11:00 http://biotechdispatch.com.au/news/adherium-launches-early-exercise-incentive-offer-to-reward-optionholders 2025-10-13T11:54:01+11:00 http://biotechdispatch.com.au/news/artrya-clears-key-us-milestone-for-coronary-device-targets-fda-filing-by-year-end 2025-10-13T11:53:01+11:00 http://biotechdispatch.com.au/news/medical-developments-international-signals-a-turn-to-growth-as-penthrox-momentum-builds 2025-10-13T11:52:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-readies-pyc-002-for-clinic-after-positive-pre-clinical-data 2025-10-13T11:51:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-unveils-2025-international-conference-program-for-australias-biggest-week-in-biotech 2025-10-09T13:11:01+11:00 http://biotechdispatch.com.au/news/cyteph-completes-recruitment-for-phase-1-trial-of-novel-therapy-for-aggressive-brain-cancer 2025-10-08T18:05:01+11:00 http://biotechdispatch.com.au/news/cureator-opens-major-funding-round-to-accelerate-early-stage-biotech-innovation 2025-10-08T10:00:01+11:00 http://biotechdispatch.com.au/news/dimerix-reports-positive-outcome-from-parasol-collaboration 2025-10-08T09:31:01+11:00 http://biotechdispatch.com.au/news/immuron-submits-ind-to-us-fda-for-novel-therapy-targeting-c-difficile-infection 2025-10-08T09:25:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-and-wholesale-investor-unite-to-accelerate-investment-in-life-sciences-sector 2025-10-08T09:21:01+11:00 http://biotechdispatch.com.au/news/percheron-therapeutics-reports-positive-final-data-from-early-phase-trial-of-hmbd-002 2025-10-08T09:20:01+11:00 http://biotechdispatch.com.au/news/fda-clears-clinical-hold-on-neurizons-nuz-001-paving-way-for-healey-als-trial 2025-10-08T09:18:01+11:00 http://biotechdispatch.com.au/news/neuroscientific-gains-tga-approval-for-first-patients-in-crohns-disease-program 2025-10-08T09:14:01+11:00 http://biotechdispatch.com.au/news/auspartnering-where-connections-drive-discovery-at-australias-biggest-week-in-biotech 2025-10-07T10:09:01+11:00 http://biotechdispatch.com.au/news/ausbiotechs-annual-report-highlights-a-defining-year-for-australias-life-sciences-sector 2025-10-07T09:55:01+11:00 http://biotechdispatch.com.au/news/cerulea-clinical-trials-appoints-dr-michelle-bradney-as-chief-executive-officer 2025-10-06T12:29:01+11:00 http://biotechdispatch.com.au/news/ltr-pharma-deepens-stake-in-levomega-to-accelerate-sustainable-omega-3-development 2025-10-06T10:33:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-136-million-investment-to-strengthen-clinical-trials 2025-10-06T10:30:01+11:00 http://biotechdispatch.com.au/news/oncosil-medical-expands-european-reach-with-first-treatment-in-portugal 2025-10-06T10:29:01+11:00 http://biotechdispatch.com.au/news/mesoblast-secures-key-us-reimbursement-milestone-for-ryoncil 2025-10-06T10:28:01+11:00 http://biotechdispatch.com.au/news/4dmedical-raises-226-million-through-near-total-exercise-of-options 2025-10-06T10:28:01+11:00 http://biotechdispatch.com.au/news/artrya-share-purchase-plan-closes-early-after-strong-investor-demand 2025-10-06T10:27:01+11:00 http://biotechdispatch.com.au/news/arovella-advances-novel-car-inkt-therapy-targeting-pancreatic-and-gastric-cancers 2025-10-02T10:19:01+10:00 http://biotechdispatch.com.au/news/cancer-vaccine-collaboration-lands-on-the-gold-coast 2025-10-01T11:49:01+10:00 http://biotechdispatch.com.au/news/inoviq-publishes-breakthrough-data-on-next-generation-cancer-therapy 2025-10-01T11:48:01+10:00 http://biotechdispatch.com.au/news/dorsavi-achieves-breakthrough-in-robotic-reflex-intelligence 2025-10-01T11:47:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-accelerates-her2-cancer-trial-after-positive-safety-review 2025-10-01T11:46:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-medicines-australia-launch-new-advisory-group-to-accelerate-advanced-therapies 2025-10-01T11:45:01+10:00 http://biotechdispatch.com.au/news/percheron-advances-the-development-of-lead-cancer-therapy-hmbd-002 2025-09-30T10:34:01+10:00 http://biotechdispatch.com.au/news/anatara-strengthens-board-with-the-appointment-of-dirk-van-dissel 2025-09-29T17:17:01+10:00 http://biotechdispatch.com.au/news/clinuvel-advances-next-generation-peptide-drug-formulations 2025-09-29T17:16:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-targets-major-market-with-ath434-in-multiple-system-atrophy 2025-09-29T17:15:01+10:00 http://biotechdispatch.com.au/news/chimeric-reports-encouraging-early-data-from-chm-cdh17-trial 2025-09-29T17:14:01+10:00 http://biotechdispatch.com.au/news/gene-therapy-shows-early-promise-in-slowing-huntingtons-disease 2025-09-25T12:46:01+10:00 http://biotechdispatch.com.au/news/federal-minister-to-address-ausbiotech-international-conference-as-sector-marks-critical-junctur 2025-09-25T10:46:01+10:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-begins-patient-dosing-in-pivotal-diabetic-foot-infection-trial 2025-09-25T10:33:01+10:00 http://biotechdispatch.com.au/news/real-world-evidence-shows-lumos-diagnostics-febridx-cuts-antibiotic-use-and-delivers-system-savi 2025-09-24T15:53:01+10:00 http://biotechdispatch.com.au/news/inoviqs-car-nk-exosomes-show-potent-tumour-killing-effect-in-breast-cancer-study 2025-09-24T10:42:01+10:00 http://biotechdispatch.com.au/news/wehi-researchers-unlock-the-immune-systems-instruction-manual 2025-09-24T10:42:01+10:00 http://biotechdispatch.com.au/news/atomos-expands-debt-facility-to-support-strategic-growth 2025-09-24T10:41:01+10:00 http://biotechdispatch.com.au/news/arovella-showcases-inkt-cell-therapy-platform-at-asx-smidcaps-conference 2025-09-24T10:40:01+10:00 http://biotechdispatch.com.au/news/race-oncology-secures-ind-approval-in-korea-for-rc220 2025-09-24T10:39:01+10:00 http://biotechdispatch.com.au/news/percheron-strengthens-leadership-team-ahead-of-next-trial-for-hmbd-002 2025-09-23T13:06:01+10:00 http://biotechdispatch.com.au/news/encapsolutions-launches-skinsync-natural-health-patches-in-the-us 2025-09-22T15:56:01+10:00 http://biotechdispatch.com.au/news/ltr-pharma-expands-into-sustainable-omega-3-with-strategic-stake-in-levomega 2025-09-22T15:54:01+10:00 http://biotechdispatch.com.au/news/starpharma-strikes-landmark-cancer-therapy-deal-with-genentech 2025-09-22T15:53:01+10:00 http://biotechdispatch.com.au/news/157-million-in-cureator-funding-boosts-australian-startups-tackling-dementia 2025-09-22T15:50:01+10:00 http://biotechdispatch.com.au/news/clinuvels-scenesse-demonstrates-promising-results-in-vitiligo-patients 2025-09-21T12:12:01+10:00 http://biotechdispatch.com.au/news/australian-blood-test-offers-breakthrough-in-detecting-deadly-esophageal-cancer 2025-09-21T12:11:01+10:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-makes-progress-on-securing-next-steps-on-marburg-antiviral 2025-09-21T12:09:01+10:00 http://biotechdispatch.com.au/news/proteomics-international-secures-key-laboratory-certification-in-boost-for-precision-diagnostics 2025-09-21T12:08:01+10:00 http://biotechdispatch.com.au/news/oncosil-reports-promising-early-results-from-groundbreaking-pancreatic-cancer-study 2025-09-18T10:19:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-announces-leadership-transition-as-chair-asteps-in-as-managing-director 2025-09-17T10:56:01+10:00 http://biotechdispatch.com.au/news/blinklab-expands-us-clinical-trial-network-with-university-of-missouris-thompson-center 2025-09-17T10:51:01+10:00 http://biotechdispatch.com.au/news/emvision-secures-12-million-to-drive-breakthrough-stroke-imaging-programs 2025-09-17T10:47:01+10:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-reports-breakthrough-survival-gata-for-galidesivir-in-marburg-and-ebola-s 2025-09-17T10:17:01+10:00 http://biotechdispatch.com.au/news/csl-partners-with-varmx-on-first-in-class-coagulation-treatment 2025-09-16T11:00:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-delivers-promising-phase-2-data-in-multiple-system-atrophy 2025-09-15T15:56:01+10:00 http://biotechdispatch.com.au/news/actinogen-secures-fda-agreement-to-advance-xanamem-for-alzheimers-disease 2025-09-15T15:55:01+10:00 http://biotechdispatch.com.au/news/cleo-diagnostics-gains-positive-fda-feedback-guiding-us-approval-for-ovarian-cancer-test 2025-09-15T15:54:01+10:00 http://biotechdispatch.com.au/news/adheriums-smartinhaler-shows-breakthrough-results-in-real-world-respiratory-study 2025-09-15T15:53:01+10:00 http://biotechdispatch.com.au/news/avita-medical-receives-ce-mark-for-recell-go-enabling-commercialisation-across-europe 2025-09-15T15:53:01+10:00 http://biotechdispatch.com.au/news/arovella-strengthens-esg-commitments-with-fourth-annual-report 2025-09-11T11:22:01+10:00 http://biotechdispatch.com.au/news/actinogen-launches-investor-hub-as-alzheimers-trial-advances 2025-09-11T10:48:01+10:00 http://biotechdispatch.com.au/news/lumos-diagnostics-signs-a-second-anz-distribution-agreement-for-febridx 2025-09-11T10:30:01+10:00 http://biotechdispatch.com.au/news/cartherics-wins-apac-award-for-most-promising-ipsc-therapy-pipeline 2025-09-11T10:11:01+10:00 http://biotechdispatch.com.au/news/haemalogix-wins-regional-recognition-for-promising-car-t-pipeline 2025-09-11T09:33:01+10:00 http://biotechdispatch.com.au/news/gold-nanoparticles-show-promise-for-faster-less-invasive-ovarian-cancer-diagnosis 2025-09-09T10:17:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-secures-20-million-to-advance-neurodegenerative-disease-pipeline 2025-09-08T10:22:01+10:00 http://biotechdispatch.com.au/news/orthocell-reports-strong-interim-results-from-remplir-real-world-evidence-study 2025-09-08T10:21:01+10:00 http://biotechdispatch.com.au/news/promarkereso-blood-test-detects-early-stages-of-esophageal-adenocarcinoma-with-high-accuracy 2025-09-08T10:20:01+10:00 http://biotechdispatch.com.au/news/real-world-data-shows-significant-reduction-in-hospital-stay-using-avita-medicals-recell 2025-09-08T10:19:01+10:00 http://biotechdispatch.com.au/news/botanix-announces-regulatory-approval-of-ecclock-in-south-korea 2025-09-08T10:17:01+10:00 http://biotechdispatch.com.au/news/sydney-virologist-wins-prestigious-gsk-award-for-pioneering-ai-and-virus-detection-research 2025-09-08T10:16:01+10:00 http://biotechdispatch.com.au/news/clinuvel-charts-a-profitable-pathway-amid-sector-volatility 2025-09-08T10:15:01+10:00 http://biotechdispatch.com.au/news/cureator-boosts-six-biotech-projects-with-123m-in-top-up-funding 2025-09-04T10:23:01+10:00 http://biotechdispatch.com.au/news/hidden-viral-protein-could-pave-the-way-for-longer-lasting-covid-19-vaccines 2025-09-04T10:21:01+10:00 http://biotechdispatch.com.au/news/mesoblast-secures-up-to-us50m-in-fresh-funding-through-convertible-note-agreements 2025-09-04T10:16:01+10:00 http://biotechdispatch.com.au/news/amplia-begins-dosing-in-new-pancreatic-cancer-trial-combining-fak-inhibitor-with-chemotherapy 2025-09-04T10:13:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-new-director-of-membership-services-and-strategic-partnerships 2025-09-04T09:47:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-draft-national-health-and-medical-research-strategy 2025-08-31T12:46:01+10:00 http://biotechdispatch.com.au/news/immuron-confirms-record-sales-and-major-clinical-milestones 2025-08-31T12:42:01+10:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-reports-clinical-progress-and-expanded-pipeline 2025-08-31T12:35:01+10:00 http://biotechdispatch.com.au/news/prescient-secures-investor-support-to-advance-ptx-100-in-cancer-trials 2025-08-31T12:30:01+10:00 http://biotechdispatch.com.au/news/oncosil-secures-regulatory-wins-and-expands-global-footprint-in-2025 2025-08-31T12:22:01+10:00 http://biotechdispatch.com.au/news/neurotech-advances-nti164-with-strong-clinical-data-and-new-leadership 2025-08-31T12:16:01+10:00 http://biotechdispatch.com.au/news/paradigm-biopharmaceuticals-enters-critical-phase-with-global-osteoarthritis-program 2025-08-31T12:05:01+10:00 http://biotechdispatch.com.au/news/adherium-pushes-ahead-with-us-expansion 2025-08-31T11:57:01+10:00 http://biotechdispatch.com.au/news/cyclopharm-reports-record-first-half-revenue-and-expanding-us-momentum 2025-08-28T13:12:01+10:00 http://biotechdispatch.com.au/news/cartherics-secures-chinese-patent-to-boost-immune-cell-function-in-solid-tumours 2025-08-27T11:32:01+10:00 http://biotechdispatch.com.au/news/starpharma-advances-dendrimer-platform-with-clinical-commercial-and-strategic-progress 2025-08-27T11:31:01+10:00 http://biotechdispatch.com.au/news/neuroscientifics-stemsmart-msc-therapy-shows-promise-in-kidney-transplantation 2025-08-27T11:31:01+10:00 http://biotechdispatch.com.au/news/neuren-doubles-profit-as-daybue-royalties-and-pipeline-progress-drive-growth 2025-08-27T11:30:01+10:00 http://biotechdispatch.com.au/news/biome-achieves-breakthrough-year-with-first-profit-and-rapid-global-expansion 2025-08-27T11:30:01+10:00 http://biotechdispatch.com.au/news/vaxxas-secures-90-million-in-funding-to-commercialise-needle-free-vaccination-delivery-technolog 2025-08-26T09:48:01+10:00 http://biotechdispatch.com.au/news/argent-biopharma-announces-results-of-independent-in-vivo-study 2025-08-26T09:47:01+10:00 http://biotechdispatch.com.au/news/world-first-clinical-trial-reveals-unprecedented-insights-into-brain-cancer-treatment 2025-08-26T09:46:01+10:00 http://biotechdispatch.com.au/news/first-site-initiated-for-neurens-phelan-mcdermid-syndrome-phase-3-trial 2025-08-26T09:45:01+10:00 http://biotechdispatch.com.au/news/botanix-appoints-dr-patricia-walker-as-a-non-executive-director 2025-08-26T09:44:01+10:00 http://biotechdispatch.com.au/news/applications-now-open-for-ausbiotech-invest-and-the-early-stage-innovation-forum 2025-08-21T14:13:01+10:00 http://biotechdispatch.com.au/news/csl-launches-strategic-initiatives-with-planned-separation-of-seqirus 2025-08-20T16:48:01+10:00 http://biotechdispatch.com.au/news/ltr-pharma-says-new-study-confirms-faster-onset-of-intranasal-treatment 2025-08-20T16:46:01+10:00 http://biotechdispatch.com.au/news/us-fda-grants-orphan-drug-designation-to-invions-inv043 2025-08-20T16:45:01+10:00 http://biotechdispatch.com.au/news/neurizons-nuz-001-ole-study-demonstrates-long-term-safety-and-efficacy-signals 2025-08-20T16:45:01+10:00 http://biotechdispatch.com.au/news/lucia-bio-raises-funds-to-advance-best-in-class-spleen-tyrosine-kinase-inhibitors-into-trials 2025-08-19T10:30:01+10:00 http://biotechdispatch.com.au/news/peter-beattie-ac-appointed-brandon-biocatalyst-chair 2025-08-19T10:25:01+10:00 http://biotechdispatch.com.au/news/new-zealand-clinical-trial-leaders-merging-to-form-australasias-largest-integrated-clinical-tria 2025-08-19T10:20:01+10:00 http://biotechdispatch.com.au/news/novo-nordisk-launches-global-first-marie-krogh-young-women-in-science-prize-in-australia 2025-08-17T17:07:01+10:00 http://biotechdispatch.com.au/news/emvision-secures-non-diluting-grant-to-fund-emu-regional-benefits-study 2025-08-17T16:19:01+10:00 http://biotechdispatch.com.au/news/fda-review-timeline-extended-for-neurizons-nuz-001-ind-clinical-hold 2025-08-17T16:18:01+10:00 http://biotechdispatch.com.au/news/bionsw-catalyst-dinner-strengthens-connections-and-investment-in-nsw-life-sciences 2025-08-17T16:17:01+10:00 http://biotechdispatch.com.au/news/new-crispr-technique-could-rewrite-future-of-genetic-disease-treatment 2025-08-17T16:17:01+10:00 http://biotechdispatch.com.au/news/argencia-therapeutics-receives-ind-feedback-from-us-fda 2025-08-14T11:11:01+10:00 http://biotechdispatch.com.au/news/orthocell-advances-us-rollout-of-nerve-repair-product-remplir 2025-08-14T10:50:01+10:00 http://biotechdispatch.com.au/news/firebrick-says-nasodine-covid-19-patent-accepted-in-europe 2025-08-14T10:49:01+10:00 http://biotechdispatch.com.au/news/australian-company-mirugen-secures-backing-to-process-cell-technology 2025-08-14T10:48:01+10:00 http://biotechdispatch.com.au/news/avita-medical-successfully-completes-australian-equity-raise 2025-08-14T10:46:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-kerri-lee-sinclair-as-its-head-of-investment 2025-08-12T10:36:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-accelerates-clinical-progress-of-pyc-003-in-pkd-trial 2025-08-12T10:30:01+10:00 http://biotechdispatch.com.au/news/neuren-expands-nnz-2591-pipeline-to-include-syngap1-related-disorder 2025-08-12T10:28:01+10:00 http://biotechdispatch.com.au/news/noxopharm-advances-heracles-trial-for-novel-autoimmune-disease-drug 2025-08-12T10:27:01+10:00 http://biotechdispatch.com.au/news/syntara-receives-fda-guidance-for-amsulostat-in-myelofibrosis-treatment 2025-08-12T10:26:01+10:00 http://biotechdispatch.com.au/news/merck-welcomes-new-expert-guidance-on-endocrine-testing-for-children 2025-08-06T13:00:01+10:00 http://biotechdispatch.com.au/news/cartherics-unveils-state-of-the-art-cleanroom-facility-for-cell-therapy-manufacturing 2025-08-06T12:59:01+10:00 http://biotechdispatch.com.au/news/tris-australia-first-bio-manufacturing-facility-unveiled-in-brisbane 2025-08-06T10:11:01+10:00 http://biotechdispatch.com.au/news/nanosonics-receives-us-fda-clearance-for-next-generation-trophon-technology 2025-08-06T09:52:01+10:00 http://biotechdispatch.com.au/news/wehi-researchers-identify-new-vaccine-target-to-block-malaria-transmission 2025-08-06T09:44:01+10:00 http://biotechdispatch.com.au/news/noxopharm-says-us-company-demonstrates-strong-potential-of-technology-plaform 2025-08-05T10:21:01+10:00 http://biotechdispatch.com.au/news/immutep-updates-investors-on-fda-feedback-for-efti-trial-in-head-and-neck-cancer 2025-08-05T10:05:01+10:00 http://biotechdispatch.com.au/news/race-oncology-announces-the-publication-of-bisantrene-clinical-trial 2025-08-05T10:02:01+10:00 http://biotechdispatch.com.au/news/compumedics-continues-expansion-into-global-pharmaceutical-clinical-trial-market 2025-08-05T10:02:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-provides-update-on-chm-cdh17-car-t-clinical-trial 2025-08-05T10:01:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-medicines-australia-celebrate-catalyst-outcomes-and-further-strengthen-industry-c 2025-07-31T15:46:01+10:00 http://biotechdispatch.com.au/news/island-announces-the-completion-of-galidesivir-transaction 2025-07-31T10:28:01+10:00 http://biotechdispatch.com.au/news/neuroscientific-partners-with-leading-biologic-manufacturer 2025-07-31T10:19:01+10:00 http://biotechdispatch.com.au/news/world-first-study-uses-dna-to-investigate-who-develops-ms-and-why 2025-07-31T10:14:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-secures-ethics-approval-for-pancreatic-cancer-trial 2025-07-31T10:12:01+10:00 http://biotechdispatch.com.au/news/syntara-says-first-patient-dosed-in-snt-9465-phase-1ab-trial 2025-07-29T10:32:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-announces-results-of-share-purchase-plan-and-launches-placement 2025-07-29T10:25:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-reports-positive-topline-data-from-phase-2-trial-of-ath434 2025-07-29T10:21:01+10:00 http://biotechdispatch.com.au/news/clarity-successfully-completes-203-million-institutional-placement 2025-07-29T10:20:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-receives-ind-approval-to-initiate-phase-1-study 2025-07-29T10:20:01+10:00 http://biotechdispatch.com.au/news/australian-life-sciences-venture-capital-firm-brandon-capital-announces-fund-six-final-close 2025-07-24T11:45:01+10:00 http://biotechdispatch.com.au/news/sanofi-to-acquire-vicebio-gaining-rights-to-queensland-discovered-technology 2025-07-23T17:02:01+10:00 http://biotechdispatch.com.au/news/nyrada-advances-xolatryp-towards-phase-2a-trial-in-cardioprotection 2025-07-23T12:29:01+10:00 http://biotechdispatch.com.au/news/oncosil-medical-completes-recruitment-in-tripp-ffx-clinical-trial 2025-07-23T12:29:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-announces-25-million-placement-and-launches-share-purchase-plan 2025-07-23T12:28:01+10:00 http://biotechdispatch.com.au/news/percheron-therapeutics-announces-publication-of-new-preclinical-hmbd-002-data 2025-07-23T12:27:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announces-new-appointment-to-advisory-board 2025-07-22T10:24:01+10:00 http://biotechdispatch.com.au/news/wehi-study-identifies-world-first-treatments-to-prevent-a-life-threatening-virus-infection 2025-07-22T09:59:01+10:00 http://biotechdispatch.com.au/news/osteopore-secures-clearance-for-jawbone-trial-at-princess-alexandra-hospital 2025-07-22T09:57:01+10:00 http://biotechdispatch.com.au/news/mesoblast-updates-investors-on-the-successful-us-launch-of-cell-medicine 2025-07-22T09:55:01+10:00 http://biotechdispatch.com.au/news/atomo-diagnostics-announces-successful-placement-from-share-purchase-plan-shortfall 2025-07-22T09:54:01+10:00 http://biotechdispatch.com.au/news/brandon-biocatalyst-welcomes-the-inclusion-of-its-cureator-in-new-program 2025-07-16T14:16:01+10:00 http://biotechdispatch.com.au/news/new-australian-collaboration-to-build-gene-and-cell-therapy-production 2025-07-16T12:55:01+10:00 http://biotechdispatch.com.au/news/noxopharm-confirms-first-patient-dosed-in-sof-skn-heracles-trial 2025-07-16T12:53:01+10:00 http://biotechdispatch.com.au/news/cancer-australia-launches-research-program-targeting-early-onset-cancers 2025-07-16T12:53:01+10:00 http://biotechdispatch.com.au/news/lumos-diagnostics-signs-febridx-us-distribution-agreement-with-phase-scientific 2025-07-16T12:52:01+10:00 http://biotechdispatch.com.au/news/imugene-completes-significant-placement-and-launches-share-purchase-plan 2025-07-16T12:51:01+10:00 http://biotechdispatch.com.au/news/australian-researchers-discover-new-route-into-cells-that-could-make-gene-therapies-safer 2025-07-15T10:58:01+10:00 http://biotechdispatch.com.au/news/government-funds-incubators-to-foster-research-commercialisation 2025-07-15T10:45:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-announces-additional-confirmed-partial-response-in-accent-trial 2025-07-15T10:34:01+10:00 http://biotechdispatch.com.au/news/imugene-reports-two-additional-complete-responses-in-azer-cel-car-t-phase-1b-trial 2025-07-15T10:31:01+10:00 http://biotechdispatch.com.au/news/final-days-to-help-build-australias-longest-running-life-sciences-benchmark-survey 2025-07-14T14:29:01+10:00 http://biotechdispatch.com.au/news/island-expands-portfolio-with-the-acquisition-of-antiviral 2025-07-10T10:56:01+10:00 http://biotechdispatch.com.au/news/orthocell-announces-first-us-remplir-sales-revenue 2025-07-10T10:28:01+10:00 http://biotechdispatch.com.au/news/race-secures-ethics-approvals-for-phase-1-trial-at-two-hong-kong-hospitals 2025-07-10T10:21:01+10:00 http://biotechdispatch.com.au/news/imagion-reports-positive-feedback-from-fda-for-her2-breast-cancer-trial 2025-07-10T10:05:01+10:00 http://biotechdispatch.com.au/news/neurizon-says-fda-provides-positive-feedback-on-strategy-to-lift-clinical-hold-for-nuz-001 2025-07-10T09:48:01+10:00 http://biotechdispatch.com.au/news/who-grants-official-inn-for-syntaras-clinical-development-asset-snt-5505 2025-07-08T09:39:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-27-new-members-in-first-half-of-2025 2025-07-08T05:00:01+10:00 http://biotechdispatch.com.au/news/neurotechs-rett-syndrome-trial-results-published-in-scientific-journal 2025-07-07T13:25:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-to-progress-polycystic-kidney-disease-trial 2025-07-07T13:24:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-announces-new-state-committees-for-2025 2025-07-07T13:00:01+10:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-announces-the-appointment-of-new-chair 2025-07-03T06:00:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-announces-additional-confirmed-partial-response-recorded-in-accent-trial 2025-07-03T06:00:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-opens-share-purchase-plan 2025-07-03T06:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-seeks-a-head-of-investment-to-drive-sector-growth 2025-07-03T06:00:01+10:00 http://biotechdispatch.com.au/news/call-for-member-submissions-october-2025-edition-of-australasian-biotechnology-journal 2025-07-02T12:35:01+10:00 http://biotechdispatch.com.au/news/neurizon-announces-global-agreement-with-elanco-for-the-commercialisation-of-nuz-001 2025-07-02T12:25:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-to-present-progress-in-phelan-mcdermid-syndrome-at-global-congress 2025-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/percheron-licenses-phase-2-ready-immuno-oncology-candidate-from-hummingbird 2025-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/arovella-therapeutics-announces-the-retirement-of-non-executive-chair 2025-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/qbiotics-announces-the-appointment-of-sergio-duchini-to-its-board 2025-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/tetratherix-lists-on-the-asx-following-successful-ipo 2025-06-30T14:33:01+10:00 http://biotechdispatch.com.au/news/ltr-pharma-achieves-key-fda-milestone-through-extractables-study 2025-06-30T14:32:01+10:00 http://biotechdispatch.com.au/news/atmo-biosciences-receives-us-fda-clearance-for-ingestible-gas-sensing-capsule 2025-06-30T14:30:01+10:00 http://biotechdispatch.com.au/news/successful-completion-of-the-phase-1-component-of-the-deflexifol-at-relapse-trial-in-paediatric- 2025-06-26T10:13:01+10:00 http://biotechdispatch.com.au/news/paradigm-acquires-proteobioactives-to-expand-osteoarthritis-portfolio 2025-06-26T10:05:01+10:00 http://biotechdispatch.com.au/news/firebrick-pharma-closes-placement-confirming-shortfall 2025-06-26T10:00:01+10:00 http://biotechdispatch.com.au/news/neuren-confirms-us-patent-allowed-for-nnz-2591-to-treat-pitt-hopkins-syndrome 2025-06-26T09:56:01+10:00 http://biotechdispatch.com.au/news/noxopharm-says-clinical-trial-recruitment-progressing-rapidly 2025-06-26T09:54:01+10:00 http://biotechdispatch.com.au/news/qbiotics-candidate-produces-strong-efficacy-result-in-soft-tissue-sarcoma-trial 2025-06-26T09:53:01+10:00 http://biotechdispatch.com.au/news/amgen-backs-women-in-cancer-research-as-survey-reveals-workforce-risks 2025-06-24T05:00:01+10:00 http://biotechdispatch.com.au/news/tryptamine-therapeutics-secures-human-ethics-approval-for-binge-eating-disorder-trial 2025-06-24T05:00:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-positive-update-from-phase-1-study-of-imp761 2025-06-24T05:00:01+10:00 http://biotechdispatch.com.au/news/proteomics-announces-release-of-new-promarkerd-test-for-predicting-diabetic-kidney-disease 2025-06-24T05:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-leads-global-engagement-to-strengthen-australias-life-sciences-sector 2025-06-23T15:51:01+10:00 http://biotechdispatch.com.au/news/amplia-announces-second-confirmed-complete-response-in-accent-trial 2025-06-19T11:04:01+10:00 http://biotechdispatch.com.au/news/race-confirms-safe-and-successful-dosing-of-first-patient-in-phase-1-solid-tumour-trial 2025-06-19T10:40:01+10:00 http://biotechdispatch.com.au/news/orthocell-says-new-study-confirms-superiority-of-remplir-over-standard-verve-repair-technique 2025-06-19T10:30:01+10:00 http://biotechdispatch.com.au/news/imugene-announces-us-patent-allowance-for-oncarlytics 2025-06-19T10:24:01+10:00 http://biotechdispatch.com.au/news/pilot-study-confirms-adjunct-nb-uvb-needed-to-activate-repigmentation-in-vitiligo 2025-06-19T10:18:01+10:00 http://biotechdispatch.com.au/news/go-healthy-with-taiwan-invites-submissions-from-australian-health-innovators 2025-06-17T11:24:01+10:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-announces-non-dilutive-financing-via-facility-with-avenue-capital-group 2025-06-17T11:06:01+10:00 http://biotechdispatch.com.au/news/clarity-enters-manufacturing-agreement-for-cu-64-sar-bispsma-with-spectronrx 2025-06-17T10:57:01+10:00 http://biotechdispatch.com.au/news/new-pathway-for-mrna-drug-delivery-shows-shape-of-things-to-come 2025-06-17T10:35:01+10:00 http://biotechdispatch.com.au/news/amplia-says-pathological-complete-response-in-patient-from-accent-trial 2025-06-17T10:33:01+10:00 http://biotechdispatch.com.au/news/australian-company-secures-fda-approval-to-progress-development-of-car-t-therapy 2025-06-17T10:30:01+10:00 http://biotechdispatch.com.au/news/radium-capital-unleashes-400m-war-chest-for-australian-innovators 2025-06-12T14:10:01+10:00 http://biotechdispatch.com.au/news/island-reports-successful-phase-2-clinical-trial-of-isla-101-in-dengue-model 2025-06-12T10:24:01+10:00 http://biotechdispatch.com.au/news/cochlear-lauunches-the-worlds-first-smart-hearing-implant-system 2025-06-12T10:04:01+10:00 http://biotechdispatch.com.au/news/cyclopharm-secures-maximum-us-patent-extension-for-technegas-to-2031 2025-06-11T10:41:01+10:00 http://biotechdispatch.com.au/news/registrations-now-open-for-australias-biggest-week-in-biotech 2025-06-11T09:59:01+10:00 http://biotechdispatch.com.au/news/strengthening-sovereign-capability-through-made-in-australia-medtech-manufacturing 2025-06-10T01:58:01+10:00 http://biotechdispatch.com.au/news/new-study-reveals-superior-efficacy-of-cell-based-flu-vaccine 2025-06-09T11:04:01+10:00 http://biotechdispatch.com.au/news/imricor-received-european-ce-mark-approval-for-northstar 2025-06-09T10:46:01+10:00 http://biotechdispatch.com.au/news/botanix-signs-debt-facility-with-kreos-capital 2025-06-09T10:37:01+10:00 http://biotechdispatch.com.au/news/argencia-updates-investors-on-us-fda-ind-application 2025-06-09T10:28:01+10:00 http://biotechdispatch.com.au/news/us-fda-fast-track-designation-granted-for-syntaras-snt-5505 2025-06-09T10:20:01+10:00 http://biotechdispatch.com.au/news/emvision-medical-devices-announces-appointment-of-non-executive-director 2025-06-05T11:22:01+10:00 http://biotechdispatch.com.au/news/proteomics-international-completes-12-million-capital-raise 2025-06-05T11:02:01+10:00 http://biotechdispatch.com.au/news/clarity-announces-positive-top-line-results-from-disco-trial 2025-06-05T10:58:01+10:00 http://biotechdispatch.com.au/news/clinical-trial-success-kicks-off-5m-fund-raising-round-for-was-lixa 2025-06-05T10:51:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-austrade-launch-partnership-to-accelerate-global-expansion-of-life-sciences-indus 2025-06-05T09:49:01+10:00 http://biotechdispatch.com.au/news/australian-innovation-could-revolutionise-the-early-detection-of-ovarian-cancer 2025-06-02T12:59:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-reports-preclinical-lu177-b7h3-mab-data 2025-06-02T11:03:01+10:00 http://biotechdispatch.com.au/news/neurotech-announces-positive-human-pk-study-results-for-nti164 2025-06-02T11:02:01+10:00 http://biotechdispatch.com.au/news/cardiex-receives-tga-approval-for-conneqt-pulse-arterial-health-monitor 2025-06-02T11:01:01+10:00 http://biotechdispatch.com.au/news/dimerix-says-first-action3-trial-site-activated-in-japan-and-first-milestone-payment-triggered 2025-06-02T11:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-shadow-ministry-and-encourages-bipartisan-support-for-life-sciences-sector 2025-06-02T10:30:01+10:00 http://biotechdispatch.com.au/news/cartherics-to-present-at-the-2025-bio-international-convention 2025-05-28T10:05:01+10:00 http://biotechdispatch.com.au/news/noxopharm-secures-green-light-for-heracles-clinical-trial 2025-05-28T09:57:01+10:00 http://biotechdispatch.com.au/news/early-detection-lasting-impact-shanon-ranjit-wins-esif-2025-for-innovation-in-kidney-diagnostics 2025-05-28T01:25:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-announces-releases-of-latest-issue-of-australasian-biotechnology 2025-05-28T01:23:01+10:00 http://biotechdispatch.com.au/news/clarity-announces-first-patient-imaged-in-amplify-clinical-trial 2025-05-28T01:08:01+10:00 http://biotechdispatch.com.au/news/life-science-leaders-on-australias-strengths-and-the-opportunity-to-do-more 2025-05-26T11:04:01+10:00 http://biotechdispatch.com.au/news/lumos-secures-sixth-contract-for-us-medicare-reimbursement-coverage-for-febridx 2025-05-26T10:49:01+10:00 http://biotechdispatch.com.au/news/prescient-says-first-patient-dosed-for-ptx-100-phase-2a-study 2025-05-26T10:39:01+10:00 http://biotechdispatch.com.au/news/atomo-secures-australian-order-for-supply-of-hiv-self-tests 2025-05-26T09:54:01+10:00 http://biotechdispatch.com.au/news/immuteps-efti-combination-meets-primary-endpoint-in-phase-2-soft-tissue-sarcoma 2025-05-26T09:46:01+10:00 http://biotechdispatch.com.au/news/blinklab-engages-leading-autism-research-centre-for-main-study-phase-of-us-diagnostic-trial 2025-05-21T11:17:01+10:00 http://biotechdispatch.com.au/news/chimeric-advances-chm-cdh17-clinical-trial-to-dose-level-2 2025-05-21T11:11:01+10:00 http://biotechdispatch.com.au/news/argencia-granted-new-us-patent-for-surgically-induced-stroke 2025-05-21T11:00:01+10:00 http://biotechdispatch.com.au/news/zelira-therapeutics-announces-full-study-publication-of-irb-approved-observational-study 2025-05-21T10:48:01+10:00 http://biotechdispatch.com.au/news/dimerix-updates-on-latest-idmc-review-of-action3-phase-3-kidney-trial 2025-05-21T10:39:01+10:00 http://biotechdispatch.com.au/news/adherium-announces-additional-capital-raise-to-progress-us-smartinhaler-roll-out 2025-05-19T09:49:01+10:00 http://biotechdispatch.com.au/news/ltr-pharma-says-access-to-spontan-expanded-to-more-pharmacies 2025-05-19T09:41:01+10:00 http://biotechdispatch.com.au/news/noxopharm-secures-new-funds-from-nyrada-share-sale 2025-05-19T09:39:01+10:00 http://biotechdispatch.com.au/news/avecho-says-new-sites-commence-recruitment-for-its-pivotal-phase-3-clinical-trial 2025-05-19T09:30:01+10:00 http://biotechdispatch.com.au/news/report-highlights-international-confidence-in-australian-clinical-trials 2025-05-19T09:27:01+10:00 http://biotechdispatch.com.au/news/polynovos-novosorb-btm-delivers-positive-first-in-human-results-in-diabetes 2025-05-14T11:36:01+10:00 http://biotechdispatch.com.au/news/amplia-reports-updated-positive-data-from-accent-trial-in-pancreatic-cancer 2025-05-14T09:54:01+10:00 http://biotechdispatch.com.au/news/immuteps-efti-with-pd-l1-and-chemotherapy-achieves-high-response-rates-in-lung-cancer 2025-05-14T09:40:01+10:00 http://biotechdispatch.com.au/news/csl-behring-wins-major-international-pharmaceutical-engineering-award 2025-05-14T09:37:01+10:00 http://biotechdispatch.com.au/news/lumos-advances-febridx-sales-with-imedical-purchase-order 2025-05-14T09:36:01+10:00 http://biotechdispatch.com.au/news/polynovos-novosorb-btm-delivers-positive-first-in-human-results-in-diabetes-1 2025-05-14T09:34:01+10:00 http://biotechdispatch.com.au/news/engeneic-launches-groundbreaking-new-australian-trial-for-innovative-cancer-therapy 2025-05-12T09:45:01+10:00 http://biotechdispatch.com.au/news/australia-gets-a-new-minister-for-industry-innovation-and-science 2025-05-12T09:37:01+10:00 http://biotechdispatch.com.au/news/polynovo-announces-tga-clearance-for-novosorb-mtx-and-enters-trading-halt 2025-05-12T09:30:01+10:00 http://biotechdispatch.com.au/news/monash-scientists-secure-mrff-funding-to-find-new-medicines-for-dementia-by-lighting-up-human-br 2025-05-12T09:25:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-accelerates-177lu-rad204-phase-1-dose-escalation-trial 2025-05-12T09:24:01+10:00 http://biotechdispatch.com.au/news/experienced-industry-executive-appointed-chair-of-tryptamine-therapeutics 2025-05-12T09:18:01+10:00 http://biotechdispatch.com.au/news/algorae-pharmaceuticals-partners-with-peter-mac-for-ai-driven-drug-synergy-screening 2025-05-07T10:03:01+10:00 http://biotechdispatch.com.au/news/neuren-updates-on-first-quarter-2025-us-sales-of-daybue 2025-05-07T09:44:01+10:00 http://biotechdispatch.com.au/news/ltr-pharma-signs-agreement-to-co-develop-novel-intranasal-spray-for-oesophageal-motility-disorde 2025-05-07T09:17:01+10:00 http://biotechdispatch.com.au/news/percheron-therapeutics-launches-bonus-loyalty-option-offer 2025-05-07T09:09:01+10:00 http://biotechdispatch.com.au/news/oncosil-medical-reports-positive-results-of-pancreatic-cancer-analysis 2025-05-07T09:08:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-andhealth-partner-to-foster-sector-connection-in-digital-health 2025-05-05T09:17:01+10:00 http://biotechdispatch.com.au/news/neurotech-says-nti164-shows-positive-tolerability-in-key-preclinical-toxicology-studies 2025-05-05T09:15:01+10:00 http://biotechdispatch.com.au/news/arovella-options-advances-baylor-college-of-technology-to-enhance-inkt-cell-platform 2025-05-05T09:13:01+10:00 http://biotechdispatch.com.au/news/fda-grants-fast-track-designation-for-alteritys-ath434-to-treat-multiple-system-atrophy 2025-05-05T09:11:01+10:00 http://biotechdispatch.com.au/news/positive-trial-result-for-immuteps-efti-in-combination-with-msds-anti-pd-1-therapy 2025-05-05T09:10:01+10:00 http://biotechdispatch.com.au/news/medtech-investment-event-unites-investors-and-innovators-to-boost-sector-growth 2025-05-05T09:09:01+10:00 http://biotechdispatch.com.au/news/race-oncology-confirms-successful-and-safe-dosing-of-first-patient-in-phase-1-solid-tumour-trial 2025-05-01T01:00:01+10:00 http://biotechdispatch.com.au/news/adalta-announces-renounceable-rights-issue-to-raise-up-to-13-million 2025-05-01T01:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-secures-exclusive-us-licence-agreement-with-amicus-therapeutic 2025-05-01T01:00:01+10:00 http://biotechdispatch.com.au/news/blinklab-capital-raise-to-advance-ai-powered-diagnostics-for-autism-and-adhd-trials 2025-05-01T01:00:01+10:00 http://biotechdispatch.com.au/news/idt-reports-significant-growth-for-the-march-quarter 2025-04-29T11:04:01+10:00 http://biotechdispatch.com.au/news/dimerix-says-fda-confirms-proteinuria-as-acceptable-endpoint-for-dmx-200-phase-3-trial 2025-04-29T11:01:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-doses-first-patient-in-us-phase-2b-imaging-study-of-brain-metastasis 2025-04-29T11:00:01+10:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-enters-research-and-development-agreement-with-us-defence 2025-04-29T10:59:01+10:00 http://biotechdispatch.com.au/news/atomo-diagnostics-completes-capital-raise-and-undertakes-restructure 2025-04-24T10:46:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announces-the-completion-of-entitlement-offer 2025-04-24T10:39:01+10:00 http://biotechdispatch.com.au/news/orthocell-appoints-its-first-four-us-remplir-distributors-and-expects-near-term-sales 2025-04-23T11:31:01+10:00 http://biotechdispatch.com.au/news/lumos-secures-additional-us-reimbursement-coverage-for-febridx 2025-04-23T11:25:01+10:00 http://biotechdispatch.com.au/news/mesoblast-says-ryoncil-payer-coverage-extended-to-over-100-million-americans 2025-04-22T11:44:01+10:00 http://biotechdispatch.com.au/news/antara-provides-update-following-completion-of-analysis-of-phase-2-garp-ibs-clinical-trial 2025-04-22T11:27:01+10:00 http://biotechdispatch.com.au/news/neurizon-announces-the-appointment-of-chief-financial-officer 2025-04-22T11:17:01+10:00 http://biotechdispatch.com.au/news/recce-phase-2-trial-receives-additional-approval-for-treating-diabetic-patients-with-topical-gel 2025-04-22T11:00:01+10:00 http://biotechdispatch.com.au/news/races-says-patient-enrolment-opened-at-second-site-for-rc220-solid-tumour-trial 2025-04-22T10:39:01+10:00 http://biotechdispatch.com.au/news/imricor-secures-european-approval-for-its-advantage-mr 2025-04-17T09:31:01+10:00 http://biotechdispatch.com.au/news/telix-says-ipax-linz-study-shows-promising-efficacy-for-glioma-therapy-candidate 2025-04-17T09:02:01+10:00 http://biotechdispatch.com.au/news/cartherics-announces-board-changes-including-a-new-chair 2025-04-17T09:01:01+10:00 http://biotechdispatch.com.au/news/prescients-ptx-100-receives-us-fda-fast-track-designation 2025-04-17T09:01:01+10:00 http://biotechdispatch.com.au/news/uq-tests-vaccine-response-in-cepi-backed-150-day-moonshot-challenge 2025-04-17T09:00:01+10:00 http://biotechdispatch.com.au/news/argent-biopharma-and-auscann-enter-heads-of-agreement-for-cannabinoid-drug-development 2025-04-15T11:05:01+10:00 http://biotechdispatch.com.au/news/botanix-secures-commitments-for-40-million-to-accelerate-sofdra-rollout 2025-04-15T10:51:01+10:00 http://biotechdispatch.com.au/news/carina-biotech-completes-5-million-capital-raise 2025-04-15T10:42:01+10:00 http://biotechdispatch.com.au/news/noxopharm-announces-sof-skn-successfully-passes-final-pre-trial-study 2025-04-15T09:08:01+10:00 http://biotechdispatch.com.au/news/neuren-confirms-primary-endpoints-for-phase-3-trial-of-nnz-2591-in-pms 2025-04-15T08:55:01+10:00 http://biotechdispatch.com.au/news/recce-announces-placement-and-entitlement-offer-to-support-late-stage-trial 2025-04-10T11:31:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-announces-the-appointment-of-new-non-executive-director 2025-04-10T09:57:01+10:00 http://biotechdispatch.com.au/news/opthea-updates-investors-confirming-significant-staff-reduction 2025-04-10T09:42:01+10:00 http://biotechdispatch.com.au/news/wehi-says-study-puts-first-long-covid-treatment-on-horizon 2025-04-10T09:26:01+10:00 http://biotechdispatch.com.au/news/osteopore-secures-european-approval-for-custom-orthopaedic-and-cranial-implants 2025-04-10T09:24:01+10:00 http://biotechdispatch.com.au/news/universal-hepatitis-b-testing-needed-to-stop-rise-in-liver-cancer-deaths 2025-04-08T11:35:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-announces-the-completion-of-placement 2025-04-08T11:16:01+10:00 http://biotechdispatch.com.au/news/atomo-announces-national-scale-up-of-publicly-funded-hiv-self-test-vending-machines 2025-04-08T11:10:01+10:00 http://biotechdispatch.com.au/news/baker-says-advanced-omics-technology-will-supercharge-cardiovascular-research 2025-04-08T11:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-statement-on-us-tariff-announcement 2025-04-08T10:20:01+10:00 http://biotechdispatch.com.au/news/algorae-announces-the-appointment-of-chief-commercial-officer 2025-04-03T09:22:01+11:00 http://biotechdispatch.com.au/news/races-opens-first-australian-clinical-site-for-rc220-phase-1-solid-tumour-trial 2025-04-03T09:16:01+11:00 http://biotechdispatch.com.au/news/percheron-updates-shareholders-after-disappointing-clinical-trial-result 2025-04-03T08:57:01+11:00 http://biotechdispatch.com.au/news/biome-secures-news-debt-facility-to-support-growth 2025-04-03T08:47:01+11:00 http://biotechdispatch.com.au/news/research-shows-gut-microbiome-could-delay-onset-of-type-1-diabetes 2025-04-03T08:17:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-announces-significant-us-milestone-for-technegas-sales 2025-04-01T12:38:01+11:00 http://biotechdispatch.com.au/news/artrya-secures-contract-with-lumus-imaging-for-use-of-salix-coronary-anatomy 2025-04-01T10:20:01+11:00 http://biotechdispatch.com.au/news/bionsw-launches-bioinvest-catalyst-events-to-support-life-sciences-investment-in-nsw 2025-04-01T10:17:01+11:00 http://biotechdispatch.com.au/news/gsk-brings-melbourne-discovered-treatment-home-to-australian-patients 2025-04-01T10:17:01+11:00 http://biotechdispatch.com.au/news/opthea-announces-decision-to-discontinue-wet-amd-clinical-trials 2025-04-01T10:16:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-says-life-sciences-is-the-sleeping-giant-of-australian-economy 2025-03-27T11:54:01+11:00 http://biotechdispatch.com.au/news/mesoblast-says-its-fda-approved-mesenchymal-stromal-cell-therapy-available-for-sale-in-the-us 2025-03-27T10:32:01+11:00 http://biotechdispatch.com.au/news/neuren-initiates-development-of-nnz-2591-to-treat-hie-in-newborns 2025-03-27T10:07:01+11:00 http://biotechdispatch.com.au/news/amplia-therapeutics-reports-updated-data-from-pancreatic-cancer-trial 2025-03-27T09:44:01+11:00 http://biotechdispatch.com.au/news/clinuvel-announces-positive-preliminary-results-for-prnumbra-instant-in-stroke-patients 2025-03-27T09:31:01+11:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-immuteps-tacti-004-phase-3-non-small-cell-lung-cancer-trial 2025-03-25T11:40:01+11:00 http://biotechdispatch.com.au/news/chimeric-announces-us-patent-allowed-for-chm-cdh17-technology 2025-03-25T11:27:01+11:00 http://biotechdispatch.com.au/news/nanotechnology-could-improve-odds-in-treating-aggressive-breast-cancers 2025-03-25T11:26:01+11:00 http://biotechdispatch.com.au/news/noxopharm-expands-collaboration-with-hudson-institute 2025-03-25T11:22:01+11:00 http://biotechdispatch.com.au/news/opthea-now-managing-the-fallout-of-clinical-trial-result 2025-03-25T11:19:01+11:00 http://biotechdispatch.com.au/news/immutep-confirms-presentation-of-pivotal-tacti-004-trial-at-major-international-meeting 2025-03-20T12:11:01+11:00 http://biotechdispatch.com.au/news/osteopore-enhances-strategic-refocus-with-early-cessation-of-dental-grant-project 2025-03-20T11:55:01+11:00 http://biotechdispatch.com.au/news/island-raises-272-million-through-exercise-of-listed-options 2025-03-20T09:27:01+11:00 http://biotechdispatch.com.au/news/imugenes-azer-cel-granted-fda-fast-track-designation-in-blood-cancer 2025-03-20T09:26:01+11:00 http://biotechdispatch.com.au/news/brisbane-based-drugmaker-qbiotics-celebrates-25-years-since-its-creation 2025-03-20T09:25:01+11:00 http://biotechdispatch.com.au/news/oncosil-medical-appoints-as-chief-financial-officer 2025-03-18T09:19:01+11:00 http://biotechdispatch.com.au/news/nyrada-commences-recruitment-for-phase-one-clinical-trial 2025-03-18T09:16:01+11:00 http://biotechdispatch.com.au/news/neurizon-therapeutics-updates-investors-on-initiatives-to-lift-clinical-hold 2025-03-18T09:14:01+11:00 http://biotechdispatch.com.au/news/race-secures-ethics-approval-for-rc220-phase-1-solid-tumour-trial 2025-03-18T09:13:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-says-new-data-confirms-positive-tumour-uptake 2025-03-18T09:12:01+11:00 http://biotechdispatch.com.au/news/telix-completes-the-acquisition-of-fap-targeting-theranostic-candidates 2025-03-13T12:23:01+11:00 http://biotechdispatch.com.au/news/argent-biopharma-signs-exclusive-agreement-for-malta-manufacturing-facility 2025-03-13T12:12:01+11:00 http://biotechdispatch.com.au/news/proteomics-international-launches-predictive-test-for-diabetic-kidney-disease-in-australia 2025-03-13T09:18:01+11:00 http://biotechdispatch.com.au/news/australian-company-confirms-the-location-of-key-clinical-trial 2025-03-13T09:16:01+11:00 http://biotechdispatch.com.au/news/prescient-therapeutics-announces-appointment-of-new-board-chair 2025-03-11T11:54:01+11:00 http://biotechdispatch.com.au/news/4dmedical-secures-contract-extension-with-the-cleveland-clinic 2025-03-11T09:58:01+11:00 http://biotechdispatch.com.au/news/polynovo-announces-chief-executive-change 2025-03-11T09:50:01+11:00 http://biotechdispatch.com.au/news/anatara-lifesciences-updates-on-garp-irritable-bowel-syndrome-trial 2025-03-11T09:42:01+11:00 http://biotechdispatch.com.au/news/medtech-innovators-invited-to-pitch-at-esif-2025 2025-03-06T14:55:01+11:00 http://biotechdispatch.com.au/news/new-data-supports-effective-delivery-of-dna-based-vaccines-using-patch 2025-03-06T09:06:01+11:00 http://biotechdispatch.com.au/news/atmo-biosciences-announces-publication-of-pivotal-clinical-study-results-supporting-initial-indi 2025-03-06T09:05:01+11:00 http://biotechdispatch.com.au/news/the-george-institute-for-global-health-welcomes-a-new-board-chair 2025-03-06T09:03:01+11:00 http://biotechdispatch.com.au/news/biomelbourne-network-announces-the-appointment-of-new-board-chair 2025-03-06T08:46:01+11:00 http://biotechdispatch.com.au/news/telix-report-calls-for-regulatory-enforcement-and-funding-to-secure-nuclear-medicine-potential 2025-03-06T08:45:01+11:00 http://biotechdispatch.com.au/news/international-conference-on-microneedles-2025-a-landmark-conference-in-the-southern-hemisphere 2025-03-04T13:27:01+11:00 http://biotechdispatch.com.au/news/imugene-appoints-chief-financial-officer-and-company-secretary 2025-03-04T11:37:01+11:00 http://biotechdispatch.com.au/news/firebrick-secures-strategic-iinvestment-from-philippines-partner 2025-03-04T09:55:01+11:00 http://biotechdispatch.com.au/news/australian-startup-launches-the-worlds-first-commercial-biological-computer 2025-03-04T09:49:01+11:00 http://biotechdispatch.com.au/news/avecho-biotechnology-secures-ten-year-agreement-with-sandoz 2025-03-04T09:40:01+11:00 http://biotechdispatch.com.au/news/csl-seqirus-secures-australia-nz-rights-to-commercialise-cholesterol-lowering-therapy 2025-03-04T09:38:01+11:00 http://biotechdispatch.com.au/news/the-cell-and-gene-catalyst-mobilises-71-influential-leaders-to-accelerate-cell-and-gene-industry 2025-02-27T10:57:01+11:00 http://biotechdispatch.com.au/news/neuren-says-us-sales-of-rett-syndrome-therapy-towards-the-top-end-of-guidance 2025-02-27T10:43:01+11:00 http://biotechdispatch.com.au/news/us-fda-approves-elate-ocular-phase-3-clinical-trial-protocol 2025-02-26T15:45:01+11:00 http://biotechdispatch.com.au/news/arovella-receives-commitments-for-15-million-following-cancellation-of-january-placement 2025-02-26T15:44:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-refreshes-board-with-new-appointment-and-retirement 2025-02-26T15:44:01+11:00 http://biotechdispatch.com.au/news/us-fda-accepts-application-for-telixs-zircaix-and-grants-priority-review 2025-02-26T15:43:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-announces-record-full-year-result-and-us-expansion-update 2025-02-25T11:25:01+11:00 http://biotechdispatch.com.au/news/orthocell-submits-for-remplir-regulatory-approval-in-thailand 2025-02-25T11:23:01+11:00 http://biotechdispatch.com.au/news/new-whitepaper-reveals-strategies-to-manage-salary-trends-revealed-in-report 2025-02-25T10:06:01+11:00 http://biotechdispatch.com.au/news/new-zealand-medtech-start-up-avasa-hits-milestone-in-development-of-worlds-first-arterial-couple 2025-02-25T09:38:01+11:00 http://biotechdispatch.com.au/news/neuren-receives-rare-paediatric-disease-designation-from-the-us-fda 2025-02-25T09:32:01+11:00 http://biotechdispatch.com.au/news/vaxxas-completes-enrolment-for-largest-clinical-trial-of-hd-map-for-vaccine-delivery 2025-02-20T09:09:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-launches-member-only-spotlight-series 2025-02-20T09:06:01+11:00 http://biotechdispatch.com.au/news/idt-delivers-strong-first-half-performance-following-strategic-pivot 2025-02-19T16:10:01+11:00 http://biotechdispatch.com.au/news/us-fda-fast-track-designation-for-claritys-cu-67-sar-bispsma-for-prostate-cancer 2025-02-19T15:49:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-successfully-completes-institutional-component-of-the-entitlement-offer 2025-02-19T15:44:01+11:00 http://biotechdispatch.com.au/news/fda-grants-fast-track-designation-for-neurens-nnz-2591-in-pitt-hopkins-syndrome 2025-02-18T20:00:01+11:00 http://biotechdispatch.com.au/news/syntaras-topical-anti-fibrotic-drug-leads-to-significant-normalisation-of-skin-in-established-sc 2025-02-18T12:03:01+11:00 http://biotechdispatch.com.au/news/the-first-wver-women-in-life-sciences-leadership-summit 2025-02-18T03:00:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-to-raise-up-to-146-million-to-support-late-stage-trials 2025-02-17T16:03:01+11:00 http://biotechdispatch.com.au/news/althea-group-appoints-new-non-executive-director 2025-02-17T15:43:01+11:00 http://biotechdispatch.com.au/news/axelia-oncology-announces-supply-agreement-for-pbs-listed-cancer-medicines 2025-02-17T15:31:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-national-prioritisation-of-rd-to-build-a-stronger-australia 2025-02-14T10:36:01+11:00 http://biotechdispatch.com.au/news/artrya-secures-multi-year-commercial-contract-with-sonic-healthcare 2025-02-12T11:09:01+11:00 http://biotechdispatch.com.au/news/emvision-secures-ethics-approval-for-pivotal-validation-trial-1 2025-02-12T11:04:01+11:00 http://biotechdispatch.com.au/news/firebrick-announces-launch-of-nasodine-in-fiji-and-south-pacific 2025-02-12T10:52:01+11:00 http://biotechdispatch.com.au/news/island-announces-the-completion-of-patient-dosing-in-phase-2b-clinical-trial-1 2025-02-12T10:42:01+11:00 http://biotechdispatch.com.au/news/advancell-enters-strategic-collaboration-with-lilly-to-advance-novel-targeted-alpha-therapies 2025-02-11T12:21:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-extends-abstract-deadline-for-april-edition-of-australasian-biotechnology-journal 2025-02-11T11:19:01+11:00 http://biotechdispatch.com.au/news/us-university-joins-chimerics-chm-cdh17-clinical-trial 2025-02-11T10:58:01+11:00 http://biotechdispatch.com.au/news/immunoglobulin-sales-drives-a-strong-first-half-for-csl 2025-02-11T10:56:01+11:00 http://biotechdispatch.com.au/news/clarity-expands-pipeline-in-breast-cancer-with-cu-6467-sar-trastuzumab 2025-02-11T10:26:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-to-commence-human-clinical-trials-of-pyc-003-for-polycystic-kidney-disease 2025-02-11T09:34:01+11:00 http://biotechdispatch.com.au/news/vaxxas-appoints-vaccine-experts-as-it-prepares-for-late-stage-clinical-trials 2025-02-06T10:40:01+11:00 http://biotechdispatch.com.au/news/adalta-announces-it-will-prioritise-east-to-west-cellular-immunotherapy-strategy 2025-02-06T10:11:01+11:00 http://biotechdispatch.com.au/news/little-green-pharma-completes-health-house-acquisition 2025-02-06T10:05:01+11:00 http://biotechdispatch.com.au/news/impedimed-secures-significant-growth-capital-facility 2025-02-06T09:58:01+11:00 http://biotechdispatch.com.au/news/argenica-therapeutics-says-arg-007-reduced-damage-to-brain-cells-in-preclinical-study 2025-02-04T10:05:01+11:00 http://biotechdispatch.com.au/news/emyria-announces-promising-follow-up-clinical-trial-results-for-ptsd-program 2025-02-04T09:51:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-mtpconnect-use-joint-pre-budget-submission-to-promote-investment-in-strategic-ini 2025-02-04T09:42:01+11:00 http://biotechdispatch.com.au/news/advancell-successfully-completes-an-oversubscribed-series-c-financing 2025-02-04T09:27:01+11:00 http://biotechdispatch.com.au/news/noxopharm-says-sof-skn-passes-required-in-vitro-safety-tests 2025-02-04T09:16:01+11:00 http://biotechdispatch.com.au/news/anatara-announces-australian-patent-granted-for-garp-product 2025-01-30T10:34:01+11:00 http://biotechdispatch.com.au/news/biome-reports-positive-results-on-clinical-development-of-bmb18 2025-01-30T10:13:01+11:00 http://biotechdispatch.com.au/news/alterity-therapeutics-announces-positive-trial-results-in-multiple-system-atrophy 2025-01-30T10:02:01+11:00 http://biotechdispatch.com.au/news/new-link-revealed-between-hypertension-and-the-gut 2025-01-30T09:52:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-congratulates-members-recognised-in-australia-day-honours 2025-01-30T09:25:01+11:00 http://biotechdispatch.com.au/news/tga-approves-csls-locally-discovered-and-developed-biologic 2025-01-28T12:08:01+11:00 http://biotechdispatch.com.au/news/idt-updates-investors-expecting-a-significant-spike-in-revenue 2025-01-28T12:04:01+11:00 http://biotechdispatch.com.au/news/zeliras-hope-spv-secures-fourth-funding-tranche-to-support-fda-program 2025-01-28T11:25:01+11:00 http://biotechdispatch.com.au/news/telix-completes-the-acquisition-of-us-based-rls-radiopharmacies 2025-01-28T11:03:01+11:00 http://biotechdispatch.com.au/news/emyria-announces-key-leadership-changes 2025-01-22T11:37:01+11:00 http://biotechdispatch.com.au/news/immutep-completes-patient-enrolment-for-eftisarc-neo-phase-2-trial 2025-01-22T11:37:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-says-all-subjects-now-enrolled-in-key-arm-protect-clinical-trial 2025-01-22T11:36:01+11:00 http://biotechdispatch.com.au/news/ltr-pharma-signs-national-pharmacy-distribution-agreement-with-symbion 2025-01-22T11:35:01+11:00 http://biotechdispatch.com.au/news/neuren-partner-submits-trofinetide-marketing-application-in-europe 2025-01-21T05:52:01+11:00 http://biotechdispatch.com.au/news/australian-company-vaxxas-named-stage-winner-of-us-prize-to-advance-vaccine-patches 2025-01-21T05:51:01+11:00 http://biotechdispatch.com.au/news/biocina-and-novacina-merger-aims-to-bolster-the-global-cdmo-industry 2025-01-21T05:50:01+11:00 http://biotechdispatch.com.au/news/stoking-good-antibodies-key-to-reducing-serious-bee-venom-allergic-reactions 2025-01-21T05:49:01+11:00 http://biotechdispatch.com.au/news/race-oncology-appoints-opthea-founder-to-its-board 2024-12-19T09:26:01+11:00 http://biotechdispatch.com.au/news/researchers-say-australias-first-mrna-vaccine-candidate-could-address-covid-immune-imprinting 2024-12-19T09:25:01+11:00 http://biotechdispatch.com.au/news/cartherics-secures-g-rex-grant-to-support-its-in-house-manufacturing-program 2024-12-19T09:24:01+11:00 http://biotechdispatch.com.au/news/if-you-have-ovarian-cancer-genomic-testing-may-open-up-new-treatment-option 2024-12-19T09:23:01+11:00 http://biotechdispatch.com.au/news/call-for-member-contributions-to-april-2025-edition-of-australasian-biotechnology-journal 2024-12-17T11:34:01+11:00 http://biotechdispatch.com.au/news/blood-test-could-make-cancer-treatments-safer-and-more-effective 2024-12-17T09:09:01+11:00 http://biotechdispatch.com.au/news/immutep-and-monash-announce-first-publication-detailing-how-human-lag-3-binds-to-mhc-class-ii 2024-12-17T09:08:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-bionsw-deepen-collaboration-with-new-mou 2024-12-17T09:05:01+11:00 http://biotechdispatch.com.au/news/australian-medtech-manufacturing-alliance-strengthens-with-new-steering-group-members 2024-12-17T09:03:01+11:00 http://biotechdispatch.com.au/news/pyc-nominates-fourth-clinical-drug-candidate-in-phelan-mcdermid-program 2024-12-17T09:02:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-confirms-the-completion-of-priority-review-voucher-sale 2024-12-12T10:00:01+11:00 http://biotechdispatch.com.au/news/immutep-reports-promising-new-data-in-head-and-neck-cancer-at-esmo-immuno-oncology-2024 2024-12-12T09:57:01+11:00 http://biotechdispatch.com.au/news/qimr-berghofer-says-cell-therapy-saving-lives-of-immunocompromised-patients 2024-12-12T09:38:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-biomelbourne-network-welcome-victorias-economic-growth-statement 2024-12-12T09:37:01+11:00 http://biotechdispatch.com.au/news/fivephusion-secures-resectassist-platform-technology-for-the-localised-delivery-of-cancer-drugs 2024-12-10T15:45:01+11:00 http://biotechdispatch.com.au/news/fivephusion-secures-ethics-approval-of-a-phase-1b-deflexifol-clinical-trial 2024-12-10T09:18:01+11:00 http://biotechdispatch.com.au/news/recce-receives-approval-from-indonesias-regulator-for-registrational-phase-3-clinical-trial 2024-12-10T09:16:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-says-furst-us-clinical-paper-highlights-technegas-clinical-effectiveness 2024-12-10T09:15:01+11:00 http://biotechdispatch.com.au/news/potential-australian-developed-treatment-for-mnd-shows-positive-early-trial-results 2024-12-10T09:14:01+11:00 http://biotechdispatch.com.au/news/paradigm-completes-16-million-capital-raise-to-support-global-phase-3-clinical-trial 2024-12-10T09:12:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-celebrates-early-stage-innovation-forum-winners 2024-12-05T11:58:01+11:00 http://biotechdispatch.com.au/news/orthocell-says-it-has-achieved-all-endpoints-in-pivotal-of-nerve-repair-product-1 2024-12-05T10:01:01+11:00 http://biotechdispatch.com.au/news/alterity-therapeutics-completes-last-patient-visit-in-ath434-201-trial-in-multiple-system-atroph 2024-12-05T10:00:01+11:00 http://biotechdispatch.com.au/news/digital-health-company-adherium-secures-rd-loan-facility 2024-12-05T09:59:01+11:00 http://biotechdispatch.com.au/news/acrux-says-us-fda-approves-its-nitroglycerin-ointment-for-moderate-to-severe-pain 2024-12-05T09:59:01+11:00 http://biotechdispatch.com.au/news/anatara-provides-irritable-bowel-syndrome-clinical-trial-update 2024-12-05T09:58:01+11:00 http://biotechdispatch.com.au/news/albanese-government-launches-review-of-australias-research-and-development 2024-12-03T10:00:01+11:00 http://biotechdispatch.com.au/news/brisbane-health-tech-unveils-advanced-manufacturing-facility 2024-12-03T09:58:01+11:00 http://biotechdispatch.com.au/news/orthocell-says-it-has-achieved-all-endpoints-in-pivotal-of-nerve-repair-product 2024-12-03T09:57:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-experienced-industry-executive-to-its-board 2024-12-03T09:56:01+11:00 http://biotechdispatch.com.au/news/4dmedical-signs-contract-to-expand-in-western-australia 2024-12-03T09:53:01+11:00 http://biotechdispatch.com.au/news/macquarie-university-spinout-secures-landmark-funding-for-breakthrough-als-gene-therapy 2024-11-28T10:49:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-mtpconnect-release-summit-communique 2024-11-28T10:46:01+11:00 http://biotechdispatch.com.au/news/australian-backed-triple-combination-hypertension-treatment-proceeding-to-regulatory-submission 2024-11-28T10:45:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-says-isla-101-shows-anti-dengue-activity-in-phase-2a-study-readout 2024-11-28T10:43:01+11:00 http://biotechdispatch.com.au/news/vaxxas-expands-global-ip-portfolio-for-exclusive-manufacture-and-sale-of-needle-free-vaccination 2024-11-28T10:43:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-congratulates-professor-david-thomas-on-receiving-nsw-award 2024-11-26T12:13:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-announces-name-change-to-clever-culture-systems 2024-11-26T10:17:01+11:00 http://biotechdispatch.com.au/news/epiminder-announces-5-year-milestone-of-long-term-continuous-eeg-monitoring-implant 2024-11-26T09:24:01+11:00 http://biotechdispatch.com.au/news/omicos-professor-david-thomas-receives-nsw-premiers-award-for-outstanding-cancer-researcher 2024-11-26T09:20:01+11:00 http://biotechdispatch.com.au/news/ge-healthcare-and-peter-maccallum-cancer-centre-partner-to-advance-cancer-research 2024-11-26T09:17:01+11:00 http://biotechdispatch.com.au/news/fostering-collaboration-between-our-sector-and-policy-makers 2024-11-21T12:41:01+11:00 http://biotechdispatch.com.au/news/clinuvel-says-scenesse-dosage-expansion-under-review-by-european-medicines-agency 2024-11-21T10:56:01+11:00 http://biotechdispatch.com.au/news/opyl-signs-service-level-agreement-with-southern-clinical-development-consulting 2024-11-21T10:35:01+11:00 http://biotechdispatch.com.au/news/race-oncology-says-it-has-discovered-multiple-novel-fto-inhibitor-candidates 2024-11-21T09:50:01+11:00 http://biotechdispatch.com.au/news/new-digital-project-to-reveal-medical-research-career-opportunities 2024-11-21T09:28:01+11:00 http://biotechdispatch.com.au/news/australian-companys-candidate-reduces-aggregation-of-key-als-disease-target 2024-11-19T10:04:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-mtpconnect-bring-together-life-sciences-sector-for-national-summit 2024-11-19T09:19:01+11:00 http://biotechdispatch.com.au/news/adalta-announces-appointment-of-two-new-non-executive-directors 2024-11-19T09:17:01+11:00 http://biotechdispatch.com.au/news/radiopharm-says-targeted-therapy-demonstrates-potential-for-pancreatic-cancer-patients 2024-11-19T09:16:01+11:00 http://biotechdispatch.com.au/news/clinuvel-announces-plan-to-prioritises-three-strategic-programs 2024-11-19T09:15:01+11:00 http://biotechdispatch.com.au/news/immutep-says-efti-insight-003-lung-cancer-trial-reveals-positive-survival-data-1 2024-11-14T11:59:01+11:00 http://biotechdispatch.com.au/news/amplia-enters-into-preclinical-collaboration-with-korean-drug-screening-company 2024-11-14T10:27:01+11:00 http://biotechdispatch.com.au/news/botanix-adds-to-payer-coverage-with-65-million-commercial-lives 2024-11-14T10:08:01+11:00 http://biotechdispatch.com.au/news/immutep-says-efti-insight-003-lung-cancer-trial-reveals-positive-survival-data 2024-11-14T09:34:01+11:00 http://biotechdispatch.com.au/news/avita-medical-announces-distribution-agreement-to-expand-to-australia-and-new-zealand 2024-11-14T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-announces-the-inaugural-depaz-oration 2024-11-12T10:39:01+11:00 http://biotechdispatch.com.au/news/monash-study-shows-ivf-innovation-boosts-viable-embryo-selection 2024-11-12T10:16:01+11:00 http://biotechdispatch.com.au/news/heramed-completes-further-1-million-institutional-placement 2024-11-12T10:09:01+11:00 http://biotechdispatch.com.au/news/artrya-completes-successful-5-million-placement 2024-11-12T10:04:01+11:00 http://biotechdispatch.com.au/news/emvision-says-neurodiagnostic-algorithms-deliver-positive-results 2024-11-12T09:49:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-mtpconnect-launch-joint-discussion-paper-on-critical-life-science-growth-issues 2024-11-07T15:03:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-life-sciences-western-australia-sign-first-ever-mou 2024-11-07T11:40:01+11:00 http://biotechdispatch.com.au/news/new-study-reveals-gaps-in-antimicrobial-knowledge-and-planetary-health-education 2024-11-07T11:03:01+11:00 http://biotechdispatch.com.au/news/alterity-therapeutics-announces-new-publication-describing-ath434-novel-mechanism-of-action 2024-11-07T10:17:01+11:00 http://biotechdispatch.com.au/news/neuren-to-receive-one-third-of-us150m-from-sale-of-priority-review-voucher 2024-11-07T10:11:01+11:00 http://biotechdispatch.com.au/news/doctors-in-australia-lead-phase-3-theranostics-study-targeting-advanced-prostate-cancer 2024-11-07T10:00:01+11:00 http://biotechdispatch.com.au/news/optiscan-signs-agreement-with-monash-to-progress-gi-scope 2024-11-05T11:58:01+11:00 http://biotechdispatch.com.au/news/immugene-says-bile-tract-cancer-patient-maintains-complete-response-in-mast-study 2024-11-05T11:48:01+11:00 http://biotechdispatch.com.au/news/recce-says-patient-dosing-in-phase-2-clinical-trial-advances-to-final-stages 2024-11-05T11:17:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-says-first-patient-doses-eye-disease-study 2024-11-05T10:11:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-biomelbourne-network-strength-collaboration 2024-10-31T09:13:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-life-sciences-queensland-unite-to-strengthen-national-life-sciences-sector 2024-10-31T09:06:01+11:00 http://biotechdispatch.com.au/news/a-decade-of-collaboration-ausbiotech-and-korean-health-industry-development-institute-sign-mou 2024-10-31T09:04:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-conference-attracts-record-numbers-as-biotech-industry-looks-to-future 2024-10-31T08:49:01+11:00 http://biotechdispatch.com.au/news/amplia-announces-capital-raise-to-support-the-completion-of-phase-2a-accent-tr 2024-10-31T08:46:01+11:00 http://biotechdispatch.com.au/news/australias-biggest-week-in-biotech-officially-begins-at-ausbioinvest 2024-10-29T10:11:01+11:00 http://biotechdispatch.com.au/news/emv-prepares-for-validation-trial-following-fda-engagement 2024-10-29T10:06:01+11:00 http://biotechdispatch.com.au/news/actinogen-appoints-andrew-udell-as-its-chief-commercial-officer 2024-10-29T09:43:01+11:00 http://biotechdispatch.com.au/news/externa-secures-seed-funding-to-develop-first-in-class-therapeutics 2024-10-29T09:30:01+11:00 http://biotechdispatch.com.au/news/vaxxas-licenses-rsv-vaccine-antigen-candidate-from-the-us-national-institutes-of-health 2024-10-29T09:23:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-2024-conference-programme-highlights 2024-10-24T10:37:01+11:00 http://biotechdispatch.com.au/news/fda-accepts-application-and-grants-priority-review-for-telixs-brain-cancer-imaging-agent 2024-10-24T10:32:01+11:00 http://biotechdispatch.com.au/news/osteopore-steps-up-global-expansion-in-brazilian-craniofacial-market 2024-10-24T10:08:01+11:00 http://biotechdispatch.com.au/news/percheron-therapeutics-launches-limited-share-purchase-plan 2024-10-24T09:41:01+11:00 http://biotechdispatch.com.au/news/adalta-appoints-consultant-chief-medical-officer-for-adcella 2024-10-24T09:30:01+11:00 http://biotechdispatch.com.au/news/senior-victorian-ministers-to-speak-during-australias-biggest-week-in-biotech 2024-10-22T12:21:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-board-of-director-nominations 2024-10-22T12:02:01+11:00 http://biotechdispatch.com.au/news/pyc-provides-interim-update-on-progress-in-rp11-repeat-dose-clinical-trials 2024-10-22T10:09:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-and-bamf-health-announce-collaboration-to-manufacture-and-dose-18f-rad-1 2024-10-22T09:58:01+11:00 http://biotechdispatch.com.au/news/chimeric-completes-placement-to-progress-developed-of-chm-cdh17 2024-10-22T09:28:01+11:00 http://biotechdispatch.com.au/news/us-fda-grants-rare-paediatric-designation-to-pycs-drug-development-program 2024-10-22T09:18:01+11:00 http://biotechdispatch.com.au/news/more-opportunities-for-connection-during-australias-biggest-week-in-biotech 2024-10-17T10:51:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-cements-us-medtech-links-through-mou-with-medical-alley 2024-10-17T10:32:01+11:00 http://biotechdispatch.com.au/news/osteopore-partners-with-nasdaq-listed-cytomed-to-advance-msc-powered-regeneration 2024-10-17T10:19:01+11:00 http://biotechdispatch.com.au/news/anatara-lifesciences-provides-garp-ibs-clinical-trial-update 2024-10-17T09:59:01+11:00 http://biotechdispatch.com.au/news/neuren-announces-that-trofinetide-has-received-marketing-authorisation-in-canada 2024-10-17T09:52:01+11:00 http://biotechdispatch.com.au/news/nyrada-says-it-has-completed-safety-studies-ahead-of-phase-1-clinical-trial 2024-10-17T09:47:01+11:00 http://biotechdispatch.com.au/news/immuron-reports-continued-strong-sales-growth-for-travelan 2024-10-15T11:11:01+11:00 http://biotechdispatch.com.au/news/respiri-announces-it-has-secures-a-major-strategic-invesment 2024-10-15T11:03:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-releases-2023-2024-annual-report 2024-10-15T10:56:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-calling-on-experts-to-become-mentors-for-industry-growth-program 2024-10-15T10:39:01+11:00 http://biotechdispatch.com.au/news/ltr-pharma-says-spontan-achieves-faster-absorption-in-completed-pivotal-study 2024-10-15T10:12:01+11:00 http://biotechdispatch.com.au/news/australias-premier-life-science-investment-event-ausbioinvest-2024 2024-10-10T12:07:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-announces-the-completion-of-share-purchase-plan 2024-10-10T10:12:01+11:00 http://biotechdispatch.com.au/news/noxopharm-contracts-specialist-manufacturer-for-sof-skn-clinical-trial 2024-10-10T09:49:01+11:00 http://biotechdispatch.com.au/news/tga-approves-new-indication-for-telixs-illuccix-to-include-patient-selection-for-psma-targeted-t 2024-10-10T09:47:01+11:00 http://biotechdispatch.com.au/news/amplia-therapeutics-ceo-shares-prime-ministers-prize-for-innovation 2024-10-10T09:41:01+11:00 http://biotechdispatch.com.au/news/federal-minister-for-health-and-aged-care-to-speak-at-australias-biggest-week-in-biotech 2024-10-08T11:45:01+11:00 http://biotechdispatch.com.au/news/chimeric-says-cancer-patient-achieves-complete-response-in-chm-core-nk-trial 2024-10-08T11:00:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-signs-agreement-makes-major-progress-with-us-veterans-and-defence-administrations 2024-10-08T10:59:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-secures-new-funding-to-support-key-inflection-points-and-pipeline-build 2024-10-08T10:57:01+11:00 http://biotechdispatch.com.au/news/new-drug-could-be-answer-to-an-overlooked-yet-devastating-type-of-dementia 2024-10-08T10:56:01+11:00 http://biotechdispatch.com.au/news/new-alliance-to-drive-increased-procurement-of-homegrown-medtech 2024-10-03T09:51:01+10:00 http://biotechdispatch.com.au/news/australian-company-vaxxas-receives-significant-investment-from-endpoints-capital 2024-10-03T09:49:01+10:00 http://biotechdispatch.com.au/news/cartherics-raises-over-15-million-in-private-financing-round 2024-10-03T09:48:01+10:00 http://biotechdispatch.com.au/news/nyradas-says-lead-drug-candidate-demonstrates-significant-cardioprotection 2024-10-03T09:47:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-more-new-members-from-across-australias-life-sciences-ecosystem 2024-10-01T09:45:01+10:00 http://biotechdispatch.com.au/news/percheron-therapeutics-updates-on-avicursen-primate-toxicology-study 2024-10-01T09:44:01+10:00 http://biotechdispatch.com.au/news/mesoblast-option-to-issue-up-to-us50-million-convertible-notes-for-product-launch 2024-10-01T09:42:01+10:00 http://biotechdispatch.com.au/news/polynovo-announces-the-retirement-of-long-term-non-executive-director 2024-10-01T09:41:01+10:00 http://biotechdispatch.com.au/news/artrya-submits-application-for-salix-to-the-us-fda 2024-10-01T09:40:01+10:00 http://biotechdispatch.com.au/news/insights-to-innovation-bridging-the-funding-gap-ausbiotechs-voice-on-investment-survey-2024 2024-09-25T17:23:01+10:00 http://biotechdispatch.com.au/news/argenica-reports-positive-results-in-ind-enabling-trials 2024-09-25T17:19:01+10:00 http://biotechdispatch.com.au/news/lumos-awarded-national-contract-with-medigroup-for-febridx 2024-09-25T17:14:01+10:00 http://biotechdispatch.com.au/news/opyl-announced-the-signing-of-new-service-agreement-with-biointelect 2024-09-25T17:02:01+10:00 http://biotechdispatch.com.au/news/chimeric-announces-new-collaboration-with-achieve-clinics 2024-09-25T16:56:01+10:00 http://biotechdispatch.com.au/news/bioxyne-signs-amendment-with-aura-therapeutics-to-manufacture-product-volumes 2024-09-24T12:35:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-now-accepting-ausmedtech-2025-session-submissions 2024-09-24T10:46:01+10:00 http://biotechdispatch.com.au/news/lumos-says-it-achieves-first-phase-2-milestone-in-hologic-ffn-development-agreement 2024-09-24T10:39:01+10:00 http://biotechdispatch.com.au/news/immutep-receives-36-million-rd-tax-incentive-from-french-government 2024-09-24T09:49:01+10:00 http://biotechdispatch.com.au/news/telix-to-acquire-north-american-manufacturing-and-distribution-platform 2024-09-24T09:37:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-launching-american-depositary-receipt-program 2024-09-19T12:16:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-mtpconnect-partner-to-deliver-australian-first-national-summit 2024-09-19T12:08:01+10:00 http://biotechdispatch.com.au/news/invion-updates-on-phase-2-prostate-cancer-trial-of-inv043 2024-09-19T11:07:01+10:00 http://biotechdispatch.com.au/news/cochlear-announces-chief-financial-officer-appointment 2024-09-19T11:02:01+10:00 http://biotechdispatch.com.au/news/new-research-reveals-poor-outcomes-from-advanced-prostate-cancer-could-be-reversed-with-targeted 2024-09-19T10:53:01+10:00 http://biotechdispatch.com.au/news/remembering-biotech-trailblazer-leon-serry-am 2024-09-17T10:27:01+10:00 http://biotechdispatch.com.au/news/ema-pre-submission-meeting-paves-the-way-for-orphan-designation-request 2024-09-17T10:20:01+10:00 http://biotechdispatch.com.au/news/magellan-stem-cells-welcomes-7-million-federal-government-grant 2024-09-17T10:10:01+10:00 http://biotechdispatch.com.au/news/simple-immune-cell-could-become-off-the-shelf-rapid-tissue-muscle-and-bone-healing-therapy 2024-09-17T10:04:01+10:00 http://biotechdispatch.com.au/news/immutep-says-it-candidate-in-combination-with-keytruda-delivered-positive-efficacy-and-safety-pr 2024-09-17T10:02:01+10:00 http://biotechdispatch.com.au/news/victorians-gain-access-to-precision-cancer-therapies-following-landmark-donation 2024-09-12T09:46:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-release-of-hta-reviews-final-report 2024-09-12T09:40:01+10:00 http://biotechdispatch.com.au/news/vaxxas-initiates-phase-1-clinical-trial-of-pre-ppandemic-avian-influenza-a-virus-vaccine 2024-09-12T09:19:01+10:00 http://biotechdispatch.com.au/news/telixs-phase-3-zircon-trial-for-kidney-cancer-imaging-published-in-the-lancet-oncology 2024-09-12T09:17:01+10:00 http://biotechdispatch.com.au/news/brandon-biocatalysts-cureator-incubator-boosts-preclinical-and-health-security-innovations-with- 2024-09-12T09:15:01+10:00 http://biotechdispatch.com.au/news/dimerix-announces-that-first-patient-enters-dmx-200-open-label-extension-1 2024-09-12T09:13:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-industry-growth-program-manager 2024-09-10T12:39:01+10:00 http://biotechdispatch.com.au/news/dimerix-announces-that-first-patient-enters-dmx-200-open-label-extension 2024-09-10T12:37:01+10:00 http://biotechdispatch.com.au/news/nyrada-provides-update-on-its-brain-injury-program-glp-studies 2024-09-10T12:35:01+10:00 http://biotechdispatch.com.au/news/biotron-updates-on-bit225-012-phase-2-covid-19-clinical-trial 2024-09-10T12:33:01+10:00 http://biotechdispatch.com.au/news/ena-respiratory-secures-extension-of-us-funding-for-novel-prophylactic-antiviral 2024-09-10T10:36:01+10:00 http://biotechdispatch.com.au/news/strengthening-australia-hong-kong-health-and-investment-ties 2024-09-05T14:43:01+10:00 http://biotechdispatch.com.au/news/csl-announces-sale-of-wuhan-plasma-collection-and-fractionation-operations 2024-09-05T12:14:01+10:00 http://biotechdispatch.com.au/news/noxopharm-reports-results-from-chroma-platform-drug-development-program 2024-09-05T11:50:01+10:00 http://biotechdispatch.com.au/news/lumos-diagnostics-announces-equity-raise-and-welcomes-major-new-shareholder 2024-09-05T10:11:01+10:00 http://biotechdispatch.com.au/news/opthea-announces-executive-leadership-changes-and-senior-appointments 2024-09-05T09:49:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-cohosts-quantum-meets-health-workshop 2024-09-03T12:50:01+10:00 http://biotechdispatch.com.au/news/percheron-therapeutics-announces-positive-preclinical-data-for-avicursen 2024-09-03T10:25:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-launches-industry-backed-accelerator-investment-program 2024-09-03T10:17:01+10:00 http://biotechdispatch.com.au/news/emyria-announces-interim-clinical-trial-results-for-ptsd-program 2024-09-03T10:16:01+10:00 http://biotechdispatch.com.au/news/race-oncology-announces-the-detail-of-first-phase-of-board-renewal 2024-09-03T10:15:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-2024-national-conference-programme-unveiled 2024-08-29T13:47:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-senior-leaders-focused-on-advocacy-policy-and-elevating-the-voice-of-industr 2024-08-29T08:31:01+10:00 http://biotechdispatch.com.au/news/novotech-earns-renewed-certification-as-an-employer-of-choice-for-gender-equality 2024-08-29T08:26:01+10:00 http://biotechdispatch.com.au/news/telix-submits-nda-for-tlx101-cdx-brain-cancer-imaging-agent 2024-08-29T08:20:01+10:00 http://biotechdispatch.com.au/news/monash-engineers-developing-finger-prick-test-to-screen-for-early-alzheimers 2024-08-29T08:18:01+10:00 http://biotechdispatch.com.au/news/chimeric-says-first-patient-dosed-in-trial-of-cdh17-directed-car-t-cell-therapy 2024-08-29T08:17:01+10:00 http://biotechdispatch.com.au/news/eminent-cancer-researcher-confirmed-as-translational-research-institute-ceo 2024-08-27T13:53:01+10:00 http://biotechdispatch.com.au/news/ato-to-release-report-on-entities-utilising-the-rd-tax-incentive 2024-08-27T13:49:01+10:00 http://biotechdispatch.com.au/news/pharmaust-says-reports-positive-interim-study-results-from-study-in-als 2024-08-26T19:22:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-increases-ownership-in-jointly-owned-venture-firm 2024-08-26T19:21:01+10:00 http://biotechdispatch.com.au/news/archies-embrace-funds-australian-research-into-rare-genetic-disorder 2024-08-26T19:20:01+10:00 http://biotechdispatch.com.au/news/tga-seeks-sector-views-on-proposed-changes-to-essential-principles-for-medical-devices 2024-08-22T10:37:01+10:00 http://biotechdispatch.com.au/news/zelira-says-it-has-received-positive-feedback-from-pre-ind-meeting-with-fda 2024-08-22T10:11:01+10:00 http://biotechdispatch.com.au/news/amplia-says-five-patients-recording-sustained-reduction-in-tumour-size-in-trial 2024-08-22T09:49:01+10:00 http://biotechdispatch.com.au/news/bioxyne-delivers-australias-first-pharmaceutical-cannabis-pastilles 2024-08-22T09:41:01+10:00 http://biotechdispatch.com.au/news/queensland-researchers-identify-potential-new-treatment-pathway-for-bladder-cancer 2024-08-22T09:38:01+10:00 http://biotechdispatch.com.au/news/ausbioinvest-2024-keynote-speaker-announced 2024-08-20T10:38:01+10:00 http://biotechdispatch.com.au/news/de-motu-cordis-welcomes-fda-approval-of-needle-free-anaphylaxis-treatment 2024-08-20T10:05:01+10:00 http://biotechdispatch.com.au/news/chimeric-says-phase-12-chm-cdh17-car-t-gmp-manufacturing-complete 2024-08-20T09:57:01+10:00 http://biotechdispatch.com.au/news/noxopharm-targets-clinical-trial-for-first-in-class-investigative-therapy 2024-08-20T09:54:01+10:00 http://biotechdispatch.com.au/news/moderna-welcomes-the-governments-national-science-statement 2024-08-20T09:39:01+10:00 http://biotechdispatch.com.au/news/remembering-industry-champion-and-leader-dr-iris-depaz 2024-08-15T12:03:01+10:00 http://biotechdispatch.com.au/news/new-clue-into-the-curious-case-of-our-ageing-immune-system 2024-08-15T09:59:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-first-participant-dosed-in-phase-1-study-of-imp761 2024-08-15T09:51:01+10:00 http://biotechdispatch.com.au/news/noxopharm-announces-cro-67-results-in-complex-pancreatic-cancer-studies 2024-08-15T09:42:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-selected-as-partner-organisation-for-industry-growth-program 2024-08-15T09:36:01+10:00 http://biotechdispatch.com.au/news/federal-government-announces-national-science-statement-and-national-science-and-research-priori 2024-08-13T13:35:01+10:00 http://biotechdispatch.com.au/news/tryptamine-therapeutics-reports-positive-results-phase-2a-fibromyalgia-study 2024-08-13T10:25:01+10:00 http://biotechdispatch.com.au/news/we-think-the-life-sciences-sector-should-be-central-to-our-national-growth 2024-08-13T10:15:01+10:00 http://biotechdispatch.com.au/news/csl-reports-strong-profit-growth-for-full-year-2024 2024-08-13T09:57:01+10:00 http://biotechdispatch.com.au/news/cell-therapy-company-chimeric-announces-collaboration-with-cell-therapies 2024-08-13T09:53:01+10:00 http://biotechdispatch.com.au/news/pfizer-upgrades-melbourne-plant-making-it-one-of-the-most-advanced-facilities-in-australia 2024-08-08T10:24:01+10:00 http://biotechdispatch.com.au/news/bio-gene-says-it-makes-strong-progress-against-strategic-priorities 2024-08-08T10:06:01+10:00 http://biotechdispatch.com.au/news/new-funding-available-for-quantum-technologies-and-advanced-manufacturing 2024-08-08T10:04:01+10:00 http://biotechdispatch.com.au/news/researchers-develop-ground-breaking-immunotherapy-for-aggressive-brain-cancer 2024-08-08T09:47:01+10:00 http://biotechdispatch.com.au/news/australian-company-island-progresses-trial-of-dengue-fever-candidate 2024-08-08T09:46:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-announces-the-appointment-of-deputy-chief-executive 2024-08-06T12:25:01+10:00 http://biotechdispatch.com.au/news/melbourne-based-researchers-showcase-worlds-first-wearable-device-to-treat-epilepsy 2024-08-06T12:16:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-receives-us2-million-payment-from-lantheus-holdings-1 2024-08-06T12:00:01+10:00 http://biotechdispatch.com.au/news/the-pharmacology-of-human-decision-making-study-with-monash-university 2024-08-06T10:56:01+10:00 http://biotechdispatch.com.au/news/personalised-cancer-vaccines-to-be-produced-at-new-uq-lab 2024-08-06T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-more-new-members-in-the-second-quarter 2024-08-01T13:00:01+10:00 http://biotechdispatch.com.au/news/imagion-biosystems-announces-changes-to-its-board-of-directors 2024-08-01T10:35:01+10:00 http://biotechdispatch.com.au/news/anu-researchers-working-to-unlock-the-full-potential-of-rna 2024-08-01T10:19:01+10:00 http://biotechdispatch.com.au/news/vita-medical-expands-portfolio-with-dermal-matrix-to-advance-wound-care 2024-08-01T09:55:01+10:00 http://biotechdispatch.com.au/news/pharmaceutical-manufacturer-tops-revenue-guidance-in-latest-update 2024-08-01T09:53:01+10:00 http://biotechdispatch.com.au/news/tga-seeks-views-on-therapeutic-goods-testing-regulations 2024-07-30T09:41:01+10:00 http://biotechdispatch.com.au/news/race-oncology-says-phase-2-trial-of-bisantrene-meets-predetermined-efficacy-criteria 2024-07-30T09:39:01+10:00 http://biotechdispatch.com.au/news/cochlear-announces-the-appointment-of-caroline-clarke-to-its-board 2024-07-30T09:14:01+10:00 http://biotechdispatch.com.au/news/monash-welcomes-funding-for-new-national-centre-for-mrna-medicines 2024-07-30T09:10:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-targets-nasdaq-listing-by-the-end-of-2024 2024-07-30T09:09:01+10:00 http://biotechdispatch.com.au/news/ltr-pharma-completes-105-million-placement-to-expedite-commercialisation-of-nasal-spray 2024-07-25T11:04:01+10:00 http://biotechdispatch.com.au/news/remembering-nobel-laureate-professor-robin-warren-ac 2024-07-25T10:57:01+10:00 http://biotechdispatch.com.au/news/orthocell-moves-ahead-on-global-market-expansion-with-seven-new-regulatory-applications 2024-07-25T10:32:01+10:00 http://biotechdispatch.com.au/news/telix-completes-significant-raise-that-could-be-used-for-acquisitions 2024-07-25T10:23:01+10:00 http://biotechdispatch.com.au/news/cartherics-announces-new-licensing-agreement-for-innovative-cardiac-cell-therapy 2024-07-25T10:02:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-early-stage-innovation-forum-opens 2024-07-23T10:15:01+10:00 http://biotechdispatch.com.au/news/neuren-receives-rare-pediatric-disease-designation-from-fda 2024-07-23T10:05:01+10:00 http://biotechdispatch.com.au/news/australian-medtech-emvision-unveils-backpack-sized-brain-scanner-to-empower-first-responders 2024-07-23T10:01:01+10:00 http://biotechdispatch.com.au/news/noxopharm-says-several-companies-evaluating-its-assets 2024-07-23T09:51:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-says-first-patient-enrolledin-cell-therapy-trial 2024-07-23T09:49:01+10:00 http://biotechdispatch.com.au/news/views-sought-in-national-health-and-medical-research-workforce-audit 2024-07-18T12:36:01+10:00 http://biotechdispatch.com.au/news/new-perth-based-rna-facility-to-improve-cancer-outcomes 2024-07-18T09:53:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-reports-positive-interim-data-from-multiple-system-atrophy-trial 2024-07-18T09:51:01+10:00 http://biotechdispatch.com.au/news/queensland-based-de-motu-cordis-progresses-development-of-innovativeanaphylaxis-treatment 2024-07-18T09:50:01+10:00 http://biotechdispatch.com.au/news/burnet-senior-research-officer-awarded-moderna-global-fellowship 2024-07-18T09:49:01+10:00 http://biotechdispatch.com.au/news/dimerix-awarded-bioshares-excellence-award 2024-07-16T09:50:01+10:00 http://biotechdispatch.com.au/news/gilead-welcomes-first-regional-car-t-treatment-centre-in-far-north-queensland 2024-07-16T09:48:01+10:00 http://biotechdispatch.com.au/news/immutep-reports-positive-results-from-trial-of-combinationcancer-therapy 2024-07-16T09:46:01+10:00 http://biotechdispatch.com.au/news/merck-expands-its-fertility-benefit-to-employees-in-new-zealand 2024-07-16T09:44:01+10:00 http://biotechdispatch.com.au/news/bio-innovation-hub-opens-opportunities-for-new-disease-treatments 2024-07-16T09:43:01+10:00 http://biotechdispatch.com.au/news/orthocell-receives-regulatory-approval-to-commence-sales-of-striate-in-canada 2024-07-11T10:35:01+10:00 http://biotechdispatch.com.au/news/nominations-sought-for-new-shared-mrff-and-nhmrc-advisory-committees 2024-07-11T10:31:01+10:00 http://biotechdispatch.com.au/news/zelira-says-it-advances-hope-autism-drug-program-with-us-fda-meeting 2024-07-11T10:26:01+10:00 http://biotechdispatch.com.au/news/telix-celcomes-cms-proposal-to-improve-payment-for-specialised-diagnostic-radiopharmaceuticals 2024-07-11T10:19:01+10:00 http://biotechdispatch.com.au/news/the-new-medicines-manufacturing-innovation-centre-opens-at-monash 2024-07-11T10:06:01+10:00 http://biotechdispatch.com.au/news/opyl-partners-with-l39-capital-to-launch-ai-biotech-fund-utilising-trialkey-technology 2024-07-09T12:28:01+10:00 http://biotechdispatch.com.au/news/orthocell-reports-record-quarterly-and-yearly-revenue 2024-07-09T12:11:01+10:00 http://biotechdispatch.com.au/news/genetic-technologies-genetype-to-enter-canadian-and-new-zealand-markets 2024-07-09T12:02:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-announces-the-appointment-of-its-new-board-chair 2024-07-09T11:11:01+10:00 http://biotechdispatch.com.au/news/florey-biotech-spin-out-secures-seed-investment-from-curiebio 2024-07-09T11:10:01+10:00 http://biotechdispatch.com.au/news/top-performing-asx-companies 2024-07-04T11:14:01+10:00 http://biotechdispatch.com.au/news/amplia-anounces-completion-of-recruitment-of-first-26-patients-in-phase-2-trial 2024-07-04T10:29:01+10:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-provides-update-on-isla-101-clinical-program 2024-07-04T10:18:01+10:00 http://biotechdispatch.com.au/news/lumos-diagnostics-expands-febridx-distribution-partnership-in-australia-and-new-zealand 2024-07-04T10:08:01+10:00 http://biotechdispatch.com.au/news/dimerix-says-the-recruitment-of-adolescent-patients-to-commence-in-phase-3-trial 2024-07-04T09:59:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-journal-articles-2 2024-07-02T12:01:01+10:00 http://biotechdispatch.com.au/news/actinogens-phase-2a-depression-trial-completes-final-patient-visit 2024-07-02T10:40:01+10:00 http://biotechdispatch.com.au/news/biomelbourne-network-board-strengthened-with-five-new-appointments 2024-07-02T10:25:01+10:00 http://biotechdispatch.com.au/news/first-ceo-for-the-sydney-based-viral-vector-manufacturing-facility 2024-07-02T10:23:01+10:00 http://biotechdispatch.com.au/news/professor-peter-van-wijngaarden-to-become-next-director-and-ceo-of-the-florey 2024-07-02T10:11:01+10:00 http://biotechdispatch.com.au/news/members-sought-for-new-policy-taskforce 2024-06-27T13:34:01+10:00 http://biotechdispatch.com.au/news/actinogen-medical-says-positive-xanamem-phase-2a-biomarker-trial-published-in-key-journal 2024-06-27T11:16:01+10:00 http://biotechdispatch.com.au/news/immutep-reports-positive-topline-results-from-tacti-003-phase-2b-trial 2024-06-27T11:00:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-completes-70-million-placement 2024-06-27T10:38:01+10:00 http://biotechdispatch.com.au/news/funding-available-for-dementia-and-cognitive-decline-innovations-through-cureator 2024-06-27T10:27:01+10:00 http://biotechdispatch.com.au/news/ketamine-slow-release-tablet-reduces-symptoms-of-severe-depression 2024-06-25T10:29:01+10:00 http://biotechdispatch.com.au/news/state-government-budget-wrap-for-life-sciences-1 2024-06-25T10:27:01+10:00 http://biotechdispatch.com.au/news/immutep-signs-exclusive-license-agreement-with-cardiff-university-for-anti-lag-3-molecules 2024-06-25T10:11:01+10:00 http://biotechdispatch.com.au/news/the-winners-of-of-australias-first-ai-sprint-announced 2024-06-25T10:02:01+10:00 http://biotechdispatch.com.au/news/imugene-doses-the-first-patient-in-pioneering-phase-1-oncarlytics-trial 2024-06-25T09:59:01+10:00 http://biotechdispatch.com.au/news/registrations-open-for-australias-biggest-week-in-biotech 2024-06-20T12:22:01+10:00 http://biotechdispatch.com.au/news/fda-approves-botanixs-sofdra-the-first-new-drug-for-primary-axillary-hyperhidrosis 2024-06-20T10:27:01+10:00 http://biotechdispatch.com.au/news/qut-joins-artificial-heart-frontiers-program-consortium 2024-06-20T10:17:01+10:00 http://biotechdispatch.com.au/news/biotron-says-bit225-011-meets-objectives-in-hiv-efficacy-trial 2024-06-20T10:00:01+10:00 http://biotechdispatch.com.au/news/merck-life-science-opens-applications-for-2024-anz-advance-biotech-grant-program 2024-06-19T18:18:01+10:00 http://biotechdispatch.com.au/news/opthea-completes-placement-and-institutional-component-of-entitlement-offer 2024-06-18T12:27:01+10:00 http://biotechdispatch.com.au/news/leading-eye-experts-set-out-to-make-smartphones-capable-of-predicting-skin-cancer 2024-06-18T12:20:01+10:00 http://biotechdispatch.com.au/news/us-fda-grants-rare-paediatric-disease-designation-to-race-oncologys-rc220-bisantrene 2024-06-18T11:58:01+10:00 http://biotechdispatch.com.au/news/new-grant-programme-for-quantum-technologies 2024-06-18T11:52:01+10:00 http://biotechdispatch.com.au/news/mark-butler-launches-new-biotech-company-targeting-hard-to-treat-cancers 2024-06-18T11:43:01+10:00 http://biotechdispatch.com.au/news/cervical-cancer-screening-pioneer-among-biotech-sectors-kings-birthday-recipients 2024-06-13T11:24:01+10:00 http://biotechdispatch.com.au/news/qbiotics-says-recruitment-completed-in-phase-2a-clinical-trial-of-tigilanol-tiglate 2024-06-13T11:00:01+10:00 http://biotechdispatch.com.au/news/opthea-taps-investors-to-raise-almost-230-million-to-fund-late-stage-trials 2024-06-13T10:51:01+10:00 http://biotechdispatch.com.au/news/cartherics-secures-an-australian-patent-for-its-cancer-cell-therapy 2024-06-13T10:49:01+10:00 http://biotechdispatch.com.au/news/race-says-bisantrene-highly-active-in-a-mouse-model-of-multiple-myeloma 2024-06-13T10:18:01+10:00 http://biotechdispatch.com.au/news/member-views-sought-on-tgas-companion-diagnostic-guidance-update 2024-06-11T10:25:01+10:00 http://biotechdispatch.com.au/news/fifth-patient-is-treated-with-the-oncosil-device-in-pancosil-trial 2024-06-11T10:04:01+10:00 http://biotechdispatch.com.au/news/artrya-commences-commercial-operations-in-australia-with-agreement-with-the-cardiac-centre-nsw 2024-06-11T09:40:01+10:00 http://biotechdispatch.com.au/news/neuroscientific-completes-fda-pre-ind-meeting-on-emtinb-for-advanced-glaucoma 2024-06-11T09:37:01+10:00 http://biotechdispatch.com.au/news/mcri-and-incepta-pharmaceuticals-partner-to-protect-children-from-rotavirus 2024-06-11T09:27:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-bio-partner-to-deliver-investing-in-australia-roundtable-at-bio-2024 2024-06-06T10:32:01+10:00 http://biotechdispatch.com.au/news/genetic-signatures-secures-fda-clearance-for-gastrointestinal-parasite-detection-kit 2024-06-06T09:41:01+10:00 http://biotechdispatch.com.au/news/chimeric-announces-progress-in-phase-1b-blood-cancer-cell-therapy-trial-1 2024-06-06T09:38:01+10:00 http://biotechdispatch.com.au/news/genomic-profiling-prospect-achieves-a-significant-patient-milestone 2024-06-06T09:37:01+10:00 http://biotechdispatch.com.au/news/cyclopharms-technegas-receives-pass-through-status-from-us-agency 2024-06-06T09:33:01+10:00 http://biotechdispatch.com.au/news/world-intellectual-property-organization-approves-landmark-treaty-on-ip-and-genetic-resources 2024-06-04T11:27:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-supports-team-australia-delegation-at-bio-2024 2024-06-04T11:22:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-signs-mou-with-biocom-california-at-the-2024-bio-convention 2024-06-04T10:50:01+10:00 http://biotechdispatch.com.au/news/fda-approves-avita-medicals-recell-go-system 2024-06-04T10:47:01+10:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-says-new-data-leads-to-isla-101-phase-2-study-changes 2024-06-04T10:46:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-major-capital-raise-and-third-collaboration-with-msd 2024-06-04T10:45:01+10:00 http://biotechdispatch.com.au/news/best-translational-research-awarded-at-ausmedtech-2024 2024-05-30T12:36:01+10:00 http://biotechdispatch.com.au/news/actinogen-says-entitlement-offer-closed-and-oversubscribed 2024-05-30T10:14:01+10:00 http://biotechdispatch.com.au/news/tryptamine-therapeutics-limited-commences-trading-on-the-asx 2024-05-30T09:58:01+10:00 http://biotechdispatch.com.au/news/percheron-therapeutics-completes-recruitment-in-phase-2b-study-o 2024-05-30T09:53:01+10:00 http://biotechdispatch.com.au/news/australian-company-noxopharm-joins-global-alliance-for-mrna-medi 2024-05-30T09:52:01+10:00 http://biotechdispatch.com.au/news/adherium-will-provide-its-hailie-smartinhaler-for-an-astrazeneca 2024-05-28T09:53:01+10:00 http://biotechdispatch.com.au/news/stem-cell-medicine-advancements-to-be-showcased-at-renews-scient 2024-05-28T09:51:01+10:00 http://biotechdispatch.com.au/news/dimerix-announces-middle-east-license-agreement-for-dmx-200 2024-05-28T09:50:01+10:00 http://biotechdispatch.com.au/news/sydney-announced-as-host-location-for-ausmedtech-2025 2024-05-28T09:48:01+10:00 http://biotechdispatch.com.au/news/neuren-says-trial-shows-significant-improvements-in-pitt-hopkins 2024-05-28T09:28:01+10:00 http://biotechdispatch.com.au/news/ausmedtech-2024-underway-in-adelaide-1 2024-05-23T10:58:01+10:00 http://biotechdispatch.com.au/news/cartherics-granted-a-european-patent-for-multiple-development-ca 2024-05-23T10:43:01+10:00 http://biotechdispatch.com.au/news/clinuvel-and-valentech-enter-scenesse-latam-partnership 2024-05-23T10:28:01+10:00 http://biotechdispatch.com.au/news/telix-completes-proof-of-concept-study-of-tlx592-in-prostate-can 2024-05-23T10:19:01+10:00 http://biotechdispatch.com.au/news/ausmedtech-2024-underway-in-adelaide 2024-05-23T10:00:01+10:00 http://biotechdispatch.com.au/news/australian-cell-therapy-company-launches-mid-stage-clinical-tria 2024-05-23T09:54:01+10:00 http://biotechdispatch.com.au/news/australian-cell-therapy-company-launches-mid-stage-clinical-tria 2024-05-23T04:52:01+10:00 http://biotechdispatch.com.au/news/pancreatic-cancer-research-receives-8m-philanthropic-funding-boo 2024-05-21T08:14:01+10:00 http://biotechdispatch.com.au/news/new-centre-to-bring-more-international-eye-clinical-trials-to-vi 2024-05-21T08:00:01+10:00 http://biotechdispatch.com.au/news/australian-comprehensive-cancer-network-launches-across-the-coun 2024-05-21T07:55:01+10:00 http://biotechdispatch.com.au/news/recognising-australias-clinical-trial-capability-at-ausmedtech-2 2024-05-21T07:50:01+10:00 http://biotechdispatch.com.au/news/emerging-australian-biotech-appoints-former-health-minister-to-i 2024-05-21T07:48:01+10:00 http://biotechdispatch.com.au/news/federal-2024-25-budget-wrap-up-for-biotech 2024-05-16T14:16:01+10:00 http://biotechdispatch.com.au/news/anteris-technologies-welcomes-first-procedures-using-its-duravr 2024-05-16T11:47:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-updates-on-dosing-study-of-eye-disease-study 2024-05-16T11:29:01+10:00 http://biotechdispatch.com.au/news/digital-health-research-sector-welcomes-budget-initiatives 2024-05-16T11:24:01+10:00 http://biotechdispatch.com.au/news/chimeric-announces-re-opening-of-phase-1b-study-of-chm-core-nk 2024-05-16T11:09:01+10:00 http://biotechdispatch.com.au/news/tga-seeks-views-on-proposed-medical-device-reform-changes 2024-05-14T13:37:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-plans-to-progress-candidate-to-human-clinical-t 2024-05-14T12:16:01+10:00 http://biotechdispatch.com.au/news/race-shares-the-results-of-preclinical-studies-combining-bisantr 2024-05-14T12:07:01+10:00 http://biotechdispatch.com.au/news/noxopharm-reaches-milestone-and-plans-to-scale-up-production-of- 2024-05-14T11:53:01+10:00 http://biotechdispatch.com.au/news/australian-company-appoints-melbourne-based-cell-therapies-as-pr 2024-05-14T11:44:01+10:00 http://biotechdispatch.com.au/news/cell-gene-catalyst-champions-industry-at-biokorea-2024 2024-05-09T10:25:01+10:00 http://biotechdispatch.com.au/news/novartis-monash-university-and-monash-health-partner-for-heart-h 2024-05-09T10:21:01+10:00 http://biotechdispatch.com.au/news/visabl-afl-trial-for-us-fda-approval-receives-final-approval-at- 2024-05-09T10:05:01+10:00 http://biotechdispatch.com.au/news/launch-of-new-queensland-based-research-and-manufacturing-hub-ta 2024-05-09T09:55:01+10:00 http://biotechdispatch.com.au/news/island-announces-reallocation-of-us-grant-funding-to-support-den 2024-05-09T09:14:01+10:00 http://biotechdispatch.com.au/news/island-announces-reallocation-of-grant-funding-to-directly-suppo 2024-05-08T11:08:01+10:00 http://biotechdispatch.com.au/news/echo-iq-submits-application-seeking-fda-approval-of-ai-supported 2024-05-07T12:15:01+10:00 http://biotechdispatch.com.au/news/tga-seeks-nominations-for-statutory-advisory-committees 2024-05-07T12:00:01+10:00 http://biotechdispatch.com.au/news/polynovo-announces-appointment-of-general-counsel-and-company-se 2024-05-07T11:11:01+10:00 http://biotechdispatch.com.au/news/scholarships-open-for-supporting-women-into-stem-careers 2024-05-07T10:52:01+10:00 http://biotechdispatch.com.au/news/cureator-deploys-721-million-to-propel-local-life-sciences-poten 2024-05-07T10:40:01+10:00 http://biotechdispatch.com.au/news/industry-applauds-funding-commitment-for-national-one-stop-shop- 2024-05-02T11:58:01+10:00 http://biotechdispatch.com.au/news/immutep-reports-positive-initial-clinical-data-from-eftisarc-neo 2024-05-02T09:50:01+10:00 http://biotechdispatch.com.au/news/anatara-lifesciences-announces-the-completion-of-successful-plac 2024-05-02T09:39:01+10:00 http://biotechdispatch.com.au/news/illumina-partners-with-the-garvan-on-major-new-genome-project 2024-05-02T09:32:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announces-resignation-of-ceo-and-managing- 2024-05-02T09:20:01+10:00 http://biotechdispatch.com.au/news/ausmedtechinvest-keynote-and-panel-speakers-announced 2024-04-30T10:36:01+10:00 http://biotechdispatch.com.au/news/mesoblast-announces-the-appointment-of-new-board-chair 2024-04-30T10:29:01+10:00 http://biotechdispatch.com.au/news/opyl-expands-trialkey-coverage-revolutionising-ai-clinical-trial 2024-04-30T09:00:01+10:00 http://biotechdispatch.com.au/news/fivephusion-announces-ethics-approval-of-phase-1b-trial-of-defle 2024-04-30T08:03:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-presents-new-data-demonstrating-potential- 2024-04-30T07:53:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-announces-incoming-ceo 2024-04-23T13:55:01+10:00 http://biotechdispatch.com.au/news/osteopore-launches-first-first-in-human-clinical-trials-begin-in 2024-04-23T09:37:01+10:00 http://biotechdispatch.com.au/news/tour-de-cure-backs-further-development-of-noxopharms-preclinical 2024-04-23T09:33:01+10:00 http://biotechdispatch.com.au/news/mark-butler-announces-nhmrc-funding-for-six-telehealth-research- 2024-04-23T09:33:01+10:00 http://biotechdispatch.com.au/news/bms-and-australian-venture-capital-firm-back-immunotherapy-compa 2024-04-23T09:31:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-submits-response-on-nsw-innovation-blueprint 2024-04-18T10:38:01+10:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-records-another-quarter-of-strong-revenue- 2024-04-18T10:31:01+10:00 http://biotechdispatch.com.au/news/immutep-appoints-research-institute-to-conduct-first-in-human-st 2024-04-18T10:24:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-says-australia-poised-to-lead-revolution-in-radiophar 2024-04-18T10:10:01+10:00 http://biotechdispatch.com.au/news/bioxyne-receives-commitments-to-raise-funds-to-further-product-d 2024-04-18T09:50:01+10:00 http://biotechdispatch.com.au/news/telixs-tlx101-cdx-granted-fast-track-designation-by-us-fda 2024-04-16T10:59:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-the-medical-science-co-investment-plan 2024-04-16T09:47:01+10:00 http://biotechdispatch.com.au/news/next-science-says-study-shows-efficacy-in-reducing-infection-whe 2024-04-16T09:33:01+10:00 http://biotechdispatch.com.au/news/first-turkish-patient-treated-with-oncosil-cancer-treatment-devi 2024-04-16T09:26:01+10:00 http://biotechdispatch.com.au/news/dorsavi-enters-aged-care-market-with-proprietary-natural-movemen 2024-04-16T09:09:01+10:00 http://biotechdispatch.com.au/news/seaport-therapeutics-receives-100-million-in-funding-to-maximise 2024-04-16T09:03:01+10:00 http://biotechdispatch.com.au/news/join-the-australian-delegation-to-bio-2024 2024-04-11T10:41:01+10:00 http://biotechdispatch.com.au/news/atmo-biosciences-reaches-primary-endpoints-in-pivotal-clinical-s 2024-04-11T10:21:01+10:00 http://biotechdispatch.com.au/news/cleo-appoints-organisation-to-manage-us-ovarian-cancer-clinical- 2024-04-11T09:56:01+10:00 http://biotechdispatch.com.au/news/monash-partners-comprehensive-cancer-consortium-awards-precision 2024-04-11T09:33:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-secures-investor-commitments-to-support-pipelin 2024-04-11T09:16:01+10:00 http://biotechdispatch.com.au/news/cell-gene-catalyst-webinar-to-highlight-opportunities-for-sector 2024-04-09T10:15:01+10:00 http://biotechdispatch.com.au/news/algorae-pharmaceuticals-reports-positive-pre-clinical-neuronal-c 2024-04-09T09:51:01+10:00 http://biotechdispatch.com.au/news/biotron-provides-update-on-preliminary-analyses-of-data-from-bit 2024-04-09T09:48:01+10:00 http://biotechdispatch.com.au/news/starpharma-partners-with-uk-investment-firm-to-create-petalion-t 2024-04-09T09:47:01+10:00 http://biotechdispatch.com.au/news/chimeric-secures-us-patent-for-its-chm-0201-cell-therapy-platfor 2024-04-09T09:45:01+10:00 http://biotechdispatch.com.au/news/sponsors-given-opportunity-to-review-proposed-benefits 2024-04-04T12:02:01+11:00 http://biotechdispatch.com.au/news/opthea-appoints-sujal-shah-to-its-board-of-directors 2024-04-04T09:40:01+11:00 http://biotechdispatch.com.au/news/imugenes-oncolytic-virotherapy-cf33-patent-granted-in-china 2024-04-04T09:34:01+11:00 http://biotechdispatch.com.au/news/accc-says-it-will-not-oppose-revised-cochlear-oticon-medical-tra 2024-04-04T09:22:01+11:00 http://biotechdispatch.com.au/news/percheron-therapeutics-provides-update-on-atl1102-duchenne-muscu 2024-04-04T09:15:01+11:00 http://biotechdispatch.com.au/news/optiscan-imagine-announces-the-appointment-of-us-clinical-and-re 2024-04-02T12:22:01+11:00 http://biotechdispatch.com.au/news/call-for-sessions-and-speakers-for-australias-biggest-week-in-bi 2024-04-02T12:19:01+11:00 http://biotechdispatch.com.au/news/artrya-commences-commercial-operations-in-australia-under-agreem 2024-04-02T11:34:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-says-nasodine-phase-2-covid-19-trial-results-pu 2024-04-02T11:24:01+11:00 http://biotechdispatch.com.au/news/cartherics-enters-new-collaborative-research-agreement-with-tica 2024-04-02T11:12:01+11:00 http://biotechdispatch.com.au/news/ausmedtech-2024-programme-launched 2024-03-28T11:49:01+11:00 http://biotechdispatch.com.au/news/clarity-successfully-completes-placement-and-institutional-entit 2024-03-28T10:15:01+11:00 http://biotechdispatch.com.au/news/osteopore-announces-singapore-and-vietnam-market-approvals 2024-03-28T10:08:01+11:00 http://biotechdispatch.com.au/news/csl-prices-us125-billion-in-new-corporate-bonds 2024-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/amplia-therapeutics-updates-on-next-stage-of-accent-pancreatic-c 2024-03-28T09:34:01+11:00 http://biotechdispatch.com.au/news/clarity-pharmaceuticals-launches-121-million-fully-underwritten- 2024-03-26T11:50:01+11:00 http://biotechdispatch.com.au/news/sector-invited-to-support-national-strategy-for-non-animal-resea 2024-03-26T09:38:01+11:00 http://biotechdispatch.com.au/news/reaching-this-point-in-the-development-of-bisantrene-is-a-major- 2024-03-26T09:24:01+11:00 http://biotechdispatch.com.au/news/cochlear-announces-the-resignation-of-non-executive-director-yas 2024-03-26T09:19:01+11:00 http://biotechdispatch.com.au/news/orthocell-completes-all-nerve-repair-surgeries-in-remplir-us-mar 2024-03-26T09:18:01+11:00 http://biotechdispatch.com.au/news/cicada-innovations-launches-healthtech-hub-in-sydneys-hidden-inn 2024-03-26T09:09:01+11:00 http://biotechdispatch.com.au/news/gut-microbiome-and-gene-editing-projects-share-in-3-million-rese 2024-03-21T11:09:01+11:00 http://biotechdispatch.com.au/news/cell-gene-catalyst-submits-feedback-on-hta-consultation 2024-03-21T11:01:01+11:00 http://biotechdispatch.com.au/news/applications-open-for-modernas-2024-australia-fellowship-program 2024-03-20T15:25:01+11:00 http://biotechdispatch.com.au/news/ltr-pharma-says-first-patient-first-dose-in-the-spontan-pivotal- 2024-03-20T15:23:01+11:00 http://biotechdispatch.com.au/news/rhythm-biosciences-establishes-internationally-renowned-clinical 2024-03-20T15:22:01+11:00 http://biotechdispatch.com.au/news/queenslands-biomedical-grant-programme-opens 2024-03-19T11:14:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-says-milestone-achieved-with-first-us-patients-imaged 2024-03-19T10:48:01+11:00 http://biotechdispatch.com.au/news/telix-announces-qdose-platform-partnership-for-personalised-dosi 2024-03-19T10:36:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-announces-the-completion-of-institutional-place 2024-03-19T10:13:01+11:00 http://biotechdispatch.com.au/news/csiro-announces-the-appointment-of-new-australian-centre-for-dis 2024-03-19T08:29:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-new-board-observer 2024-03-14T09:39:01+11:00 http://biotechdispatch.com.au/news/neurotech-international-announces-extension-of-nti164-in-female- 2024-03-14T09:27:01+11:00 http://biotechdispatch.com.au/news/althea-group-welcomes-french-plan-to-legalise-medicinal-cannabis 2024-03-14T09:20:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-announces-that-its-apas-pharmaqc-product-is-comm 2024-03-14T09:07:01+11:00 http://biotechdispatch.com.au/news/dimerix-raises-20-million-to-continue-and-expand-late-stage-clin 2024-03-14T09:06:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-launches-asx-feed 2024-03-12T10:54:01+11:00 http://biotechdispatch.com.au/news/snow-medical-research-foundation-announces-grrant-for-uq-genetic 2024-03-12T10:47:01+11:00 http://biotechdispatch.com.au/news/anteris-technologies-welcomes-updated-duravr-thv-for-serious-hea 2024-03-12T10:30:01+11:00 http://biotechdispatch.com.au/news/imricor-says-paris-based-cv-institute-grants-ethics-approval-for 2024-03-12T10:28:01+11:00 http://biotechdispatch.com.au/news/mesoblast-says-us-fda-feedback-indicates-support-for-accelerated 2024-03-12T10:26:01+11:00 http://biotechdispatch.com.au/news/proteomics-international-retains-its-iso-13485-certification 2024-03-07T08:59:01+11:00 http://biotechdispatch.com.au/news/innovations-in-equality-highlighted-on-international-womens-day 2024-03-07T08:58:01+11:00 http://biotechdispatch.com.au/news/nyrada-successfully-raises-1755-million-to-support-the-developme 2024-03-07T08:37:01+11:00 http://biotechdispatch.com.au/news/clarity-pharmaceuticals-says-sar-bispsma-detects-pc-lesions-in-t 2024-03-07T08:36:01+11:00 http://biotechdispatch.com.au/news/adalta-announces-positive-results-from-phase-1-extension-study-o 2024-03-07T08:34:01+11:00 http://biotechdispatch.com.au/news/member-views-sought-to-inform-nsws-innovation-blueprint 2024-03-05T10:53:01+11:00 http://biotechdispatch.com.au/news/invion-announces-positive-results-from-pre-clinical-study-of-inv 2024-03-05T10:36:01+11:00 http://biotechdispatch.com.au/news/telix-announces-major-acquisition-of-canadian-based-artms 2024-03-05T10:28:01+11:00 http://biotechdispatch.com.au/news/data-management-company-enlitic-appoints-experienced-executive-t 2024-03-05T10:26:01+11:00 http://biotechdispatch.com.au/news/emvision-medical-devices-secures-strategic-investment-from-us-ba 2024-03-05T10:24:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-submits-feedback-on-tga-fees-and-charges-consultation 2024-02-29T10:43:01+11:00 http://biotechdispatch.com.au/news/artrya-progresses-fda-application-ahead-of-us-commercial-launch 2024-02-29T10:26:01+11:00 http://biotechdispatch.com.au/news/pharmaust-reports-positive-top-line-results-from-phase-1-mend-st 2024-02-29T10:09:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-reports-fourth-quarter-royalties-from-day 2024-02-29T10:00:01+11:00 http://biotechdispatch.com.au/news/nyrada-says-preclinical-brain-injury-study-shows-statistically-s 2024-02-29T09:59:01+11:00 http://biotechdispatch.com.au/news/recommendations-made-to-increase-diversity-in-australias-stem-in 2024-02-27T11:42:01+11:00 http://biotechdispatch.com.au/news/telix-says-strong-revenue-growth-underpins-investment-in-late-st 2024-02-27T11:28:01+11:00 http://biotechdispatch.com.au/news/dimerix-announces-successful-collection-of-data-for-first-patien 2024-02-27T10:45:01+11:00 http://biotechdispatch.com.au/news/little-green-pharma-welcomes-legislative-changes-in-germany 2024-02-27T09:24:01+11:00 http://biotechdispatch.com.au/news/investors-back-avita-medical-after-it-reported-full-year-results 2024-02-27T09:21:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-confirms-deliver-of-apas-pharmaqc-to-thermo-fish 2024-02-22T11:12:01+11:00 http://biotechdispatch.com.au/news/ivds-used-in-fmt-screening-exempt-from-class-4-ivd-requirement 2024-02-22T11:08:01+11:00 http://biotechdispatch.com.au/news/clinuvel-reports-increased-revenue-for-six-months-to-the-end-of- 2024-02-22T11:01:01+11:00 http://biotechdispatch.com.au/news/adherium-exhibiting-its-hailie-platform-at-major-us-meeting 2024-02-22T10:07:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-says-ttra-program-delivering-at-its-halfway-mark 2024-02-22T09:58:01+11:00 http://biotechdispatch.com.au/news/monash-to-lead-australian-revolution-in-next-generation-heart-de 2024-02-20T12:53:01+11:00 http://biotechdispatch.com.au/news/csl-seqirus-welcomes-extended-approval-for-iron-treatment 2024-02-20T12:51:01+11:00 http://biotechdispatch.com.au/news/inaugural-ausmedtechinvest-2024-launched 2024-02-20T12:49:01+11:00 http://biotechdispatch.com.au/news/ltr-pharma-says-patient-recruitment-commences-for-pivotal-clinic 2024-02-20T12:44:01+11:00 http://biotechdispatch.com.au/news/certa-therapeutics-ft011-granted-us-fda-fast-track-for-systemic- 2024-02-20T12:39:01+11:00 http://biotechdispatch.com.au/news/csiro-launches-free-sme-programme-for-medtech-and-digital-health 2024-02-15T12:38:01+11:00 http://biotechdispatch.com.au/news/government-selects-brandon-biocatalyst-in-partnership-with-andhe 2024-02-15T12:26:01+11:00 http://biotechdispatch.com.au/news/opthea-completes-enrolment-in-first-pivotal-trial-with-soziniber 2024-02-15T12:19:01+11:00 http://biotechdispatch.com.au/news/claritys-announces-positive-results-of-us-based-cobra-prostate-c 2024-02-15T12:09:01+11:00 http://biotechdispatch.com.au/news/syntara-launches-new-blood-cancer-trial-of-lead-candidate 2024-02-15T12:06:01+11:00 http://biotechdispatch.com.au/news/immuon-reports-record-sales-of-travelan-immune-supplement 2024-02-13T10:39:01+11:00 http://biotechdispatch.com.au/news/nsw-women-in-life-sciences-luncheon-2024-speakers-announced 2024-02-13T09:25:01+11:00 http://biotechdispatch.com.au/news/csl-reports-strong-first-half-growth-with-immunoglobulins-the-hi 2024-02-13T09:05:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-announces-the-appointment-of-new-chief-financial-offi 2024-02-13T09:03:01+11:00 http://biotechdispatch.com.au/news/lumos-appoints-henry-schein-as-us-distributor-for-febridx 2024-02-13T08:58:01+11:00 http://biotechdispatch.com.au/news/competition-opens-to-elevate-early-stage-medtech-pitches 2024-02-08T09:52:01+11:00 http://biotechdispatch.com.au/news/first-patient-receives-treatment-in-chimerics-trial-of-chm-0201- 2024-02-08T09:36:01+11:00 http://biotechdispatch.com.au/news/cochlear-upgrades-earnings-guidance-on-better-than-expected-impl 2024-02-08T09:29:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-secures-share-facility-agreement 2024-02-08T09:16:01+11:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-signs-mou-with-indonesian-partner-to-progr 2024-02-08T09:13:01+11:00 http://biotechdispatch.com.au/news/sustainable-funding-sought-for-national-one-stop-shop-for-clinic 2024-02-06T10:15:01+11:00 http://biotechdispatch.com.au/news/opyls-opin-secures-patient-recruitment-contract-for-us-based-lum 2024-02-06T10:08:01+11:00 http://biotechdispatch.com.au/news/radiopharm-updates-on-models-of-pan-cancer-antibody-dunp19 2024-02-06T09:48:01+11:00 http://biotechdispatch.com.au/news/deflexifol-clinical-data-presented-at-asco-gastrointestinal-canc 2024-02-06T09:47:01+11:00 http://biotechdispatch.com.au/news/bioxyne-secures-australias-first-gmp-license-for-psilocybin-and- 2024-02-06T09:46:01+11:00 http://biotechdispatch.com.au/news/cell-gene-catalyst-working-groups-members-announced 2024-02-01T12:42:01+11:00 http://biotechdispatch.com.au/news/little-green-pharma-confirms-it-has-received-5-million-rd-tax-re 2024-02-01T12:18:01+11:00 http://biotechdispatch.com.au/news/little-green-pharma-confirms-it-has-received-5-million-rd-tax-re 2024-02-01T12:18:01+11:00 http://biotechdispatch.com.au/news/cartherics-completes-successful-pre-ind-meeting-with-us-fda 2024-02-01T12:12:01+11:00 http://biotechdispatch.com.au/news/adherium-appoints-experienced-industry-leader-as-new-ceo 2024-02-01T10:40:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-files-positive-report-for-final-quarter-o 2024-02-01T09:44:01+11:00 http://biotechdispatch.com.au/news/pioneering-melanoma-researchers-named-2024-australian-of-the-yea 2024-01-30T11:07:01+11:00 http://biotechdispatch.com.au/news/arovella-licences-novel-carinkt-cell-armouring-technology 2024-01-30T10:58:01+11:00 http://biotechdispatch.com.au/news/pharmaust-announces-ethics-committee-approval-for-mnd-extension- 2024-01-30T09:48:01+11:00 http://biotechdispatch.com.au/news/starpharma-says-viraleze-shows-antiviral-efficacy-in-covid-19-pa 2024-01-30T08:58:01+11:00 http://biotechdispatch.com.au/news/aroa-says-new-evidence-from-pilot-study-paves-the-way-for-potent 2024-01-30T08:42:01+11:00 http://biotechdispatch.com.au/news/resmed-reports-revenue-growth-for-final-three-months-of-2023 2024-01-25T12:04:01+11:00 http://biotechdispatch.com.au/news/placement-of-entitlement-offer-shortfall-on-31-october-2023-radi 2024-01-25T11:59:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-members-invited-to-capital-attraction-roundtable 2024-01-25T11:58:01+11:00 http://biotechdispatch.com.au/news/aravax-closes-funding-round-to-accelerate-development-for-peanut 2024-01-24T10:16:01+11:00 http://biotechdispatch.com.au/news/new-years-resolutions-for-a-healthy-future-1 2024-01-23T06:57:01+11:00 http://biotechdispatch.com.au/news/avita-medical-signs-us-distribution-agreement-with-stedical-scie 2024-01-23T06:23:01+11:00 http://biotechdispatch.com.au/news/aft-broadens-rd-pipeline-with-new-product-candidate-in-burning-m 2024-01-23T05:36:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-completes-placement-with-shortfall-commitm 2024-01-23T05:28:01+11:00 http://biotechdispatch.com.au/news/opthea-receives-additional-funding-under-development-funding-agr 2024-01-23T05:17:01+11:00 http://biotechdispatch.com.au/news/a-year-of-collective-success-2023-in-review 2023-12-19T10:51:01+11:00 http://biotechdispatch.com.au/news/envision-sciences-announces-thee-appointment-of-new-chief-execut 2023-12-19T10:03:01+11:00 http://biotechdispatch.com.au/news/telix-submits-application-for-tlx250-cdx-for-kidney-cancer-imagi 2023-12-19T09:53:01+11:00 http://biotechdispatch.com.au/news/carina-biotech-doses-first-patient-in-phase-12a-trial-of-lgr5-ta 2023-12-19T09:48:01+11:00 http://biotechdispatch.com.au/news/azura-ophthalmics-reports-positive-results-in-trial-of-people-wi 2023-12-19T09:37:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-announces-top-line-results-of-phase-2-nnz 2023-12-19T09:33:01+11:00 http://biotechdispatch.com.au/news/brooker-consulting-launches-two-new-initiative-for-life-science- 2023-12-14T10:57:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-journal-articles-1 2023-12-14T10:53:01+11:00 http://biotechdispatch.com.au/news/cmax-clinical-research-preparing-to-celebrate-three-decades-of-c 2023-12-14T10:29:01+11:00 http://biotechdispatch.com.au/news/syntara-commences-dosing-in-phase-2-myelofibrosis-trial-of-its-p 2023-12-14T09:36:01+11:00 http://biotechdispatch.com.au/news/fda-grants-fast-track-designation-for-engeneics-pancreatic-cance 2023-12-14T09:35:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-ex-tga-head-and-ceo-of-argenica-therapeutics 2023-12-12T13:10:01+11:00 http://biotechdispatch.com.au/news/australias-clinical-trial-sector-connects-at-ausbiotech-2023 2023-12-12T10:20:01+11:00 http://biotechdispatch.com.au/news/4dmedical-launches-capital-raise-to-fund-acquisition-of-us-based 2023-12-12T09:58:01+11:00 http://biotechdispatch.com.au/news/victorian-government-backs-the-development-of-cybans-brain-injur 2023-12-12T09:47:01+11:00 http://biotechdispatch.com.au/news/new-leadership-for-health-security-systems-australia 2023-12-12T09:34:01+11:00 http://biotechdispatch.com.au/news/prescient-announces-the-results-of-ptx-100-phase-1b-study-in-t-c 2023-12-12T09:32:01+11:00 http://biotechdispatch.com.au/news/australias-cell-and-gene-catalyst-calls-for-expressions-of-inter 2023-12-07T10:38:01+11:00 http://biotechdispatch.com.au/news/cynata-therapeutics-secures-approval-for-phase-2-trial-in-turkey 2023-12-07T10:01:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-completes-enrolment-in-pitt-hopkins-syndr 2023-12-07T10:00:01+11:00 http://biotechdispatch.com.au/news/telix-says-the-first-patient-dosed-in-european-early-access-prog 2023-12-07T10:00:01+11:00 http://biotechdispatch.com.au/news/microba-life-sciences-announces-results-of-successful-phase-ibd- 2023-12-07T10:00:01+11:00 http://biotechdispatch.com.au/news/new-ausbionsw-committee-chair-appointed-state-strategy-developed 2023-12-05T10:14:01+11:00 http://biotechdispatch.com.au/news/fda-confirms-approach-to-sofdra-nda-resubmission-and-the-materia 2023-12-05T10:05:01+11:00 http://biotechdispatch.com.au/news/pharmaust-completes-phase-1-mend-study-and-files-for-us-orphan-d 2023-12-05T10:02:01+11:00 http://biotechdispatch.com.au/news/oncosil-medical-onboards-first-patient-in-the-pancosil-clinical- 2023-12-05T10:01:01+11:00 http://biotechdispatch.com.au/news/korean-regulator-approves-amplia-therapeutics-pancreatic-cancer- 2023-12-05T10:00:01+11:00 http://biotechdispatch.com.au/news/national-reconstruction-fund-investment-mandate-released 2023-11-30T07:00:01+11:00 http://biotechdispatch.com.au/news/claritys-theranostic-prostate-cancer-trial-progresses-at-the-hig 2023-11-30T06:00:01+11:00 http://biotechdispatch.com.au/news/4dmedical-and-philips-sign-memorandum-of-understanding 2023-11-30T05:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-provides-additional-information-on-vitro-d 2023-11-30T05:00:01+11:00 http://biotechdispatch.com.au/news/microba-completes-stage-one-screening-for-its-autoimmune-disease 2023-11-30T05:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-weighs-in-on-australias-rna-future 2023-11-28T10:18:01+11:00 http://biotechdispatch.com.au/news/federal-government-backs-the-development-of-treatment-for-childh 2023-11-28T10:12:01+11:00 http://biotechdispatch.com.au/news/medical-science-a-priority-area-for-new-industry-growth-program 2023-11-28T10:09:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-doses-first-cohort-in-isla-101-study 2023-11-28T10:08:01+11:00 http://biotechdispatch.com.au/news/dimerixs-action3-investigational-new-drug-approved-in-china 2023-11-28T09:52:01+11:00 http://biotechdispatch.com.au/news/the-cell-and-gene-catalyst-call-for-change-in-submission-to-scop 2023-11-23T10:30:01+11:00 http://biotechdispatch.com.au/news/antimicrobial-resistance-highlighted-in-global-campaign-1 2023-11-23T10:14:01+11:00 http://biotechdispatch.com.au/news/successful-clinical-trial-for-re-engineered-uq-vaccine 2023-11-23T09:39:01+11:00 http://biotechdispatch.com.au/news/alterity-therapeutics-raises-48-million-in-new-placement 2023-11-23T09:20:01+11:00 http://biotechdispatch.com.au/news/australian-company-announces-the-appointment-of-new-chief-execut 2023-11-23T09:00:01+11:00 http://biotechdispatch.com.au/news/4dmedical-receives-us-fda-clearance-for-its-ct-based-ventilation 2023-11-21T10:32:01+11:00 http://biotechdispatch.com.au/news/anteris-reports-positive-30-day-haemodynamic-results-from-trial 2023-11-21T10:06:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announces-presentation-of-trial-at-major-u 2023-11-21T09:56:01+11:00 http://biotechdispatch.com.au/news/best-early-stage-projects-awarded-at-ausbiotech-2023 2023-11-21T09:55:01+11:00 http://biotechdispatch.com.au/news/orthocell-announces-final-positive-results-of-cell-therapy-in-te 2023-11-21T09:53:01+11:00 http://biotechdispatch.com.au/news/biotech-headed-to-the-hill-for-ausbiotechs-policy-forum 2023-11-16T11:53:01+11:00 http://biotechdispatch.com.au/news/us-fda-grants-argenica-therapeutics-arg-007-orphan-drug-designat 2023-11-16T11:48:01+11:00 http://biotechdispatch.com.au/news/alterity-therapeutics-announces-presentation-of-new-data-demonst 2023-11-16T11:37:01+11:00 http://biotechdispatch.com.au/news/certa-therapeutics-presents-positive-data-from-phase-2-clinical- 2023-11-16T11:37:01+11:00 http://biotechdispatch.com.au/news/certa-therapeutics-presents-positive-data-from-phase-2-clinical- 2023-11-16T10:56:01+11:00 http://biotechdispatch.com.au/news/monash-harnesses-new-frontier-in-technology-to-propel-promising- 2023-11-16T10:00:01+11:00 http://biotechdispatch.com.au/news/new-report-demonstrates-benefit-of-long-term-policy-commitment 2023-11-14T09:35:01+11:00 http://biotechdispatch.com.au/news/university-of-queensland-to-establish-world-leading-mrna-lab 2023-11-14T09:22:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-says-fourth-candidate-has-potential-in-polycyst 2023-11-14T08:31:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-completes-phelan-mcdermid-syndrome-phase- 2023-11-14T08:00:01+11:00 http://biotechdispatch.com.au/news/telix-says-first-patient-dosed-in-prostact-study-of-prostate-can 2023-11-14T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-election-results-and-board-changes-announced 2023-11-09T11:22:01+11:00 http://biotechdispatch.com.au/news/recruitment-target-achieved-for-phase-ii-sar-bombesin-prostate-c 2023-11-07T10:29:01+11:00 http://biotechdispatch.com.au/news/dimerix-receives-first-payment-from-uk-based-partner-for-dmx-200 2023-11-07T10:02:01+11:00 http://biotechdispatch.com.au/news/immutep-announces-the-completion-of-key-stage-of-aipac-003-trial 2023-11-07T10:01:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-secures-fda-agreement-on-clinical-trial-pathway 2023-11-07T09:59:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-2023-underway-in-queensland 2023-11-02T14:36:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-says-first-patient-doses-in-phase-1b-gliob 2023-11-02T10:17:01+11:00 http://biotechdispatch.com.au/news/next-cohort-reached-in-intravenous-arms-of-monotherapy-and-combi 2023-11-02T09:58:01+11:00 http://biotechdispatch.com.au/news/new-report-quantifies-the-importance-of-rd-tax-incentive-on-aust 2023-11-02T09:53:01+11:00 http://biotechdispatch.com.au/news/eminent-australian-to-lead-one-stop-shop-clinical-trials-reform- 2023-11-02T09:40:01+11:00 http://biotechdispatch.com.au/news/ausbioinvest-2023-connects-innovators-with-investment 2023-10-31T10:25:01+11:00 http://biotechdispatch.com.au/news/emyria-secures-ethics-dndorsement-for-mdma-authorised-prescriber 2023-10-31T08:57:01+11:00 http://biotechdispatch.com.au/news/lumos-diagnostics-raises-265-million-in-placement-to-existing-in 2023-10-31T08:52:01+11:00 http://biotechdispatch.com.au/news/bio-gene-technology-announces-the-appointment-of-joint-company-s 2023-10-31T08:38:01+11:00 http://biotechdispatch.com.au/news/opthea-announces-leadership-transition-with-the-appointment-of-u 2023-10-31T08:29:01+11:00 http://biotechdispatch.com.au/news/top-performing-asx-life-science-companies-1 2023-10-26T10:14:01+11:00 http://biotechdispatch.com.au/news/anteris-reports-positive-results-from-interim-analysis-of-its-us 2023-10-26T10:08:01+11:00 http://biotechdispatch.com.au/news/phase-1-clinical-trial-opens-with-oncarlytics-cd19-virus-technol 2023-10-26T09:54:01+11:00 http://biotechdispatch.com.au/news/chimeric-to-raise-approximately-10-million-through-entitlement-o 2023-10-26T09:44:01+11:00 http://biotechdispatch.com.au/news/projected-us-australia-biotech-trade-could-inject-us-10-billion- 2023-10-26T09:34:01+11:00 http://biotechdispatch.com.au/news/ausbioinvest-2023-programme-launched 2023-10-24T10:12:01+11:00 http://biotechdispatch.com.au/news/certa-therapeutics-ft011-granted-us-fda-orphan-drug-designation- 2023-10-24T09:52:01+11:00 http://biotechdispatch.com.au/news/adalta-reports-favourable-patient-tolerability-after-third-dose- 2023-10-24T09:34:01+11:00 http://biotechdispatch.com.au/news/chimeric-announces-positive-preliminary-data-for-cltx-car-t-in-b 2023-10-24T09:33:01+11:00 http://biotechdispatch.com.au/news/positive-efficacy-result-for-immuteps-efti-in-combination-with-m 2023-10-24T09:31:01+11:00 http://biotechdispatch.com.au/news/cartherics-announces-the-appointment-of-new-chief-scientific-off 2023-10-19T06:00:01+11:00 http://biotechdispatch.com.au/news/us-fda-gives-green-light-for-trivehexin-diagnostic-phase-1-pancr 2023-10-19T06:00:01+11:00 http://biotechdispatch.com.au/news/clinuvel-announces-the-starts-global-phase-3-vitiligo-clinical-t 2023-10-18T06:00:01+11:00 http://biotechdispatch.com.au/news/shortage-in-regional-nuclear-medicine-workforce-attracts-new-fin 2023-10-18T06:00:01+11:00 http://biotechdispatch.com.au/news/jp-morgans-chairman-of-investment-banking-announced-as-ausbioinv 2023-10-18T06:00:01+11:00 http://biotechdispatch.com.au/news/australian-biotechnologists-and-scientists-celebrated-in-prime-m 2023-10-17T10:09:01+11:00 http://biotechdispatch.com.au/news/victoria-backing-australias-first-stem-cell-trial-for-rare-genet 2023-10-17T10:00:01+11:00 http://biotechdispatch.com.au/news/anatara-announces-positive-results-from-analysis-of-secondary-en 2023-10-17T09:26:01+11:00 http://biotechdispatch.com.au/news/pharmaust-says-sinal-mnd-patient-in-cohort-4-successfully-comple 2023-10-17T09:11:01+11:00 http://biotechdispatch.com.au/news/prescient-to-announce-phase-1b-cancer-trial-results-at-worlds-la 2023-10-17T09:00:01+11:00 http://biotechdispatch.com.au/news/oculus-biomed-partners-with-centre-for-eye-research-australia-in 2023-10-12T10:56:01+11:00 http://biotechdispatch.com.au/news/arovella-therapeutics-licences-monoclonal-antibody-for-cell-ther 2023-10-12T10:40:01+11:00 http://biotechdispatch.com.au/news/melodiol-says-subsidiary-halucenex-reports-remission-in-80-perce 2023-10-12T10:34:01+11:00 http://biotechdispatch.com.au/news/imricor-medical-systems-commences-new-activation-site-in-croatia 2023-10-12T10:28:01+11:00 http://biotechdispatch.com.au/news/posthumous-recognition-of-benevolent-billionaire-1 2023-10-12T10:20:01+11:00 http://biotechdispatch.com.au/news/training-session-on-new-prescribed-list-products 2023-10-10T11:57:01+11:00 http://biotechdispatch.com.au/news/adherium-has-commenced-production-and-market-release-of-the-new- 2023-10-10T11:49:01+11:00 http://biotechdispatch.com.au/news/fivephusion-announces-the-appointment-of-experienced-industry-ex 2023-10-10T11:45:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-receives-approval-for-study-of-pdl1-nano 2023-10-10T11:44:01+11:00 http://biotechdispatch.com.au/news/pharmaust-says-data-from-canine-oncology-study-supports-progress 2023-10-10T11:43:01+11:00 http://biotechdispatch.com.au/news/director-appointed-to-australias-cell-and-gene-catalyst 2023-10-05T12:34:01+11:00 http://biotechdispatch.com.au/news/dimerix-and-advanz-pharma-enter-agreement-to-commercialise-dmx-2 2023-10-05T12:28:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-says-studies-show-program-effective-in-key-mode 2023-10-05T12:20:01+11:00 http://biotechdispatch.com.au/news/atmo-biosciences-reaches-60-per-cent-recruitment-target-in-dysmo 2023-10-04T12:22:01+11:00 http://biotechdispatch.com.au/news/us-fda-grants-orphan-drug-designation-for-noxopharms-cro-67 2023-10-04T12:21:01+11:00 http://biotechdispatch.com.au/news/csl-announces-seven-new-global-research-acceleration-initiative- 2023-10-04T11:55:01+11:00 http://biotechdispatch.com.au/news/polynovo-received-an-additional-us10-million-in-funding-from-bar 2023-10-03T09:39:01+11:00 http://biotechdispatch.com.au/news/a-name-change-and-significant-sale-as-pharmaxis-becomes-syntara 2023-10-03T09:23:01+11:00 http://biotechdispatch.com.au/news/increase-your-company-profile-via-global-life-sciences-directory 2023-10-03T09:16:01+11:00 http://biotechdispatch.com.au/news/bionomics-announces-positive-topline-results-from-clinical-trial 2023-10-03T07:54:01+11:00 http://biotechdispatch.com.au/news/cyclopharm-announces-us-approval-for-nuclear-medicine-imaging-ag 2023-10-03T07:53:01+11:00 http://biotechdispatch.com.au/news/novel-therapeutics-development-highlighted-in-australasian-biote 2023-09-28T09:13:01+10:00 http://biotechdispatch.com.au/news/starpharma-announces-the-presentation-of-dep-irinotecan-combinat 2023-09-28T08:52:01+10:00 http://biotechdispatch.com.au/news/completion-of-bisantrene-cgmp-api-manufacturing-at-laurus-labs 2023-09-28T08:47:01+10:00 http://biotechdispatch.com.au/news/national-team-to-advance-innovative-biopolymer-particle-based-pl 2023-09-28T08:41:01+10:00 http://biotechdispatch.com.au/news/uq-and-oxford-nanopore-technologies-team-up-to-accelerate-resear 2023-09-28T08:34:01+10:00 http://biotechdispatch.com.au/news/healthtech-innovationaus-award-finalists-announced 2023-09-26T11:29:01+10:00 http://biotechdispatch.com.au/news/avita-medical-receives-best-product-ward-at-the-american-associa 2023-09-26T09:00:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-says-safety-review-committee-approves-dose-esca 2023-09-26T08:24:01+10:00 http://biotechdispatch.com.au/news/us-fda-grants-conditional-approval-to-the-brand-name-of-dimerixs 2023-09-26T08:00:01+10:00 http://biotechdispatch.com.au/news/polynovo-updates-investors-with-significant-revenue-growth 2023-09-26T08:00:01+10:00 http://biotechdispatch.com.au/news/rhythm-biosciences-provides-breast-cancer-diagnostic-test-update 2023-09-21T10:09:01+10:00 http://biotechdispatch.com.au/news/immutep-welcomes-authorisation-of-commercial-manufacturing-of-ef 2023-09-21T09:56:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-announces-the-departure-of-ceo 2023-09-21T09:48:01+10:00 http://biotechdispatch.com.au/news/emyria-secures-local-mdma-to-start-ptsd-clinical-trial-dosing 2023-09-21T09:16:01+10:00 http://biotechdispatch.com.au/news/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries 2023-09-21T09:12:01+10:00 http://biotechdispatch.com.au/news/optiscan-imaging-correlates-with-histology-in-breast-cancer-stud 2023-09-18T20:34:01+10:00 http://biotechdispatch.com.au/news/australian-developed-drug-receives-us-fda-approval 2023-09-18T20:32:01+10:00 http://biotechdispatch.com.au/news/moderna-marks-half-way-point-in-construction-of-mrna-manufacturi 2023-09-18T20:29:01+10:00 http://biotechdispatch.com.au/news/adherium-announces-new-partnership-with-leading-us-allergy-and-a 2023-09-18T20:28:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announces-clinicalddata-presentation-for 2023-09-18T20:27:01+10:00 http://biotechdispatch.com.au/news/agribiotech-summit-2023-programme-launched 2023-09-14T09:00:01+10:00 http://biotechdispatch.com.au/news/investors-boost-starpharma-in-response-to-interim-data-from-clin 2023-09-14T08:24:01+10:00 http://biotechdispatch.com.au/news/adapt-ideations-announces-the-appointment-of-chief-operating-off 2023-09-14T08:23:01+10:00 http://biotechdispatch.com.au/news/early-diagnosis-a-step-closer-for-those-at-risk-of-oesophageal-c 2023-09-14T08:22:01+10:00 http://biotechdispatch.com.au/news/new-leadership-for-vaccine-platform-technology-company-sementis 2023-09-14T08:00:01+10:00 http://biotechdispatch.com.au/news/bcal-diagnostics-says-it-has-locked-down-crucial-breast-cancer-s 2023-09-12T10:01:01+10:00 http://biotechdispatch.com.au/news/us-fda-grants-emergency-use-authorisation-for-viradx 2023-09-12T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-seeking-feedback-on-employee-share-schemes-policy 2023-09-12T09:00:01+10:00 http://biotechdispatch.com.au/news/imugene-secures-new-patent-in-japan-for-pd1-vaxx-clinical-drug-c 2023-09-12T09:00:01+10:00 http://biotechdispatch.com.au/news/bio-gene-technology-completes-share-purchase-plan 2023-09-12T09:00:01+10:00 http://biotechdispatch.com.au/news/bod-science-updates-on-clinical-trial-of-cbd-formulation-in-inso 2023-09-07T11:44:01+10:00 http://biotechdispatch.com.au/news/terragen-appoints-scobie-ward-to-its-board-of-directors 2023-09-07T11:17:01+10:00 http://biotechdispatch.com.au/news/actinogen-medical-closes-10-million-rights-issue-offer 2023-09-07T11:10:01+10:00 http://biotechdispatch.com.au/news/save-350-with-ausbiotech-2023-early-bird-rates 2023-09-07T09:21:01+10:00 http://biotechdispatch.com.au/news/fivephusion-says-first-patient-treated-in-paediatric-brain-cance 2023-09-07T09:05:01+10:00 http://biotechdispatch.com.au/news/emyria-announces-capital-raise-to-progress-mental-healthcare-pro 2023-09-05T11:31:01+10:00 http://biotechdispatch.com.au/news/clinuvel-updates-investors-on-european-label-expansion-for-scene 2023-09-05T11:05:01+10:00 http://biotechdispatch.com.au/news/non-animal-models-could-deliver-15-billion-growth 2023-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/resonance-health-announces-the-appointment-of-chief-financial-of 2023-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/resonance-health-announces-the-appointment-of-chief-financial-of 2023-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/genetic-signatures-submits-to-fda-for-clearance-of-gi-parasite-d 2023-09-05T10:00:01+10:00 http://biotechdispatch.com.au/news/evaluation-of-mrffs-clinical-trials-activity-initiative-released 2023-08-31T09:31:01+10:00 http://biotechdispatch.com.au/news/ena-respiratory-expands-leadership-team-and-extends-us-departmen 2023-08-31T09:19:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-announces-the-publication-of-positive-preclinical-data 2023-08-31T09:12:01+10:00 http://biotechdispatch.com.au/news/recognition-for-vetter-in-annual-frost-sullivan-awards 2023-08-31T08:36:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announces-changes-to-its-board-of-director 2023-08-31T08:31:01+10:00 http://biotechdispatch.com.au/news/feedback-sought-on-fmt-exemption-and-draft-guidance 2023-08-29T09:53:01+10:00 http://biotechdispatch.com.au/news/gordon-brothers-ritchie-bros-alliance-facilitates-auction-of-ell 2023-08-29T09:00:01+10:00 http://biotechdispatch.com.au/news/five-promising-digital-health-companies-selected-to-scale-new-he 2023-08-29T05:00:01+10:00 http://biotechdispatch.com.au/news/first-participant-treated-at-the-highest-dose-level-in-claritys- 2023-08-29T04:00:01+10:00 http://biotechdispatch.com.au/news/botanix-pharmaceuticals-elevates-chief-operating-officer-to-ceo- 2023-08-28T04:00:01+10:00 http://biotechdispatch.com.au/news/opthea-announces-placement-and-fully-underwritten-entitlement-of 2023-08-24T13:09:01+10:00 http://biotechdispatch.com.au/news/ausbioinvest-2023-keynote-speaker-announced 2023-08-24T10:47:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announces-expanded-agreement-with-terthe 2023-08-24T10:38:01+10:00 http://biotechdispatch.com.au/news/telix-says-result-reflects-its-transition-to-a-sustainable-comme 2023-08-24T10:32:01+10:00 http://biotechdispatch.com.au/news/vaxxas-awarded-grants-wellcome-for-needle-free-typhoid-vaccine-p 2023-08-24T10:15:01+10:00 http://biotechdispatch.com.au/news/nominations-open-for-ausbiotech-board-1 2023-08-22T08:56:01+10:00 http://biotechdispatch.com.au/news/new-collaboration-aims-to-push-back-against-viruses-with-pandemi 2023-08-22T08:55:01+10:00 http://biotechdispatch.com.au/news/albanese-government-consulting-on-australias-rna-potential 2023-08-22T08:54:01+10:00 http://biotechdispatch.com.au/news/cleo-diagnostics-to-commercialise-australian-developed-ovarian-c 2023-08-22T08:53:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-says-dosing-complete-in-first-patient-cohort-fo 2023-08-22T08:52:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-2023-programme-launched 2023-08-17T08:18:01+10:00 http://biotechdispatch.com.au/news/imugene-licenses-allogeneic-car-t-with-a-potential-registration- 2023-08-17T08:14:01+10:00 http://biotechdispatch.com.au/news/cureator-delivers-funding-boost-to-commercially-focused-biomedte 2023-08-17T08:13:01+10:00 http://biotechdispatch.com.au/news/biotron-completes-clinical-phase-of-bit225-covid-19-clinical-tri 2023-08-17T08:12:01+10:00 http://biotechdispatch.com.au/news/change-in-leadership-for-medicinal-cannabis-company-little-green 2023-08-17T08:11:01+10:00 http://biotechdispatch.com.au/news/chimeric-reports-positive-in-vitro-data-for-chm-0301-next-genera 2023-08-15T10:37:01+10:00 http://biotechdispatch.com.au/news/csl-reports-strong-profit-growth-with-record-plasma-collections 2023-08-15T10:00:01+10:00 http://biotechdispatch.com.au/news/servatus-strengthens-board-with-the-appointment-of-bi-executive 2023-08-15T09:00:01+10:00 http://biotechdispatch.com.au/news/a-major-day-for-moderna-as-the-company-builds-its-australian-pre 2023-08-15T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-2023-millis-orator-announced 2023-08-15T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-launches-world-first-esg-guide-for-biotech-smes 2023-08-10T09:39:01+10:00 http://biotechdispatch.com.au/news/firebrick-phase-3-trial-fully-recruited-with-500-subjects 2023-08-10T09:35:01+10:00 http://biotechdispatch.com.au/news/claritys-theranostic-prostate-cancer-trial-advances-to-highest-d 2023-08-10T09:24:01+10:00 http://biotechdispatch.com.au/news/merck-partners-to-pilot-the-first-deadlylabs-kit 2023-08-10T09:12:01+10:00 http://biotechdispatch.com.au/news/australian-vaccine-breakthrough-offers-hope-against-ebv-associat 2023-08-10T09:08:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-weighs-in-on-industry-growth-program-consultation 2023-08-08T09:55:01+10:00 http://biotechdispatch.com.au/news/dimerix-announces-successful-completion-of-second-dsmb-review-of 2023-08-08T09:39:01+10:00 http://biotechdispatch.com.au/news/medibio-receives-commitments-to-raise-225m-with-funding-to-fast- 2023-08-08T09:13:01+10:00 http://biotechdispatch.com.au/news/adherium-announces-collaboration-agreement-with-major-us-asthma- 2023-08-08T08:59:01+10:00 http://biotechdispatch.com.au/news/firebrick-pharma-says-nasal-spray-achieved-endpoint-in-covid-19- 2023-08-08T08:58:01+10:00 http://biotechdispatch.com.au/news/new-ausbiotech-report-shows-increasing-us-investment-in-australi 2023-08-03T10:23:01+10:00 http://biotechdispatch.com.au/news/bod-science-announces-capital-raise-to-progress-rd 2023-08-03T10:00:01+10:00 http://biotechdispatch.com.au/news/peter-mac-selects-bindimaps-to-launch-victorias-first-hospital-g 2023-08-03T10:00:01+10:00 http://biotechdispatch.com.au/news/immutep-receives-positive-scientific-advice-from-the-european-me 2023-08-03T09:00:01+10:00 http://biotechdispatch.com.au/news/bio-gene-says-new-us-patent-extends-the-protection-of-its-molecu 2023-08-03T04:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-research-funds-consultation 2023-08-01T10:21:01+10:00 http://biotechdispatch.com.au/news/imricor-receives-medical-ethics-approval-to-commence-visabl-vt-t 2023-08-01T10:00:01+10:00 http://biotechdispatch.com.au/news/allarity-therapeutics-and-fivephusion-announce-collaboration-for 2023-08-01T10:00:01+10:00 http://biotechdispatch.com.au/news/curvebeam-ai-to-list-on-the-asx-in-fully-underwritten-ipo-raisin 2023-08-01T10:00:01+10:00 http://biotechdispatch.com.au/news/national-genomics-initiative-gives-23000-people-their-best-chanc 2023-08-01T09:00:01+10:00 http://biotechdispatch.com.au/news/phase-12-mnd-trial-successfully-completes-third-patient-cohort 2023-08-01T08:00:01+10:00 http://biotechdispatch.com.au/news/bio-gene-executes-development-and-license-agreement-with-stk-bio 2023-07-27T09:25:01+10:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-wins-bioshares-excellence-award 2023-07-27T09:13:01+10:00 http://biotechdispatch.com.au/news/haemalogix-and-peter-maccallum-cancer-centre-announce-car-t-clin 2023-07-27T09:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-receives-patent-allowance-for-chlorotoxin-in-japan 2023-07-27T09:00:01+10:00 http://biotechdispatch.com.au/news/emvision-says-clinical-trial-progressing-and-asa-milestone-achie 2023-07-27T09:00:01+10:00 http://biotechdispatch.com.au/news/report-reviewing-gender-equity-initiatives-launched 2023-07-25T11:10:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-appoints-vice-president-of-medical-and-c 2023-07-25T11:04:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-backing-homegrown-australian-innovation 2023-07-25T10:00:01+10:00 http://biotechdispatch.com.au/news/federation-asset-management-confirms-the-sale-of-george-clinical 2023-07-25T10:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-updates-on-expected-timing-of-dmx-200-phase-3-kidney-tri 2023-07-25T10:00:01+10:00 http://biotechdispatch.com.au/news/australian-company-collaborates-on-us-launch-of-prostate-cancer- 2023-07-20T06:00:01+10:00 http://biotechdispatch.com.au/news/opal-biosciences-awarded-investment-attraction-fund-grant-by-wa- 2023-07-20T06:00:01+10:00 http://biotechdispatch.com.au/news/biocurate-in-new-partnership-with-the-european-healthtech-ventur 2023-07-19T06:00:01+10:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-study-of-telixs-tlx250-with-mercks-pepose 2023-07-19T06:00:01+10:00 http://biotechdispatch.com.au/news/national-cell-and-gene-manufacturing-blueprint-launched 2023-07-19T06:00:01+10:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-announces-global-expansion-of-agreement-w 2023-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/eyerising-myopia-management-device-added-to-the-australian-regis 2023-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/actinogen-cmo-presents-academic-poster-to-alzheimers-association 2023-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/henry-schein-medical-expands-distribution-partnership-with-lumos 2023-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/sensible-approach-for-medtech-clinical-trials 2023-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/incannex-healthcare-receives-approval-for-new-phase-2-trial 2023-07-13T09:09:01+10:00 http://biotechdispatch.com.au/news/early-stage-innovation-forum-invites-expressions-of-interest 2023-07-13T09:07:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-reports-positive-analysis-of-data-from-phase-2-pxs-550 2023-07-13T09:00:01+10:00 http://biotechdispatch.com.au/news/victoria-invites-expressions-of-interest-for-industry-rd-infrast 2023-07-13T09:00:01+10:00 http://biotechdispatch.com.au/news/firebrick-provides-update-on-timing-of-phase-2-trial-results 2023-07-13T08:00:01+10:00 http://biotechdispatch.com.au/news/build-your-profile-through-biotechdispatch 2023-07-11T10:51:01+10:00 http://biotechdispatch.com.au/news/adalta-releases-new-data-on-phase-1-trial-of-ad-214-in-idiopathi 2023-07-11T10:00:01+10:00 http://biotechdispatch.com.au/news/fda-fast-track-designation-for-kazia-therapeutics-cancer-candida 2023-07-11T10:00:01+10:00 http://biotechdispatch.com.au/news/first-cohort-dosed-in-recce-327-rapid-infusion-uti-clinical-tria 2023-07-11T10:00:01+10:00 http://biotechdispatch.com.au/news/lumos-completes-placement-and-launches-share-purchase-plan 2023-07-11T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbionsw-announces-appointment-of-general-manager 2023-07-06T11:15:01+10:00 http://biotechdispatch.com.au/news/moderna-submits-rsv-vaccine-to-global-regulatory-agencies 2023-07-06T11:11:01+10:00 http://biotechdispatch.com.au/news/motor-neuron-disease-biomarkers-and-pharmacodynamics-results 2023-07-06T09:38:01+10:00 http://biotechdispatch.com.au/news/genetic-discovery-could-help-prevent-irreversible-blindness-in-p 2023-07-06T09:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-receives-european-approval-for-paediatric-investigation- 2023-07-06T09:00:01+10:00 http://biotechdispatch.com.au/news/takedas-cockpi-t-programme-calls-for-applications 2023-07-04T08:14:01+10:00 http://biotechdispatch.com.au/news/lumos-diagnostics-secures-us-clearance-for-febridx-rapid-point-o 2023-07-04T08:00:01+10:00 http://biotechdispatch.com.au/news/nutromics-to-progress-wearable-diagnostic-platform-with-latest-c 2023-07-04T07:46:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-announces-ceo-succession-and-board-changes 2023-07-04T07:00:01+10:00 http://biotechdispatch.com.au/news/rhythm-biosciences-looks-ahead-to-market-entry-with-launch-of-uk 2023-07-04T07:00:01+10:00 http://biotechdispatch.com.au/news/industry-growth-program-consultation-opens 2023-06-29T10:21:01+10:00 http://biotechdispatch.com.au/news/australian-company-microba-launches-clinical-development-of-ibd- 2023-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/neuren-opens-first-site-in-us-for-prader-willi-syndrome-phase-2- 2023-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-releases-further-data-from-pivotal-phase-3-zircon-study-of 2023-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/bio-gene-technology-confirms-us-patent-for-use-of-flavesone 2023-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/mark-butler-announces-73-million-for-19-medtech-and-facility-gra 2023-06-27T08:00:01+10:00 http://biotechdispatch.com.au/news/mrna-victoria-grant-for-university-bioengineers-to-fast-track-br 2023-06-27T08:00:01+10:00 http://biotechdispatch.com.au/news/yeast-dust-makes-a-cheap-fast-virus-sensor-for-human-animal-and- 2023-06-27T08:00:01+10:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-nominates-epiresatide-as-flagship-candidate 2023-06-27T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-australasian-biotechnology-journal-articles 2023-06-27T08:00:01+10:00 http://biotechdispatch.com.au/news/top-performing-asx-life-science-companies 2023-06-22T11:15:01+10:00 http://biotechdispatch.com.au/news/imagion-biosystems-announces-the-appointment-of-new-ceo 2023-06-22T10:44:01+10:00 http://biotechdispatch.com.au/news/australian-invention-for-potential-treatment-of-anxiety-disorder 2023-06-22T10:00:01+10:00 http://biotechdispatch.com.au/news/inventia-expands-into-indian-market-through-distribution-agreeme 2023-06-22T09:00:01+10:00 http://biotechdispatch.com.au/news/the-new-jumar-bioincubator-calls-for-biotechnology-start-ups 2023-06-22T08:51:01+10:00 http://biotechdispatch.com.au/news/avita-medical-announces-fda-approval-of-recell-for-skin-repigmen 2023-06-20T08:00:01+10:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-study-of-tlx250-cdx-exploring-indication- 2023-06-20T08:00:01+10:00 http://biotechdispatch.com.au/news/wehis-professor-doug-hilton-appointed-chief-executive-of-csiro 2023-06-20T08:00:01+10:00 http://biotechdispatch.com.au/news/vaxxas-opens-needle-free-vaccine-manufacturing-site-and-global-h 2023-06-20T08:00:01+10:00 http://biotechdispatch.com.au/news/state-government-budget-wrap-for-life-sciences 2023-06-20T08:00:01+10:00 http://biotechdispatch.com.au/news/atomo-and-newfoundland-sign-agreement-for-hiv-testing-in-europe 2023-06-15T10:09:01+10:00 http://biotechdispatch.com.au/news/milestone-achieved-first-cohort-complete-for-phase-1-pain-indica 2023-06-15T10:05:01+10:00 http://biotechdispatch.com.au/news/fivephusion-announces-strategic-collaboration-with-treehill-part 2023-06-15T09:00:01+10:00 http://biotechdispatch.com.au/news/views-sought-on-coordination-of-research-funds 2023-06-15T09:00:01+10:00 http://biotechdispatch.com.au/news/azd0466-clinical-data-presented-by-astrazeneca-at-international- 2023-06-15T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-epens-european-radiopharmaceutical-production-facility 2023-06-13T12:31:01+10:00 http://biotechdispatch.com.au/news/former-ausbiotech-ceo-awarded-kings-birthday-honours 2023-06-13T10:45:01+10:00 http://biotechdispatch.com.au/news/anteris-technologies-reports-positive-30-day-data-from-first-in- 2023-06-13T10:14:01+10:00 http://biotechdispatch.com.au/news/emvision-medical-devices-receives-progress-payments-under-manufa 2023-06-13T10:01:01+10:00 http://biotechdispatch.com.au/news/commencement-of-the-third-cohort-3-in-pharmaausts-mnd-trial 2023-06-13T09:33:01+10:00 http://biotechdispatch.com.au/news/clinical-trials-one-stop-shop-report-released 2023-06-08T10:18:01+10:00 http://biotechdispatch.com.au/news/avita-medical-announces-us-approval-of-recell-for-full-thickness 2023-06-08T10:10:01+10:00 http://biotechdispatch.com.au/news/vaxxas-appoints-former-pfizer-executive-as-chief-medical-officer 2023-06-08T10:08:01+10:00 http://biotechdispatch.com.au/news/kinoxis-therapeutics-secures-us-government-grant-to-progress-dru 2023-06-08T10:07:01+10:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-receives-milestone-payment-from-us-partne 2023-06-08T10:00:01+10:00 http://biotechdispatch.com.au/news/team-australia-shines-at-bio-2023 2023-06-06T09:14:01+10:00 http://biotechdispatch.com.au/news/starpharma-announces-that-viraleze-approved-in-malaysia 2023-06-06T08:59:01+10:00 http://biotechdispatch.com.au/news/anatara-lifesciences-updates-on-garp-irritable-bowel-syndrome-tr 2023-06-06T08:47:01+10:00 http://biotechdispatch.com.au/news/aravax-launches-new-phase-2-trial-of-peanut-allergy-candidate 2023-06-06T08:46:01+10:00 http://biotechdispatch.com.au/news/immvirx-raising-25-million-to-be-led-by-healthcare-vc-oneventure 2023-06-06T08:00:01+10:00 http://biotechdispatch.com.au/news/optiscan-imaging-launches-entitlement-offer-to-raise-167-million 2023-06-01T09:29:01+10:00 http://biotechdispatch.com.au/news/zelira-therapeutics-announces-the-appointment-of-new-non-executi 2023-06-01T09:18:01+10:00 http://biotechdispatch.com.au/news/imugene-doses-first-patient-in-pd1-vaxx-and-immune-checkpoint-in 2023-06-01T09:08:01+10:00 http://biotechdispatch.com.au/news/new-esg-guide-seeks-industry-feedback 2023-06-01T09:05:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announced-new-trial-for-chm-1101-in-gliobl 2023-06-01T08:55:01+10:00 http://biotechdispatch.com.au/news/kazia-therapeutics-participates-in-cancer-moonshot-brain-cancers 2023-05-30T08:35:01+10:00 http://biotechdispatch.com.au/news/best-early-stage-project-at-awarded-at-ausmedtech-2023 2023-05-30T08:32:01+10:00 http://biotechdispatch.com.au/news/orthocell-taps-former-health-sector-leader-to-chair-its-board-of 2023-05-30T08:22:01+10:00 http://biotechdispatch.com.au/news/immutep-selects-charles-river-laboratories-for-imp761s-glp-toxic 2023-05-30T08:00:01+10:00 http://biotechdispatch.com.au/news/dr-robert-lin-named-named-the-new-ceo-of-greenlight-clinical 2023-05-30T08:00:01+10:00 http://biotechdispatch.com.au/news/monash-talent-inviting-applications-for-next-internship-program 2023-05-25T08:40:01+10:00 http://biotechdispatch.com.au/news/csiro-launches-a-free-programme-to-support-small-to-medium-compa 2023-05-25T08:37:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-reports-positive-results-from-trial-of-pxs6302 2023-05-25T08:32:01+10:00 http://biotechdispatch.com.au/news/cartherics-to-present-at-the-2023-bio-international-convention 2023-05-25T08:00:01+10:00 http://biotechdispatch.com.au/news/cyteph-secures-vital-funding-for-brain-cancer-immunotherapy-clin 2023-05-25T08:00:01+10:00 http://biotechdispatch.com.au/news/ebr-systems-meets-endpoints-early-in-pivotal-solve-crt-trial 2023-05-23T11:22:01+10:00 http://biotechdispatch.com.au/news/oncosil-announces-tirst-patient-treatment-in-italy 2023-05-23T11:17:01+10:00 http://biotechdispatch.com.au/news/victorian-based-digital-health-companies-selected-for-inaugural- 2023-05-23T11:07:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-receives-grant-to-collaborate-with-csiro 2023-05-23T11:06:01+10:00 http://biotechdispatch.com.au/news/ausmedtech-2023-kicks-off-in-adelaide 2023-05-23T11:04:01+10:00 http://biotechdispatch.com.au/news/celebrating-australias-clinical-trial-capabilities 2023-05-18T06:35:01+10:00 http://biotechdispatch.com.au/news/avecho-biotechnology-commences-manufacturing-for-phase-3-insomni 2023-05-18T06:25:01+10:00 http://biotechdispatch.com.au/news/silverstone-receives-approval-for-advanced-life-sciences-facilit 2023-05-18T06:14:01+10:00 http://biotechdispatch.com.au/news/optiscan-imaging-oral-study-published-in-international-medical-j 2023-05-18T06:08:01+10:00 http://biotechdispatch.com.au/news/positive-results-for-immuteps-cancer-candidate-in-combination-wi 2023-05-18T06:06:01+10:00 http://biotechdispatch.com.au/news/avita-medical-reports-strong-revenue-growth-for-first-quarter 2023-05-16T12:02:01+10:00 http://biotechdispatch.com.au/news/new-report-calls-on-national-cell-and-gene-therapy-plan 2023-05-16T11:00:01+10:00 http://biotechdispatch.com.au/news/merck-backing-indigenous-communities-in-creating-a-new-approach- 2023-05-16T11:00:01+10:00 http://biotechdispatch.com.au/news/us-investors-back-australian-innovation-with-investment-in-ai 2023-05-16T11:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announces-new-capital-raise 2023-05-16T11:00:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-says-third-cohort-enrolment-completed-in-acc 2023-05-11T00:00:01+10:00 http://biotechdispatch.com.au/news/cyclopharm-confirms-dates-of-us-fda-facility-inspection 2023-05-11T00:00:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-receives-fda-orphan-drug-designation-for 2023-05-11T00:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-says-monepantel-has-anti-cancer-effects-across-multipl 2023-05-11T00:00:01+10:00 http://biotechdispatch.com.au/news/federal-2023-24-budget-wrap-up-for-biotech-1 2023-05-11T00:00:01+10:00 http://biotechdispatch.com.au/news/fda-removes-clinical-hold-on-immurons-new-campylobacter-etec-the 2023-05-09T03:00:01+10:00 http://biotechdispatch.com.au/news/showcasing-australian-biotech-at-biokorea-2023 2023-05-09T03:00:01+10:00 http://biotechdispatch.com.au/news/telix-to-supply-bayer-with-illuccix-for-global-late-stage-prosta 2023-05-09T03:00:01+10:00 http://biotechdispatch.com.au/news/lbt-innovations-begins-search-for-new-board-chair 2023-05-09T03:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-announces-the-appointment-of-new-ceo-and- 2023-05-09T03:00:01+10:00 http://biotechdispatch.com.au/news/opportunity-to-invest-in-australian-biotech-companies 2023-05-04T06:00:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announces-positive-new-publication-for-r 2023-05-04T03:00:01+10:00 http://biotechdispatch.com.au/news/carina-biotech-to-present-details-of-planned-trial-of-car-t-cell 2023-05-04T03:00:01+10:00 http://biotechdispatch.com.au/news/bostongene-and-mater-research-collaborate-in-new-follicular-lymp 2023-05-04T03:00:01+10:00 http://biotechdispatch.com.au/news/patent-granted-in-india-and-notice-of-allowance-issued-in-israel 2023-05-04T03:00:01+10:00 http://biotechdispatch.com.au/news/find-and-be-found-utilising-free-global-life-sciences-directory 2023-05-02T04:36:01+10:00 http://biotechdispatch.com.au/news/cartherics-grants-shunxi-licence-for-car-t-cell-therapy-for-ovar 2023-05-02T04:00:01+10:00 http://biotechdispatch.com.au/news/new-approval-for-trial-of-immuteps-efti-with-mercks-pd-l1-inhibi 2023-05-02T04:00:01+10:00 http://biotechdispatch.com.au/news/atmo-biosciences-appoints-world-renowned-gastroenterologist-as-m 2023-05-02T04:00:01+10:00 http://biotechdispatch.com.au/news/cytiva-supports-biocina-with-first-gmp-production-and-developmen 2023-05-02T04:00:01+10:00 http://biotechdispatch.com.au/news/cytiva-supports-biocina-with-first-gmp-production-and-developmen 2023-05-02T03:59:01+10:00 http://biotechdispatch.com.au/news/minister-engages-in-industry-forum 2023-04-27T06:11:01+10:00 http://biotechdispatch.com.au/news/cannatrek-foundation-to-provide-support-for-veterans-and-first-r 2023-04-27T04:00:01+10:00 http://biotechdispatch.com.au/news/oncosil-announces-new-presentation-of-clinical-outcomes-data 2023-04-27T04:00:01+10:00 http://biotechdispatch.com.au/news/emyria-adds-to-its-pipeline-with-new-high-potency-cannabidiol-do 2023-04-27T04:00:01+10:00 http://biotechdispatch.com.au/news/mark-butler-directs-more-funding-to-long-covid-research-in-respo 2023-04-27T04:00:01+10:00 http://biotechdispatch.com.au/news/industry-minister-launches-the-latest-bridge-commercialisation-t 2023-04-20T08:29:01+10:00 http://biotechdispatch.com.au/news/telix-reports-its-first-quarter-of-100-million-in-revenue 2023-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/major-milestone-for-australian-pharmaceutical-company-neuren 2023-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/andhealth-partners-with-chicago-arc-to-bring-australian-digital- 2023-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/regulatory-changes-for-medical-device-clinical-trials-not-needed 2023-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/assessors-needed-for-industry-phd-program 2023-04-18T08:20:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announced-new-supply-agreement-for-terbi 2023-04-18T08:19:01+10:00 http://biotechdispatch.com.au/news/telix-says-olaratumab-antibody-licensed-from-lilly-demonstrates- 2023-04-18T08:18:01+10:00 http://biotechdispatch.com.au/news/proto-axiom-invests-in-university-of-sydney-spin-out-endoaxiom 2023-04-18T08:17:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-initiation-of-phase-23-trial-of-efti-in-metast 2023-04-18T08:16:01+10:00 http://biotechdispatch.com.au/news/atmo-biosciences-builds-us-focus-with-board-appointment-and-san- 2023-04-18T08:15:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-adds-combination-arm-to-pxs5505-myelofibrosis-study 2023-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/melbourne-based-immvirx-says-first-patient-dosed-in-trial-of-its 2023-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/cynata-receives-ethics-approval-for-proposed-agvhd-phase-2-clini 2023-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/medibio-appoints-ceo-as-an-executive-director 2023-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/focus-turns-to-all-things-medtech 2023-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/imricor-establishes-the-first-icmr-site-in-switzerland 2023-04-11T09:00:01+10:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-announces-planned-grant-of-patent-family-4 2023-04-11T08:41:01+10:00 http://biotechdispatch.com.au/news/osteopore-strengthens-presence-in-the-eastern-region-of-the-us 2023-04-11T08:29:01+10:00 http://biotechdispatch.com.au/news/australian-academy-of-technological-sciences-engineering-seek-vi 2023-04-11T08:25:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-changes-to-its-board-of-directors 2023-04-11T08:00:01+10:00 http://biotechdispatch.com.au/news/launch-of-new-connected-health-innovation-and-commercialisation- 2023-04-06T08:00:01+10:00 http://biotechdispatch.com.au/news/botanix-secures-investor-commitments-to-progress-its-lead-develo 2023-04-06T08:00:01+10:00 http://biotechdispatch.com.au/news/optiscan-imaging-established-us-commercial-operation-in-minnesot 2023-04-06T08:00:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-enrols-first-patient-in-trial-of-ath434-mu 2023-04-06T08:00:01+10:00 http://biotechdispatch.com.au/news/consultation-on-australias-science-priorities-nears-its-end 2023-04-06T08:00:01+10:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-receives-rd-advance-from-radium-capital 2023-04-04T10:18:01+10:00 http://biotechdispatch.com.au/news/race-releases-cardio-protection-market-potential-data 2023-04-04T10:00:01+10:00 http://biotechdispatch.com.au/news/emyria-and-aspen-australia-sign-exclusive-binding-licensing-and- 2023-04-04T09:19:01+10:00 http://biotechdispatch.com.au/news/firebrick-pharma-completes-recruitment-of-covid-19-nasal-spray-t 2023-04-04T08:24:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-invites-innovators-to-pitch-their-early-stage-medtech 2023-04-04T08:00:01+10:00 http://biotechdispatch.com.au/news/mnd-trial-completes-enrolment-of-cohort-2-and-prepares-for-inter 2023-03-30T09:45:01+11:00 http://biotechdispatch.com.au/news/industry-groups-welcome-senate-backing-of-national-reconstructio 2023-03-30T09:41:01+11:00 http://biotechdispatch.com.au/news/brisbane-based-company-targets-major-global-market 2023-03-30T09:39:01+11:00 http://biotechdispatch.com.au/news/orthocell-appoints-us-based-nerve-surgeons-to-medical-advisory-b 2023-03-30T09:38:01+11:00 http://biotechdispatch.com.au/news/learn-about-the-clinical-trials-governance-framework-implementat 2023-03-30T09:00:01+11:00 http://biotechdispatch.com.au/news/idt-achieves-milestone-with-tga-approved-expansion-of-manufactur 2023-03-28T11:30:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-and-genesiscare-partner-on-development-o 2023-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/stable-patient-in-cohort-1-of-mnd-trial-reaches-6-months-on-mpl 2023-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-announces-novel-mrna-vaccine-enhancer 2023-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/ausmedtech-programme-goes-back-to-the-future 2023-03-28T05:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-reports-positive-feedback-on-plan-for-chm- 2023-03-23T09:36:01+11:00 http://biotechdispatch.com.au/news/funding-deployed-to-accelerate-global-australian-digital-health- 2023-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/women-join-australias-landmark-maternity-medical-device-study 2023-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/csl-seqirus-seasonal-flu-vaccine-now-available-via-private-provi 2023-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/directory-of-australian-accelerators-and-incubators-launched 2023-03-22T15:40:01+11:00 http://biotechdispatch.com.au/news/support-for-passage-of-nrf-legislation-through-senate-1 2023-03-21T11:15:01+11:00 http://biotechdispatch.com.au/news/heramed-announces-gold-coast-trial-of-heracare-platform 2023-03-21T11:05:01+11:00 http://biotechdispatch.com.au/news/australian-company-clinuvel-initiates-second-trial-of-new-anti-s 2023-03-21T10:50:01+11:00 http://biotechdispatch.com.au/news/brandon-biocatalyst-with-andhealth-to-deliver-biomedtech-incubat 2023-03-21T10:37:01+11:00 http://biotechdispatch.com.au/news/monash-university-in-new-partnership-with-leading-israeli-resear 2023-03-21T10:19:01+11:00 http://biotechdispatch.com.au/news/monash-university-in-new-partnership-with-leading-israeli-resear 2023-03-21T08:00:01+11:00 http://biotechdispatch.com.au/news/first-of-its-kind-study-now-recruiting-australians-on-insulin-th 2023-03-16T08:00:01+11:00 http://biotechdispatch.com.au/news/proteomics-says-it-will-resubmit-promarkerd-predictive-test-for- 2023-03-16T08:00:01+11:00 http://biotechdispatch.com.au/news/call-for-speakers-for-biggest-week-in-biotech 2023-03-15T16:03:01+11:00 http://biotechdispatch.com.au/news/interim-analysis-shows-accuracy-of-optiscan-imaging-platform 2023-03-15T13:50:01+11:00 http://biotechdispatch.com.au/news/patrys-says-preclinical-data-supports-synthetic-lethality-mechan 2023-03-15T08:54:01+11:00 http://biotechdispatch.com.au/news/us-approval-for-neurens-innovative-treatment-for-rett-syndrome 2023-03-14T08:00:01+11:00 http://biotechdispatch.com.au/news/sanofi-launches-recruitment-drive-for-its-translational-science- 2023-03-14T08:00:01+11:00 http://biotechdispatch.com.au/news/mark-butler-announces-funding-for-mitochondrial-donation-pilot-p 2023-03-14T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-announces-the-initiation-of-a-new-breast-cancer-trial 2023-03-14T08:00:01+11:00 http://biotechdispatch.com.au/news/national-reconstruction-fund-moves-closer-to-reality 2023-03-14T08:00:01+11:00 http://biotechdispatch.com.au/news/us-fda-grants-orphan-drug-designation-to-ptx-100-for-broader-tcl 2023-03-09T11:51:01+11:00 http://biotechdispatch.com.au/news/biotech-stocks-back-on-road-to-recovery-according-to-latest-repo 2023-03-09T11:41:01+11:00 http://biotechdispatch.com.au/news/bionomics-reports-dpdated-on-dnalysis-from-prevail-phase-2-study 2023-03-09T11:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-advances-manufacture-of-chm-2101-viral-vec 2023-03-09T11:00:01+11:00 http://biotechdispatch.com.au/news/women-in-leadership-development-program-expands-with-advance 2023-03-09T09:36:01+11:00 http://biotechdispatch.com.au/news/embracing-equity-in-the-life-sciences-sector 2023-03-07T10:00:01+11:00 http://biotechdispatch.com.au/news/emyria-partners-with-specialist-trauma-psychiatric-service-to-ad 2023-03-07T09:00:01+11:00 http://biotechdispatch.com.au/news/greenlight-clinical-and-cure-therapeutics-look-to-future-collabo 2023-03-07T08:00:01+11:00 http://biotechdispatch.com.au/news/starpharma-announces-the-appointment-of-chief-financial-officer 2023-03-07T08:00:01+11:00 http://biotechdispatch.com.au/news/australian-company-looks-to-shake-up-us-proteomics-sector 2023-03-07T08:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-says-an-interim-analysis-recommended-in-mnd-trial 2023-03-02T09:47:01+11:00 http://biotechdispatch.com.au/news/csl-seqirus-secures-australia-nz-rights-to-cardiovascular-therap 2023-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/microba-life-sciences-announces-new-distribution-agreements-in-e 2023-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-appoints-experienced-industry-executive-t 2023-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/the-australian-cell-and-gene-catalyst-takes-step-forward 2023-03-02T04:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-propose-overhaul-of-tga-funding 2023-02-28T09:14:01+11:00 http://biotechdispatch.com.au/news/incannex-launches-new-trial-assessing-ihl-675a-in-rheumatoid-art 2023-02-28T09:00:01+11:00 http://biotechdispatch.com.au/news/peter-mac-and-cartherics-in-new-collaboration-to-develop-car-t-t 2023-02-28T03:00:01+11:00 http://biotechdispatch.com.au/news/csl-reports-positive-results-from-pivotal-late-stage-trial-of-fi 2023-02-28T03:00:01+11:00 http://biotechdispatch.com.au/news/trajan-raised-full-year-guidance-after-delivering-a-strong-first 2023-02-28T03:00:01+11:00 http://biotechdispatch.com.au/news/tga-provisionally-approves-modernas-new-bivalent-covid-19-vaccin 2023-02-23T11:56:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-leads-australian-pavilion-to-bio-with-exclusive-rate- 2023-02-23T11:43:01+11:00 http://biotechdispatch.com.au/news/cyban-says-trial-reveals-the-potential-benefit-of-alternative-to 2023-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/clinical-program-with-the-lambert-initiative-expands-to-include- 2023-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-to-oresent-sofra-study-at-international-lupus-2023-con 2023-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-develops-report-to-boost-cell-and-gene-manufacturing 2023-02-21T11:16:01+11:00 http://biotechdispatch.com.au/news/europe-approves-csls-first-gene-therapy-for-haemophilia-b 2023-02-21T10:00:01+11:00 http://biotechdispatch.com.au/news/dr-joe-smith-reappointed-as-chair-of-the-agricultural-biotechnol 2023-02-21T09:52:01+11:00 http://biotechdispatch.com.au/news/brisbane-medtech-start-ups-wow-global-investors-to-win-top-gongs 2023-02-21T09:00:01+11:00 http://biotechdispatch.com.au/news/australian-company-inventia-life-science-in-new-collaboration-wi 2023-02-21T09:00:01+11:00 http://biotechdispatch.com.au/news/anteotech-announces-the-appointment-of-chief-marketing-officer 2023-02-16T09:22:01+11:00 http://biotechdispatch.com.au/news/wa-launches-inaugural-health-and-medical-research-strategy 2023-02-16T09:06:01+11:00 http://biotechdispatch.com.au/news/unit-growth-for-cochlear-as-markets-return-to-pre-pandemic-level 2023-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/key-franchise-delivers-for-csl-as-plasma-collections-top-pre-pan 2023-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/clarity-reaches-recruitment-milestone-for-neuroendocrine-tumour- 2023-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-initiates-process-for-nasdaq-listing 2023-02-14T10:49:01+11:00 http://biotechdispatch.com.au/news/acurabio-partners-with-cytiva-to-alleviate-supply-constraints-fo 2023-02-14T06:00:01+11:00 http://biotechdispatch.com.au/news/adapt-ideations-announces-the-appointment-of-new-senior-adviser 2023-02-14T06:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-develops-first-biotech-esg-guidance 2023-02-13T16:22:01+11:00 http://biotechdispatch.com.au/news/genetic-technologies-says-new-publication-highlights-benefits-of 2023-02-13T06:00:01+11:00 http://biotechdispatch.com.au/news/anteris-technologies-completes-placement-to-raise-35-million 2023-02-09T10:00:01+11:00 http://biotechdispatch.com.au/news/argenica-therapeutics-releases-preclinical-study-data-on-its-arg 2023-02-09T10:00:01+11:00 http://biotechdispatch.com.au/news/call-for-feedback-on-revised-clinical-quality-registries-framewo 2023-02-09T10:00:01+11:00 http://biotechdispatch.com.au/news/certa-therapeutics-announces-positive-results-in-phase-2-sclerod 2023-02-09T09:00:01+11:00 http://biotechdispatch.com.au/news/dimerix-announces-successful-conclusion-of-clinical-trial-review 2023-02-09T09:00:01+11:00 http://biotechdispatch.com.au/news/optiscan-imaging-announces-collaboration-with-canadian-based-com 2023-02-07T08:55:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-national-reconstruction-fund-consultation 2023-02-07T03:00:01+11:00 http://biotechdispatch.com.au/news/emyria-to-expand-mdma-programs-following-tga-psychedelic-decisio 2023-02-07T03:00:01+11:00 http://biotechdispatch.com.au/news/immutep-reaches-enrolment-target-for-insight-003-trial-in-first- 2023-02-07T03:00:01+11:00 http://biotechdispatch.com.au/news/genetic-technologies-announces-registered-direct-offering 2023-02-07T03:00:01+11:00 http://biotechdispatch.com.au/news/keynote-speaker-announced-for-women-in-life-sciences-luncheon 2023-02-02T10:39:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-strengthens-board-with-new-appointments 2023-02-02T10:35:01+11:00 http://biotechdispatch.com.au/news/island-pharmaceuticals-receives-additional-fda-feedback-on-ind-f 2023-02-02T10:22:01+11:00 http://biotechdispatch.com.au/news/gtg-to-form-strategic-alliance-with-global-testing-leader-qiagen 2023-02-02T10:18:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-announces-outcomes-in-dmd-combination-ani 2023-02-02T10:10:01+11:00 http://biotechdispatch.com.au/news/agilex-biolabs-announces-the-appointment-of-new-ceo 2023-02-02T09:41:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-advocates-for-sustainable-funding-model-for-tga 2023-01-31T10:15:01+11:00 http://biotechdispatch.com.au/news/alteritys-ath434-prevents-loss-of-brain-cells-in-parkinsons-dise 2023-01-31T10:08:01+11:00 http://biotechdispatch.com.au/news/cynata-receives-irb-approval-for-proposed-phase-2-agvhd-clinical 2023-01-31T10:05:01+11:00 http://biotechdispatch.com.au/news/emyria-confirms-the-first-dosing-for-emd-rx5-phase-3-trial 2023-01-31T10:05:01+11:00 http://biotechdispatch.com.au/news/centenary-institute-announces-its-new-executive-director 2023-01-31T10:03:01+11:00 http://biotechdispatch.com.au/news/nsw-launches-biosciences-fund-to-boost-the-states-world-class-in 2023-01-24T12:39:01+11:00 http://biotechdispatch.com.au/news/bio-gene-and-stk-bio-ag-technologies-announce-global-collaborati 2023-01-24T12:32:01+11:00 http://biotechdispatch.com.au/news/pharmaust-progresses-to-elevated-doses-of-mpl-in-motor-neurone-d 2023-01-24T12:25:01+11:00 http://biotechdispatch.com.au/news/fda-approves-ind-for-prader-willi-syndrome-study-of-neurens-nnz- 2023-01-24T12:23:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-updates-on-cltx-car-t-clinical-trial 2023-01-24T12:15:01+11:00 http://biotechdispatch.com.au/news/us-recruitment-milestone-for-trial-of-immurons-travelan 2023-01-19T07:00:01+11:00 http://biotechdispatch.com.au/news/adherium-awarded-uk-national-health-services-sbri-healthcare-mon 2023-01-19T07:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotechs-draft-national-reconstruction-fund-submission-open-f 2023-01-19T03:00:01+11:00 http://biotechdispatch.com.au/news/clinuvel-says-trial-results-show-afamelanotide-reduces-dna-damag 2023-01-19T03:00:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-says-new-research-points-to-potential-role-in-m 2023-01-18T13:01:01+11:00 http://biotechdispatch.com.au/news/new-years-resolutions-for-a-healthy-future 2023-01-17T11:03:01+11:00 http://biotechdispatch.com.au/news/dimerix-confirm-the-outcomes-of-a-meeting-with-the-fda-on-paedia 2023-01-17T06:00:01+11:00 http://biotechdispatch.com.au/news/victorian-program-aims-to-connect-organisations-with-digital-tal 2023-01-17T06:00:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-appoints-senior-manufacturing-executive 2023-01-17T06:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-completes-dosing-of-first-cohort-of-patients-in-new-tr 2023-01-17T06:00:01+11:00 http://biotechdispatch.com.au/news/moderna-seeking-applicants-for-2023-global-fellowship-program 2022-12-20T10:46:01+11:00 http://biotechdispatch.com.au/news/avita-medical-submits-fda-pma-application-to-expand-indication 2022-12-20T08:00:01+11:00 http://biotechdispatch.com.au/news/dimerix-completes-recruitment-in-first-part-of-dmx-200-trial 2022-12-20T06:00:01+11:00 http://biotechdispatch.com.au/news/bionomics-reports-topline-results-in-prevail-study-of-bnc210 2022-12-20T06:00:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-subsidiary-appoints-apas-independence-distributo 2022-12-20T03:00:01+11:00 http://biotechdispatch.com.au/news/2022-the-year-we-came-alive-again 2022-12-20T03:00:01+11:00 http://biotechdispatch.com.au/news/arcs-signature-program-launched-for-senior-leaders 2022-12-15T06:00:01+11:00 http://biotechdispatch.com.au/news/moderna-appoints-director-of-regional-research-centre 2022-12-15T06:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-appoints-experienced-industry-executive-to-its-board 2022-12-15T04:00:01+11:00 http://biotechdispatch.com.au/news/positive-preliminary-results-from-trial-involving-candidate-from 2022-12-15T04:00:01+11:00 http://biotechdispatch.com.au/news/race-oncology-appoints-new-managing-director-and-ceo 2022-12-15T04:00:01+11:00 http://biotechdispatch.com.au/news/csl-announces-the-appointment-of-its-new-ceo-and-managing-direct 2022-12-13T08:46:01+11:00 http://biotechdispatch.com.au/news/major-industry-award-for-australian-scientist-at-the-forefront-o 2022-12-13T06:00:01+11:00 http://biotechdispatch.com.au/news/researchers-infect-a-brain-in-a-dish-in-search-for-zika-antivira 2022-12-13T06:00:01+11:00 http://biotechdispatch.com.au/news/avita-medical-submits-to-us-fda-with-the-goal-of-expanding-indic 2022-12-13T06:00:01+11:00 http://biotechdispatch.com.au/news/the-george-institute-sells-george-clinical-and-reinvests-in-its- 2022-12-13T06:00:01+11:00 http://biotechdispatch.com.au/news/have-your-say-on-the-national-reconstruction-fund-with-ausbiotec 2022-12-13T06:00:01+11:00 http://biotechdispatch.com.au/news/construction-is-officially-underway-atmodernas-mrna-site 2022-12-08T09:01:01+11:00 http://biotechdispatch.com.au/news/novotech-awarded-the-asia-pacific-cro-of-the-year-2022-for-best- 2022-12-08T09:00:01+11:00 http://biotechdispatch.com.au/news/csl-opens-its-new-australian-plasma-fractionation-facility-in-me 2022-12-08T06:00:01+11:00 http://biotechdispatch.com.au/news/genetic-technologies-announces-the-publication-of-paper-on-genet 2022-12-08T05:00:01+11:00 http://biotechdispatch.com.au/news/nominations-open-for-pms-prizes-for-science-1 2022-12-08T03:00:01+11:00 http://biotechdispatch.com.au/news/tessara-therapeutics-and-netri-in-new-organ-on-chip-collaboratio 2022-12-06T06:00:01+11:00 http://biotechdispatch.com.au/news/collaboration-with-the-university-of-sa-and-successful-capital-r 2022-12-06T06:00:01+11:00 http://biotechdispatch.com.au/news/vaxxas-appoints-doug-cubbin-as-its-new-chief-financial-officer 2022-12-06T06:00:01+11:00 http://biotechdispatch.com.au/news/sanofi-partners-with-queensland-to-create-the-mrna-translational 2022-12-06T06:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-provides-an-update-on-trial-of-its-oncology-drug-candi 2022-12-05T06:00:01+11:00 http://biotechdispatch.com.au/news/contributions-now-open-for-upcoming-australasian-biotechnology 2022-12-05T06:00:01+11:00 http://biotechdispatch.com.au/news/accc-raises-preliminary-competition-concerns-over-cochlears-acqu 2022-12-01T09:00:01+11:00 http://biotechdispatch.com.au/news/pre-clinical-data-for-kazia-therapeutics-evt801-published-in-can 2022-12-01T09:00:01+11:00 http://biotechdispatch.com.au/news/wehi-scientist-recognised-with-csl-florey-medal-for-malaria-rese 2022-12-01T05:02:01+11:00 http://biotechdispatch.com.au/news/national-reconstruction-fund-takes-a-step-forward 2022-12-01T05:00:01+11:00 http://biotechdispatch.com.au/news/developer-announces-plans-for-new-medical-research-facility-in-b 2022-11-30T16:18:01+11:00 http://biotechdispatch.com.au/news/sonic-healthcare-takes-a-major-strategic-stake-in-microba 2022-11-29T10:03:01+11:00 http://biotechdispatch.com.au/news/queensland-based-microbio-completes-successful-investment-round 2022-11-29T09:00:01+11:00 http://biotechdispatch.com.au/news/inventia-secures-nsw-government-support-to-build-a-new-manufactu 2022-11-29T09:00:01+11:00 http://biotechdispatch.com.au/news/emyria-accepted-into-us-national-institutes-of-health-research-p 2022-11-29T09:00:01+11:00 http://biotechdispatch.com.au/news/immutep-announces-new-collaboration-for-cancer-treatment-combina 2022-11-29T09:00:01+11:00 http://biotechdispatch.com.au/news/artificial-intelligence-high-on-life-sciences-agenda 2022-11-29T09:00:01+11:00 http://biotechdispatch.com.au/news/csl-secures-us-approval-for-breakthrough-one-time-haemophilia-ge 2022-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/australian-venture-capital-fund-joins-partners-in-backing-new-im 2022-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/additional-data-released-from-positive-imaging-trial-in-brain-me 2022-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/ionopticks-launches-a-new-age-of-proteomics-with-aurora-frontier 2022-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-gets-behind-campaign-to-combat-the-silent-pandemic 2022-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-policy-forum-biotech-leaders-head-to-parliament 2022-11-22T09:12:01+11:00 http://biotechdispatch.com.au/news/phase-2-trial-of-chulacov19-bna159-mrna-vaccine-to-start-in-aust 2022-11-22T03:00:01+11:00 http://biotechdispatch.com.au/news/zelira-therapeutics-announces-successful-enrolment-in-new-trial 2022-11-21T18:33:01+11:00 http://biotechdispatch.com.au/news/ind-approval-from-the-us-fda-for-theranostic-sarbombesin-trial-i 2022-11-21T17:37:01+11:00 http://biotechdispatch.com.au/news/lumos-diagnostics-announces-agreement-for-capital-raise-and-gene 2022-11-21T17:07:01+11:00 http://biotechdispatch.com.au/news/bionomics-announces-pricing-of-offering-of-american-depositary-s 2022-11-17T10:22:01+11:00 http://biotechdispatch.com.au/news/genome-sequencing-could-curb-hospital-infection-outbreaks 2022-11-17T10:04:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-connects-the-sector-to-celebrate-2022 2022-11-17T09:54:01+11:00 http://biotechdispatch.com.au/news/cynata-announces-presentation-of-data-demonstrating-consistency- 2022-11-17T09:48:01+11:00 http://biotechdispatch.com.au/news/new-hope-for-australian-families-carrying-deadly-cancer-gene-var 2022-11-17T09:46:01+11:00 http://biotechdispatch.com.au/news/positive-trials-results-for-que-oncologys-non-hormonal-oral-ther 2022-11-15T10:00:01+11:00 http://biotechdispatch.com.au/news/telix-acquires-us-radiochemistry-business-optimal-tracers 2022-11-15T10:00:01+11:00 http://biotechdispatch.com.au/news/promising-results-from-in-utero-treatment-of-child-with-pompe-di 2022-11-15T10:00:01+11:00 http://biotechdispatch.com.au/news/commercialisation-one-of-key-priorities-in-future-mrff-decisions 2022-11-15T10:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-announces-16-redi-fellowships-in-industry-roles 2022-11-15T10:00:01+11:00 http://biotechdispatch.com.au/news/qimr-and-wehi-take-home-prizes-for-best-early-stage-project 2022-11-10T09:43:01+11:00 http://biotechdispatch.com.au/news/brandon-capital-invests-in-neuroscience-company-nrg-therapeutics 2022-11-10T09:19:01+11:00 http://biotechdispatch.com.au/news/biomebank-announces-world-first-regulatory-approval-for-donor-de 2022-11-10T09:00:01+11:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-in-new-agreement-with-us-research-hospital 2022-11-10T09:00:01+11:00 http://biotechdispatch.com.au/news/vaxxas-launches-clinical-trial-of-needle-free-covid-19-vaccine-c 2022-11-10T08:00:01+11:00 http://biotechdispatch.com.au/news/certa-therapeutics-welcomes-ground-breaking-results-from-researc 2022-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/telix-announces-positive-topline-results-of-late-stage-imaging-s 2022-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/join-australians-in-biotech-during-jp-morgan-week-2023 2022-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/uk-approval-artryas-salix-coronary-anatomy-product 2022-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/alterity-therapeutics-updates-on-multiple-system-atrophy-study 2022-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/new-ausbiotech-board-fit-for-the-era 2022-11-03T14:00:01+11:00 http://biotechdispatch.com.au/news/rhythm-biosciences-colostat-authorised-for-sale-in-new-zealand 2022-11-03T09:22:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-in-new-research-agreement-with-us-universi 2022-11-03T09:09:01+11:00 http://biotechdispatch.com.au/news/new-partnership-aims-to-drive-efficiencies-in-clinical-trials 2022-11-03T08:53:01+11:00 http://biotechdispatch.com.au/news/csl-secures-rights-to-late-stage-mrna-covid-19-vaccine 2022-11-03T08:52:01+11:00 http://biotechdispatch.com.au/news/life-sciences-industrys-highest-achievers-celebrated-at-prestigi 2022-11-01T13:42:01+11:00 http://biotechdispatch.com.au/news/australian-digital-health-agency-and-csiro-in-new-collaboration 2022-11-01T09:55:01+11:00 http://biotechdispatch.com.au/news/orthocells-remplir-added-to-australias-prostheses-list 2022-11-01T09:47:01+11:00 http://biotechdispatch.com.au/news/australia-rises-in-global-rankings-of-early-and-mid-stage-clinic 2022-11-01T09:44:01+11:00 http://biotechdispatch.com.au/news/world-first-brain-cancer-clinical-trials-launched-in-melbourne 2022-11-01T09:33:01+11:00 http://biotechdispatch.com.au/news/telix-and-uniquest-to-collaborate-on-radiolabelled-immune-target 2022-10-27T12:02:01+11:00 http://biotechdispatch.com.au/news/federal-budget-mostly-vanilla-with-a-bit-of-sting 2022-10-27T12:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-signs-mou-with-us-based-medical-health-industry-assoc 2022-10-27T11:58:01+11:00 http://biotechdispatch.com.au/news/csl-secures-licence-agreement-for-potential-blood-clot-therapy 2022-10-27T11:57:01+11:00 http://biotechdispatch.com.au/news/andhealth-and-launchvic-partner-on-new-digital-health-accelerato 2022-10-27T11:55:01+11:00 http://biotechdispatch.com.au/news/world-class-locally-developed-australias-largest-annual-biotech- 2022-10-25T09:10:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-secures-key-patent-in-singapore 2022-10-25T08:56:01+11:00 http://biotechdispatch.com.au/news/agilex-biolabs-opens-australias-first-satellite-bioanalytical-la 2022-10-25T03:00:01+11:00 http://biotechdispatch.com.au/news/aculeus-therapeutics-reaches-major-milestone-with-launch-of-stud 2022-10-25T03:00:01+11:00 http://biotechdispatch.com.au/news/university-of-sydney-led-research-consortium-manufactures-living 2022-10-25T03:00:01+11:00 http://biotechdispatch.com.au/news/fda-submission-triggers-milestone-payment-for-neuren-pharmaceuti 2022-10-20T09:45:01+11:00 http://biotechdispatch.com.au/news/ausbiotechs-virtual-2022-agm-open-to-members 2022-10-20T05:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-reports-positive-interim-data-from-myelofibrosis-study 2022-10-19T05:00:01+11:00 http://biotechdispatch.com.au/news/report-says-australia-can-be-a-global-destination-for-digital-he 2022-10-19T05:00:01+11:00 http://biotechdispatch.com.au/news/new-study-confirms-rhinoswab-as-preferred-method-for-testing-chi 2022-10-19T05:00:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announces-positive-data-from-brain-cance 2022-10-19T05:00:01+11:00 http://biotechdispatch.com.au/news/ag-biotech-summit-to-feature-sustainable-food 2022-10-18T11:02:01+11:00 http://biotechdispatch.com.au/news/health-canada-approves-telixs-illuccix-for-prostate-cancer-imagi 2022-10-18T10:35:01+11:00 http://biotechdispatch.com.au/news/study-should-patrys-pat-dx3-crosses-blood-brain-barrier-in-healt 2022-10-17T10:02:01+11:00 http://biotechdispatch.com.au/news/microbiogen-opens-state-of-the-art-laboratory-facilities-in-sydn 2022-10-16T10:51:01+11:00 http://biotechdispatch.com.au/news/andhealth-ceo-awarded-the-2022-telstra-brilliant-women-in-digita 2022-10-16T10:03:01+11:00 http://biotechdispatch.com.au/news/botanix-announces-positive-btx-1702-clinical-study-outcome 2022-10-13T09:59:01+11:00 http://biotechdispatch.com.au/news/accelerating-investment-in-queenslands-early-stage-companies 2022-10-13T09:56:01+11:00 http://biotechdispatch.com.au/news/federal-government-to-set-gender-targets-for-major-nhmrc-researc 2022-10-13T09:51:01+11:00 http://biotechdispatch.com.au/news/us-based-bio-looking-for-new-leadership-after-challenging-period 2022-10-13T09:50:01+11:00 http://biotechdispatch.com.au/news/illumina-and-astrazeneca-team-up-on-ai-based-research-project 2022-10-13T09:47:01+11:00 http://biotechdispatch.com.au/news/international-consultation-on-medicines-and-biologicals-1 2022-10-11T10:00:01+11:00 http://biotechdispatch.com.au/news/idt-australia-announces-new-appointments-to-board-of-directors 2022-10-11T09:53:01+11:00 http://biotechdispatch.com.au/news/csl-seqirus-secures-us-government-agreement-to-develop-vaccine-c 2022-10-11T09:42:01+11:00 http://biotechdispatch.com.au/news/biontech-chooses-melbourne-for-its-asia-pacific-mrna-rd-centre 2022-10-11T09:40:01+11:00 http://biotechdispatch.com.au/news/major-appointments-and-rebrand-for-australian-medicinal-cannabis 2022-10-11T09:38:01+11:00 http://biotechdispatch.com.au/news/industry-responds-to-proposed-regulatory-changes-for-clinical-tr 2022-10-06T12:34:01+11:00 http://biotechdispatch.com.au/news/us-grants-patient-to-cartherics-investigational-car-t-therapy 2022-10-06T12:09:01+11:00 http://biotechdispatch.com.au/news/atmo-announces-publication-of-positive-gas-capsule-clinical-tria 2022-10-06T12:03:01+11:00 http://biotechdispatch.com.au/news/illumina-unveils-novaseq-x-series-to-accelerate-genomic-discover 2022-10-06T12:00:01+11:00 http://biotechdispatch.com.au/news/second-fast-track-designation-for-australian-immunotherapy-compa 2022-10-06T11:55:01+11:00 http://biotechdispatch.com.au/news/tga-provisional-determination-for-modernas-covid-19-bivalent-boo 2022-10-04T10:37:01+11:00 http://biotechdispatch.com.au/news/australian-biotechnology-incubator-proto-axiom-completes-initial 2022-10-04T10:27:01+11:00 http://biotechdispatch.com.au/news/ature-publishes-data-on-dunp19-receptors-role-in-cancer-growth 2022-10-04T10:20:01+11:00 http://biotechdispatch.com.au/news/move-to-expand-intellectual-property-waiver-presents-concern 2022-10-04T10:18:01+11:00 http://biotechdispatch.com.au/news/pharmaust-doses-first-patient-in-clinical-trial-of-motor-neurone 2022-10-04T10:16:01+11:00 http://biotechdispatch.com.au/news/new-investor-guide-profiles-biotech-companies-to-watch 2022-09-29T09:55:01+10:00 http://biotechdispatch.com.au/news/csl-announces-seven-recipients-of-global-research-acceleration-i 2022-09-29T09:52:01+10:00 http://biotechdispatch.com.au/news/federal-government-announces-almost-100-new-mrff-grants 2022-09-29T09:21:01+10:00 http://biotechdispatch.com.au/news/telix-announces-first-patient-enrolled-in-prostact-target-study 2022-09-29T03:00:01+10:00 http://biotechdispatch.com.au/news/agilex-biolabs-expands-capacity-with-the-commissioning-of-new-br 2022-09-29T03:00:01+10:00 http://biotechdispatch.com.au/news/success-stories-featured-in-latest-edition-of-australasian-biote 2022-09-27T10:50:01+10:00 http://biotechdispatch.com.au/news/emyria-advances-phase-3-trial-of-cannabinoid-treatment 2022-09-27T04:00:01+10:00 http://biotechdispatch.com.au/news/botanix-pharmaceuticals-submits-new-drug-application-to-fda 2022-09-27T03:00:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-announces-poster-presentation-from-major-s 2022-09-27T03:00:01+10:00 http://biotechdispatch.com.au/news/grant-go-support-cardiovascular-study-of-cynata-therapeutics-cel 2022-09-26T10:09:01+10:00 http://biotechdispatch.com.au/news/noxopharm-founder-to-depart-board-as-part-of-natural-evolution 2022-09-20T08:46:01+10:00 http://biotechdispatch.com.au/news/applications-open-for-global-female-scholars-award-programme 2022-09-20T08:17:01+10:00 http://biotechdispatch.com.au/news/medibio-appoints-experienced-medical-executive-as-new-ceo-1 2022-09-20T08:09:01+10:00 http://biotechdispatch.com.au/news/major-milestone-for-polynovo-for-fda-clearance-of-wound-care-inn 2022-09-20T08:00:01+10:00 http://biotechdispatch.com.au/news/major-milestone-for-polynovo-for-fda-clearance-of-wound-care-inn 2022-09-19T11:17:01+10:00 http://biotechdispatch.com.au/news/fda-grants-important-designation-to-radiopharm-theranostics-dunp 2022-09-19T09:29:01+10:00 http://biotechdispatch.com.au/news/noxopharm-reports-promising-results-from-pancreatic-cancer-study 2022-09-15T08:00:01+10:00 http://biotechdispatch.com.au/news/immutep-provides-clinical-update-on-efti-and-confirms-board-appo 2022-09-15T08:00:01+10:00 http://biotechdispatch.com.au/news/biotron-confirms-start-of-new-covid-19-human-study 2022-09-15T08:00:01+10:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-announces-collaboration-with-canadian-resea 2022-09-15T08:00:01+10:00 http://biotechdispatch.com.au/news/linking-biotech-and-investors-stellar-ausbioinvest-2022-programm 2022-09-14T16:04:01+10:00 http://biotechdispatch.com.au/news/clarity-strengthens-protection-of-the-sar-bispsma-product-with-c 2022-09-13T06:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-says-dosing-has-commenced-in-combination- 2022-09-13T03:00:01+10:00 http://biotechdispatch.com.au/news/botanix-completes-issue-of-first-tranche-of-major-placement 2022-09-12T18:58:01+10:00 http://biotechdispatch.com.au/news/asia-pacific-takes-the-lead-in-cell-and-gene-clinical-trials 2022-09-12T18:47:01+10:00 http://biotechdispatch.com.au/news/us-fda-grants-orphan-designation-for-radiopharm-theranostics-dun 2022-09-12T11:23:01+10:00 http://biotechdispatch.com.au/news/imugene-doses-first-patient-in-nextherizon-phase-2-clinical-tria 2022-09-08T10:14:01+10:00 http://biotechdispatch.com.au/news/leading-global-health-md-joins-ausbiotech-2022-line-up 2022-09-08T10:12:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-announces-revised-clinical-development-pl 2022-09-08T08:40:01+10:00 http://biotechdispatch.com.au/news/new-molecule-chip-changing-the-face-of-modern-manufacturing 2022-09-08T08:37:01+10:00 http://biotechdispatch.com.au/news/victoria-backs-new-andhealth-created-innovation-and-commercialis 2022-09-08T08:34:01+10:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-announces-appointment-of-executive-chairma 2022-09-06T09:42:01+10:00 http://biotechdispatch.com.au/news/framework-released-to-facilitate-university-industry-partnership 2022-09-06T09:35:01+10:00 http://biotechdispatch.com.au/news/esfam-biotech-receives-1-million-for-covid-19-treatment-discover 2022-09-06T03:00:01+10:00 http://biotechdispatch.com.au/news/qimr-berghofer-grants-option-and-license-agreement-for-potential 2022-09-06T03:00:01+10:00 http://biotechdispatch.com.au/news/occurx-secures-funding-to-progress-potential-inflammation-and-fi 2022-09-06T03:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-4 2022-09-01T06:31:01+10:00 http://biotechdispatch.com.au/news/clinuvel-reports-sixth-consecutive-annual-profit 2022-08-31T01:42:01+10:00 http://biotechdispatch.com.au/news/rebranded-acurabio-acquired-by-major-investors 2022-08-30T22:56:01+10:00 http://biotechdispatch.com.au/news/starpharma-wins-recognition-for-development-of-covid-19-antivira 2022-08-30T22:48:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-appoints-new-non-executive-director 2022-08-30T22:39:01+10:00 http://biotechdispatch.com.au/news/emvision-medical-confirms-manufacturing-grant-will-proceed 2022-08-30T06:11:01+10:00 http://biotechdispatch.com.au/news/optiscan-imaging-submits-510k-application-to-the-us-fda 2022-08-30T06:05:01+10:00 http://biotechdispatch.com.au/news/nominations-open-for-ausbiotech-board 2022-08-30T05:58:01+10:00 http://biotechdispatch.com.au/news/monash-university-ai-model-could-predict-the-best-epilepsy-medic 2022-08-30T05:55:01+10:00 http://biotechdispatch.com.au/news/university-of-sydney-announces-landmark-investment-to-create-bio 2022-08-30T05:52:01+10:00 http://biotechdispatch.com.au/news/alterity-therapeutics-launches-clinical-trial-in-europe 2022-08-25T11:30:01+10:00 http://biotechdispatch.com.au/news/proposed-regulatory-changes-for-clinical-trials-of-medical-devic 2022-08-25T11:27:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-launches-share-purchase-plan-to-raise-8-m 2022-08-25T08:12:01+10:00 http://biotechdispatch.com.au/news/trajan-reports-strong-sales-and-profit-growth-across-the-group 2022-08-25T07:54:01+10:00 http://biotechdispatch.com.au/news/biotron-announces-phase-2-trial-of-bit225-now-fully-recruited 2022-08-25T07:49:01+10:00 http://biotechdispatch.com.au/news/dimerix-confirms-clarity-20-covid-19-study-concludes-recruitment 2022-08-23T11:38:01+10:00 http://biotechdispatch.com.au/news/choroid-plexus-tissue-shipped-to-sydney-as-ntcell-research-advan 2022-08-23T11:00:01+10:00 http://biotechdispatch.com.au/news/positions-vacant-on-key-tga-statutory-advisory-committees 2022-08-23T11:00:01+10:00 http://biotechdispatch.com.au/news/long-covid-19-study-identifies-novel-blood-markers-as-potential- 2022-08-23T11:00:01+10:00 http://biotechdispatch.com.au/news/telix-revenue-soars-after-us-commercialisation 2022-08-23T11:00:01+10:00 http://biotechdispatch.com.au/news/csl-starts-planning-to-submit-new-antibody-treatment 2022-08-18T08:19:01+10:00 http://biotechdispatch.com.au/news/accelerating-biotechs-future-workforce-needs 2022-08-18T03:00:01+10:00 http://biotechdispatch.com.au/news/tattarang-launches-new-250m-venture-capital-business 2022-08-18T03:00:01+10:00 http://biotechdispatch.com.au/news/csl-looking-to-strong-post-pandemic-growth 2022-08-18T03:00:01+10:00 http://biotechdispatch.com.au/news/cyclopharm-reports-strong-revenue-growth-for-six-months-to-june 2022-08-17T19:38:01+10:00 http://biotechdispatch.com.au/news/best-practice-resource-for-life-sciences-to-be-updated 2022-08-16T09:09:01+10:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-and-peptilogics-announce-new-collaboration 2022-08-16T09:01:01+10:00 http://biotechdispatch.com.au/news/carina-biotech-capital-raise-backed-by-new-cornerstone-investor 2022-08-16T04:00:01+10:00 http://biotechdispatch.com.au/news/microbio-receives-clearance-to-sell-in-vitro-diagnostic-test-in- 2022-08-16T03:00:01+10:00 http://biotechdispatch.com.au/news/major-capital-raise-for-opthea-as-it-prepares-for-commercialisat 2022-08-15T12:16:01+10:00 http://biotechdispatch.com.au/news/avita-medical-announced-topline-results-for-recell-system-trial 2022-08-15T09:46:01+10:00 http://biotechdispatch.com.au/news/first-patient-enrolled-in-new-trial-of-novosorb-synpath-treatmen 2022-08-11T10:27:01+10:00 http://biotechdispatch.com.au/news/industry-leaders-to-develop-esg-framework 2022-08-11T10:13:01+10:00 http://biotechdispatch.com.au/news/csiro-opens-missing-link-lab-to-developing-australian-vaccine-pi 2022-08-11T10:03:01+10:00 http://biotechdispatch.com.au/news/starpharma-announces-new-research-agreement-for-dep-drug-deliver 2022-08-10T11:00:01+10:00 http://biotechdispatch.com.au/news/partrys-candidate-in-combination-improves-survival-in-brain-canc 2022-08-10T10:37:01+10:00 http://biotechdispatch.com.au/news/neuren-commences-enrolment-new-phase-2-trials-of-nnz-2591 2022-08-09T15:57:01+10:00 http://biotechdispatch.com.au/news/life-sciences-directory-to-connecting-the-industry 2022-08-09T11:33:01+10:00 http://biotechdispatch.com.au/news/telix-and-uq-led-consortium-awarded-australian-research-council- 2022-08-09T10:15:01+10:00 http://biotechdispatch.com.au/news/neuren-commences-new-phase-2-trials-of-nnz-2591 2022-08-09T10:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-announces-new-patent-family-for-dmx-700 2022-08-09T10:00:01+10:00 http://biotechdispatch.com.au/news/lumos-withdraws-from-participation-in-victorian-manufacturing-pr 2022-08-08T03:00:01+10:00 http://biotechdispatch.com.au/news/osteopore-secures-us-distribution-agreement-for-government-facil 2022-08-04T10:39:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announces-new-agreements-with-lantheus-a 2022-08-04T10:24:01+10:00 http://biotechdispatch.com.au/news/medical-developments-international-announces-fully-underwritten- 2022-08-04T10:17:01+10:00 http://biotechdispatch.com.au/news/pfizer-raises-offer-for-australian-digital-health-company 2022-08-04T10:14:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-2022-programme-features-top-industry-experts 2022-08-04T10:13:01+10:00 http://biotechdispatch.com.au/news/australias-cell-and-gene-catalyst-moves-ahead 2022-08-02T10:58:01+10:00 http://biotechdispatch.com.au/news/new-study-published-demonstrating-the-utility-of-promarkerd-test 2022-08-02T10:00:01+10:00 http://biotechdispatch.com.au/news/lumos-diagnostics-announces-plan-to-close-us-facility 2022-08-02T10:00:01+10:00 http://biotechdispatch.com.au/news/immutep-reports-new-data-from-phase-2-tacti-002-trial 2022-08-02T08:47:01+10:00 http://biotechdispatch.com.au/news/recruitment-open-for-new-study-of-lung-disease 2022-08-02T08:00:01+10:00 http://biotechdispatch.com.au/news/nominations-open-to-recognise-sector-leaders 2022-07-28T11:34:01+10:00 http://biotechdispatch.com.au/news/immuron-provides-update-on-fda-review-of-ind-application 2022-07-28T10:00:01+10:00 http://biotechdispatch.com.au/news/genetic-signatures-completes-recruitment-in-pivotal-clinical-tri 2022-07-28T10:00:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-launches-next-funding-opportunity-for-medical-device- 2022-07-28T09:00:01+10:00 http://biotechdispatch.com.au/news/volpara-health-announces-outcomes-of-strategic-review 2022-07-28T09:00:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-trial-to-be-presented-at-major-us-conference 2022-07-26T10:08:01+10:00 http://biotechdispatch.com.au/news/adherium-wins-us-clearance-for-gsk-inhaler-users-to-connect-to-n 2022-07-26T10:00:01+10:00 http://biotechdispatch.com.au/news/patent-filings-increase-in-new-intellectual-property-report 2022-07-26T09:00:01+10:00 http://biotechdispatch.com.au/news/industry-responds-to-waiver-with-its-own-access-declaration 2022-07-26T09:00:01+10:00 http://biotechdispatch.com.au/news/impedimed-announces-departure-of-long-term-chief-executive 2022-07-26T09:00:01+10:00 http://biotechdispatch.com.au/news/international-consultation-on-medical-device-cybersecurity 2022-07-21T09:49:01+10:00 http://biotechdispatch.com.au/news/building-real-world-evidence-the-goal-of-new-collaboration 2022-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/australias-first-national-biotechnology-incubator-announces-roun 2022-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-company-one-step-closer-to-major-product- 2022-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/accc-clears-pfizer-acquisition-of-australian-digital-health-comp 2022-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/the-national-clinical-trials-governance-framework-launched 2022-07-18T17:23:01+10:00 http://biotechdispatch.com.au/news/ausbiotechs-lorraine-chiroiu-a-hollow-victory-and-slap-in-the-fa 2022-07-18T17:21:01+10:00 http://biotechdispatch.com.au/news/emyria-expands-drug-candidate-library-inspired-by-mdma-analogue 2022-07-18T11:57:01+10:00 http://biotechdispatch.com.au/news/imugene-appoints-experienced-industry-executive-as-new-chief-fin 2022-07-18T10:05:01+10:00 http://biotechdispatch.com.au/news/rhinomed-announces-rhinoswab-supply-deal-with-surescreen 2022-07-18T09:51:01+10:00 http://biotechdispatch.com.au/news/genetic-technologies-completes-acquisition-of-affinitydna 2022-07-14T11:00:01+10:00 http://biotechdispatch.com.au/news/tgas-new-report-on-cell-and-gene-therapy-regulation 2022-07-14T10:00:01+10:00 http://biotechdispatch.com.au/news/actinogen-confirms-alzheimers-disease-biomarker-study-timing-and 2022-07-14T10:00:01+10:00 http://biotechdispatch.com.au/news/neuren-commences-phase-2-trial-of-nnz-2591-in-angelman-syndrome 2022-07-14T09:46:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-secures-us-patent-for-use-of-the-cymerus-msc 2022-07-14T09:00:01+10:00 http://biotechdispatch.com.au/news/neuroscientific-biopharmaceuticals-seeks-approval-for-phase-1-tr 2022-07-12T09:58:01+10:00 http://biotechdispatch.com.au/news/emerging-australian-company-appoints-industry-research-leader-to 2022-07-12T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-expands-its-investment-attraction-portfolio 2022-07-12T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-announces-major-leadership-appointment 2022-07-12T09:00:01+10:00 http://biotechdispatch.com.au/news/study-identifies-kids-with-cancer-at-risk-of-lethal-infections 2022-07-12T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-csiro-partner-to-connect-sector 2022-07-07T11:13:01+10:00 http://biotechdispatch.com.au/news/australian-study-uncovers-a-driving-factor-in-the-development-of 2022-07-07T11:00:01+10:00 http://biotechdispatch.com.au/news/patrys-says-pat-dx1-engineering-run-successfully-completed 2022-07-07T11:00:01+10:00 http://biotechdispatch.com.au/news/botanix-pharmaceuticals-accelerates-filing-of-nda 2022-07-07T11:00:01+10:00 http://biotechdispatch.com.au/news/resapp-health-extends-agreement-with-europes-medgate 2022-07-07T11:00:01+10:00 http://biotechdispatch.com.au/news/funding-programme-increases-support-for-wa-researchers 2022-07-05T11:16:01+10:00 http://biotechdispatch.com.au/news/australian-researchers-identify-new-drug-target-for-inflammatory 2022-07-05T10:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-updates-with-new-and-positive-dmx-700-data 2022-07-05T10:00:01+10:00 http://biotechdispatch.com.au/news/csiro-supports-cureator-with-funding-for-health-security-stream 2022-07-05T10:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-adds-three-new-us-sites-to-cep-2-sarcoma-study 2022-07-05T10:00:01+10:00 http://biotechdispatch.com.au/news/starpharmas-anti-viral-nasal-spray-relaunched-in-the-uk 2022-06-30T11:49:01+10:00 http://biotechdispatch.com.au/news/novotech-secures-regional-best-biologics-cro-award 2022-06-30T11:43:01+10:00 http://biotechdispatch.com.au/news/neuroscientific-biopharmaceuticals-updates-on-early-stage-trial 2022-06-30T11:43:01+10:00 http://biotechdispatch.com.au/news/new-leadership-for-medtech-regulatory-advisory-group 2022-06-30T11:00:01+10:00 http://biotechdispatch.com.au/news/digital-clinical-trial-recruitment-platform-in-new-agreements-wi 2022-06-30T10:00:01+10:00 http://biotechdispatch.com.au/news/lumos-diagnostics-secures-authorisation-for-test-in-canada 2022-06-28T10:54:01+10:00 http://biotechdispatch.com.au/news/starpharma-signs-expanded-dep-research-agreement-with-genentech 2022-06-28T10:51:01+10:00 http://biotechdispatch.com.au/news/mgc-pharmaceuticals-updates-on-pre-clinical-trial-progress 2022-06-28T10:43:01+10:00 http://biotechdispatch.com.au/news/investment-funds-support-university-commercialisation 2022-06-28T10:36:01+10:00 http://biotechdispatch.com.au/news/orthocell-announces-new-agreement-with-us-based-biohorizons 2022-06-28T10:10:01+10:00 http://biotechdispatch.com.au/news/trajan-announces-share-purchase-plan-after-successful-institutio 2022-06-23T11:06:01+10:00 http://biotechdispatch.com.au/news/goldilocks-treatment-window-could-lead-to-cancer-therapy-without 2022-06-23T10:57:01+10:00 http://biotechdispatch.com.au/news/volpara-health-in-new-collaboration-with-microsoft 2022-06-23T10:53:01+10:00 http://biotechdispatch.com.au/news/victorian-government-grant-to-hudson-institute-for-collaboration 2022-06-23T10:46:01+10:00 http://biotechdispatch.com.au/news/nsw-and-qld-government-investments-into-industry-welcomed 2022-06-23T10:44:01+10:00 http://biotechdispatch.com.au/news/high-appetite-for-biotech-vc-cited-in-new-report 2022-06-21T10:34:01+10:00 http://biotechdispatch.com.au/news/trajan-acquires-us-based-manufacturer-chromatography-research-su 2022-06-20T11:43:01+10:00 http://biotechdispatch.com.au/news/vaccine-manufacturing-facility-secures-queensland-government-fun 2022-06-20T11:36:01+10:00 http://biotechdispatch.com.au/news/new-orphan-drug-designation-for-kazia-therapeutics-paxalisib 2022-06-20T11:27:01+10:00 http://biotechdispatch.com.au/news/life-sciences-industry-says-ip-waiver-an-empty-shell-and-fact-fr 2022-06-20T10:00:01+10:00 http://biotechdispatch.com.au/news/genetic-technologies-says-modelling-demonstrates-benefit-of-new- 2022-06-16T10:58:01+10:00 http://biotechdispatch.com.au/news/major-software-acquisition-for-leading-australian-company-resmed 2022-06-16T10:00:01+10:00 http://biotechdispatch.com.au/news/new-treatments-help-drive-improvements-in-childhood-cancer-survi 2022-06-16T10:00:01+10:00 http://biotechdispatch.com.au/news/registrations-are-open-to-come-alive-at-ausbiotech-2022 2022-06-16T10:00:01+10:00 http://biotechdispatch.com.au/news/neuroscientific-biopharmaceuticals-reports-positive-data-from-an 2022-06-16T10:00:01+10:00 http://biotechdispatch.com.au/news/neurotech-international-reports-positive-preclinical-data-from-c 2022-06-14T05:57:01+10:00 http://biotechdispatch.com.au/news/telix-and-reflexion-expand-partnership-for-prostate-cancer-treat 2022-06-14T05:47:01+10:00 http://biotechdispatch.com.au/news/regeneus-chief-executive-makes-off-market-investment-in-company 2022-06-14T05:39:01+10:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-says-clinical-trial-validates-targeting-lsd 2022-06-14T05:30:01+10:00 http://biotechdispatch.com.au/news/significant-growth-symbolic-of-biotech-sectors-sovereign-value 2022-06-14T05:27:01+10:00 http://biotechdispatch.com.au/news/strong-australian-delegation-to-bio-2022-marks-biotechs-global-r 2022-06-09T07:25:01+10:00 http://biotechdispatch.com.au/news/new-blood-test-could-spare-patients-from-unnecessary-chemotherap 2022-06-09T04:21:01+10:00 http://biotechdispatch.com.au/news/new-blood-test-could-spare-patients-from-unnecessary-chemotherap 2022-06-09T04:21:01+10:00 http://biotechdispatch.com.au/news/australian-women-at-risk-of-cancer-missing-out-on-genetic-testin 2022-06-09T04:17:01+10:00 http://biotechdispatch.com.au/news/dimerix-enters-agreement-for-new-trial-of-dmx-200-in-diabetic-ki 2022-06-09T04:11:01+10:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-reports-significant-rd-tax-refund 2022-06-09T04:06:01+10:00 http://biotechdispatch.com.au/news/early-stage-medtech-celebrated-at-ausmedtech-2022 2022-06-07T05:40:01+10:00 http://biotechdispatch.com.au/news/avita-wins-best-emerging-company-investor-relations-award 2022-06-07T05:25:01+10:00 http://biotechdispatch.com.au/news/immutep-reports-positive-overall-response-rate-in-lung-cancer-tr 2022-06-07T05:19:01+10:00 http://biotechdispatch.com.au/news/clarity-secures-us-ind-approval-for-phase-2-prostate-cancer-tria 2022-06-07T05:13:01+10:00 http://biotechdispatch.com.au/news/starpharma-one-of-a-number-of-leading-australian-companies-in-th 2022-06-07T05:07:01+10:00 http://biotechdispatch.com.au/news/one-stop-shop-for-clinical-trials-enters-its-second-phase 2022-06-02T05:47:01+10:00 http://biotechdispatch.com.au/news/new-appointment-to-imugenes-scientific-advisory-board 2022-06-02T05:28:01+10:00 http://biotechdispatch.com.au/news/healthcare-super-fund-hesta-directly-invests-in-inventia-life-sc 2022-06-02T05:22:01+10:00 http://biotechdispatch.com.au/news/first-patient-recruited-in-dimerix-late-stage-trial 2022-06-02T05:04:01+10:00 http://biotechdispatch.com.au/news/carina-biotech-appoints-cell-therapies-to-manufacture-lgr5-car-t 2022-06-02T05:01:01+10:00 http://biotechdispatch.com.au/news/adherium-provides-update-on-senior-management 2022-05-31T05:38:01+10:00 http://biotechdispatch.com.au/news/medical-developments-international-appoints-general-counsel-and- 2022-05-31T05:34:01+10:00 http://biotechdispatch.com.au/news/cynata-adds-new-site-for-mend-clinical-trial 2022-05-30T19:41:01+10:00 http://biotechdispatch.com.au/news/channel-bio-opens-new-state-of-the-art-facility-in-sydney 2022-05-30T18:37:01+10:00 http://biotechdispatch.com.au/news/profile-successes-and-add-your-voice 2022-05-30T18:34:01+10:00 http://biotechdispatch.com.au/news/thriving-medtech-community-celebrated-at-record-breaking-ausmedt 2022-05-26T05:44:01+10:00 http://biotechdispatch.com.au/news/brandon-capital-backs-new-zealand-immunotherapy-start-up 2022-05-25T09:43:01+10:00 http://biotechdispatch.com.au/news/anteris-technologies-expands-its-medical-advisory-board 2022-05-25T09:36:01+10:00 http://biotechdispatch.com.au/news/archer-materials-secures-australian-patent-for-quantum-computing 2022-05-24T13:01:01+10:00 http://biotechdispatch.com.au/news/new-clinical-trial-to-test-cancer-drug-in-motor-neuron-disease 2022-05-24T09:40:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-incoming-federal-government 2022-05-24T09:32:01+10:00 http://biotechdispatch.com.au/news/new-government-starts-work-on-key-election-commitments 2022-05-24T08:13:01+10:00 http://biotechdispatch.com.au/news/4dmedical-appoints-director-to-executive-position 2022-05-24T08:00:01+10:00 http://biotechdispatch.com.au/news/living-cell-technologies-announces-new-agreement-to-use-ai-in-tr 2022-05-24T08:00:01+10:00 http://biotechdispatch.com.au/news/mcia-releases-roadmap-to-growth-for-the-australian-medicinal-can 2022-05-24T07:00:01+10:00 http://biotechdispatch.com.au/news/updated-covid-19-rat-receives-regulatory-approval-in-europe 2022-05-19T08:58:01+10:00 http://biotechdispatch.com.au/news/fda-confirms-a-diagnostic-method-for-medibios-final-depression-v 2022-05-19T08:52:01+10:00 http://biotechdispatch.com.au/news/celebrating-industry-leaders-on-international-clinical-trials-da 2022-05-19T08:43:01+10:00 http://biotechdispatch.com.au/news/spl7013-in-viraleze-virucidal-against-influenza-a-and-b 2022-05-18T13:08:01+10:00 http://biotechdispatch.com.au/news/immutep-appoints-leading-oncologists-to-clinical-advisory-board 2022-05-18T10:37:01+10:00 http://biotechdispatch.com.au/news/4dmedical-copd-trial-results-presented-at-us-lung-conference 2022-05-17T09:07:01+10:00 http://biotechdispatch.com.au/news/illuminas-susan-tousi-on-genomics-and-changing-healthcare 2022-05-17T08:59:01+10:00 http://biotechdispatch.com.au/news/pharmaust-says-mpl-tablets-arrive-for-motor-neuron-disease-trial 2022-05-17T08:53:01+10:00 http://biotechdispatch.com.au/news/nyrada-says-european-patent-to-be-granted-for-cholesterol-loweri 2022-05-17T08:44:01+10:00 http://biotechdispatch.com.au/news/help-the-ausbiotech-2022-programme-come-alive 2022-05-17T08:42:01+10:00 http://biotechdispatch.com.au/news/industry-backed-plan-to-navigate-australian-biotech-into-the-fut 2022-05-12T13:07:01+10:00 http://biotechdispatch.com.au/news/neuroscientific-biopharmaceuticals-submits-for-approval-of-early 2022-05-12T09:47:01+10:00 http://biotechdispatch.com.au/news/pharmaust-expands-bonepantel-lymphoma-canine-trial-to-the-us 2022-05-12T09:00:01+10:00 http://biotechdispatch.com.au/news/ena-respiratory-joins-initiative-to-boost-development-of-nasal-s 2022-05-12T08:37:01+10:00 http://biotechdispatch.com.au/news/immuron-partner-submits-ind-application-to-us-fda-for-new-therap 2022-05-12T08:00:01+10:00 http://biotechdispatch.com.au/news/clinuvel-progresses-us-based-vitiligo-study 2022-05-10T09:00:01+10:00 http://biotechdispatch.com.au/news/prescient-expands-ptx-200-aml-cohort-following-additional-comple 2022-05-10T08:48:01+10:00 http://biotechdispatch.com.au/news/us-fda-ind-approval-for-dimerix-late-stage-study 2022-05-10T08:00:01+10:00 http://biotechdispatch.com.au/news/nsw-government-launches-20-year-roadmap-for-industry 2022-05-10T08:00:01+10:00 http://biotechdispatch.com.au/news/imugene-secures-australian-ethics-approval-for-her-vaxx-trial 2022-05-10T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-victorian-government-industry-investment 2022-05-05T09:52:01+10:00 http://biotechdispatch.com.au/news/new-senior-appointments-for-tessara-therapeutics 2022-05-05T09:47:01+10:00 http://biotechdispatch.com.au/news/emvision-medical-devices-announces-agreement-with-keysight 2022-05-05T09:33:01+10:00 http://biotechdispatch.com.au/news/botanix-acquires-rights-to-new-dermatology-product 2022-05-05T09:23:01+10:00 http://biotechdispatch.com.au/news/clinuvel-reports-positive-final-results-in-stroke-study 2022-05-05T08:39:01+10:00 http://biotechdispatch.com.au/news/inoviq-announces-manufacturing-agreement-with-mp-biomedicals 2022-05-03T10:19:01+10:00 http://biotechdispatch.com.au/news/servatus-strengthens-board-with-new-appointment 2022-05-03T09:45:01+10:00 http://biotechdispatch.com.au/news/medtech-featured-in-latest-edition-of-australasian-biotechnology 2022-05-03T09:33:01+10:00 http://biotechdispatch.com.au/news/biotron-says-bit225-against-sars-cov-2-infection-in-animals 2022-05-03T09:00:01+10:00 http://biotechdispatch.com.au/news/investment-in-australian-collaboration-targeting-inflammatory-lu 2022-05-03T01:00:01+10:00 http://biotechdispatch.com.au/news/adherium-releases-next-generation-respiratory-platform-integrati 2022-04-28T11:00:01+10:00 http://biotechdispatch.com.au/news/osteopore-announces-the-appointment-of-chief-operating-officer 2022-04-28T10:00:01+10:00 http://biotechdispatch.com.au/news/first-subjects-randomised-and-dosed-in-paradigms-late-stage-tria 2022-04-28T10:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-agrees-to-acquire-oticon-medical 2022-04-28T09:00:01+10:00 http://biotechdispatch.com.au/news/industry-dinner-to-reignite-sector 2022-04-28T09:00:01+10:00 http://biotechdispatch.com.au/news/nsw-government-seeks-operator-for-rna-manufacturing 2022-04-26T11:00:01+10:00 http://biotechdispatch.com.au/news/stuart-dignam-the-new-ceo-of-mtpconnect 2022-04-26T09:00:01+10:00 http://biotechdispatch.com.au/news/opthea-announces-appointment-of-two-new-directors 2022-04-26T08:00:01+10:00 http://biotechdispatch.com.au/news/kazia-therapeutics-establishes-new-capital-raising-facility 2022-04-26T08:00:01+10:00 http://biotechdispatch.com.au/news/new-uk-based-business-development-executive-for-adherium 2022-04-26T08:00:01+10:00 http://biotechdispatch.com.au/news/kazia-therapeutics-says-phase-2-study-of-paxalisib-completed 2022-04-21T10:00:01+10:00 http://biotechdispatch.com.au/news/misison-to-biokorea-to-strengthen-ties 2022-04-21T09:54:01+10:00 http://biotechdispatch.com.au/news/volpara-health-announces-leadership-and-board-changes 2022-04-21T09:00:01+10:00 http://biotechdispatch.com.au/news/arovella-therapeutics-announces-manufacturing-agreement-with-q-g 2022-04-21T08:00:01+10:00 http://biotechdispatch.com.au/news/medlab-clinical-confirms-northern-hemisphere-distribution 2022-04-21T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-supports-pre-election-statement-on-research 2022-04-19T09:00:01+10:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-appoints-new-chief-science-officer 2022-04-19T08:28:01+10:00 http://biotechdispatch.com.au/news/uq-microbiopsy-deal-could-change-the-way-skin-conditions-are-dia 2022-04-19T08:00:01+10:00 http://biotechdispatch.com.au/news/prime-minister-confirms-south-australian-senator-for-health-port 2022-04-19T08:00:01+10:00 http://biotechdispatch.com.au/news/zelira-therapeutics-executes-acquisition-of-health-house 2022-04-19T08:00:01+10:00 http://biotechdispatch.com.au/news/emyria-announces-agreement-for-multi-site-phase-3-trial-for-emd- 2022-04-14T09:00:01+10:00 http://biotechdispatch.com.au/news/botanix-confirms-presentation-of-data-at-upcoming-congress 2022-04-14T08:49:01+10:00 http://biotechdispatch.com.au/news/workforce-and-capacity-summit-white-paper-released 2022-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/neuroscientific-biopharmaceuticals-reports-on-preclinical-progra 2022-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/imugene-says-first-cohort-two-patient-dose-in-phase-1-clinical-t 2022-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/australian-pavilion-returns-in-person-to-bio-2022 2022-04-12T11:41:01+10:00 http://biotechdispatch.com.au/news/research-collaboration-developing-sustainable-textile-coating-in 2022-04-12T11:34:01+10:00 http://biotechdispatch.com.au/news/rhinomed-completes-institutional-component-of-capital-raise 2022-04-12T11:27:01+10:00 http://biotechdispatch.com.au/news/pfizer-announces-acquisition-of-australian-digital-health-compan 2022-04-12T11:00:01+10:00 http://biotechdispatch.com.au/news/microbio-is-a-step-closer-to-launching-its-infectid-bsi-tests-in 2022-04-12T11:00:01+10:00 http://biotechdispatch.com.au/news/consultation-opens-on-reforming-research-block-grants-to-boost-c 2022-04-07T10:53:01+10:00 http://biotechdispatch.com.au/news/race-receives-human-ethics-approval-for-new-trial 2022-04-07T08:39:01+10:00 http://biotechdispatch.com.au/news/agilex-biolabs-appoints-a-new-chief-scientific-officer 2022-04-07T08:00:01+10:00 http://biotechdispatch.com.au/news/inoviq-and-university-of-queensland-expand-collaboration 2022-04-07T08:00:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-announces-support-for-major-new-resilience-projects 2022-04-07T08:00:01+10:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-1 2022-04-05T09:00:01+10:00 http://biotechdispatch.com.au/news/bio-gene-signs-agreement-on-flavocide-technology 2022-04-05T08:53:01+10:00 http://biotechdispatch.com.au/news/australian-healthcare-investor-urges-greater-support-from-peers 2022-04-05T08:51:01+10:00 http://biotechdispatch.com.au/news/rd-tax-incentive-determination-published 2022-04-05T08:49:01+10:00 http://biotechdispatch.com.au/news/microba-announces-new-research-partnership-and-senior-appointmen 2022-04-05T08:00:01+10:00 http://biotechdispatch.com.au/news/genetic-signatures-secures-supply-deal-in-wales 2022-03-31T08:30:01+11:00 http://biotechdispatch.com.au/news/avecho-reports-positive-results-for-phase-2-topical-cbd-osteoart 2022-03-31T08:00:01+11:00 http://biotechdispatch.com.au/news/ntcell-to-be-produced-in-australia-under-uts-research-agreement 2022-03-31T08:00:01+11:00 http://biotechdispatch.com.au/news/government-launches-biotechnology-strategic-plan-for-health-and- 2022-03-31T08:00:01+11:00 http://biotechdispatch.com.au/news/research-australia-raises-concern-over-lack-of-investment-in-key 2022-03-31T08:00:01+11:00 http://biotechdispatch.com.au/news/hexima-presents-data-on-new-topical-treatment 2022-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/launching-ausbionsw-promoting-and-strengthening-the-states-capab 2022-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/neuren-receives-fda-approval-for-pitt-hopkins-ind-and-phase-2-tr 2022-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/dimerix-receives-rd-tax-rebate-for-last-financial-year 2022-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/microbio-announces-capital-raise-to-support-product-launch 2022-03-29T09:00:01+11:00 http://biotechdispatch.com.au/news/industry-concerned-by-leaked-covid-19-vaccine-ip-waiver-text 2022-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/unisuper-invests-with-uniseed-australias-longest-running-early-s 2022-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/bioscience-managers-welcomes-fda-approval-of-saluda-technology 2022-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/large-molecule-facility-doubles-size-of-leading-bioanalytical-la 2022-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/partnership-creates-australian-vaccine-development-and-manufactu 2022-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/access-savings-by-registering-early-for-ausmedtech-2022 2022-03-22T12:00:01+11:00 http://biotechdispatch.com.au/news/us-fda-grants-new-orphan-designation-to-noxopharms-veyonda 2022-03-22T10:46:01+11:00 http://biotechdispatch.com.au/news/official-opening-of-new-south-wales-rna-institute 2022-03-22T08:00:01+11:00 http://biotechdispatch.com.au/news/biotron-updates-on-pre-clinical-study-of-bit225-in-covid-19 2022-03-22T08:00:01+11:00 http://biotechdispatch.com.au/news/tga-approval-for-orthocells-remplir-peripheral-nerve-repair-devi 2022-03-22T08:00:01+11:00 http://biotechdispatch.com.au/news/wa-funding-programmes-open 2022-03-17T10:00:01+11:00 http://biotechdispatch.com.au/news/first-participants-dosed-in-ena-respiratorys-phase-2a-study 2022-03-17T10:00:01+11:00 http://biotechdispatch.com.au/news/price-cuts-in-new-agreement-that-imposes-limits-on-medical-devic 2022-03-17T10:00:01+11:00 http://biotechdispatch.com.au/news/paradigm-secures-uk-approvals-for-paraoa002-clinical-trial 2022-03-17T10:00:01+11:00 http://biotechdispatch.com.au/news/zantrene-highly-effective-in-a-mouse-model-of-extramedullary-aml 2022-03-17T10:00:01+11:00 http://biotechdispatch.com.au/news/gold-standard-commercialisation-for-biotech 2022-03-15T06:12:01+11:00 http://biotechdispatch.com.au/news/race-oncology-says-preclinical-study-confirms-promising-kidney-c 2022-03-15T05:54:01+11:00 http://biotechdispatch.com.au/news/haemokinesis-ipo-to-expand-global-rapid-blood-diagnostic-platfor 2022-03-15T03:53:01+11:00 http://biotechdispatch.com.au/news/neuren-receives-ethics-approval-for-angelman-phase-2-trial 2022-03-15T03:50:01+11:00 http://biotechdispatch.com.au/news/partnership-wants-change-in-how-universities-and-industry-collab 2022-03-15T03:00:01+11:00 http://biotechdispatch.com.au/news/victorias-medtech-manufacturing-capability-programme-opens 2022-03-10T08:24:01+11:00 http://biotechdispatch.com.au/news/collaboration-welcomes-new-commitment-to-cepi-moonshot 2022-03-10T08:23:01+11:00 http://biotechdispatch.com.au/news/emyria-starts-emd-rx5-clinical-development-program 2022-03-10T08:15:01+11:00 http://biotechdispatch.com.au/news/rebrand-for-australias-largest-life-sciences-venture-fund 2022-03-10T08:00:01+11:00 http://biotechdispatch.com.au/news/telixs-zircon-lates-stage-kidney-cancer-imaging-study-completes- 2022-03-10T08:00:01+11:00 http://biotechdispatch.com.au/news/international-womens-day-ausbiotech-moving-the-dial-on-gender-eq 2022-03-08T07:00:01+11:00 http://biotechdispatch.com.au/news/adherium-submits-new-hailie-sensor-for-us-fda-clerance 2022-03-08T06:45:01+11:00 http://biotechdispatch.com.au/news/bio-gene-announces-positive-stored-grain-pest-results 2022-03-08T06:35:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announces-final-results-from-phase-1-trial 2022-03-08T06:28:01+11:00 http://biotechdispatch.com.au/news/recognition-for-vetter-in-cmo-leadership-awards 2022-03-08T06:24:01+11:00 http://biotechdispatch.com.au/news/new-expedited-regulatory-pathway-proposed-for-novel-biologicals 2022-03-02T12:03:01+11:00 http://biotechdispatch.com.au/news/active-agent-in-australian-developed-nasal-spray-highly-active-a 2022-03-02T12:00:01+11:00 http://biotechdispatch.com.au/news/anteris-technologies-secures-the-backing-of-us-healthcare-invest 2022-03-02T11:53:01+11:00 http://biotechdispatch.com.au/news/mental-illness-diet-and-physical-activity-targeted-in-new-heart- 2022-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-confirms-atl1102-poster-presentation 2022-03-01T15:02:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-highlights-clarity-and-transparency-is-key-in-recent- 2022-03-01T12:17:01+11:00 http://biotechdispatch.com.au/news/fda-approval-neuren-pharmaceuticalss-phase-2-trial-in-angelman-s 2022-03-01T04:00:01+11:00 http://biotechdispatch.com.au/news/lucy-lucy-turnbull-ao-rejoins-the-board-of-immutep 2022-03-01T04:00:01+11:00 http://biotechdispatch.com.au/news/ppatrys-select-stable-cell-line-for-the-production-of-pat-dx3atr 2022-03-01T04:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-updates-on-us-market-entry-and-growth 2022-03-01T04:00:01+11:00 http://biotechdispatch.com.au/news/record-revenue-and-profit-for-australian-company-clinuvel 2022-02-24T08:00:01+11:00 http://biotechdispatch.com.au/news/new-award-recognises-industrys-role-in-clinical-trials 2022-02-24T08:00:01+11:00 http://biotechdispatch.com.au/news/us-grants-patent-for-genetic-technologies-covid-19-risk-test 2022-02-24T08:00:01+11:00 http://biotechdispatch.com.au/news/kazia-therapeutics-to-be-transformed-by-pipeline-progress 2022-02-24T08:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-updates-on-preliminary-mpl-anti-viral-leukaemia-precli 2022-02-24T08:00:01+11:00 http://biotechdispatch.com.au/news/starpharma-reports-revenue-growth-and-advances-development 2022-02-22T09:00:01+11:00 http://biotechdispatch.com.au/news/important-support-programme-oversubscribed 2022-02-22T09:00:01+11:00 http://biotechdispatch.com.au/news/developed-country-markets-drive-cochlear-growth 2022-02-22T09:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-announces-plans-for-a-capital-raise 2022-02-22T09:00:01+11:00 http://biotechdispatch.com.au/news/arovella-therapeutics-closes-over-subscribed-share-purchase-plan 2022-02-22T09:00:01+11:00 http://biotechdispatch.com.au/news/gertrude-biomedical-appoints-new-non-executive-director 2022-02-17T10:00:01+11:00 http://biotechdispatch.com.au/news/engage-early-on-reimbursement-and-regulation-strategies 2022-02-17T10:00:01+11:00 http://biotechdispatch.com.au/news/telix-announces-commercial-distribution-agreement-in-australia 2022-02-17T10:00:01+11:00 http://biotechdispatch.com.au/news/amplia-says-new-report-paves-the-way-for-its-phase-2-trial 2022-02-17T10:00:01+11:00 http://biotechdispatch.com.au/news/firebrick-pharma-confirms-us-patent-granted-for-covid-19 2022-02-17T10:00:01+11:00 http://biotechdispatch.com.au/news/new-chair-for-the-agricultural-biotechnology-council-of-australi 2022-02-15T08:00:01+11:00 http://biotechdispatch.com.au/news/vaccine-developer-sementis-appoints-chief-operating-officer 2022-02-15T08:00:01+11:00 http://biotechdispatch.com.au/news/new-prostheses-list-pathways-proposed 2022-02-15T08:00:01+11:00 http://biotechdispatch.com.au/news/opthea-data-for-opt-302-in-polypoidal-choroidal-vasculopathy-pre 2022-02-15T08:00:01+11:00 http://biotechdispatch.com.au/news/clinuvel-updates-on-cuv151-study-in-dna-damaged-skin 2022-02-15T08:00:01+11:00 http://biotechdispatch.com.au/news/patent-box-legislation-now-before-the-parliament 2022-02-10T11:41:01+11:00 http://biotechdispatch.com.au/news/tessara-therapeutics-announces-key-senior-appointments 2022-02-10T09:00:01+11:00 http://biotechdispatch.com.au/news/senate-inquiry-into-sovereign-manufacturing-report-released 2022-02-10T08:00:01+11:00 http://biotechdispatch.com.au/news/csl-campaign-challenging-stereotypes-about-people-working-in-sci 2022-02-10T08:00:01+11:00 http://biotechdispatch.com.au/news/telix-expands-lutetium-177-network-with-eckert-ziegler-clinical- 2022-02-10T08:00:01+11:00 http://biotechdispatch.com.au/news/applications-for-bridge-programme-2022-open 2022-02-08T08:00:01+11:00 http://biotechdispatch.com.au/news/neuroscientific-biopharmaceuticals-reports-outcomes-of-pre-clini 2022-02-08T08:00:01+11:00 http://biotechdispatch.com.au/news/medlab-clinical-updates-on-progress-towards-phase-3-trial 2022-02-08T08:00:01+11:00 http://biotechdispatch.com.au/news/dimerix-appoints-chief-medical-officer 2022-02-08T08:00:01+11:00 http://biotechdispatch.com.au/news/clarity-pharmaceuticals-announces-us-based-cobra-study-to-procee 2022-02-08T08:00:01+11:00 http://biotechdispatch.com.au/news/planet-innovation-and-lumos-diagnostics-collaborate-to-establish 2022-02-03T10:21:01+11:00 http://biotechdispatch.com.au/news/changes-proposed-to-tga-fees-and-charges 2022-02-03T10:00:01+11:00 http://biotechdispatch.com.au/news/victorian-research-consortium-to-fight-childhood-cancer 2022-02-03T07:00:01+11:00 http://biotechdispatch.com.au/news/action-plan-to-supercharge-research-commercialisation 2022-02-03T07:00:01+11:00 http://biotechdispatch.com.au/news/cytiva-announces-winner-of-australia-nz-biochallenge 2022-02-03T07:00:01+11:00 http://biotechdispatch.com.au/news/certainty-offered-for-rdti-clinical-trial-activities 2022-02-01T10:00:01+11:00 http://biotechdispatch.com.au/news/new-trial-underway-of-pharmaxis-first-in-class-lox-inhibitor 2022-02-01T07:00:01+11:00 http://biotechdispatch.com.au/news/exopharm-announces-new-agreement-with-astellas-institute-for-reg 2022-02-01T07:00:01+11:00 http://biotechdispatch.com.au/news/telix-signs-distribution-agreement-for-prostate-cancer-imaging-i 2022-02-01T07:00:01+11:00 http://biotechdispatch.com.au/news/board-changes-for-zelira-therapeutics 2022-02-01T07:00:01+11:00 http://biotechdispatch.com.au/news/opthea-receives-66million-rd-tax-incentive-payment 2022-01-27T08:00:01+11:00 http://biotechdispatch.com.au/news/resonance-health-contracted-to-support-nash-clinical-trial 2022-01-27T08:00:01+11:00 http://biotechdispatch.com.au/news/new-partnership-between-biomebank-and-hudson-institute 2022-01-27T08:00:01+11:00 http://biotechdispatch.com.au/news/first-patient-doses-in-telix-prostact-therapeutic-program 2022-01-27T08:00:01+11:00 http://biotechdispatch.com.au/news/keynote-announced-for-nsw-women-in-life-sciences-luncheon 2022-01-27T08:00:01+11:00 http://biotechdispatch.com.au/news/global-biomanufacturing-report-seeks-australian-voice 2022-01-25T10:00:01+11:00 http://biotechdispatch.com.au/news/significant-capital-raise-for-emerging-australian-company 2022-01-25T10:00:01+11:00 http://biotechdispatch.com.au/news/technovalia-announces-interim-safety-results-from-vaccine-phase- 2022-01-25T10:00:01+11:00 http://biotechdispatch.com.au/news/novavax-covid-19-vaccine-to-be-distributed-in-coming-weeks 2022-01-25T10:00:01+11:00 http://biotechdispatch.com.au/news/arovella-therapeutics-appoints-new-head-of-development-and-trans 2022-01-25T10:00:01+11:00 http://biotechdispatch.com.au/news/have-your-say-on-our-industrys-decadal-strategy 2022-01-20T11:11:01+11:00 http://biotechdispatch.com.au/news/biomebank-appoints-new-chair-to-accelerate-commercialisation-str 2022-01-20T11:00:01+11:00 http://biotechdispatch.com.au/news/fivephusion-announces-independent-expert-clinical-advisory-board 2022-01-20T11:00:01+11:00 http://biotechdispatch.com.au/news/emyria-set-to-commence-clinical-trials-of-cbd-drug-candidate 2022-01-20T11:00:01+11:00 http://biotechdispatch.com.au/news/federal-government-seeking-feedback-on-new-assurance-to-support- 2022-01-20T11:00:01+11:00 http://biotechdispatch.com.au/news/recharged-with-resolutions-for-2022 2022-01-18T10:37:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-welcomes-government-research-grants-for-new-study-coll 2022-01-18T09:41:01+11:00 http://biotechdispatch.com.au/news/avita-medical-completes-enrolment-in-trial-for-soft-tissue-recon 2022-01-18T09:36:01+11:00 http://biotechdispatch.com.au/news/patients-dosed-in-dimerixs-dmx-200-covid-19-late-stage-study-in- 2022-01-18T09:31:01+11:00 http://biotechdispatch.com.au/news/clinuvel-completes-enrolment-in-world-first-stroke-study 2022-01-18T09:00:01+11:00 http://biotechdispatch.com.au/news/uniting-to-progress-biotech-in-the-year-ahead 2021-12-16T11:26:01+11:00 http://biotechdispatch.com.au/news/australias-health-security-audit-closing-with-the-year 2021-12-16T11:24:01+11:00 http://biotechdispatch.com.au/news/csl-completes-63-billion-placement-to-support-vifor-acquisition 2021-12-16T09:00:01+11:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-recruits-first-cohort-in-new-study 2021-12-16T08:00:01+11:00 http://biotechdispatch.com.au/news/qimr-berghofer-attracts-support-for-potential-multiple-sclerosis 2021-12-16T08:00:01+11:00 http://biotechdispatch.com.au/news/carina-biotech-licenses-german-technology-for-car-t 2021-12-16T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-advances-imp761-manufacturing-with-new-agreement 2021-12-16T08:00:01+11:00 http://biotechdispatch.com.au/news/stem-cell-advocacy-highly-commended 2021-12-14T10:00:01+11:00 http://biotechdispatch.com.au/news/agtech-company-bio-gene-technology-completes-capital-raise 2021-12-14T04:00:01+11:00 http://biotechdispatch.com.au/news/starpharma-announces-early-orders-following-vietnam-distribution 2021-12-14T04:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-announces-planned-key-management-changes 2021-12-14T04:00:01+11:00 http://biotechdispatch.com.au/news/servatus-completes-capital-raise-to-progress-projects 2021-12-13T15:23:01+11:00 http://biotechdispatch.com.au/news/save-the-date-nsw-women-in-life-sciences-luncheon-announced 2021-12-09T12:17:01+11:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-update-on-clinical-trial-of-burn-wound-inf 2021-12-08T10:32:01+11:00 http://biotechdispatch.com.au/news/resapp-health-establishes-covid-19-scientific-advisory-board 2021-12-08T10:25:01+11:00 http://biotechdispatch.com.au/news/emyria-announces-positive-initial-mdma-analogue-screening-and-pa 2021-12-08T10:16:01+11:00 http://biotechdispatch.com.au/news/change-in-leadership-for-cochlear-north-america 2021-12-08T10:07:01+11:00 http://biotechdispatch.com.au/news/telix-in-licences-novel-tumour-microenvironment-pet-tracer 2021-12-08T09:00:01+11:00 http://biotechdispatch.com.au/news/positive-late-stage-trial-results-for-neuren-pharmaceuticals-tro 2021-12-07T10:00:01+11:00 http://biotechdispatch.com.au/news/australians-should-be-the-first-in-the-world-to-access-new-medic 2021-12-07T10:00:01+11:00 http://biotechdispatch.com.au/news/2021-brilliant-women-in-digital-health 2021-12-07T08:35:01+11:00 http://biotechdispatch.com.au/news/australian-produced-eucalyptus-compound-effective-at-treating-lu 2021-12-07T08:00:01+11:00 http://biotechdispatch.com.au/news/neurotech-looks-to-progress-clinical-development-of-nti164 2021-12-07T08:00:01+11:00 http://biotechdispatch.com.au/news/call-for-australasian-biotechnology-journal-abstracts-1 2021-12-02T10:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-gains-exclusive-licence-to-new-cell-platfo 2021-12-02T08:00:01+11:00 http://biotechdispatch.com.au/news/us-fda-grants-new-fast-designation-for-bionomics-bnc210 2021-12-02T08:00:01+11:00 http://biotechdispatch.com.au/news/zelira-therapeutics-confirms-ethics-approval-for-chronic-pain-st 2021-12-02T08:00:01+11:00 http://biotechdispatch.com.au/news/new-discoveries-make-steps-toward-lipoedema-diagnosis-and-treatm 2021-12-02T08:00:01+11:00 http://biotechdispatch.com.au/news/victoria-produces-australias-first-mrna-covid-19-vaccine-candida 2021-11-30T11:08:01+11:00 http://biotechdispatch.com.au/news/new-bard1-exosome-liquid-biopsy-agreement-with-griffith-universi 2021-11-30T08:00:01+11:00 http://biotechdispatch.com.au/news/emyria-appoints-experienced-executive-to-its-board 2021-11-30T08:00:01+11:00 http://biotechdispatch.com.au/news/resapp-receives-first-regulatory-approvals-for-cough-counter-sma 2021-11-30T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-parliamentary-inquiry-report 2021-11-30T08:00:01+11:00 http://biotechdispatch.com.au/news/q-sera-announces-agreement-with-terumo-for-rapclot-in-japan 2021-11-30T08:00:01+11:00 http://biotechdispatch.com.au/news/nuheara-updates-on-clinical-development-of-new-medical-device 2021-11-25T10:18:01+11:00 http://biotechdispatch.com.au/news/biotrons-bit225-effective-against-covid-19-in-animal-study 2021-11-25T09:00:01+11:00 http://biotechdispatch.com.au/news/nominations-open-for-prime-ministers-science-prizes 2021-11-25T09:00:01+11:00 http://biotechdispatch.com.au/news/researchers-find-new-target-to-combat-lung-disease 2021-11-25T09:00:01+11:00 http://biotechdispatch.com.au/news/official-reopening-of-biologics-manufacturing-facility-in-adelai 2021-11-25T07:00:01+11:00 http://biotechdispatch.com.au/news/member-feedback-sought-on-mandatory-reporting-of-adverse-events 2021-11-23T09:00:01+11:00 http://biotechdispatch.com.au/news/study-investigating-new-treatment-for-pancreatic-cancer 2021-11-23T08:00:01+11:00 http://biotechdispatch.com.au/news/csls-new-headquarters-will-be-home-to-a-new-biotech-incubator 2021-11-23T08:00:01+11:00 http://biotechdispatch.com.au/news/race-oncology-announces-chemotherapy-heart-protection-data 2021-11-23T08:00:01+11:00 http://biotechdispatch.com.au/news/trajan-acquires-german-based-manufacturing-company 2021-11-23T04:00:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-announces-the-successful-completion-of-key-tran 2021-11-18T08:00:01+11:00 http://biotechdispatch.com.au/news/imugene-announces-new-study-supply-agreement-for-pd-l1 2021-11-18T08:00:01+11:00 http://biotechdispatch.com.au/news/call-for-ausmedtech-2022-session-submissions 2021-11-18T07:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-announces-placement-and-share-purchase-plan 2021-11-18T07:00:01+11:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-closes-ipo-with-asx-listing-next-week 2021-11-18T07:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-highlights-cell-and-gene-therapy-opportunity-to-senat 2021-11-16T09:00:01+11:00 http://biotechdispatch.com.au/news/us-company-ginkgo-bioworks-plan-to-grow-mrna-in-victoria 2021-11-16T08:00:01+11:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-says-first-australian-patient-doses-in-glo 2021-11-16T06:11:01+11:00 http://biotechdispatch.com.au/news/orthocell-shoulder-tendon-study-database-lock 2021-11-16T04:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-expands-studies-into-new-zealand 2021-11-16T04:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-confirms-presentation-of-abstracts-with-ph 2021-11-16T04:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-feedback-on-national-one-stop-shop-for-clin 2021-11-11T10:10:01+11:00 http://biotechdispatch.com.au/news/new-incubator-to-support-the-translation-of-local-innovation 2021-11-11T07:00:01+11:00 http://biotechdispatch.com.au/news/nirtek-begins-rd-collaboration-with-ttra-funding-support 2021-11-11T07:00:01+11:00 http://biotechdispatch.com.au/news/immuron-restarts-clinical-development-program 2021-11-11T07:00:01+11:00 http://biotechdispatch.com.au/news/experienced-researcher-and-us-executive-for-arovella-therapeutic 2021-11-11T07:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-announces-the-appointment-of-new-chair 2021-11-09T12:12:01+11:00 http://biotechdispatch.com.au/news/winner-of-2021s-prime-ministers-prize-for-innovation-congratulat 2021-11-09T12:08:01+11:00 http://biotechdispatch.com.au/news/us-fda-clears-pharmaxis-trial-of-pxs5505-in-liver-cancer 2021-11-09T08:52:01+11:00 http://biotechdispatch.com.au/news/amplia-therapeutics-capital-raise-to-fund-phase-two-trial 2021-11-09T08:26:01+11:00 http://biotechdispatch.com.au/news/clinuvel-pharmaceuticals-expands-pharmaceutical-portfolio 2021-11-09T08:13:01+11:00 http://biotechdispatch.com.au/news/microbiome-discovery-could-help-save-kids-hearing 2021-11-09T08:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-commences-darrt-2-trial-in-the-us 2021-11-04T09:00:01+11:00 http://biotechdispatch.com.au/news/decadal-biotech-blueprint-opens-for-sector-wide-consultation 2021-11-04T08:00:01+11:00 http://biotechdispatch.com.au/news/tga-approves-telix-pharmaceuticals-illuccix-for-prostate-cancer 2021-11-04T08:00:01+11:00 http://biotechdispatch.com.au/news/greg-hunt-announces-239-million-for-australian-health-and-medica 2021-11-04T08:00:01+11:00 http://biotechdispatch.com.au/news/uq-research-progress-a-national-blueprint-for-melanoma-screening 2021-11-04T08:00:01+11:00 http://biotechdispatch.com.au/news/biotron-commences-two-new-clinical-trials-of-bit225-1 2021-11-02T09:43:01+11:00 http://biotechdispatch.com.au/news/imugene-announces-new-collaboration-with-eureka-therapeutics 2021-11-02T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-farewell-chair-who-has-contributed-so-much-for-so- 2021-11-02T08:58:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-advances-development-with-capital-raise 2021-11-02T08:18:01+11:00 http://biotechdispatch.com.au/news/biotron-commences-two-new-clinical-trials-of-bit225 2021-11-02T08:00:01+11:00 http://biotechdispatch.com.au/news/us-fda-clears-bionomics-new-clinical-trial-of-bnc210 2021-11-02T08:00:01+11:00 http://biotechdispatch.com.au/news/monash-progressing-new-treatment-models-for-lung-disease 2021-10-28T12:33:01+11:00 http://biotechdispatch.com.au/news/two-australian-scientists-secure-csl-centenary-fellowships 2021-10-27T17:20:01+11:00 http://biotechdispatch.com.au/news/life-sciences-highest-achievers-awarded-with-prestigious-industr 2021-10-27T12:40:01+11:00 http://biotechdispatch.com.au/news/new-non-executive-director-for-oncology-one 2021-10-27T11:51:01+11:00 http://biotechdispatch.com.au/news/rhinomed-announces-details-of-new-trial-for-rhinoswab 2021-10-27T11:30:01+11:00 http://biotechdispatch.com.au/news/starpharma-signs-distribution-agreement-for-antiviral-in-vietnam 2021-10-26T10:00:01+11:00 http://biotechdispatch.com.au/news/australias-biggest-week-in-biotech-begins 2021-10-26T09:27:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-achieves-manufacturing-milestone-for-car-t 2021-10-26T09:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-announces-patents-and-launch-of-new-trial 2021-10-26T05:00:01+11:00 http://biotechdispatch.com.au/news/federal-governments-announces-membership-of-nhmrc-council 2021-10-25T10:22:01+11:00 http://biotechdispatch.com.au/news/australian-businesses-invited-to-advance-the-future-of-healthcar 2021-10-21T10:00:01+11:00 http://biotechdispatch.com.au/news/inventia-life-science-platform-recognised-with-price-for-innovat 2021-10-21T09:33:01+11:00 http://biotechdispatch.com.au/news/hearing-company-hemideina-completes-successful-capital-raise 2021-10-21T08:23:01+11:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-phase-one-clinical-trial-of-new-oncolytic 2021-10-21T08:00:01+11:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals 2021-10-21T08:00:01+11:00 http://biotechdispatch.com.au/news/proposal-to-amend-definitions-of-gm-for-food-classifications 2021-10-21T08:00:01+11:00 http://biotechdispatch.com.au/news/late-stage-trial-for-dimerixs-investigative-covid-19-treatment 2021-10-19T08:09:01+11:00 http://biotechdispatch.com.au/news/pharmaust-prepares-phase-3-trial-in-dogs-with-b-cell-lymphoma 2021-10-19T08:00:01+11:00 http://biotechdispatch.com.au/news/microbio-moves-to-brisbanes-translational-research-institute 2021-10-19T08:00:01+11:00 http://biotechdispatch.com.au/news/patrys-deoxymab-significantly-increases-survival-in-animal-model 2021-10-19T08:00:01+11:00 http://biotechdispatch.com.au/news/voluntary-standardised-ip-framework-supported 2021-10-19T08:00:01+11:00 http://biotechdispatch.com.au/news/bright-ideas-sought-to-keep-our-country-disease-and-pest-free 2021-10-14T10:00:01+11:00 http://biotechdispatch.com.au/news/idt-announces-deal-with-monash-to-produce-mrna-vaccine-for-trial 2021-10-14T09:00:01+11:00 http://biotechdispatch.com.au/news/prescient-therapeutics-presents-new-omnicar-data 2021-10-14T09:00:01+11:00 http://biotechdispatch.com.au/news/greg-hunt-announces-30-million-in-new-mrff-grant-opportunities 2021-10-14T08:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-doses-first-patient-in-phase-2-bone-marrow-cancer-tria 2021-10-14T08:00:01+11:00 http://biotechdispatch.com.au/news/us-patent-to-2034-granted-for-neurens-nnz-2591-in-autism 2021-10-12T09:00:01+11:00 http://biotechdispatch.com.au/news/oncosil-medical-appoints-new-non-executive-director 2021-10-12T09:00:01+11:00 http://biotechdispatch.com.au/news/resapp-health-submits-premarket-notification-to-the-us-fda 2021-10-12T09:00:01+11:00 http://biotechdispatch.com.au/news/covid-19-vaccine-designer-joins-ausbiotech-2021-line-up 2021-10-12T08:45:01+11:00 http://biotechdispatch.com.au/news/gene-therapy-prevents-children-with-eye-disease-from-going-blind 2021-10-12T08:00:01+11:00 http://biotechdispatch.com.au/news/race-oncology-secures-new-us-patent-for-cancer-therapy 2021-10-07T10:07:01+11:00 http://biotechdispatch.com.au/news/nsws-first-trade-statement-aims-to-double-exports-by-2031 2021-10-07T09:00:01+11:00 http://biotechdispatch.com.au/news/immuron-not-to-proceed-with-acquisition-of-vaccine-company 2021-10-07T09:00:01+11:00 http://biotechdispatch.com.au/news/adalta-announces-transfer-of-btb-funding-agreement-to-ad-214-inh 2021-10-07T09:00:01+11:00 http://biotechdispatch.com.au/news/emyria-to-participate-in-foundry-builders-program 2021-10-07T09:00:01+11:00 http://biotechdispatch.com.au/news/federal-government-announces-agreement-for-doses-of-covid-19-ora 2021-10-05T12:19:01+11:00 http://biotechdispatch.com.au/news/race-oncology-updates-on-melanoma-study-of-zantrene 2021-10-05T12:12:01+11:00 http://biotechdispatch.com.au/news/global-pipeline-tracker-provides-view-of-global-pipeline-and-pos 2021-10-05T12:04:01+11:00 http://biotechdispatch.com.au/news/opthea-opens-patient-recruitment-in-europe-for-pivotal-late-stag 2021-10-05T11:51:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-cleared-to-progress-to-phase-2-bone-marrow-cancer-tria 2021-10-05T11:38:01+11:00 http://biotechdispatch.com.au/news/standardised-agreements-proposed-to-support-commercialisation 2021-09-30T10:00:01+10:00 http://biotechdispatch.com.au/news/new-paper-describes-biology-of-amplia-therapeutics-fak-inhibitor 2021-09-30T10:00:01+10:00 http://biotechdispatch.com.au/news/antisense-receives-positive-draft-opinion-on-atl1102-development 2021-09-30T10:00:01+10:00 http://biotechdispatch.com.au/news/csl-partners-with-university-on-advanced-manufacturing-initiativ 2021-09-30T10:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-announces-abstract-presentations-to-global-meeting 2021-09-30T10:00:01+10:00 http://biotechdispatch.com.au/news/eoi-sought-for-new-cell-and-gene-catalyst 2021-09-28T11:38:01+10:00 http://biotechdispatch.com.au/news/indian-regulator-approves-study-of-dimerixs-dmx-200-in-covid-19 2021-09-28T09:00:01+10:00 http://biotechdispatch.com.au/news/us-patent-office-allows-claims-for-use-of-noxopharms-veyonda 2021-09-28T09:00:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-announces-publication-of-new-paper 2021-09-28T09:00:01+10:00 http://biotechdispatch.com.au/news/engeneic-launches-trial-of-nano-cellular-covid-19-vaccine 2021-09-28T09:00:01+10:00 http://biotechdispatch.com.au/news/manufacturing-opportunities-in-cell-and-gene-therapies-highlight 2021-09-23T09:00:01+10:00 http://biotechdispatch.com.au/news/japanese-patent-for-imugenes-her-vaxx-immunotherapy 2021-09-23T09:00:01+10:00 http://biotechdispatch.com.au/news/a-new-board-chair-for-rhythm-biosciences 2021-09-23T08:00:01+10:00 http://biotechdispatch.com.au/news/new-research-shows-drug-repurposing-is-no-panacea-in-race-to-tre 2021-09-23T08:00:01+10:00 http://biotechdispatch.com.au/news/victoria-funds-creation-of-health-innovation-centre-at-monash 2021-09-23T08:00:01+10:00 http://biotechdispatch.com.au/news/feedback-sought-on-review-of-the-national-medicines-policy 2021-09-21T11:10:01+10:00 http://biotechdispatch.com.au/news/bionomics-expands-clinical-trial-plan-for-bnc210 2021-09-21T09:00:01+10:00 http://biotechdispatch.com.au/news/certa-therapeutics-announces-new-clinical-trials-of-investigativ 2021-09-21T09:00:01+10:00 http://biotechdispatch.com.au/news/researchers-identify-potential-cause-and-treatment-for-obesity-a 2021-09-21T09:00:01+10:00 http://biotechdispatch.com.au/news/another-new-industry-minister-as-incumbent-resigns 2021-09-21T09:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-vaccine-patent-waiver-will-not-speed-up-global-vaccinat 2021-09-16T10:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-appoints-new-experts-to-scientific-advisor 2021-09-16T08:00:01+10:00 http://biotechdispatch.com.au/news/new-publication-on-radiopharm-theranostics-rad201 2021-09-16T08:00:01+10:00 http://biotechdispatch.com.au/news/australian-companys-covid-19-tests-approved-in-europe 2021-09-16T08:00:01+10:00 http://biotechdispatch.com.au/news/emyria-expands-psychiatry-advisory-to-advance-psychedelic-assist 2021-09-16T08:00:01+10:00 http://biotechdispatch.com.au/news/472-million-investment-in-australias-health-and-medical-research 2021-09-14T09:00:01+10:00 http://biotechdispatch.com.au/news/joint-statement-supports-australian-patent-box 2021-09-14T09:00:01+10:00 http://biotechdispatch.com.au/news/neuren-completes-placement-to-accelerate-development-of-nnz-2591 2021-09-14T07:00:01+10:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-secures-italian-distribution-agreement 2021-09-14T07:00:01+10:00 http://biotechdispatch.com.au/news/rhinomed-announces-deal-with-victorian-government 2021-09-14T07:00:01+10:00 http://biotechdispatch.com.au/news/australian-researchers-leading-in-the-development-of-new-mental- 2021-09-09T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-japanese-prostate-cancer-imaging-study-completes-enrolment 2021-09-09T09:00:01+10:00 http://biotechdispatch.com.au/news/rd-tax-incentive-administration-model-review 2021-09-09T09:00:01+10:00 http://biotechdispatch.com.au/news/wehi-collaborates-with-msd-on-researcher-exchange 2021-09-09T09:00:01+10:00 http://biotechdispatch.com.au/news/adherium-receives-us-clearance-for-next-generation-sensor-with-p 2021-09-09T09:00:01+10:00 http://biotechdispatch.com.au/news/global-female-scholars-award-opens-for-2022 2021-09-07T09:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-welcomes-new-patents-for-celgro-collagen-medical-devic 2021-09-07T09:00:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-announces-the-appointment-of-new-ceo 2021-09-07T06:00:01+10:00 http://biotechdispatch.com.au/news/us-fda-grants-orphan-designation-to-neurens-nnz-2591 2021-09-07T06:00:01+10:00 http://biotechdispatch.com.au/news/new-chief-medical-office-for-anteris-technologies 2021-09-07T06:00:01+10:00 http://biotechdispatch.com.au/news/neuren-rett-syndrome-clinical-trial-for-trofinetide-in-girls-age 2021-09-02T10:00:01+10:00 http://biotechdispatch.com.au/news/httpscarinabiotechcom 2021-09-02T10:00:01+10:00 http://biotechdispatch.com.au/news/victoria-recognises-andhealth-leader-for-outstanding-contributio 2021-09-02T10:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-updates-on-shoulder-tendon-study 2021-09-02T10:00:01+10:00 http://biotechdispatch.com.au/news/australias-regenerative-medicine-clinical-trials-and-manufacturi 2021-09-02T10:00:01+10:00 http://biotechdispatch.com.au/news/emerging-australian-biotech-appoints-experienced-industry-exec-a 2021-08-31T08:00:01+10:00 http://biotechdispatch.com.au/news/mrff-grant-criteria-expanded 2021-08-31T08:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-wound-and-scar-treatment-clears-phase-one-trial 2021-08-31T08:00:01+10:00 http://biotechdispatch.com.au/news/immuteps-chinese-partner-to-expand-efti-trial-pipeline 2021-08-31T08:00:01+10:00 http://biotechdispatch.com.au/news/nutromics-capital-raise-to-progress-cmm-platform 2021-08-31T08:00:01+10:00 http://biotechdispatch.com.au/news/anataras-ibs-d-clinical-trial-to-leverage-precision-microbiome-a 2021-08-26T09:00:01+10:00 http://biotechdispatch.com.au/news/csiro-reports-reveals-potential-of-synthetic-biology-ecosystem 2021-08-26T09:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-commences-study-of-dmx-200-in-fsgs-patients 2021-08-26T09:00:01+10:00 http://biotechdispatch.com.au/news/nominations-open-in-recognition-and-celebration-of-life-science- 2021-08-26T09:00:01+10:00 http://biotechdispatch.com.au/news/oncology-one-announces-new-drug-discovery-project-with-childrens 2021-08-26T09:00:01+10:00 http://biotechdispatch.com.au/news/nsw-government-joins-the-push-for-mrna-manufacturing 2021-08-24T09:00:01+10:00 http://biotechdispatch.com.au/news/australias-first-national-biotech-incubator-established-with-40- 2021-08-24T09:00:01+10:00 http://biotechdispatch.com.au/news/fda-approves-early-stage-trial-for-chimeric-car-t 2021-08-24T09:00:01+10:00 http://biotechdispatch.com.au/news/adalta-and-carina-in-new-collaboration-focused-on-car-t-candidat 2021-08-24T09:00:01+10:00 http://biotechdispatch.com.au/news/andhealth-secures-funding-and-announces-tga-partnership 2021-08-24T09:00:01+10:00 http://biotechdispatch.com.au/news/new-nasdaq-rule-encourages-diversity 2021-08-24T09:00:01+10:00 http://biotechdispatch.com.au/news/volpara-confirms-board-changes-aimed-at-driving-us-growth 2021-08-19T09:09:01+10:00 http://biotechdispatch.com.au/news/impact-of-investors-tax-concessions-reviewed 2021-08-19T09:00:01+10:00 http://biotechdispatch.com.au/news/speedx-expands-sars-cov-2-variant-analysis-pipeline 2021-08-19T09:00:01+10:00 http://biotechdispatch.com.au/news/csl-the-pandemic-has-produced-a-headwind-and-tailwind 2021-08-19T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-updates-on-new-collaborations-and-studies 2021-08-19T08:00:01+10:00 http://biotechdispatch.com.au/news/women-in-stem-leadership-program-to-go-national 2021-08-17T10:49:01+10:00 http://biotechdispatch.com.au/news/dimerix-capital-raise-to-progress-late-stage-trial 2021-08-17T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-chair-successor 2021-08-17T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-workable-patent-box-design 2021-08-17T10:00:01+10:00 http://biotechdispatch.com.au/news/radiopharm-theranostics-secures-funding-to-advance-nuclear-medic 2021-08-17T10:00:01+10:00 http://biotechdispatch.com.au/news/tga-approval-for-speedx-covid-19-diagnostic-test 2021-08-17T10:00:01+10:00 http://biotechdispatch.com.au/news/strengthening-australias-regenerative-medicine-value-chain 2021-08-12T12:27:01+10:00 http://biotechdispatch.com.au/news/focused-effort-needed-in-the-fight-against-neurodegenerative-dis 2021-08-12T09:51:01+10:00 http://biotechdispatch.com.au/news/rhinomed-announces-first-government-order-for-new-nasal-swab 2021-08-12T09:00:01+10:00 http://biotechdispatch.com.au/news/emvision-announces-milestone-with-assembly-of-portable-brain-sca 2021-08-12T09:00:01+10:00 http://biotechdispatch.com.au/news/proteomics-international-contracts-biotem-to-manufacture-promark 2021-08-12T09:00:01+10:00 http://biotechdispatch.com.au/news/clinuvel-says-afamelanotide-well-tolerated-by-first-stroke-patie 2021-08-10T10:00:01+10:00 http://biotechdispatch.com.au/news/opthea-announces-patient-recruitment-open-in-canadian-trial 2021-08-10T10:00:01+10:00 http://biotechdispatch.com.au/news/race-oncology-updates-on-zantrene-trial-in-acute-myeloid-leukaem 2021-08-10T10:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-announces-collaboration-with-the-us-national-institute 2021-08-10T10:00:01+10:00 http://biotechdispatch.com.au/news/employee-share-scheme-consultation-open 2021-08-10T10:00:01+10:00 http://biotechdispatch.com.au/news/feedback-sought-on-recommendations-for-australias-proposed-paten 2021-08-05T12:20:01+10:00 http://biotechdispatch.com.au/news/neuren-says-rett-syndrome-phase-3-trial-enrolment-successfully-c 2021-08-05T09:00:01+10:00 http://biotechdispatch.com.au/news/immutep-reports-dosing-of-first-patient-in-insight-003-study 2021-08-05T09:00:01+10:00 http://biotechdispatch.com.au/news/positive-pre-clinical-data-for-pharmaxis-liver-cancer-candidate 2021-08-05T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-updates-on-belgium-production-facility 2021-08-05T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-study-incorporating-dimerixs-dmx-200-adds-more-sites 2021-08-03T10:44:01+10:00 http://biotechdispatch.com.au/news/bionomics-announces-plans-for-us-initial-public-offering 2021-08-03T10:00:01+10:00 http://biotechdispatch.com.au/news/faecal-transplants-to-help-treat-symptoms-of-parkinsons 2021-08-03T10:00:01+10:00 http://biotechdispatch.com.au/news/glyscend-therapeutics-commences-clinical-trial-of-potential-diab 2021-08-03T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-2021-programme-released 2021-08-03T09:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-announces-transition-to-new-board-chair 2021-07-29T10:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-licenses-car-t-therapy-from-the-university 2021-07-29T10:00:01+10:00 http://biotechdispatch.com.au/news/carina-biotech-announces-the-members-of-its-new-medical-advisory 2021-07-29T10:00:01+10:00 http://biotechdispatch.com.au/news/draft-roadmap-for-australian-regenerative-medicine-released-for- 2021-07-29T10:00:01+10:00 http://biotechdispatch.com.au/news/aroa-completes-significant-capital-raise 2021-07-29T10:00:01+10:00 http://biotechdispatch.com.au/news/hexima-announces-the-completion-of-enrolment-in-phase-iib-clinic 2021-07-27T08:00:01+10:00 http://biotechdispatch.com.au/news/patrys-announces-preclinical-data-for-pat-dx1-in-pancreatic-canc 2021-07-27T08:00:01+10:00 http://biotechdispatch.com.au/news/ctxone-rebrands-as-oncology-one 2021-07-27T08:00:01+10:00 http://biotechdispatch.com.au/news/tga-issues-updated-international-alignment-strategy 2021-07-27T08:00:01+10:00 http://biotechdispatch.com.au/news/feedback-sought-on-proposed-changes-to-medical-devices-that-are- 2021-07-27T08:00:01+10:00 http://biotechdispatch.com.au/news/technovalia-starts-phase-one-trial-of-its-covid-19-vaccine-candi 2021-07-22T08:00:01+10:00 http://biotechdispatch.com.au/news/bcal-diagnostics-debuts-on-the-australian-securities-exchange 2021-07-22T08:00:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-completion-of-share-purchase-plan 2021-07-22T08:00:01+10:00 http://biotechdispatch.com.au/news/digital-health-state-of-the-industry-survey-open 2021-07-21T08:00:01+10:00 http://biotechdispatch.com.au/news/new-report-says-time-to-prepare-for-cell-and-gene-therapies 2021-07-21T08:00:01+10:00 http://biotechdispatch.com.au/news/funding-opening-for-large-scale-life-science-manufacturers 2021-07-20T08:00:01+10:00 http://biotechdispatch.com.au/news/ena-respiratory-launches-trial-of-covid-19-preventative-nasal-sp 2021-07-20T08:00:01+10:00 http://biotechdispatch.com.au/news/jj-innovation-extends-innovation-partnering-office-at-monash-uni 2021-07-20T08:00:01+10:00 http://biotechdispatch.com.au/news/new-prevention-and-treatment-approaches-for-heart-disease-with-d 2021-07-20T08:00:01+10:00 http://biotechdispatch.com.au/news/south-australia-calls-for-expressions-of-interest-for-new-interm 2021-07-20T08:00:01+10:00 http://biotechdispatch.com.au/news/planet-innovation-opens-new-cleanroom-in-melbourne 2021-07-15T09:00:01+10:00 http://biotechdispatch.com.au/news/nominations-open-for-australian-export-investment-awards 2021-07-15T09:00:01+10:00 http://biotechdispatch.com.au/news/vaxxas-to-receive-44-million-in-finding-under-manufacturing-init 2021-07-15T09:00:01+10:00 http://biotechdispatch.com.au/news/biointelect-come-forward-for-support-on-securing-investment 2021-07-15T09:00:01+10:00 http://biotechdispatch.com.au/news/sa-government-backs-new-bioanalytical-laboratory 2021-07-15T09:00:01+10:00 http://biotechdispatch.com.au/news/mgc-pharma-recruits-first-patient-in-late-stage-trial 2021-07-13T10:22:01+10:00 http://biotechdispatch.com.au/news/uniquest-partners-with-csl-to-develop-potential-new-therapy 2021-07-13T09:00:01+10:00 http://biotechdispatch.com.au/news/polynovo-stars-in-new-global-bbc-biotech-series 2021-07-13T09:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-and-wehi-to-investigate-monepantel-in-htlv-1-viral-inf 2021-07-13T09:00:01+10:00 http://biotechdispatch.com.au/news/patrys-full-size-pat-dx3-able-to-cross-the-blood-brain-barrier 2021-07-13T09:00:01+10:00 http://biotechdispatch.com.au/news/nz-rna-start-up-secures-significant-investment-to-progress-cance 2021-07-08T10:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-establishes-monepantel-gmp-tablet-stability 2021-07-08T10:00:01+10:00 http://biotechdispatch.com.au/news/deloitte-wins-contract-to-modernise-national-digital-health-infr 2021-07-08T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-3 2021-07-08T10:00:01+10:00 http://biotechdispatch.com.au/news/federal-government-announces-grants-for-new-manufacturing-projec 2021-07-08T10:00:01+10:00 http://biotechdispatch.com.au/news/resapp-publication-of-copd-data-and-new-commercial-agreement 2021-07-06T09:00:01+10:00 http://biotechdispatch.com.au/news/tessara-therapeutics-announces-new-collaboration-with-the-florey 2021-07-06T09:00:01+10:00 http://biotechdispatch.com.au/news/fda-fast-track-designation-for-optheas-opt-302 2021-07-06T09:00:01+10:00 http://biotechdispatch.com.au/news/treasury-opens-patent-box-design-consultation 2021-07-06T09:00:01+10:00 http://biotechdispatch.com.au/news/strong-asx-debut-for-lumos-diagnostics-after-63m-ipo 2021-07-05T10:00:01+10:00 http://biotechdispatch.com.au/news/biomebank-submits-for-market-authorisation-of-world-first-microb 2021-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-announces-first-positive-results-in-cancer-trial 2021-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/mesoblast-updates-on-pathway-to-us-approval-1 2021-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/fda-grants-approval-for-noxopharms-darrt-2-cancer-study 2021-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/speedx-and-molgen-announce-partnership-for-covid-19-test-solutio 2021-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/preserving-biotechs-ip-rights 2021-07-01T07:00:01+10:00 http://biotechdispatch.com.au/news/new-collaboration-between-antisense-therapeutics-and-mcri 2021-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/nyradas-updates-on-preclinical-study-of-nyx-pcsk9i-with-statin 2021-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/biocurate-announces-expansion-of-board-and-investment-committee 2021-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/call-for-nominations-victoria-prize-for-science-innovation 2021-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/qbiotics-completes-successful-85-million-capital-raise 2021-06-29T09:00:01+10:00 http://biotechdispatch.com.au/news/capital-raise-for-currus-biologics-to-progress-car-t-development 2021-06-29T08:00:01+10:00 http://biotechdispatch.com.au/news/opal-biosciences-seeking-partners-to-establish-precinct 2021-06-24T09:00:01+10:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-study-of-tlx250-cdx-in-bladder-cancer 2021-06-24T09:00:01+10:00 http://biotechdispatch.com.au/news/atl1102-for-dmd-ema-pip-feedback-and-fda-regulatory-progress 2021-06-24T09:00:01+10:00 http://biotechdispatch.com.au/news/kazia-therapeutics-secures-new-patents-for-manufacturing-process 2021-06-24T09:00:01+10:00 http://biotechdispatch.com.au/news/expressions-of-interest-mrna-victoria-industry-panel 2021-06-24T09:00:01+10:00 http://biotechdispatch.com.au/news/new-international-guidelines-for-stem-cell-research 2021-06-22T10:23:01+10:00 http://biotechdispatch.com.au/news/new-australian-rd-collaboration-for-pfizers-centers-for-therapeu 2021-06-22T09:00:01+10:00 http://biotechdispatch.com.au/news/major-capital-raise-and-new-trial-for-immutep 2021-06-22T09:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-announces-positive-nerve-regeneration-results-for-celg 2021-06-22T09:00:01+10:00 http://biotechdispatch.com.au/news/suda-licenses-inkt-cell-therapy-platform-from-imperial-college-l 2021-06-22T09:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-temporarily-halts-uk-sales-of-nasal-spray-over-promot 2021-06-22T09:00:01+10:00 http://biotechdispatch.com.au/news/ena-respiratory-advances-covid-19-therapy-with-capital-raise 2021-06-17T10:00:01+10:00 http://biotechdispatch.com.au/news/team-australia-pavilion-in-top-four-on-global-stage 2021-06-17T10:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-announces-new-patents-in-china-and-nz 2021-06-17T10:00:01+10:00 http://biotechdispatch.com.au/news/consortium-to-develop-and-commercialise-world-first-durable-tota 2021-06-17T10:00:01+10:00 http://biotechdispatch.com.au/news/government-commits-funds-to-global-alliance-for-chronic-diseases 2021-06-17T10:00:01+10:00 http://biotechdispatch.com.au/news/progress-welcome-on-national-front-door-for-clinical-trials 2021-06-15T11:32:01+10:00 http://biotechdispatch.com.au/news/nyrada-says-improved-drug-candidate-selected-for-wrair-studies 2021-06-15T10:00:01+10:00 http://biotechdispatch.com.au/news/starpharmas-viraleze-registered-for-sale-in-india 2021-06-15T10:00:01+10:00 http://biotechdispatch.com.au/news/emyria-files-ip-protections-for-new-emd-004-program 2021-06-15T10:00:01+10:00 http://biotechdispatch.com.au/news/msd-and-government-in-discussions-over-covid-19-treatment 2021-06-15T10:00:01+10:00 http://biotechdispatch.com.au/news/bayer-advances-cell-and-gene-therapies-for-parkinsons-disease 2021-06-10T08:00:01+10:00 http://biotechdispatch.com.au/news/queensland-enters-the-push-to-grow-australian-manufacturing 2021-06-10T08:00:01+10:00 http://biotechdispatch.com.au/news/world-bank-says-no-to-ip-waiver-as-wto-debate-resumes 2021-06-10T08:00:01+10:00 http://biotechdispatch.com.au/news/engage-on-upcoming-udi-system-changes 2021-06-10T08:00:01+10:00 http://biotechdispatch.com.au/news/proteomics-international-announces-new-executive-appointments 2021-06-10T08:00:01+10:00 http://biotechdispatch.com.au/news/immutep-reports-final-data-from-phase-one-study-of-lag-3-therapy 2021-06-08T04:00:01+10:00 http://biotechdispatch.com.au/news/first-stroke-patient-treated-with-clinuvels-afamelanotide 2021-06-08T04:00:01+10:00 http://biotechdispatch.com.au/news/telix-and-ats-awarded-eurostars-frant-for-alpha-therapy 2021-06-08T04:00:01+10:00 http://biotechdispatch.com.au/news/pyc-therapeutics-accelerates-program-for-inherited-eye-disease-t 2021-06-08T04:00:01+10:00 http://biotechdispatch.com.au/news/taking-action-against-ip-protection-threats 2021-06-08T04:00:01+10:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-combination-trial-of-qbiotics-and-msd-the 2021-06-03T10:00:01+10:00 http://biotechdispatch.com.au/news/2022-sees-biggest-week-in-biotech-heading-to-wa 2021-06-03T10:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-to-proceed-with-early-stage-alsmnd-trial 2021-06-02T10:00:01+10:00 http://biotechdispatch.com.au/news/amplia-therapeutics-updates-on-data-from-cancer-collaboration 2021-06-02T10:00:01+10:00 http://biotechdispatch.com.au/news/new-data-showing-potential-of-vaxxas-covid-19-vaccine-patch 2021-06-02T10:00:01+10:00 http://biotechdispatch.com.au/news/testing-shows-starpharmas-viraleze-highly-active-against-uk-covi 2021-06-01T10:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-elevates-director-to-succeed-retiring-chair 2021-06-01T09:00:01+10:00 http://biotechdispatch.com.au/news/neuren-to-proceed-with-inds-for-three-trials-after-fda-meeting 2021-06-01T09:00:01+10:00 http://biotechdispatch.com.au/news/adherium-submits-to-fda-for-approval-of-updated-hailie-sensor 2021-06-01T09:00:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-new-collaboration-with-merck 2021-06-01T09:00:01+10:00 http://biotechdispatch.com.au/news/help-shape-the-ausbiotech-2021-programme 2021-06-01T09:00:01+10:00 http://biotechdispatch.com.au/news/new-china-patent-for-immuteps-eftilagimod-alpha 2021-05-27T09:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-provides-atl1102-manufacturing-update 2021-05-27T09:00:01+10:00 http://biotechdispatch.com.au/news/new-collagen-rope-patent-for-celgro-platform-technology 2021-05-27T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-bolsters-advocacy-capabilities 2021-05-27T09:00:01+10:00 http://biotechdispatch.com.au/news/iqvia-launches-biotech-division-in-asia-pacific 2021-05-27T08:00:01+10:00 http://biotechdispatch.com.au/news/microba-life-sciences-and-illumina-partner-to-accelerate-microbi 2021-05-25T11:00:01+10:00 http://biotechdispatch.com.au/news/nutromics-wins-best-early-stage-project-award 2021-05-25T11:00:01+10:00 http://biotechdispatch.com.au/news/tlx66-meets-objectives-in-al-amyloidosis-safety-trial 2021-05-25T11:00:01+10:00 http://biotechdispatch.com.au/news/adalta-and-ge-healthcare-advance-candidate-to-pre-clinical-devel 2021-05-25T11:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-therapeuticss-updates-on-car-t-clinical-trial 2021-05-25T11:00:01+10:00 http://biotechdispatch.com.au/news/cancer-council-nsw-funds-new-research-into-advanced-melanoma 2021-05-25T04:00:01+10:00 http://biotechdispatch.com.au/news/progresses-r327-in-sars-cov-2-screening-program 2021-05-20T11:36:01+10:00 http://biotechdispatch.com.au/news/appointment-of-principal-scientist 2021-05-20T10:00:01+10:00 http://biotechdispatch.com.au/news/professor-allan-cripps-ao-new-director-of-neurotech 2021-05-20T10:00:01+10:00 http://biotechdispatch.com.au/news/4dmedical-commences-patient-recruitment-for-vq-clinical-trial 2021-05-20T10:00:01+10:00 http://biotechdispatch.com.au/news/celebrating-international-clinical-trials-day 2021-05-20T10:00:01+10:00 http://biotechdispatch.com.au/news/telix-announces-distribution-agreement-for-germany 2021-05-18T11:00:01+10:00 http://biotechdispatch.com.au/news/biocurate-and-monash-university-launch-oncology-startup-company 2021-05-18T11:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-presents-at-parliamentary-inquiry 2021-05-18T11:00:01+10:00 http://biotechdispatch.com.au/news/the-theme-reimagine-and-reconnect 2021-05-18T11:00:01+10:00 http://biotechdispatch.com.au/news/sanofi-and-gsk-advance-covid-19-vaccine-to-late-stage-trial 2021-05-18T11:00:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-urges-industry-support-for-new-fellowships 2021-05-13T10:10:01+10:00 http://biotechdispatch.com.au/news/nsw-government-backs-expansion-of-speedx-and-baxter 2021-05-13T10:08:01+10:00 http://biotechdispatch.com.au/news/telixs-phase-three-prostate-cancer-trial 2021-05-13T10:00:01+10:00 http://biotechdispatch.com.au/news/2021-federal-budget-backs-biotech 2021-05-13T10:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-updates-on-mx-200-study-in-covid-19-patients-in-india 2021-05-13T10:00:01+10:00 http://biotechdispatch.com.au/news/bnc210-to-include-social-anxiety-disorder 2021-05-11T10:00:01+10:00 http://biotechdispatch.com.au/news/avance-clinical-expands-gene-technology-services 2021-05-11T10:00:01+10:00 http://biotechdispatch.com.au/news/potential-combinations-for-race-oncology-therapy 2021-05-11T10:00:01+10:00 http://biotechdispatch.com.au/news/international-ip-protection-at-risk-for-covid-19-vaccines 2021-05-11T10:00:01+10:00 http://biotechdispatch.com.au/news/prescient-signs-car-t-agreement-with-peter-mac-cancer-centre 2021-05-11T10:00:01+10:00 http://biotechdispatch.com.au/news/leukaemia-foundation-backs-blood-cancer-research-projects 2021-05-06T08:00:01+10:00 http://biotechdispatch.com.au/news/new-cholesterol-lowering-drug-candidates 2021-05-06T08:00:01+10:00 http://biotechdispatch.com.au/news/race-oncology-completes-oversubscribed-placement 2021-05-06T08:00:01+10:00 http://biotechdispatch.com.au/news/autism-study-for-neurotechs-medicinal-cannabis 2021-05-06T08:00:01+10:00 http://biotechdispatch.com.au/news/last-chance-to-register-for-ausmedtech-2021 2021-05-06T08:00:01+10:00 http://biotechdispatch.com.au/news/australian-drug-discovery-to-be-studied-in-the-us 2021-05-04T09:00:01+10:00 http://biotechdispatch.com.au/news/companies-sought-for-ausbiotechs-new-pitching-series 2021-05-04T09:00:01+10:00 http://biotechdispatch.com.au/news/botanix-updates-on-the-development-of-antimicrobial-platform 2021-05-04T09:00:01+10:00 http://biotechdispatch.com.au/news/medibio-secures-new-us-patent-for-technology-platform 2021-05-04T09:00:01+10:00 http://biotechdispatch.com.au/news/r327-shows-promise-against-pathogens 2021-05-04T09:00:01+10:00 http://biotechdispatch.com.au/news/csl-funding-to-fast-track-australian-research-programs 2021-04-29T07:00:01+10:00 http://biotechdispatch.com.au/news/collaboration-for-epiminder-and-seer-medical 2021-04-29T07:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-says-study-results-open-us-market-opportunity 2021-04-29T07:00:01+10:00 http://biotechdispatch.com.au/news/artificial-super-stool-to-bring-hope-for-people-with-chronic-gut 2021-04-29T07:00:01+10:00 http://biotechdispatch.com.au/news/medtech-featured-in-aprils-australasian-biotechnology-journal-1 2021-04-29T07:00:01+10:00 http://biotechdispatch.com.au/news/report-shows-life-sciences-economic-contribution 2021-04-27T11:19:01+10:00 http://biotechdispatch.com.au/news/bms-report-says-government-action-the-key-on-trials 2021-04-27T09:00:01+10:00 http://biotechdispatch.com.au/news/new-manufacturing-agreement-for-telix-pharmaceuticals 2021-04-27T09:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-updates-on-trial-in-pet-dogs-with-lymphoma 2021-04-27T09:00:01+10:00 http://biotechdispatch.com.au/news/supports-potential-of-its-antimicrobial-platform 2021-04-27T09:00:01+10:00 http://biotechdispatch.com.au/news/emyria-secures-placement-to-advance-development-and-expand-pipel 2021-04-22T08:00:01+10:00 http://biotechdispatch.com.au/news/kazia-licenses-global-rights 2021-04-22T08:00:01+10:00 http://biotechdispatch.com.au/news/federal-government-announces-funding-to-develop-australian-cance 2021-04-22T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-promotes-australian-capabilities-at-biokorea-2021 2021-04-22T08:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-updates-on-cltx-car-t-cell-clinical-trial 2021-04-22T08:00:01+10:00 http://biotechdispatch.com.au/news/interim-data-from-noxcovid-veyonda-trial 2021-04-22T08:00:01+10:00 http://biotechdispatch.com.au/news/telix-launches-international-noble-registry-of-spect-based-prost 2021-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/australian-medtech-consultancy-merges-with-international-leader 2021-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/exopharm-completes-12-million-capital-raise 2021-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/race-oncology-appoints-its-first-chief-medical-officer 2021-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-new-director-dr-james-campbell 2021-04-20T08:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-sells-bronchitol-rights-in-russia-and-completes-placem 2021-04-15T09:00:01+10:00 http://biotechdispatch.com.au/news/ex-ausbiotech-ceo-joins-board-of-emerging-local-biotech 2021-04-15T09:00:01+10:00 http://biotechdispatch.com.au/news/amplia-completes-dosing-in-phase-one-study-of-amp945 2021-04-15T09:00:01+10:00 http://biotechdispatch.com.au/news/zelira-announces-record-revenue-in-the-march-quarter 2021-04-15T09:00:01+10:00 http://biotechdispatch.com.au/news/csls-plasma-protein-purification-challenge-opens 2021-04-15T09:00:01+10:00 http://biotechdispatch.com.au/news/alcidion-group-acquires-uk-company-and-confirms-capital-raise 2021-04-15T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-led-discovery-could-speed-up-bone-implant-recovery 2021-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/approval-to-start-trial-of-new-australian-covid-19-vaccine 2021-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-university-research-commercialisation-con 2021-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/genetic-technologies 2021-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/approval-for-anteotechs-covid-19-test 2021-04-13T08:00:01+10:00 http://biotechdispatch.com.au/news/impedimed-on-publication-of-new-sozo-data 2021-04-08T09:00:01+10:00 http://biotechdispatch.com.au/news/rd-tax-refund-for-subsidiaries 2021-04-08T09:00:01+10:00 http://biotechdispatch.com.au/news/fda-fast-track-designation-for-immuteps-efti 2021-04-08T09:00:01+10:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-patient-response-encouraging 2021-04-08T09:00:01+10:00 http://biotechdispatch.com.au/news/opportunity-to-join-team-australia-at-bio 2021-04-08T09:00:01+10:00 http://biotechdispatch.com.au/news/exopharm-announces-preclinical-data-from-osteoarthritis-animal-s 2021-04-06T07:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-applies-to-patent-veyonda-in-septic-shock-treatment 2021-04-06T07:00:01+10:00 http://biotechdispatch.com.au/news/creso-pharma-appoints-cannabis-executive-to-lead-us-business-dev 2021-04-06T07:00:01+10:00 http://biotechdispatch.com.au/news/us-fda-approves-new-aroa-biosurgery-product 2021-04-06T07:00:01+10:00 http://biotechdispatch.com.au/news/grant-open-for-boosting-female-founders-initiative-round-2 2021-04-06T07:00:01+10:00 http://biotechdispatch.com.au/news/world-first-trial-for-australian-company-pharmaxis 2021-04-01T10:00:01+11:00 http://biotechdispatch.com.au/news/new-us-manufacturing-agreement-for-telix-pharmaceuticals 2021-04-01T10:00:01+11:00 http://biotechdispatch.com.au/news/uk-launch-for-starpharmas-covid-19-nasal-spray 2021-04-01T10:00:01+11:00 http://biotechdispatch.com.au/news/investment-support-for-early-stage-translation 2021-04-01T10:00:01+11:00 http://biotechdispatch.com.au/news/appointment-of-new-cfo 2021-04-01T10:00:01+11:00 http://biotechdispatch.com.au/news/emyria-and-cann-group-to-partner-on-medicine-cbd-product-registr 2021-03-30T09:00:01+11:00 http://biotechdispatch.com.au/news/pfizer-hosts-stakeholder-roundtable-on-the-future-of-australian- 2021-03-30T09:00:01+11:00 http://biotechdispatch.com.au/news/australian-company-says-bms-study-validates-its-own-technology 2021-03-30T09:00:01+11:00 http://biotechdispatch.com.au/news/ausmedtech-2021-best-value-registration-available-for-few-more-d 2021-03-30T09:00:01+11:00 http://biotechdispatch.com.au/news/icon-group-looking-to-grow-research-links-with-singapore 2021-03-30T09:00:01+11:00 http://biotechdispatch.com.au/news/btx-1702-rosacea-study-approval 2021-03-30T09:00:01+11:00 http://biotechdispatch.com.au/news/clinuvel-expands-dna-repair-program 2021-03-25T06:00:01+11:00 http://biotechdispatch.com.au/news/mrff-backs-development-of-devices-through-to-early-stage-manufac 2021-03-25T06:00:01+11:00 http://biotechdispatch.com.au/news/respiri-receives-us-fda-clearance-for-wheezo-and-app 2021-03-25T06:00:01+11:00 http://biotechdispatch.com.au/news/first-australian-produced-covid-19-vaccine-doses-released 2021-03-25T06:00:01+11:00 http://biotechdispatch.com.au/news/encouraging-university-research-commercialisation 2021-03-25T06:00:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-appoints-new-non-executive-director 2021-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/nyrada-raises-11-million-in-new-placement 2021-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/novartis-oncology-leader-joins-board-of-local-biotech 2021-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/chiesi-announces-us-launch-of-pharmaxis-bronchitol 2021-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/adherium-secures-18-million-commitment-in-share-placement 2021-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/modernising-and-future-proofing-the-gene-technology-scheme 2021-03-23T09:00:01+11:00 http://biotechdispatch.com.au/news/government-announces-grants-for-new-mental-health-therapies 2021-03-18T08:00:01+11:00 http://biotechdispatch.com.au/news/alessa-therapeutics-announces-australia-nz-prostate-cancer-trial 2021-03-18T08:00:01+11:00 http://biotechdispatch.com.au/news/microba-life-sciences-partners-with-unilever-to-target-sleep-thr 2021-03-18T08:00:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics-appoints-experienced-us-biotech-executive-to-it 2021-03-18T08:00:01+11:00 http://biotechdispatch.com.au/news/nsw-ensures-access-to-gm-crop-innovation 2021-03-18T08:00:01+11:00 http://biotechdispatch.com.au/news/greg-hunt-announces-10-million-for-national-mental-health-resear 2021-03-16T09:00:01+11:00 http://biotechdispatch.com.au/news/new-plans-for-australias-biggest-biotech-industry-gathering 2021-03-16T08:50:01+11:00 http://biotechdispatch.com.au/news/australian-researchers-discover-potential-new-therapeutic-target 2021-03-16T08:00:01+11:00 http://biotechdispatch.com.au/news/opthea-launches-late-stage-study-of-eye-therapy 2021-03-16T08:00:01+11:00 http://biotechdispatch.com.au/news/new-collaboration-between-immutep-and-msd 2021-03-16T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-2 2021-03-11T09:00:01+11:00 http://biotechdispatch.com.au/news/new-mtpconnect-report-highlights-skill-gaps 2021-03-11T08:00:01+11:00 http://biotechdispatch.com.au/news/era-consulting-acquired 2021-03-11T08:00:01+11:00 http://biotechdispatch.com.au/news/nutritional-growth-solutions-launches-healthy-height-in-eu 2021-03-11T08:00:01+11:00 http://biotechdispatch.com.au/news/neuren-completes-drug-substance-manufacturing-for-nnz-2591-phase 2021-03-11T08:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-launches-second-part-of-noxcovid-1-clinical-trial 2021-03-09T09:00:01+11:00 http://biotechdispatch.com.au/news/the-three-women-leading-emerging-australian-biotech 2021-03-09T09:00:01+11:00 http://biotechdispatch.com.au/news/european-patent-for-cartherics-cell-therapy 2021-03-09T09:00:01+11:00 http://biotechdispatch.com.au/news/azura-ophthalmics-announces-positive-results-in-phase-two-progra 2021-03-09T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-1 2021-03-09T09:00:01+11:00 http://biotechdispatch.com.au/news/othocell-confirms-australian-reimbursement-for-celgro 2021-03-04T08:42:01+11:00 http://biotechdispatch.com.au/news/kazia-therapeutics-signs-global-agreement-for-lead-candidate 2021-03-04T08:00:01+11:00 http://biotechdispatch.com.au/news/csl-we-have-well-over-one-million-doses-in-the-fridge 2021-03-04T08:00:01+11:00 http://biotechdispatch.com.au/news/mesoblast-private-placement 2021-03-04T08:00:01+11:00 http://biotechdispatch.com.au/news/research-identifies-cause-and-potential-treatment-for-covid-19-i 2021-03-04T08:00:01+11:00 http://biotechdispatch.com.au/news/ausmedtech-2021-programme-launched 2021-03-04T08:00:01+11:00 http://biotechdispatch.com.au/news/osprey-expands-us-sales-coverage-with-new-sales-agency-agreement 2021-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/botanix-expands-its-management-team 2021-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/funding-for-advances-in-medical-research-technology 2021-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/cynata-therapeutics-announces-new-study-of-cell-therapy 2021-03-02T09:00:01+11:00 http://biotechdispatch.com.au/news/funding-opens-for-advanced-bio-manufacturing 2021-03-02T04:00:01+11:00 http://biotechdispatch.com.au/news/opthea-confirms-plans-and-protocols-for-late-stage-opt-302-studi 2021-02-25T09:00:01+11:00 http://biotechdispatch.com.au/news/fda-approval-for-new-cochlear-sound-processor 2021-02-25T09:00:01+11:00 http://biotechdispatch.com.au/news/feedback-sought-on-gene-technology-changes 2021-02-25T09:00:01+11:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-secures-clearance 2021-02-25T09:00:01+11:00 http://biotechdispatch.com.au/news/csiro-secures-licence-to-develop-medicinal-cannabis 2021-02-25T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-launches-new-trial-of-potential-cancer-therapy 2021-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/applications-open-for-bridge-program-1 2021-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/pyc-therapeutics 2021-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/race-oncology 2021-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/groups-issue-joint-call-for-practical-reform-of-prostheses-list 2021-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/starpharmaviraleze 2021-02-23T09:00:01+11:00 http://biotechdispatch.com.au/news/maintaining-access-to-innovation-through-the-prostheses-list 2021-02-18T11:26:01+11:00 http://biotechdispatch.com.au/news/bionomics-in-collaboration-with-empathbio 2021-02-18T09:00:01+11:00 http://biotechdispatch.com.au/news/czech-republic-authorises-telixs-prostate-cancer-imaging-product 2021-02-18T09:00:01+11:00 http://biotechdispatch.com.au/news/mesoblast 2021-02-18T09:00:01+11:00 http://biotechdispatch.com.au/news/csl-reports-strong-first-half-and-details-scale-of-covid-19-resp 2021-02-18T09:00:01+11:00 http://biotechdispatch.com.au/news/maintaining-access-to-innovation-through-the-protheses-list 2021-02-18T09:00:01+11:00 http://biotechdispatch.com.au/news/cochlear 2021-02-18T09:00:01+11:00 http://biotechdispatch.com.au/news/tga-approves-first-australian-commercial-car-t-manufacturing-sit 2021-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/avita-medical-reports-significant-jump-in-revenue 2021-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/neuren-pharmaceuticals-updates-on-phase-one-trial 2021-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-secures-type-c-meeting-with-fda 2021-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-secures-another-us-patent-for-celgro 2021-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/australias-rm-manufacturing-capabilities-expanding 2021-02-16T09:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-funding-for-cardiovascular-device-clinical-trial-coll 2021-02-11T09:00:01+11:00 http://biotechdispatch.com.au/news/research-funding-and-advocacy-support-for-genetic-condition-2 2021-02-11T09:00:01+11:00 http://biotechdispatch.com.au/news/new-research-cooperation-agreement-for-telix-pharmaceuticals 2021-02-11T09:00:01+11:00 http://biotechdispatch.com.au/news/global-biotech-executive-to-boost-microbiome-drug-development-fo 2021-02-11T09:00:01+11:00 http://biotechdispatch.com.au/news/two-new-investments-for-bioscience-managers 2021-02-11T09:00:01+11:00 http://biotechdispatch.com.au/news/biotech-boards-gender-diversity-moving-forward 2021-02-11T09:00:01+11:00 http://biotechdispatch.com.au/news/member-feedback-sought-on-protheses-list-consultation 2021-02-09T11:19:01+11:00 http://biotechdispatch.com.au/news/orthocells-striate-recommended-for-inclusion-on-the-prosthesis-l 2021-02-09T10:00:01+11:00 http://biotechdispatch.com.au/news/experienced-medtech-executive-sue-macleman-appointed-to-board-of 2021-02-09T10:00:01+11:00 http://biotechdispatch.com.au/news/biocurate-says-it-eyes-next-phase-of-growth-with-appointment-of- 2021-02-09T10:00:01+11:00 http://biotechdispatch.com.au/news/first-export-to-the-us-triggers-milestone-payment-for-pharmaxis 2021-02-09T10:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-uses-global-conference-to-update-in-veyonda-combinatio 2021-02-09T04:00:01+11:00 http://biotechdispatch.com.au/news/positive-study-result-for-botanixs-btx-1801-in-golden-staph 2021-02-04T07:00:01+11:00 http://biotechdispatch.com.au/news/early-bird-registrations-open-for-ausmedtech-2021 2021-02-04T07:00:01+11:00 http://biotechdispatch.com.au/news/resapp-receives-rd-tax-incentive-refund-and-grant 2021-02-04T07:00:01+11:00 http://biotechdispatch.com.au/news/incannex-expands-ihl-675a-study-indications 2021-02-04T07:00:01+11:00 http://biotechdispatch.com.au/news/australian-developed-covid-nasal-spray-set-to-land-in-europe-1 2021-02-04T07:00:01+11:00 http://biotechdispatch.com.au/news/ellume-announces-new-agreement-to-scale-up-us-production 2021-02-02T10:00:01+11:00 http://biotechdispatch.com.au/news/research-australia-calls-for-ambitious-goals-in-pre-budget-submi 2021-02-02T10:00:01+11:00 http://biotechdispatch.com.au/news/emyria-appoints-navy-veteran-and-consultant-psychiatrist-to-advi 2021-02-02T10:00:01+11:00 http://biotechdispatch.com.au/news/chimeric-therapeutics-appoints-industry-veteran-to-board 2021-02-02T10:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-updates-on-world-first-case-report-for-its-tendon-repa 2021-02-02T10:00:01+11:00 http://biotechdispatch.com.au/news/industry-leaders-sought-to-drive-decadal-strategy-for-sector 2021-02-02T10:00:01+11:00 http://biotechdispatch.com.au/news/greg-hunt-launches-the-governments-covid-19-vaccine-information- 2021-01-28T07:38:01+11:00 http://biotechdispatch.com.au/news/australian-company-nyrada-reports-new-data-from-trial-or-oral-pc 2021-01-28T07:00:01+11:00 http://biotechdispatch.com.au/news/help-shape-australian-health-security-policy 2021-01-28T07:00:01+11:00 http://biotechdispatch.com.au/news/4dmedical-launches-us-pilot-of-xv-lvas-respiratory-system 2021-01-28T07:00:01+11:00 http://biotechdispatch.com.au/news/alexion-acquisition-means-the-end-for-az-ceo-on-csl-board 2021-01-28T07:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-renews-agreements-with-international-industry-bodies 2021-01-21T12:01:01+11:00 http://biotechdispatch.com.au/news/orthocell-banks-rd-tax-incentive-refund 2021-01-21T09:00:01+11:00 http://biotechdispatch.com.au/news/bionomics-says-treatment-phase-complete-in-bnc105-combination-tr 2021-01-21T09:00:01+11:00 http://biotechdispatch.com.au/news/almac-group-survey-reveals-pandemic-impact-on-clinical-trial-act 2021-01-21T09:00:01+11:00 http://biotechdispatch.com.au/news/queensland-research-institute-in-new-cell-therapy-trial 2021-01-21T08:00:01+11:00 http://biotechdispatch.com.au/news/over-20-ms-projects-funded-under-new-round-of-grants 2021-01-21T08:00:01+11:00 http://biotechdispatch.com.au/news/investors-back-chimeric-therapeutics-on-asx-debut 2021-01-19T09:00:01+11:00 http://biotechdispatch.com.au/news/csiro-and-new-study-showing-benefit-of-diet-change-for-type-2-di 2021-01-19T09:00:01+11:00 http://biotechdispatch.com.au/news/european-approval-for-medibios-mebsleep 2021-01-19T09:00:01+11:00 http://biotechdispatch.com.au/news/bluebird-split-puts-oncology-assets-in-a-stand-alone-entity 2021-01-19T09:00:01+11:00 http://biotechdispatch.com.au/news/capital-raising-hits-new-high 2021-01-19T09:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-says-study-advancing-after-clinical-review 2021-01-14T09:26:01+11:00 http://biotechdispatch.com.au/news/members-invited-to-industry-and-state-government-updates 2021-01-14T09:00:01+11:00 http://biotechdispatch.com.au/news/clinical-trial-finds-vitamin-d-does-not-ward-off-colds-and-flu 2021-01-14T09:00:01+11:00 http://biotechdispatch.com.au/news/artms-and-telix-pharmaceuticals-announce-successful-production-o 2021-01-14T09:00:01+11:00 http://biotechdispatch.com.au/news/cannatrek-to-supply-products-in-support-of-europes-project-twent 2021-01-14T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-receives-milestone-payment-from-us-partner 2021-01-12T04:00:01+11:00 http://biotechdispatch.com.au/news/greg-hunt-announces-funding-for-two-new-research-centres 2021-01-12T04:00:01+11:00 http://biotechdispatch.com.au/news/new-year-resolutions-demonstrating-commitment-to-growth 2021-01-12T04:00:01+11:00 http://biotechdispatch.com.au/news/boehringer-ingelheim-partners-with-google-on-quantum-computing 2021-01-12T04:00:01+11:00 http://biotechdispatch.com.au/news/us-courts-blocks-introduction-of-most-favoured-nation-pricing 2021-01-12T04:00:01+11:00 http://biotechdispatch.com.au/news/published-studies-show-potential-of-ena-respiratorys-inna-051 2020-12-22T09:00:01+11:00 http://biotechdispatch.com.au/news/health-policy-lead-appointed-to-mrcf-board 2020-12-22T09:00:01+11:00 http://biotechdispatch.com.au/news/2020-an-unforgettable-year 2020-12-22T09:00:01+11:00 http://biotechdispatch.com.au/news/nyrada-reports-encouraging-early-efficacy-results-from-pcskpi-pr 2020-12-22T09:00:01+11:00 http://biotechdispatch.com.au/news/companies-back-heart-foundation-covid-19-research-grants 2020-12-22T09:00:01+11:00 http://biotechdispatch.com.au/news/suda-pharmaceuticals-announces-firm-commitments-on-capital-raise 2020-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/biosceptre-partners-with-uts-for-new-analytical-laboratory 2020-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/emyria-completes-share-placement-with-new-investors 2020-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/nsw-medical-devices-fund-opens 2020-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/us-fda-grants-emergency-authorisation-to-ellumes-covid-19-test 2020-12-17T04:00:01+11:00 http://biotechdispatch.com.au/news/rhinomed-reports-positive-data-from-lab-based-study-of-covid-19- 2020-12-15T09:00:01+11:00 http://biotechdispatch.com.au/news/europe-grants-antisenses-atl1102-orphan-designation 2020-12-15T08:00:01+11:00 http://biotechdispatch.com.au/news/early-close-for-over-subscribed-chimeric-ipo 2020-12-15T08:00:01+11:00 http://biotechdispatch.com.au/news/greg-hunt-announces-twelve-new-mrff-grant-opportunities 2020-12-15T08:00:01+11:00 http://biotechdispatch.com.au/news/save-the-date-ausmedtech-2021 2020-12-15T08:00:01+11:00 http://biotechdispatch.com.au/news/queensland-government-back-ellume-manufacturing-expansion 2020-12-10T08:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-calls-for-more-industry-redi-fellowship-sponsors 2020-12-10T08:00:01+11:00 http://biotechdispatch.com.au/news/india-approves-three-aroa-biosurgery-products 2020-12-10T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-updates-on-aipac-breast-cancer-study-and-announces-new-t 2020-12-10T08:00:01+11:00 http://biotechdispatch.com.au/news/shaping-the-industrys-future-starts-with-goals 2020-12-10T08:00:01+11:00 http://biotechdispatch.com.au/news/new-guidance-on-regulatory-changes-for-custom-made-medical-devic 2020-12-08T08:00:01+11:00 http://biotechdispatch.com.au/news/qimr-berghofer-researchers-develop-new-covid-19-immune-test 2020-12-08T08:00:01+11:00 http://biotechdispatch.com.au/news/monash-university-announces-new-anti-infectives-research-agreeme 2020-12-08T08:00:01+11:00 http://biotechdispatch.com.au/news/tga-grants-priority-review-for-telix-pharmaceuticals-tlx591-cdx 2020-12-08T08:00:01+11:00 http://biotechdispatch.com.au/news/bioscience-managers-recognised-for-investment-in-avita-therapeut 2020-12-08T08:00:01+11:00 http://biotechdispatch.com.au/news/tga-head-impressed-with-covid-19-vaccine-efficacy 2020-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/rhythm-biosciences-appoints-french-company-to-manufacture-colost 2020-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/fda-grants-fast-track-designation-to-mesoblast-treatement 2020-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-completes-23m-share-placement 2020-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/global-manufacturing-survey-invites-australias-views 2020-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/uk-repurposing-sports-stadiums-as-mass-vaccination-centres 2020-12-03T04:00:01+11:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-acquires-swiss-german-counterpart 2020-12-01T09:00:01+11:00 http://biotechdispatch.com.au/news/dimerix-announces-a-new-covid-19-study-for-dmx-200 2020-12-01T09:00:01+11:00 http://biotechdispatch.com.au/news/australian-invention-deployed-as-first-instant-patient-isolation 2020-12-01T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-showcases-australias-clinical-trials-advantages-durin 2020-12-01T09:00:01+11:00 http://biotechdispatch.com.au/news/sydney-research-discovery-could-lead-to-new-cancer-therapies 2020-12-01T04:00:01+11:00 http://biotechdispatch.com.au/news/tga-registration-for-rhinomeds-new-nasal-swab 2020-11-26T07:00:01+11:00 http://biotechdispatch.com.au/news/telix-submits-prostate-cancer-imaging-product-to-fda 2020-11-26T07:00:01+11:00 http://biotechdispatch.com.au/news/race-oncology-updates-on-results-of-bisantree-study 2020-11-26T07:00:01+11:00 http://biotechdispatch.com.au/news/stem-cell-news-the-most-unexpected-result-of-my-career 2020-11-26T07:00:01+11:00 http://biotechdispatch.com.au/news/oventus-signs-agreement-to-expand-distribution-in-us 2020-11-26T07:00:01+11:00 http://biotechdispatch.com.au/news/industry-update-highlights-sa-opportunities 2020-11-26T07:00:01+11:00 http://biotechdispatch.com.au/news/monash-to-leverage-mrff-funds-in-amr-fight 2020-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/new-backing-for-australian-biotechnology-companies 2020-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/a-third-covid-19-vaccine-hits-efficacy-endpoint 2020-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/carina-biotech-teams-up-with-bionomics-on-car-t 2020-11-24T10:00:01+11:00 http://biotechdispatch.com.au/news/have-your-say-biotech-blueprint-goals 2020-11-24T04:00:01+11:00 http://biotechdispatch.com.au/news/immutep-completes-capital-raise-and-expands-collaboration-with-m 2020-11-19T10:00:01+11:00 http://biotechdispatch.com.au/news/research-australia-seeking-input-for-second-covid-19-survey 2020-11-19T10:00:01+11:00 http://biotechdispatch.com.au/news/fda-approval-for-qbiotics-canine-cancer-treatment 2020-11-19T10:00:01+11:00 http://biotechdispatch.com.au/news/gsk-backs-mtpconnect-industry-researcher-initiative 2020-11-19T10:00:01+11:00 http://biotechdispatch.com.au/news/australias-role-in-addressing-amr 2020-11-19T10:00:01+11:00 http://biotechdispatch.com.au/news/new-company-focussed-on-clinical-trials-in-sa 2020-11-17T09:19:01+11:00 http://biotechdispatch.com.au/news/csl-in-18bn-manufacturing-and-supply-deal-with-australian-govern 2020-11-17T09:00:01+11:00 http://biotechdispatch.com.au/news/clinical-trial-exemption-ctx-scheme-renamed 2020-11-17T09:00:01+11:00 http://biotechdispatch.com.au/news/brandon-capital-partners-joins-partners-in-investing-in-uk-start 2020-11-17T09:00:01+11:00 http://biotechdispatch.com.au/news/moderna-covid-19-vaccine-945-per-cent-effective 2020-11-17T09:00:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-atl1102-moving-towards-orphan-designation 2020-11-12T09:00:01+11:00 http://biotechdispatch.com.au/news/tga-approval-for-atomo-diagnosticss-rapid-hiv-test 2020-11-12T09:00:01+11:00 http://biotechdispatch.com.au/news/botanix-pharmaceuticals-updates-on-meeting-with-fda 2020-11-12T09:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-releases-first-of-three-reports-on-skill-gaps 2020-11-12T09:00:01+11:00 http://biotechdispatch.com.au/news/patents-accessibility-review-submission 2020-11-12T09:00:01+11:00 http://biotechdispatch.com.au/news/it-works-pfizers-covid-19-vaccine-hits-90-efficacy 2020-11-10T08:00:01+11:00 http://biotechdispatch.com.au/news/epi-minder-appoints-new-chief-operating-officer 2020-11-10T08:00:01+11:00 http://biotechdispatch.com.au/news/avita-therapeutics-inks-new-deal-for-skin-restoration-platform 2020-11-10T08:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-announces-veyonda-to-be-studied-in-new-immunotherapy-t 2020-11-10T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-new-chief-scientist 2020-11-10T08:00:01+11:00 http://biotechdispatch.com.au/news/new-report-calls-for-action-on-cv-testing-and-treatment 2020-11-05T08:00:01+11:00 http://biotechdispatch.com.au/news/government-announces-deals-for-two-more-covid-19-vaccines 2020-11-05T08:00:01+11:00 http://biotechdispatch.com.au/news/new-consortium-prepares-for-australias-regenerative-medicine-fut 2020-11-05T08:00:01+11:00 http://biotechdispatch.com.au/news/myopharm-welcomes-experienced-executive-as-new-chair 2020-11-05T08:00:01+11:00 http://biotechdispatch.com.au/news/new-report-looks-to-remove-barriers-to-innovation-adoption 2020-11-05T08:00:01+11:00 http://biotechdispatch.com.au/news/telix-announces-major-deal-for-its-products-in-china-market 2020-11-03T09:21:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-joins-elite-australian-club-with-us-approval 2020-11-03T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-announces-new-collaboration-with-us-based-labcorp 2020-11-03T08:00:01+11:00 http://biotechdispatch.com.au/news/tga-approves-atomos-rapid-antigen-covid-19-test 2020-11-03T08:00:01+11:00 http://biotechdispatch.com.au/news/life-science-leading-lights-celebrated-with-industry-excellence- 2020-11-03T08:00:01+11:00 http://biotechdispatch.com.au/news/industry-backs-new-regenerative-medicine-consortium 2020-10-29T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-elects-a-new-board-member 2020-10-29T09:00:01+11:00 http://biotechdispatch.com.au/news/cancer-trials-collaborative-celebrates-patient-milestone 2020-10-29T09:00:01+11:00 http://biotechdispatch.com.au/news/biocurate-inks-new-mou-with-abbvie 2020-10-29T09:00:01+11:00 http://biotechdispatch.com.au/news/new-initiative-to-accelerate-research-for-diabetes-and-cardiovas 2020-10-29T09:00:01+11:00 http://biotechdispatch.com.au/news/monash-university-centre-recognised-for-covid-19-work 2020-10-29T09:00:01+11:00 http://biotechdispatch.com.au/news/2020s-biggest-week-in-biotech-arrives 2020-10-27T09:00:01+11:00 http://biotechdispatch.com.au/news/immutep-partners-for-efti-covid-19-trial 2020-10-27T09:00:01+11:00 http://biotechdispatch.com.au/news/us-fda-grantsatl1102-orphan-designation-for-the-treatment-of-dmd 2020-10-27T09:00:01+11:00 http://biotechdispatch.com.au/news/clinuvel-pharmaceuticals-updates-on-first-xp-c-patient 2020-10-27T09:00:01+11:00 http://biotechdispatch.com.au/news/dimerix-updates-on-the-development-of-dmx-200-for-kidney-disease 2020-10-27T09:00:01+11:00 http://biotechdispatch.com.au/news/microbio-announces-development-of-replicating-sars-cov-2-virus-t 2020-10-22T11:06:01+11:00 http://biotechdispatch.com.au/news/ide-group-to-host-building-better-futures-for-health-challenge 2020-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/biosceptre-collaboration-to-progress-car-t-research-in-sydney 2020-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-secures-new-european-patent-for-imp761 2020-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/anteotech-looking-to-clinical-trial-after-receiving-results-of-v 2020-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/25-million-csl-centenary-fellowship-winners-announced 2020-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/proteomics-signs-deal-for-distribution-of-promarkerd-in-italy 2020-10-20T08:00:01+11:00 http://biotechdispatch.com.au/news/amplia-therapeutics-takes-australian-cancer-discovery-into-trial 2020-10-20T08:00:01+11:00 http://biotechdispatch.com.au/news/kazia-therapeutics-paxalisib-joins-global-glioblastoma-platform- 2020-10-20T08:00:01+11:00 http://biotechdispatch.com.au/news/sta-cancer-therapy-progressing-to-late-stage-covid-19-trial 2020-10-20T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-seeks-feedback-on-medical-device-consultations 2020-10-20T08:00:01+11:00 http://biotechdispatch.com.au/news/funding-for-brisbane-based-clinical-trial-manufacturing-facility 2020-10-15T08:00:01+11:00 http://biotechdispatch.com.au/news/technical-and-legal-barriers-are-hurdles-for-genome-sequencing 2020-10-15T08:00:01+11:00 http://biotechdispatch.com.au/news/new-ceo-for-medical-developments-international 2020-10-15T08:00:01+11:00 http://biotechdispatch.com.au/news/csls-annual-general-meeting-goes-virtual 2020-10-15T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech 2020-10-15T08:00:01+11:00 http://biotechdispatch.com.au/news/promoting-science-and-evidence-in-agritechs-gene-technology-deba 2020-10-13T08:00:01+11:00 http://biotechdispatch.com.au/news/opthea-launches-us-initial-public-offering 2020-10-13T08:00:01+11:00 http://biotechdispatch.com.au/news/parliament-backs-revised-rd-tax-incentive-changes 2020-10-13T08:00:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-confirms-sale-of-apas-independence-to-german-com 2020-10-13T08:00:01+11:00 http://biotechdispatch.com.au/news/final-patient-completes-treatment-in-noxopharms-lupin-study 2020-10-13T08:00:01+11:00 http://biotechdispatch.com.au/news/new-guidance-released-for-fmt-products 2020-10-08T12:00:01+11:00 http://biotechdispatch.com.au/news/us-government-agency-backs-accelerated-development-of-ellume-dia 2020-10-08T12:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-changes-to-rd-tax-cut 2020-10-08T12:00:01+11:00 http://biotechdispatch.com.au/news/new-australian-pateent-for-patrys-deoxymab-3e10-nanoparticle-tec 2020-10-08T12:00:01+11:00 http://biotechdispatch.com.au/news/medibio-partners-with-us-company-for-new-clinical-trial 2020-10-08T12:00:01+11:00 http://biotechdispatch.com.au/news/kazia-therapeutics-completes-first-stage-of-capital-raise 2020-10-06T11:33:01+11:00 http://biotechdispatch.com.au/news/capital-raise-and-new-leadership-for-epi-minder 2020-10-06T10:00:01+11:00 http://biotechdispatch.com.au/news/bios-joe-damond-us-sending-industry-a-signal-about-pricing-in-ot 2020-10-06T10:00:01+11:00 http://biotechdispatch.com.au/news/us-government-grant-for-vaxxas-vaccine-platform 2020-10-06T10:00:01+11:00 http://biotechdispatch.com.au/news/capital-raise-to-boos-lumos-diagnostics-commercial-operations 2020-10-06T10:00:01+11:00 http://biotechdispatch.com.au/news/12m-digital-transformation-for-tga 2020-10-06T10:00:01+11:00 http://biotechdispatch.com.au/news/astrazeneca-partners-australian-medtech-company 2020-10-01T11:00:01+10:00 http://biotechdispatch.com.au/news/another-step-forward-for-australian-rare-disease-company 2020-10-01T11:00:01+10:00 http://biotechdispatch.com.au/news/atomo-gains-rights-to-rapid-covid-19-diagnostic 2020-10-01T11:00:01+10:00 http://biotechdispatch.com.au/news/medical-manufacturing-to-feature-in-recovery-plans 2020-10-01T11:00:01+10:00 http://biotechdispatch.com.au/news/pm-says-plan-aims-to-build-on-existing-strengths-and-find-new-op 2020-10-01T11:00:01+10:00 http://biotechdispatch.com.au/news/have-your-say-mrff-priorities-2020-2022 2020-09-29T09:00:01+10:00 http://biotechdispatch.com.au/news/baker-institute-research-leads-to-new-heart-tech-start-up 2020-09-29T09:00:01+10:00 http://biotechdispatch.com.au/news/promising-pre-clinical-results-for-ena-respiratorys-covid-19-tre 2020-09-29T08:00:01+10:00 http://biotechdispatch.com.au/news/patrys-adds-full-human-antibody-to-pre-clinical-deoxymab-portfol 2020-09-29T08:00:01+10:00 http://biotechdispatch.com.au/news/actinogen-medical-announces-the-appointment-of-new-cfo 2020-09-29T08:00:01+10:00 http://biotechdispatch.com.au/news/bionomics-completes-institutional-stage-of-capital-raise 2020-09-29T08:00:01+10:00 http://biotechdispatch.com.au/news/technovalia-starts-trial-of-gene-based-covid-19-vaccine 2020-09-24T09:00:01+10:00 http://biotechdispatch.com.au/news/osprey-medical-announces-distribution-agreement-for-australia-an 2020-09-24T09:00:01+10:00 http://biotechdispatch.com.au/news/feedback-sought-on-implementing-tele-trials-in-clinical-trials 2020-09-24T09:00:01+10:00 http://biotechdispatch.com.au/news/chimeric-enters-new-development-agreement-with-us-cancer-centre 2020-09-24T09:00:01+10:00 http://biotechdispatch.com.au/news/divoc-labs-to-sell-atomos-covid-19-rapid-antibody-test-in-india 2020-09-24T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-submits-nda-to-fda-for-prostate-cancer-ima 2020-09-24T09:00:01+10:00 http://biotechdispatch.com.au/news/landmark-deal-for-australian-irish-biotech-partnership 2020-09-22T09:00:01+10:00 http://biotechdispatch.com.au/news/member-feedback-sought-on-inquiry-into-approval-processes-for-no 2020-09-22T09:00:01+10:00 http://biotechdispatch.com.au/news/greg-hunt-announces-mrff-funding-for-more-covid-19-vaccines 2020-09-22T09:00:01+10:00 http://biotechdispatch.com.au/news/neuren-initiates-manufacture-of-nnz-2591-for-phase-two-trials 2020-09-22T09:00:01+10:00 http://biotechdispatch.com.au/news/kazia-therapeutics-announces-new-collaboration-with-us-cancer-in 2020-09-22T09:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-announces-the-publication-of-celgro-trial-results 2020-09-17T12:05:01+10:00 http://biotechdispatch.com.au/news/clinuvel-doses-first-patient-with-dna-repair-therapy 2020-09-17T09:00:01+10:00 http://biotechdispatch.com.au/news/unlocking-capital-to-back-healthcare-during-covid-19-and-beyond 2020-09-17T09:00:01+10:00 http://biotechdispatch.com.au/news/rhinomed-advances-new-high-yielding-nasal-swab 2020-09-17T09:00:01+10:00 http://biotechdispatch.com.au/news/csiro-identifies-the-drivers-of-a-post-pandemic-return-to-growth 2020-09-17T09:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-updates-on-latest-kidney-disease-trial-of-dmx-200 2020-09-15T05:00:01+10:00 http://biotechdispatch.com.au/news/planet-innovation-teams-up-with-us-biotech-for-levicell 2020-09-15T05:00:01+10:00 http://biotechdispatch.com.au/news/aroa-biosurgery-updates-on-progress-of-covid-19-recovery 2020-09-15T05:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-nasal-spray-virucidal-against-covid-19-virus 2020-09-15T05:00:01+10:00 http://biotechdispatch.com.au/news/australian-commission-on-safety-and-quality-in-health-care 2020-09-15T05:00:01+10:00 http://biotechdispatch.com.au/news/carina-biotech-signs-new-development-deal-with-glytherix 2020-09-15T05:00:01+10:00 http://biotechdispatch.com.au/news/digital-technology-for-clinical-trial-research-agreements 2020-09-15T05:00:01+10:00 http://biotechdispatch.com.au/news/melbourne-researchers-get-backing-for-potential-ovarian-cancer-t 2020-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/opportunity-for-improved-treatment-of-genetic-disorders-of-the-l 2020-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/az-could-restart-covid-19-vaccine-trials-next-week 2020-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/ground-broken-at-sydneys-new-innovation-quarter 2020-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/government-opens-consultation-on-mrff-priorities 2020-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/australias-clinical-trials-open-for-business 2020-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/industry-excellence-awards-to-celebrate-greatest-sector-response 2020-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/queensland-established-covid-19-research-website 2020-09-08T10:00:01+10:00 http://biotechdispatch.com.au/news/merck-fellowship-for-brisbane-based-medical-oncologist 2020-09-08T10:00:01+10:00 http://biotechdispatch.com.au/news/australia-to-offer-incentives-in-race-for-industry-investment 2020-09-08T10:00:01+10:00 http://biotechdispatch.com.au/news/murdoch-childrens-research-institute 2020-09-08T10:00:01+10:00 http://biotechdispatch.com.au/news/global-supply-chains-resiliency-survey 2020-09-08T10:00:01+10:00 http://biotechdispatch.com.au/news/star-combo-announces-manufacturing-expansion 2020-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/ellume-extends-partnership-with-new-covid-19-test 2020-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/genomiqa-announces-new-study-of-whole-genome-test 2020-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/government-announces-support-for-covid-19-research-projects 2020-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/new-industry-advisory-group-chairs-appointed 2020-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/nyrada-appoints-experienced-biotech-executive-to-board 2020-09-01T08:00:01+10:00 http://biotechdispatch.com.au/news/funding-for-immutep-and-monash-university-lag-3-project 2020-09-01T08:00:01+10:00 http://biotechdispatch.com.au/news/new-consensus-paper-to-address-cochlear-implant-gap 2020-09-01T08:00:01+10:00 http://biotechdispatch.com.au/news/clinuvel-opens-new-rd-centre-in-singapore 2020-09-01T08:00:01+10:00 http://biotechdispatch.com.au/news/luina-bio-announces-manufacturing-expansion 2020-09-01T08:00:01+10:00 http://biotechdispatch.com.au/news/support-for-biotechs-significant-role-sought-in-pre-budget-submi 2020-09-01T08:00:01+10:00 http://biotechdispatch.com.au/news/biodiem-announces-flu-vax-launch-in-china 2020-08-27T09:00:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-completes-successful-placement 2020-08-27T09:00:01+10:00 http://biotechdispatch.com.au/news/clinuvel-pharmaceuticals-reports-strong-profit-growth 2020-08-27T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-researchers-find-new-forward-on-machine-learning-and- 2020-08-27T09:00:01+10:00 http://biotechdispatch.com.au/news/new-industry-update-roadshow-launched 2020-08-27T09:00:01+10:00 http://biotechdispatch.com.au/news/new-research-could-open-door-to-new-liver-treatments 2020-08-25T08:00:01+10:00 http://biotechdispatch.com.au/news/government-appoints-industry-executives-to-covid-19-group 2020-08-25T08:00:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-opens-patient-enrolment-in-covid-19-trial 2020-08-25T08:00:01+10:00 http://biotechdispatch.com.au/news/uq-discovery-to-aid-drug-development-and-design 2020-08-25T08:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-updates-on-development-of-covid-19-treatment 2020-08-25T08:00:01+10:00 http://biotechdispatch.com.au/news/vale-em-prof-sir-robert-elliot 2020-08-25T08:00:01+10:00 http://biotechdispatch.com.au/news/csl-reports-strong-result-on-the-back-product-growth 2020-08-20T09:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-to-initiate-new-trial-for-potential-myelofibrosis-trea 2020-08-20T09:00:01+10:00 http://biotechdispatch.com.au/news/fda-fast-track-for-kazias-potential-glioblastoma-treatment 2020-08-20T09:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-government-announces-funding-for-clinical-trias 2020-08-20T09:00:01+10:00 http://biotechdispatch.com.au/news/low-impact-expected-from-first-announcements-of-new-foreign-inve 2020-08-20T09:00:01+10:00 http://biotechdispatch.com.au/news/pandemic-and-patent-litigation-hit-cochlear-result 2020-08-18T08:00:01+10:00 http://biotechdispatch.com.au/news/uq-researchers-in-antimicrobial-resistance-breakthrough 2020-08-18T08:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-signs-new-dep-deal-with-chase-sun 2020-08-18T08:00:01+10:00 http://biotechdispatch.com.au/news/hydrix-announces-the-first-implant-of-heart-warning-device 2020-08-18T08:00:01+10:00 http://biotechdispatch.com.au/news/global-rm-financings-poised-to-break-records 2020-08-18T08:00:01+10:00 http://biotechdispatch.com.au/news/mesoblast-gets-ready-for-pivotal-fda-meeting 2020-08-13T10:39:01+10:00 http://biotechdispatch.com.au/news/qbiotics-in-new-cancer-collaboration-with-msd 2020-08-13T10:00:01+10:00 http://biotechdispatch.com.au/news/audit-on-australians-covid-19-vaccines-and-treatment-abilities 2020-08-13T10:00:01+10:00 http://biotechdispatch.com.au/news/csiro-launches-new-long-term-science-mission 2020-08-13T10:00:01+10:00 http://biotechdispatch.com.au/news/new-research-highlights-the-positive-impact-of-heart-check 2020-08-13T10:00:01+10:00 http://biotechdispatch.com.au/news/anatara-initiates-challenge-study-in-poultry 2020-08-11T09:30:01+10:00 http://biotechdispatch.com.au/news/regeneus-signs-japan-agreement-for-progenza-oa 2020-08-11T09:00:01+10:00 http://biotechdispatch.com.au/news/tga-approval-for-atomo-diagnostics-covid-19-diagnostic 2020-08-11T08:00:01+10:00 http://biotechdispatch.com.au/news/europe-validates-patent-for-bard1-ovarian-cancer-diagnostic 2020-08-11T08:00:01+10:00 http://biotechdispatch.com.au/news/cepi-survey-reveals-potential-vaccine-supply 2020-08-11T08:00:01+10:00 http://biotechdispatch.com.au/news/smes-supported-through-new-ip-portal 2020-08-11T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-novavax-vaccine-progresses-to-late-stage-trial 2020-08-06T08:00:01+10:00 http://biotechdispatch.com.au/news/cros-call-for-permanent-change-on-clinical-trials 2020-08-06T08:00:01+10:00 http://biotechdispatch.com.au/news/janssen-signs-new-research-collaboration-with-monash 2020-08-06T08:00:01+10:00 http://biotechdispatch.com.au/news/adherium-appoints-new-technology-chief 2020-08-06T08:00:01+10:00 http://biotechdispatch.com.au/news/clunies-ross-award-winners-congratulated 2020-08-06T08:00:01+10:00 http://biotechdispatch.com.au/news/sydney-researchers-achieve-world-fast-cancer-outcome 2020-08-04T08:00:01+10:00 http://biotechdispatch.com.au/news/pre-early-bird-rates-finish-tomorrow-for-ausbiotech-invest-2020 2020-08-04T08:00:01+10:00 http://biotechdispatch.com.au/news/medlab-updates-on-progress-of-nanabis-observational-study 2020-08-04T08:00:01+10:00 http://biotechdispatch.com.au/news/hatchtech-secures-us-approval-of-xeglyze 2020-08-04T08:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-submits-atl1102-for-organ-designation 2020-08-03T08:00:01+10:00 http://biotechdispatch.com.au/news/new-board-appointments-for-epiaxis-therapeutics 2020-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/approval-for-suda-pharmaceuticals-zolpimist 2020-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-reports-positive-results-from-dmx-200-trial 2020-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/fast-track-approvals-in-chinas-drugs-market-to-unlock-pharma-pro 2020-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/ge-healthcare-to-distribute-osprey-medical-portfolio 2020-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-launches-new-share-purchase-plan 2020-07-28T08:00:01+10:00 http://biotechdispatch.com.au/news/cardiex-completes-25m-share-placement 2020-07-28T08:00:01+10:00 http://biotechdispatch.com.au/news/proteomics-extends-patent-reach-for-promarkerd 2020-07-28T08:00:01+10:00 http://biotechdispatch.com.au/news/access-to-global-market-increased-for-medicinal-cannabis 2020-07-28T08:00:01+10:00 http://biotechdispatch.com.au/news/new-us-trial-site-for-starpharma-astrazeneca-therapy 2020-07-28T08:00:01+10:00 http://biotechdispatch.com.au/news/mrff-hits-20-billion-target-five-years-after-creation 2020-07-23T10:00:01+10:00 http://biotechdispatch.com.au/news/merck-in-deal-for-queensland-immunotherapies 2020-07-23T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-members-winning-funding-support 2020-07-23T10:00:01+10:00 http://biotechdispatch.com.au/news/new-omega-3-partnership-for-csiro 2020-07-23T10:00:01+10:00 http://biotechdispatch.com.au/news/race-oncology-secures-new-us-patent-for-bisantrene 2020-07-23T10:00:01+10:00 http://biotechdispatch.com.au/news/new-research-collaboration-for-csl-and-uniquest 2020-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/funding-for-the-development-of-health-focused-devices 2020-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-biotech-microba-brings-gut-analysis-to-europe-with-sy 2020-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/botanix-progresses-development-plan-for-btx-1503 2020-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/nsw-government-invests-into-rd-commercialisation-addressing-covi 2020-07-21T09:00:01+10:00 http://biotechdispatch.com.au/news/nyrada-reports-results-from-preclinical-pharmacokinetic-study 2020-07-16T05:00:01+10:00 http://biotechdispatch.com.au/news/the-three-cs-communication-collaboration-and-commercialisation 2020-07-16T05:00:01+10:00 http://biotechdispatch.com.au/news/us-orphan-status-for-pharmaxis-cancer-treatment 2020-07-16T05:00:01+10:00 http://biotechdispatch.com.au/news/biointelect-part-of-tafenoquine-development-collaboration 2020-07-16T05:00:01+10:00 http://biotechdispatch.com.au/news/new-1b-industry-led-fund-invests-in-amr 2020-07-16T05:00:01+10:00 http://biotechdispatch.com.au/news/glytherix-awarded-co-operative-research-centre-project-grant 2020-07-16T05:00:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-to-administer-new-research-accelerator 2020-07-14T09:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-to-start-search-for-new-cfo 2020-07-14T09:00:01+10:00 http://biotechdispatch.com.au/news/merck-extends-agreement-with-australian-company 2020-07-14T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-researchers-help-identify-potential-dementia-marker 2020-07-14T09:00:01+10:00 http://biotechdispatch.com.au/news/industry-should-look-to-double-in-size-says-new-report 2020-07-14T09:00:01+10:00 http://biotechdispatch.com.au/news/recce-announces-covid-19-research-agreement 2020-07-09T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-announces-new-collaboration-with-us-based-reflexion 2020-07-09T09:00:01+10:00 http://biotechdispatch.com.au/news/measuring-how-covid-19-has-changed-innovation-perspectives 2020-07-09T09:00:01+10:00 http://biotechdispatch.com.au/news/cellmid-signs-exclusive-agreement-for-sars-cov-2-laboratory-test 2020-07-09T09:00:01+10:00 http://biotechdispatch.com.au/news/australia-leads-region-on-approach-to-cancer-care 2020-07-09T09:00:01+10:00 http://biotechdispatch.com.au/news/andhealth-releases-report-on-australias-digital-health-opportuni 2020-07-07T08:00:01+10:00 http://biotechdispatch.com.au/news/nyrada-announces-positive-results-from-early-pcsk9-study 2020-07-07T08:00:01+10:00 http://biotechdispatch.com.au/news/vetter-teams-up-with-rentschler-biopharma 2020-07-07T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-zucero-therapeutics-announces-laboratory-results 2020-07-07T08:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-announces-fda-approval-of-four-new-products 2020-07-07T08:00:01+10:00 http://biotechdispatch.com.au/news/industry-stands-steadfast-in-rejecting-rdti-bill 2020-07-07T08:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-completes-recruitment-in-key-ortho-ati-shoulder-tendon 2020-07-02T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-fda-will-not-compromise-standards-on-vaccine-approval 2020-07-02T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-backs-ministers-vision-to-become-global-medical-resea 2020-07-02T08:00:01+10:00 http://biotechdispatch.com.au/news/medicinal-cannabis-company-reports-record-revenue 2020-07-02T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-positive-news-on-affinity-biosciences-antibodies 2020-07-02T08:00:01+10:00 http://biotechdispatch.com.au/news/immutep-updates-on-enrolment-in-tacti-002-efti-trial 2020-06-30T06:00:01+10:00 http://biotechdispatch.com.au/news/punitive-changes-will-force-a-choice-between-rd-and-manufacturin 2020-06-30T06:00:01+10:00 http://biotechdispatch.com.au/news/no-new-modelling-or-stakeholder-consultation-on-rd-tax-cut 2020-06-30T06:00:01+10:00 http://biotechdispatch.com.au/news/call-for-australasian-biotechnology-journal-abstracts 2020-06-30T06:00:01+10:00 http://biotechdispatch.com.au/news/little-green-pharma-announces-first-commercial-shipment-to-the-u 2020-06-29T06:00:01+10:00 http://biotechdispatch.com.au/news/csl-acquires-global-rights-to-haemophilia-gene-therapy 2020-06-25T08:00:01+10:00 http://biotechdispatch.com.au/news/grants-for-research-focussed-on-rare-cancers-rare-diseases-and-u 2020-06-25T08:00:01+10:00 http://biotechdispatch.com.au/news/100k-early-stage-research-grants-available 2020-06-25T08:00:01+10:00 http://biotechdispatch.com.au/news/nz-based-aroa-biosurgery-set-to-list-on-the-asx 2020-06-25T08:00:01+10:00 http://biotechdispatch.com.au/news/planet-innovation-produces-beta-units-of-point-of-care-blood-tes 2020-06-25T08:00:01+10:00 http://biotechdispatch.com.au/news/nominations-open-for-2020-peter-wills-award 2020-06-23T09:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-commences-phase-one-noxcovid-trial 2020-06-23T09:00:01+10:00 http://biotechdispatch.com.au/news/biotron-to-present-the-latest-data-on-bit225 2020-06-23T09:00:01+10:00 http://biotechdispatch.com.au/news/patrys-announces-new-issue-to-fund-development-of-pat-dx1 2020-06-23T09:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-completes-placement-to-support-remap-cap-study 2020-06-23T09:00:01+10:00 http://biotechdispatch.com.au/news/new-partnership-between-biocurate-and-uniseed 2020-06-18T08:00:01+10:00 http://biotechdispatch.com.au/news/speedx-moves-to-expansion-with-roche-agreement 2020-06-18T08:00:01+10:00 http://biotechdispatch.com.au/news/250m-victorian-business-growth-fund-opens 2020-06-18T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-new-report-highlights-the-impact-on-life-sciences 2020-06-17T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-novotech-and-medidata-partner-to-accelerate-research 2020-06-17T08:00:01+10:00 http://biotechdispatch.com.au/news/janssen-in-new-research-collaboration-with-monash 2020-06-17T08:00:01+10:00 http://biotechdispatch.com.au/news/delay-to-implementing-medical-device-provisions 2020-06-16T13:37:01+10:00 http://biotechdispatch.com.au/news/new-research-finds-link-between-t-cells-and-throat-cancer 2020-06-16T08:00:01+10:00 http://biotechdispatch.com.au/news/funding-for-projects-to-support-decision-making 2020-06-16T08:00:01+10:00 http://biotechdispatch.com.au/news/brandon-capital-backs-new-diabetes-treatment 2020-06-16T08:00:01+10:00 http://biotechdispatch.com.au/news/europe-commits-to-az-oxford-covid-19-vaccine 2020-06-16T08:00:01+10:00 http://biotechdispatch.com.au/news/approval-for-adalta-to-commence-phase-one-trial-of-ad-214 2020-06-11T09:00:01+10:00 http://biotechdispatch.com.au/news/biomelbourne-network-women-in-leadership-awards 2020-06-11T09:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-appoints-new-executive-director 2020-06-11T09:00:01+10:00 http://biotechdispatch.com.au/news/help-us-identify-your-workforce-skill-gaps 2020-06-11T09:00:01+10:00 http://biotechdispatch.com.au/news/opthea-announces-top-line-results-of-opt-302-dme-trial 2020-06-10T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-companies-up-for-new-pfizer-investment-initiative 2020-06-09T12:00:01+10:00 http://biotechdispatch.com.au/news/greg-hunt-features-as-team-australia-joins-bio-digital-2020 2020-06-09T12:00:01+10:00 http://biotechdispatch.com.au/news/csl-and-cepi-agreement-on-covid-19-vaccine-for-australia 2020-06-09T12:00:01+10:00 http://biotechdispatch.com.au/news/rhythm-biosciences-appoints-innovation-executive-to-board 2020-06-09T12:00:01+10:00 http://biotechdispatch.com.au/news/us-operation-warp-speed-selects-priority-vaccines 2020-06-09T12:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-investors-call-for-action-to-protect-life-sciences 2020-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/project-orbis-review-for-sta-lung-cancer-therapy 2020-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/lbt-updates-on-mrsa-analysis-module-fda-submission 2020-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/dimerixs-dmx-200-includes-in-global-covid-19-trial 2020-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/matchmaking-platform-to-boost-local-manufacturing-supply-chains 2020-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/csl-opens-applications-for-2021-fellowships 2020-06-02T08:00:01+10:00 http://biotechdispatch.com.au/news/immutep-updates-on-trial-with-msds-keytruda 2020-06-02T08:00:01+10:00 http://biotechdispatch.com.au/news/greg-hunt-announces-66-million-for-coronavirus-related-research 2020-06-02T08:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-presents-data-to-asco-2020-virtual-meeting 2020-06-02T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-delivers-roadmap-for-biotechs-fastest-recovery-possib 2020-06-02T08:00:01+10:00 http://biotechdispatch.com.au/news/expressions-of-interest-new-biotech-bbc-series-1 2020-05-28T09:00:01+10:00 http://biotechdispatch.com.au/news/zelira-therapeutics-inks-manufacturing-deal-with-tasalk 2020-05-28T09:00:01+10:00 http://biotechdispatch.com.au/news/novavax-and-nucleus-network-get-key-vaccine-trial-underway 2020-05-28T09:00:01+10:00 http://biotechdispatch.com.au/news/nanotech-company-ferronova-secures-series-a-funding 2020-05-28T09:00:01+10:00 http://biotechdispatch.com.au/news/government-boosts-funding-for-endometriosis-research 2020-05-28T09:00:01+10:00 http://biotechdispatch.com.au/news/10k-peoples-choice-awarded-to-livac 2020-05-26T09:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-atl1102-meets-study-endpoints 2020-05-26T09:00:01+10:00 http://biotechdispatch.com.au/news/nyrada-reports-milestone-reached-in-brain-injury-program 2020-05-26T09:00:01+10:00 http://biotechdispatch.com.au/news/genetic-technologies-updates-on-covid-19-test 2020-05-26T09:00:01+10:00 http://biotechdispatch.com.au/news/new-funding-for-pharmacogenomics-mental-health-research 2020-05-26T09:00:01+10:00 http://biotechdispatch.com.au/news/consultation-enhancing-transparency-measures-for-prescription-me 2020-05-21T07:00:01+10:00 http://biotechdispatch.com.au/news/fda-allows-veyonda-pre-ind-submission-for-covid-19 2020-05-21T07:00:01+10:00 http://biotechdispatch.com.au/news/oneventures-appoints-new-executives-to-healthcare-team 2020-05-21T07:00:01+10:00 http://biotechdispatch.com.au/news/us-clearance-for-4dmedicals-lung-imaging-product 2020-05-21T07:00:01+10:00 http://biotechdispatch.com.au/news/karen-andrews-hoping-for-domestic-production-and-mapping-capabil 2020-05-21T07:00:01+10:00 http://biotechdispatch.com.au/news/new-grant-for-us-inventor-of-technology-platform-used-for-patrys 2020-05-19T09:00:01+10:00 http://biotechdispatch.com.au/news/resappdx-eu-in-use-at-covid-19-respiratory-clinic 2020-05-19T09:00:01+10:00 http://biotechdispatch.com.au/news/new-bio-ceo-welcomed-by-ausbiotech 2020-05-19T09:00:01+10:00 http://biotechdispatch.com.au/news/us-court-denies-cochlear-appeal-rehearing 2020-05-19T09:00:01+10:00 http://biotechdispatch.com.au/news/latest-btb-grants-focussed-on-covid-19-treatments 2020-05-19T09:00:01+10:00 http://biotechdispatch.com.au/news/almac-facilities-remain-open-and-operational 2020-05-14T08:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-announces-new-capital-raise 2020-05-14T08:00:01+10:00 http://biotechdispatch.com.au/news/ncris-covid-19-offering 2020-05-14T08:00:01+10:00 http://biotechdispatch.com.au/news/covid-19-vaccine-doubts-but-over-400-therapies-in-development 2020-05-14T08:00:01+10:00 http://biotechdispatch.com.au/news/soblast-completes-capital-raise-to-support-scale-up-manufacturin 2020-05-14T08:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-april-revenue-down-as-pandemic-hits-surgeries 2020-05-12T08:00:01+10:00 http://biotechdispatch.com.au/news/industry-unites-to-call-for-action-on-jobkeeper 2020-05-12T08:00:01+10:00 http://biotechdispatch.com.au/news/experienced-industry-executive-joins-imagion-board 2020-05-12T08:00:01+10:00 http://biotechdispatch.com.au/news/new-appointment-for-key-patrys-advisory-board 2020-05-12T08:00:01+10:00 http://biotechdispatch.com.au/news/bod-australia-announces-first-prescriptions-received-from-uk-pro 2020-05-12T08:00:01+10:00 http://biotechdispatch.com.au/news/resapp-receives-final-design-files-for-wearable-devices 2020-05-07T09:22:01+10:00 http://biotechdispatch.com.au/news/kim-carr-pandemic-reveals-dangerous-weaknesses-in-economy 2020-05-07T08:00:01+10:00 http://biotechdispatch.com.au/news/greg-hunt-welcomes-csl-production-of-covid-19-immunoglobulin 2020-05-07T08:00:01+10:00 http://biotechdispatch.com.au/news/first-patients-dosed-in-mesoblast-covid-19-trial 2020-05-07T08:00:01+10:00 http://biotechdispatch.com.au/news/tessara-therapeutics-completes-round-one-capital-raise 2020-05-07T08:00:01+10:00 http://biotechdispatch.com.au/news/csl-begins-developing-new-covid-19-treatment 2020-05-07T08:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-appoints-us-based-director 2020-05-05T08:00:01+10:00 http://biotechdispatch.com.au/news/bod-australia-reports-first-prescriptions-in-the-uk 2020-05-05T08:00:01+10:00 http://biotechdispatch.com.au/news/360biolabs-supports-the-first-australian-covid-19-vaccine-trial 2020-05-05T08:00:01+10:00 http://biotechdispatch.com.au/news/government-pushing-for-australian-manufacture-of-vaccine 2020-05-05T08:00:01+10:00 http://biotechdispatch.com.au/news/no-joy-for-pre-revenue-companies-on-jobkeeper 2020-05-05T08:00:01+10:00 http://biotechdispatch.com.au/news/software-as-a-medical-device-consultation 2020-04-30T10:02:01+10:00 http://biotechdispatch.com.au/news/qbiotics-commercialises-first-tigilanol-tiglate-pharmaceutical-p 2020-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-updates-on-darrt-1-clinical-study 2020-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/us-fda-expected-to-authorise-emergency-use-of-remdesivir 2020-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/government-partners-to-acquire-more-covid-19-test-kits 2020-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/auscann-completes-study-recruitment 2020-04-28T08:00:01+10:00 http://biotechdispatch.com.au/news/another-approval-for-mvps-penthrox 2020-04-28T08:00:01+10:00 http://biotechdispatch.com.au/news/botanix-secures-fda-status-for-btx-1801 2020-04-28T08:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-progresses-lox-inhibitor-to-phase-2-cancer-study 2020-04-28T08:00:01+10:00 http://biotechdispatch.com.au/news/roundtable-to-accelerate-rd-in-nsw 2020-04-28T08:00:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-advances-development-of-ptx-100 2020-04-23T08:00:01+10:00 http://biotechdispatch.com.au/news/nyrada-announces-new-chief-financial-officer 2020-04-23T08:00:01+10:00 http://biotechdispatch.com.au/news/immutep-completes-enrolment-in-insight-004-study 2020-04-23T08:00:01+10:00 http://biotechdispatch.com.au/news/novartis-announces-phase-3-trial-of-hydroxychloroquine 2020-04-23T08:00:01+10:00 http://biotechdispatch.com.au/news/new-nsw-health-procedures-for-teletrial-sites 2020-04-23T08:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-and-wehi-to-evaluate-monepantel-on-covid-19-infection- 2020-04-21T09:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-to-seek-us-approval-for-covid-19-study 2020-04-21T09:00:01+10:00 http://biotechdispatch.com.au/news/latest-covid-19-information-from-tga 2020-04-21T09:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-announces-plan-to-redomicile-to-the-us 2020-04-21T09:00:01+10:00 http://biotechdispatch.com.au/news/polynovo-announces-results-of-novosorb-btm-feasibility-study 2020-04-21T09:00:01+10:00 http://biotechdispatch.com.au/news/survey-shows-how-biotech-is-faring 2020-04-16T10:34:01+10:00 http://biotechdispatch.com.au/news/starpharma-says-spl7013-shows-significant-activity-covid-19 2020-04-16T07:00:01+10:00 http://biotechdispatch.com.au/news/benitec-biopharma-announces-appointment-of-new-director 2020-04-16T07:00:01+10:00 http://biotechdispatch.com.au/news/volpara-partners-with-us-company-on-testing 2020-04-16T07:00:01+10:00 http://biotechdispatch.com.au/news/roche-and-astrazeneca-top-for-innovation-and-invention 2020-04-16T07:00:01+10:00 http://biotechdispatch.com.au/news/grey-innovation-secures-funding-to-produce-ventilators 2020-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/rd-finance-supports-health-research-through-covid-19-crisis 2020-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/cyclopharm-secures-fda-application-waiver-for-technegas 2020-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/bard1-and-sienna-announce-merger 2020-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-seeks-class-ruling-on-jobkeeper-scheme 2020-04-14T08:00:01+10:00 http://biotechdispatch.com.au/news/fda-approves-cochlears-remote-check-telehealth-assessment-tool 2020-04-09T09:00:01+10:00 http://biotechdispatch.com.au/news/zelira-therapeutics-says-zlt-101-on-track-to-launch-later-this-y 2020-04-09T09:00:01+10:00 http://biotechdispatch.com.au/news/immutep-partner-eoc-pharma-advances-efti-in-breast-cancer 2020-04-09T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-manufacturer-idt-updates-on-covid-19-impact 2020-04-09T09:00:01+10:00 http://biotechdispatch.com.au/news/national-clinical-trials-governance-pilot-extended 2020-04-09T09:00:01+10:00 http://biotechdispatch.com.au/news/sector-calls-for-action-as-pandemic-hits-clinical-trials 2020-04-07T07:00:01+10:00 http://biotechdispatch.com.au/news/mesoblast-directs-cell-therapy-to-covid-19 2020-04-07T07:00:01+10:00 http://biotechdispatch.com.au/news/cellmid-announces-supply-agreement-for-covid-19-rapid-diagnostic 2020-04-07T07:00:01+10:00 http://biotechdispatch.com.au/news/australian-researchers-developing-covid-19-immunity-test 2020-04-07T07:00:01+10:00 http://biotechdispatch.com.au/news/majority-of-biotech-companies-excluded-from-jobkeeper-payment 2020-04-07T07:00:01+10:00 http://biotechdispatch.com.au/news/evidence-of-strong-early-demand-for-flu-vaccines 2020-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-names-new-deputy-chair 2020-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/csiro-starts-trials-of-covid-19-vaccine-candidates 2020-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/oncosil-approval-for-the-treatment-of-pancreatic-cancer 2020-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/cynata-therapeutics-updates-on-clinical-trial-program 2020-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/time-for-certainty-and-practical-support 2020-03-31T11:36:01+11:00 http://biotechdispatch.com.au/news/covid-19-one-billion-spent-on-health-supplies 2020-03-31T09:00:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-announces-fda-submission 2020-03-31T09:00:01+11:00 http://biotechdispatch.com.au/news/opthea-updates-on-trial-and-opt-302-progress 2020-03-31T09:00:01+11:00 http://biotechdispatch.com.au/news/sa-company-to-produce-masks-in-fight-against-covid-19 2020-03-31T09:00:01+11:00 http://biotechdispatch.com.au/news/covid-19-accc-authorises-medtech-to-collaborate 2020-03-26T08:00:01+11:00 http://biotechdispatch.com.au/news/new-study-shows-benefit-of-novartis-sma-gene-therapy 2020-03-26T08:00:01+11:00 http://biotechdispatch.com.au/news/revised-strategy-for-immuron-in-response-to-covid-19 2020-03-26T08:00:01+11:00 http://biotechdispatch.com.au/news/investors-back-cochlear-through-new-placement 2020-03-26T08:00:01+11:00 http://biotechdispatch.com.au/news/bill-ferris-ac-the-new-chair-of-the-medical-research-commerciali 2020-03-26T08:00:01+11:00 http://biotechdispatch.com.au/news/guidance-and-support-for-clinical-trials 2020-03-26T05:00:01+11:00 http://biotechdispatch.com.au/news/grants-announced-for-covid-19-treatments-and-female-founders 2020-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/regeneus-receives-milestone-payment-from-kyocera 2020-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/covid-19-symptomatic-treatments-before-a-vaccine 2020-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/new-data-confirms-potential-of-vaxxas-patch-based-delivery-techn 2020-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/covid-19-competition-for-medical-supplies-and-clinical-trials-im 2020-03-24T11:00:01+11:00 http://biotechdispatch.com.au/news/antisense-updates-on-phase-2-atl1102-study 2020-03-19T08:00:01+11:00 http://biotechdispatch.com.au/news/government-invokes-emergency-granting-greg-hunt-extraordinary-po 2020-03-19T08:00:01+11:00 http://biotechdispatch.com.au/news/pfizer-signs-new-collaboration-targeting-covid-19-vaccine 2020-03-19T08:00:01+11:00 http://biotechdispatch.com.au/news/queensland-based-luina-bio-teams-up-with-griffith-university-for 2020-03-19T08:00:01+11:00 http://biotechdispatch.com.au/news/webinar-supporting-clinical-trials-during-covid-19 2020-03-19T08:00:01+11:00 http://biotechdispatch.com.au/news/cochlear-withdraws-guidance-in-response-to-covid-19 2020-03-17T09:00:01+11:00 http://biotechdispatch.com.au/news/patrys-pat-dx1-novel-mechanism-for-crossing-the-blood-brain-barr 2020-03-17T09:00:01+11:00 http://biotechdispatch.com.au/news/covid-19-work-from-home-rules-after-government-move-on-gathering 2020-03-17T09:00:01+11:00 http://biotechdispatch.com.au/news/recce-pharmaceuticals-updates-on-move-to-trial-of-antibiotic 2020-03-17T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-strongly-opposes-rdti-bill-at-senate-inquiry 2020-03-17T09:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-reports-results-from-celgro-study 2020-03-12T08:00:01+11:00 http://biotechdispatch.com.au/news/medlabs-nanabis-ready-for-new-trials 2020-03-12T08:00:01+11:00 http://biotechdispatch.com.au/news/government-announces-24-billion-covid-19-health-package 2020-03-12T08:00:01+11:00 http://biotechdispatch.com.au/news/walter-and-eliza-hall-institute-of-medical-research 2020-03-12T08:00:01+11:00 http://biotechdispatch.com.au/news/regulatory-roadshow-regulation-and-reimbursement-when-entering-t 2020-03-12T08:00:01+11:00 http://biotechdispatch.com.au/news/new-study-shows-potential-of-new-cancer-targeting-combination 2020-03-10T08:00:01+11:00 http://biotechdispatch.com.au/news/investors-unite-to-back-the-george-institutes-research 2020-03-10T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-secures-fda-approval-for-new-trial 2020-03-10T08:00:01+11:00 http://biotechdispatch.com.au/news/biogen-secures-gene-switch-technology-from-sangamo 2020-03-10T08:00:01+11:00 http://biotechdispatch.com.au/news/global-stage-for-australian-start-ups 2020-03-10T08:00:01+11:00 http://biotechdispatch.com.au/news/final-patient-enrolled-in-veyondas-lupin-study 2020-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/two-key-appointments-for-qld-based-biotech 2020-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/luncheon-to-celebrate-women-in-life-sciences-draws-more-than-440 2020-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/new-leadership-coming-for-medical-developments-international 2020-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/avita-medical-initiates-new-trial-in-paediatric-scald-injuries 2020-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/patrys-boosts-search-for-partners-as-investors-cheer-new-data 2020-03-03T07:00:01+11:00 http://biotechdispatch.com.au/news/biodiem-laiv-flu-vaccine-approved-in-china 2020-03-03T07:00:01+11:00 http://biotechdispatch.com.au/news/antisense-appoints-us-based-consultant-medical-director 2020-03-03T07:00:01+11:00 http://biotechdispatch.com.au/news/zelira-updates-on-trial-in-patients-on-opioid-treatment 2020-03-03T07:00:01+11:00 http://biotechdispatch.com.au/news/new-fact-sheet-human-germline-genome-editing 2020-03-03T07:00:01+11:00 http://biotechdispatch.com.au/news/piloting-the-draft-national-clinical-trials-governance-framework 2020-02-27T08:00:01+11:00 http://biotechdispatch.com.au/news/biogen-boost-from-recently-acquired-gene-therapies 2020-02-27T08:00:01+11:00 http://biotechdispatch.com.au/news/fda-approves-ind-for-noxopharms-veyonda 2020-02-27T08:00:01+11:00 http://biotechdispatch.com.au/news/framework-putting-clinical-trial-governance-in-the-picture 2020-02-27T08:00:01+11:00 http://biotechdispatch.com.au/news/on-q-recruitment-adds-expertise-to-team 2020-02-27T08:00:01+11:00 http://biotechdispatch.com.au/news/auscann-signs-exclusive-distribution-agreement 2020-02-25T08:00:01+11:00 http://biotechdispatch.com.au/news/expansion-on-the-agenda-for-biointelect 2020-02-25T08:00:01+11:00 http://biotechdispatch.com.au/news/mesoblast-presentation-of-new-ryoncil-data 2020-02-25T08:00:01+11:00 http://biotechdispatch.com.au/news/clinuvel-expands-singapore-laboratories 2020-02-25T08:00:01+11:00 http://biotechdispatch.com.au/news/changes-to-ausbiotech-board-including-new-chair 2020-02-25T08:00:01+11:00 http://biotechdispatch.com.au/news/aroa-biosurgery-launches-myriad-in-the-us 2020-02-20T07:55:01+11:00 http://biotechdispatch.com.au/news/government-directs-mrrf-funds-to-coronavirus-response 2020-02-20T07:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-announces-alliance-to-provide-compassionate-access 2020-02-20T07:00:01+11:00 http://biotechdispatch.com.au/news/immutep-provides-positive-update-on-immunotherapy-trial 2020-02-20T07:00:01+11:00 http://biotechdispatch.com.au/news/eureka-live-medtronic-australasia-launches-new-programme-at-ausm 2020-02-20T07:00:01+11:00 http://biotechdispatch.com.au/news/test-measures-immune-response-to-improve-ovarian-cancer-diagnosi 2020-02-18T08:00:01+11:00 http://biotechdispatch.com.au/news/engeneic-recognised-for-nanocell-platform 2020-02-18T08:00:01+11:00 http://biotechdispatch.com.au/news/expressions-of-interest-for-mrff-grant-assessment-panel 2020-02-18T08:00:01+11:00 http://biotechdispatch.com.au/news/companies-caught-in-new-compliance-regime 2020-02-18T08:00:01+11:00 http://biotechdispatch.com.au/news/researchers-combine-crispr-and-car-t-therapies 2020-02-18T08:00:01+11:00 http://biotechdispatch.com.au/news/solid-half-for-cochlear-on-implant-growth 2020-02-18T08:00:01+11:00 http://biotechdispatch.com.au/news/csl-jumps-again-on-strong-first-half 2020-02-13T08:00:01+11:00 http://biotechdispatch.com.au/news/starpharma-collects-milestone-payment-from-az 2020-02-13T08:00:01+11:00 http://biotechdispatch.com.au/news/australian-company-makes-progress-in-small-molecule-pcsk9-inhibi 2020-02-13T08:00:01+11:00 http://biotechdispatch.com.au/news/speedx-raises-additional-15-million-in-series-b-funding 2020-02-13T08:00:01+11:00 http://biotechdispatch.com.au/news/wa-sets-sights-on-being-next-life-sciences-hub 2020-02-13T08:00:01+11:00 http://biotechdispatch.com.au/news/cochlear-cuts-guidance-in-response-to-coronavirus 2020-02-11T09:30:01+11:00 http://biotechdispatch.com.au/news/government-fails-in-bid-to-block-senate-inquiry 2020-02-11T08:00:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-looks-to-potential-of-atl1102 2020-02-11T08:00:01+11:00 http://biotechdispatch.com.au/news/biotron-to-test-its-compounds-against-coronavirus 2020-02-11T08:00:01+11:00 http://biotechdispatch.com.au/news/australian-biotech-at-the-forefront-of-global-health-responses 2020-02-11T08:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-wins-industry-exchange-program-grant 2020-02-06T08:00:01+11:00 http://biotechdispatch.com.au/news/zelira-therapeutics-completes-capital-raise 2020-02-06T08:00:01+11:00 http://biotechdispatch.com.au/news/new-partnership-to-support-development-of-gene-therapy 2020-02-06T08:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-announces-new-patents-for-celgro 2020-02-06T08:00:01+11:00 http://biotechdispatch.com.au/news/more-work-is-needed-on-diversity-and-inclusion-in-biotech 2020-02-06T08:00:01+11:00 http://biotechdispatch.com.au/news/cronos-acquires-cannabinoid-focused-medical-practice 2020-02-04T08:00:01+11:00 http://biotechdispatch.com.au/news/tga-accepts-clinuvels-scenesse-for-priority-review 2020-02-04T08:00:01+11:00 http://biotechdispatch.com.au/news/mesoblast-submits-therapy-to-the-us-fda 2020-02-04T08:00:01+11:00 http://biotechdispatch.com.au/news/updated-data-on-immutep-therapy-to-be-presented 2020-02-04T08:00:01+11:00 http://biotechdispatch.com.au/news/help-shape-the-ausbiotech-2020-conference-programme 2020-02-04T08:00:01+11:00 http://biotechdispatch.com.au/news/roche-welcomes-new-partnership-with-government 2020-01-30T08:00:01+11:00 http://biotechdispatch.com.au/news/add-your-voice-to-global-manufacturing-survey 2020-01-30T08:00:01+11:00 http://biotechdispatch.com.au/news/cell-therapies-welcomes-car-t-manufacturing-announcement 2020-01-30T08:00:01+11:00 http://biotechdispatch.com.au/news/exopharm-announces-first-dosing-in-plexoval-study 2020-01-30T08:00:01+11:00 http://biotechdispatch.com.au/news/didier-dargent-the-era-of-disruption-has-arrived 2020-01-30T08:00:01+11:00 http://biotechdispatch.com.au/news/research-australia-calls-on-government-to-scrap-rd-tax-cut 2020-01-28T08:00:01+11:00 http://biotechdispatch.com.au/news/recognition-for-department-of-health-official 2020-01-28T08:00:01+11:00 http://biotechdispatch.com.au/news/zelira-therapeutics-partners-with-us-based-parkinsons-foundation 2020-01-28T08:00:01+11:00 http://biotechdispatch.com.au/news/new-senior-appointment-for-imagion-biosystems 2020-01-28T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-csiro-partner-to-deliver-biocheers-events 2020-01-28T08:00:01+11:00 http://biotechdispatch.com.au/news/new-leadership-for-the-department-of-health 2020-01-23T08:00:01+11:00 http://biotechdispatch.com.au/news/polynovo-announces-european-shipments-of-novosorb-btm 2020-01-23T08:00:01+11:00 http://biotechdispatch.com.au/news/new-director-for-bard1-life-sciences 2020-01-23T08:00:01+11:00 http://biotechdispatch.com.au/news/admedus-announced-new-trial-of-adapt-as-surgical-aortic-valve-re 2020-01-23T08:00:01+11:00 http://biotechdispatch.com.au/news/global-regenerative-medicine-industry-poised-for-continued-expan 2020-01-23T08:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-appoints-experienced-industry-and-rd-executive 2020-01-21T06:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-seeks-industrys-views-and-policy-priorities 2020-01-21T06:00:01+11:00 http://biotechdispatch.com.au/news/china-backs-stronger-biopharma-ip-in-us-trade-deal 2020-01-21T06:00:01+11:00 http://biotechdispatch.com.au/news/data-on-pat-dx1-to-be-presented-at-international-summit 2020-01-21T06:00:01+11:00 http://biotechdispatch.com.au/news/european-approval-for-qbiotics-tigilanol-tiglate 2020-01-21T06:00:01+11:00 http://biotechdispatch.com.au/news/feedback-sought-on-consultations-export-of-therapeutic-goods-fro 2020-01-16T08:00:01+11:00 http://biotechdispatch.com.au/news/roche-sarepta-deal-a-positive-sign-for-australian-access 2020-01-16T08:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-reports-rd-tax-incentive-refund 2020-01-16T08:00:01+11:00 http://biotechdispatch.com.au/news/painchek-secures-japanese-patent-and-progresses-expansion 2020-01-16T08:00:01+11:00 http://biotechdispatch.com.au/news/federal-government-invests-in-stem-grants 2020-01-16T08:00:01+11:00 http://biotechdispatch.com.au/news/opthea-completes-recruitment-in-dme-trial-of-opt-302 2020-01-14T08:00:01+11:00 http://biotechdispatch.com.au/news/bacteria-shredding-tech-to-fight-drug-resistant-superbugs 2020-01-14T08:00:01+11:00 http://biotechdispatch.com.au/news/botanix-attends-usa-healthcare-conferences 2020-01-14T08:00:01+11:00 http://biotechdispatch.com.au/news/new-year-resolutions-to-continue-growing-the-biotech-industry-1 2020-01-14T08:00:01+11:00 http://biotechdispatch.com.au/news/fda-approves-avita-medicals-recell-study-for-vitiligo 2020-01-14T07:40:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-updates-on-business-plan-after-bi-halts-study 2019-12-19T10:00:01+11:00 http://biotechdispatch.com.au/news/cochlears-anthony-bishop-on-the-impact-of-a-humbling-experience 2019-12-19T09:00:01+11:00 http://biotechdispatch.com.au/news/another-license-deal-with-specialised-therapeutics 2019-12-19T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotechs-2019-highlights-reel 2019-12-19T09:00:01+11:00 http://biotechdispatch.com.au/news/global-award-for-australian-company-engeneic 2019-12-19T09:00:01+11:00 http://biotechdispatch.com.au/news/childrens-medical-research-institute-welcomes-vector-investment 2019-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/nsw-women-in-life-sciences-luncheon-2020-announced 2019-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-secures-fda-confirmation-of-study-design 2019-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/csiro-researchers-finds-the-clock-for-natural-lifespan 2019-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/polynovo-announces-ce-approval-for-novosorb-btm 2019-12-17T08:00:01+11:00 http://biotechdispatch.com.au/news/bionomics-sells-french-subsidiaries-to-domain-therapeutics 2019-12-12T08:00:01+11:00 http://biotechdispatch.com.au/news/new-appointment-to-cochlear-board 2019-12-12T08:00:01+11:00 http://biotechdispatch.com.au/news/opyl-limited-sets-out-to-use-ai-to-transform-australian-healthca 2019-12-12T08:00:01+11:00 http://biotechdispatch.com.au/news/ma-board-reappoints-dr-anna-lavelle 2019-12-12T08:00:01+11:00 http://biotechdispatch.com.au/news/final-call-for-entrepreneur-award-nominations 2019-12-12T08:00:01+11:00 http://biotechdispatch.com.au/news/epichem-recognised-with-state-award 2019-12-10T13:09:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-cuts-threaten-business-sustainability 2019-12-10T12:00:01+11:00 http://biotechdispatch.com.au/news/new-report-shows-biotech-harder-hit-by-proposed-rdti-changes 2019-12-10T12:00:01+11:00 http://biotechdispatch.com.au/news/qbiotics-updates-on-publication-of-tigilanol-tiglate-trial-resul 2019-12-10T12:00:01+11:00 http://biotechdispatch.com.au/news/4dx-raises-15m-in-oversubscribed-capital-raise 2019-12-10T12:00:01+11:00 http://biotechdispatch.com.au/news/csl-highlights-pipeline-at-investor-briefing-1 2019-12-05T02:00:01+11:00 http://biotechdispatch.com.au/news/views-sought-on-the-future-of-genomics-in-australian-healthcare 2019-12-05T02:00:01+11:00 http://biotechdispatch.com.au/news/new-collaboration-for-griffith-universitys-institute-for-glycomi 2019-12-05T02:00:01+11:00 http://biotechdispatch.com.au/news/government-grants-major-project-status-for-medicinal-cannabis-ex 2019-12-05T02:00:01+11:00 http://biotechdispatch.com.au/news/new-partnership-with-feasibility-study-for-suda 2019-12-05T02:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-astonished-as-government-moves-on-plan-to-cut-rd-ince 2019-12-05T02:00:01+11:00 http://biotechdispatch.com.au/news/institutions-back-australian-company-with-50m-raise 2019-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-updates-on-positive-trial-results-2 2019-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/zelira-confirms-completion-of-acquisition 2019-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/dr-paul-stoffels-the-human-biology-revolution-2 2019-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/8m-nsw-medical-devices-fund-opens-1 2019-12-03T07:00:01+11:00 http://biotechdispatch.com.au/news/consumer-healthcare-products-confirms-new-board 2019-11-29T04:00:01+11:00 http://biotechdispatch.com.au/news/new-directors-for-arcs-board 2019-11-28T10:00:01+11:00 http://biotechdispatch.com.au/news/suda-announces-the-appointment-of-new-ceo 2019-11-28T10:00:01+11:00 http://biotechdispatch.com.au/news/new-study-shows-power-of-ai-in-matching-patients-to-clinical-tri 2019-11-28T10:00:01+11:00 http://biotechdispatch.com.au/news/new-partnership-for-atmo-biosciences-us-based-seed-health 2019-11-28T10:00:01+11:00 http://biotechdispatch.com.au/news/new-australian-register-of-clinical-registries 2019-11-28T10:00:01+11:00 http://biotechdispatch.com.au/news/new-collaboration-for-avita-medical 2019-11-26T08:00:01+11:00 http://biotechdispatch.com.au/news/new-leadership-for-digital-health-company-adherium 2019-11-26T08:00:01+11:00 http://biotechdispatch.com.au/news/kazia-therapeutics-updates-on-trial-of-gdc-0084 2019-11-26T08:00:01+11:00 http://biotechdispatch.com.au/news/penthrox-ind-approved-in-china 2019-11-26T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-calls-for-journal-articles 2019-11-26T08:00:01+11:00 http://biotechdispatch.com.au/news/australian-company-noxopharm-updates-on-pipeline 2019-11-21T08:00:01+11:00 http://biotechdispatch.com.au/news/european-approval-for-starpharmas-vivagel-condom 2019-11-21T08:00:01+11:00 http://biotechdispatch.com.au/news/imugene-appoints-world-renowned-surgeon-to-advisory-board 2019-11-21T08:00:01+11:00 http://biotechdispatch.com.au/news/more-biotech-companies-moving-into-asx-200 2019-11-21T08:00:01+11:00 http://biotechdispatch.com.au/news/antisense-completes-dosing-in-phase-two-atl1102-trial 2019-11-21T07:48:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-announces-presentation-of-additional-atl1 2019-11-19T08:00:01+11:00 http://biotechdispatch.com.au/news/cochlear-confirms-fda-clearance-for-osia-2-system 2019-11-19T08:00:01+11:00 http://biotechdispatch.com.au/news/australia-to-host-vision-biotech-leadership-programme 2019-11-19T08:00:01+11:00 http://biotechdispatch.com.au/news/research-reveals-no-link-between-statins-and-memory-loss 2019-11-19T08:00:01+11:00 http://biotechdispatch.com.au/news/greg-hunt-announces-funding-for-research-into-rare-cancers-and-d 2019-11-19T08:00:01+11:00 http://biotechdispatch.com.au/news/first-patient-doses-in-prescient-ptx-100-study 2019-11-14T11:17:01+11:00 http://biotechdispatch.com.au/news/zelda-cannabis-formulations-to-be-supplied-to-the-care-nsw-trial 2019-11-14T10:00:01+11:00 http://biotechdispatch.com.au/news/avita-medical-announces-120m-placement 2019-11-14T10:00:01+11:00 http://biotechdispatch.com.au/news/mark-glover-the-tech-opportunity-for-clinical-trials 2019-11-14T10:00:01+11:00 http://biotechdispatch.com.au/news/new-regulatory-roadshow-to-help-smes-commercialise-technologies 2019-11-14T10:00:01+11:00 http://biotechdispatch.com.au/news/biotron-secures-51m-underwriting-agreement 2019-11-12T11:00:01+11:00 http://biotechdispatch.com.au/news/bridge-program-announces-2019-pitch-winners 2019-11-12T10:00:01+11:00 http://biotechdispatch.com.au/news/new-board-appointment-for-ellume 2019-11-12T10:00:01+11:00 http://biotechdispatch.com.au/news/new-figures-show-strength-of-australian-regenerative-medicine-se 2019-11-12T10:00:01+11:00 http://biotechdispatch.com.au/news/government-backs-new-hub-for-medicinal-agriculture 2019-11-12T10:00:01+11:00 http://biotechdispatch.com.au/news/feedback-sought-on-gene-technology-issues-paper 2019-11-07T09:00:01+11:00 http://biotechdispatch.com.au/news/pi-to-manufacture-scinogys-new-cell-processing-system-for-cell-t 2019-11-07T09:00:01+11:00 http://biotechdispatch.com.au/news/still-no-disclosed-plans-for-alnylam-in-australia 2019-11-07T09:00:01+11:00 http://biotechdispatch.com.au/news/zelda-therapeutics-announces-insomnia-clinical-trial-is-fully-en 2019-11-07T09:00:01+11:00 http://biotechdispatch.com.au/news/noxopharma-appoints-new-executive-1 2019-11-07T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-new-director 2019-11-04T11:00:01+11:00 http://biotechdispatch.com.au/news/award-recognition-for-oncores-medical 2019-11-04T11:00:01+11:00 http://biotechdispatch.com.au/news/fda-grants-fast-track-for-bionomics-bnc210 2019-11-04T11:00:01+11:00 http://biotechdispatch.com.au/news/agilex-biolabs-awarded-global-top-10-bioanalytical-solutions-pro 2019-11-04T10:00:01+11:00 http://biotechdispatch.com.au/news/dentons-australia-to-host-life-sciences-event 2019-11-04T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-progressing-and-considering-partners 2019-10-31T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-confirms-board-change-and-new-deputy-chair 2019-10-31T09:00:01+11:00 http://biotechdispatch.com.au/news/emerging-australian-biotech-secures-20m-investment 2019-10-31T09:00:01+11:00 http://biotechdispatch.com.au/news/uq-spin-out-company-to-target-liver-disease 2019-10-31T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-releases-updated-sector-snapshot 2019-10-31T09:00:01+11:00 http://biotechdispatch.com.au/news/biotechs-leading-lights-recognised-at-annual-awards 2019-10-31T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-updates-on-us-bronchitol-progress 2019-10-29T07:00:01+11:00 http://biotechdispatch.com.au/news/melbourne-hosts-2019-bridge-symposium 2019-10-29T07:00:01+11:00 http://biotechdispatch.com.au/news/biotechs-biggest-week-of-2019 2019-10-29T07:00:01+11:00 http://biotechdispatch.com.au/news/presagen-launches-new-ai-service 2019-10-29T07:00:01+11:00 http://biotechdispatch.com.au/news/a-new-chair-for-rhythm-biosciences 2019-10-29T07:00:01+11:00 http://biotechdispatch.com.au/news/regulation-changes-for-faecal-microbiota-transplant-products 2019-10-24T09:00:01+11:00 http://biotechdispatch.com.au/news/csiro-opens-new-facility-to-promote-manufacturing-innovation 2019-10-24T09:00:01+11:00 http://biotechdispatch.com.au/news/us-grant-for-study-using-imugenes-oncolytic-virotherapy 2019-10-24T09:00:01+11:00 http://biotechdispatch.com.au/news/penthrox-launches-in-italy 2019-10-24T09:00:01+11:00 http://biotechdispatch.com.au/news/cochlear-adult-market-the-key-to-future-growth 2019-10-24T09:00:01+11:00 http://biotechdispatch.com.au/news/parliament-backs-abolition-of-innovation-patents 2019-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/medtech-funding-programme-opens-for-innovators 2019-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/botanix-signs-new-agreeement-with-us-company-purisys 2019-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-updates-on-veyonda-darrt-1-study 2019-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/new-gene-therapy-partnership-between-bluebird-bio-and-novo-nordi 2019-10-22T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-presents-new-efti-data 2019-10-17T09:00:01+11:00 http://biotechdispatch.com.au/news/aroa-biosurgery-appoints-us-based-commercial-head 2019-10-17T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-reports-rd-tax-incentive-payment 2019-10-17T09:00:01+11:00 http://biotechdispatch.com.au/news/botanix-receives-grant-for-synthetic-cannabidiol-analog-program 2019-10-17T09:00:01+11:00 http://biotechdispatch.com.au/news/dr-peter-french-to-lead-ausbiotech-nsw 2019-10-17T09:00:01+11:00 http://biotechdispatch.com.au/news/opthea-presents-updated-data-on-opt-302 2019-10-15T09:00:01+11:00 http://biotechdispatch.com.au/news/recognising-the-contribution-dr-john-holaday 2019-10-15T09:00:01+11:00 http://biotechdispatch.com.au/news/cancer-and-malaria-the-focus-of-new-csl-centenary-fellowships 2019-10-15T05:00:01+11:00 http://biotechdispatch.com.au/news/government-backs-new-cell-and-tissue-research-facility 2019-10-15T05:00:01+11:00 http://biotechdispatch.com.au/news/csl-marks-25-years-since-privatisation 2019-10-14T09:02:01+11:00 http://biotechdispatch.com.au/news/industry-executive-to-lead-emerging-australian-biopharma-adalta 2019-10-14T09:00:01+11:00 http://biotechdispatch.com.au/news/australian-company-surges-on-fda-approval 2019-10-10T09:00:01+11:00 http://biotechdispatch.com.au/news/final-days-to-vote-for-new-ausbiotech-director 2019-10-10T09:00:01+11:00 http://biotechdispatch.com.au/news/australian-medicinal-cannabis-company-merges-with-us-based-count 2019-10-09T09:00:01+11:00 http://biotechdispatch.com.au/news/the-roi-of-technologically-enhanced-patient-centric-clinical-tri 2019-10-09T09:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-reports-positive-celgro-nerve-regeneration-results 2019-10-09T09:00:01+11:00 http://biotechdispatch.com.au/news/gene-therapy-company-updates-on-cash-runway 2019-10-08T09:00:01+11:00 http://biotechdispatch.com.au/news/boosting-stem-skills-in-regional-queensland 2019-10-08T09:00:01+11:00 http://biotechdispatch.com.au/news/review-of-financial-assistance-to-sme-exporters 2019-10-08T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-raises-24m-in-placement 2019-10-08T09:00:01+11:00 http://biotechdispatch.com.au/news/bard1-extends-agreement-with-thermo-fisher 2019-10-08T09:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-releases-additional-review-of-veyonda-study 2019-10-03T05:00:01+10:00 http://biotechdispatch.com.au/news/opthea-reports-rd-tax-incentive-credit 2019-10-03T05:00:01+10:00 http://biotechdispatch.com.au/news/government-launches-roadmap-for-stem-cell-therapies-mission 2019-10-03T05:00:01+10:00 http://biotechdispatch.com.au/news/workshop-considers-how-to-harness-genomics 2019-10-03T05:00:01+10:00 http://biotechdispatch.com.au/news/grants-to-support-new-translation-projects 2019-10-01T09:00:01+10:00 http://biotechdispatch.com.au/news/us-grant-for-university-of-sydney-spinout-kinoxis-therapeutics 2019-10-01T09:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-lists-on-nasdaq 2019-10-01T09:00:01+10:00 http://biotechdispatch.com.au/news/tia-launches-scheme-to-support-high-throughput-screening 2019-10-01T09:00:01+10:00 http://biotechdispatch.com.au/news/new-appointments-for-cyclopharm 2019-10-01T09:00:01+10:00 http://biotechdispatch.com.au/news/csl-a-key-backer-of-new-university-spinout 2019-09-26T09:00:01+10:00 http://biotechdispatch.com.au/news/immutep-confirms-expansion-of-tacti-002-clinical-trial 2019-09-26T09:00:01+10:00 http://biotechdispatch.com.au/news/victorian-pharma-and-medtech-export-growth-soars 2019-09-26T09:00:01+10:00 http://biotechdispatch.com.au/news/positive-results-for-bionomics-solid-dose-formulation-of-bnc210 2019-09-26T09:00:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-receives-license-fee 2019-09-26T09:00:01+10:00 http://biotechdispatch.com.au/news/pfizer-inks-new-agreement-with-theuniversity-of-melbourne 2019-09-24T10:00:01+10:00 http://biotechdispatch.com.au/news/immutep-secures-milestone-payment-from-gsk 2019-09-24T10:00:01+10:00 http://biotechdispatch.com.au/news/new-leadership-for-suda-pharmaceuticals 2019-09-24T10:00:01+10:00 http://biotechdispatch.com.au/news/australian-digital-health-survey 2019-09-24T10:00:01+10:00 http://biotechdispatch.com.au/news/rhythm-biosciences-updates-on-colostat-development 2019-09-24T10:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-updates-on-preliminary-results-from-atl11 2019-09-19T09:00:01+10:00 http://biotechdispatch.com.au/news/new-deal-for-australian-cell-therapy-company 2019-09-19T09:00:01+10:00 http://biotechdispatch.com.au/news/tga-teams-up-with-fda-and-health-canada-on-oncology-approval 2019-09-19T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-biotech-2030-vision-to-emerge-from-ausbiotech-ceo-pol 2019-09-19T09:00:01+10:00 http://biotechdispatch.com.au/news/adalta-secures-licensing-deal-for-the-i-body-platform 2019-09-19T09:00:01+10:00 http://biotechdispatch.com.au/news/kazia-therapeutics-wins-trans-tasman-innovation-award 2019-09-17T10:00:01+10:00 http://biotechdispatch.com.au/news/ausmedtech-programme-committee-refresh 2019-09-17T10:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-announces-new-us-study-approval 2019-09-17T10:00:01+10:00 http://biotechdispatch.com.au/news/botanix-launches-new-clinical-research-program 2019-09-17T10:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-confirms-veyonda-presentation-at-two-conferences 2019-09-17T10:00:01+10:00 http://biotechdispatch.com.au/news/australian-companies-make-region-innovation-list 2019-09-12T10:00:01+10:00 http://biotechdispatch.com.au/news/new-sydney-office-for-global-search-specialist 2019-09-12T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotechs-ceo-policy-forum 2019-09-12T10:00:01+10:00 http://biotechdispatch.com.au/news/mesoblast-partners-with-grnenthal-on-cell-therapy 2019-09-12T10:00:01+10:00 http://biotechdispatch.com.au/news/icon-acquires-hong-kong-oncology-group 2019-09-12T10:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-added-to-spasx-300-index 2019-09-10T11:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-commences-phase-2-dog-trial 2019-09-10T11:00:01+10:00 http://biotechdispatch.com.au/news/dr-emanuele-ostuni-on-building-a-cell-and-gene-organisation 2019-09-10T11:00:01+10:00 http://biotechdispatch.com.au/news/qld-luncheon-highlights-research-and-initiatives-for-women-in-st 2019-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/opthea-updates-on-new-trial-analysis 2019-09-10T10:00:01+10:00 http://biotechdispatch.com.au/news/cannabinoid-rd-and-clinical-trial-expert-appointed-to-auscann-bo 2019-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/cook-marks-40-years-of-manufacturing-in-australia 2019-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/feedback-sought-on-consultations-exporting-and-attracting-invest 2019-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/cell-therapies-secures-first-australian-commercial-car-t-tga-lic 2019-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/the-go-big-or-go-home-challenge 2019-09-05T11:00:01+10:00 http://biotechdispatch.com.au/news/science-and-technology-australia-launched-new-stem-resource 2019-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/companies-urged-to-help-with-information-on-rdti 2019-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-updates-on-atl1102-dmd-meetings 2019-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/new-collaboration-for-uniquest-with-grnenthal 2019-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/janssen-extends-collaboration-with-melbourne-based-research-inst 2019-09-03T08:00:01+10:00 http://biotechdispatch.com.au/news/exopharm-starts-phase-1-wound-healing-trial 2019-08-29T08:00:01+10:00 http://biotechdispatch.com.au/news/keeping-people-out-of-hospital-the-latest-mrff-focus 2019-08-29T08:00:01+10:00 http://biotechdispatch.com.au/news/lunch-to-discuss-stem-and-women-in-life-sciences 2019-08-29T08:00:01+10:00 http://biotechdispatch.com.au/news/bupa-health-foundation-announces-award-finalists 2019-08-29T08:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-updates-on-dep-trials 2019-08-28T08:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-updates-on-atl1103-eap 2019-08-27T08:00:01+10:00 http://biotechdispatch.com.au/news/john-alexander-joins-students-for-amgen-biotech-experience 2019-08-27T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-senate-inquiry-on-ip 2019-08-27T08:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-confirms-new-japanese-patent-for-orthocell 2019-08-27T08:00:01+10:00 http://biotechdispatch.com.au/news/federal-government-still-finalising-car-t-agreement-with-peter-m 2019-08-27T08:00:01+10:00 http://biotechdispatch.com.au/news/new-partner-initiative-for-adherium 2019-08-22T08:00:01+10:00 http://biotechdispatch.com.au/news/opal-to-participate-in-arc-funded-hub 2019-08-22T08:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-updates-on-veyonda-proof-of-principle-experiments 2019-08-22T08:00:01+10:00 http://biotechdispatch.com.au/news/pfizer-to-invest-us500m-in-gene-therapy-manufacturing 2019-08-22T08:00:01+10:00 http://biotechdispatch.com.au/news/last-call-for-early-stage-investment-forum 2019-08-22T08:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-announces-first-regulatory-approval-in-asia-for-vivag 2019-08-20T08:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-delivers-positive-outlook-for-implant-growth 2019-08-20T08:00:01+10:00 http://biotechdispatch.com.au/news/telix-updates-on-share-purchase-plan 2019-08-20T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-board-election-opens-as-members-invited-to-gather-for 2019-08-20T08:00:01+10:00 http://biotechdispatch.com.au/news/race-announces-successful-completion-of-placement 2019-08-20T08:00:01+10:00 http://biotechdispatch.com.au/news/sydney-based-noxoxpharm-looking-to-make-cold-tumours-hot 2019-08-15T10:00:01+10:00 http://biotechdispatch.com.au/news/greg-hunt-launches-long-term-national-health-plan 2019-08-15T10:00:01+10:00 http://biotechdispatch.com.au/news/csl-reports-higher-revenue-and-profit 2019-08-15T10:00:01+10:00 http://biotechdispatch.com.au/news/rd-tax-incentive-most-important-for-increasing-berd 2019-08-15T10:00:01+10:00 http://biotechdispatch.com.au/news/bod-australia-updates-on-collaboration-with-uts 2019-08-15T10:00:01+10:00 http://biotechdispatch.com.au/news/greenfield-mc-announces-joint-venture-with-canadian-licensed-pro 2019-08-13T08:00:01+10:00 http://biotechdispatch.com.au/news/nationwide-network-of-car-t-treatment-centres 2019-08-13T08:00:01+10:00 http://biotechdispatch.com.au/news/government-marks-the-start-of-national-science-week 2019-08-13T08:00:01+10:00 http://biotechdispatch.com.au/news/kazia-completes-recruitment-of-phase-1-cantrixil-trial 2019-08-13T08:00:01+10:00 http://biotechdispatch.com.au/news/call-for-companies-for-australias-largest-life-science-investmen 2019-08-13T08:00:01+10:00 http://biotechdispatch.com.au/news/victoria-looks-to-grow-biomedical-precinct 2019-08-08T09:00:01+10:00 http://biotechdispatch.com.au/news/new-global-headquarters-for-csl 2019-08-08T09:00:01+10:00 http://biotechdispatch.com.au/news/opthea-soars-on-positive-results-for-lucentis-combination 2019-08-08T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-applauds-ai-groups-rdti-recommendations 2019-08-08T09:00:01+10:00 http://biotechdispatch.com.au/news/cancer-survey-highlights-patient-perspective 2019-08-08T09:00:01+10:00 http://biotechdispatch.com.au/news/federal-government-moves-to-back-medicinal-cannabis-sector 2019-08-06T09:00:01+10:00 http://biotechdispatch.com.au/news/imagion-biosystems-files-for-first-in-human-study 2019-08-06T09:00:01+10:00 http://biotechdispatch.com.au/news/nsw-industry-development-manger-sought 2019-08-06T09:00:01+10:00 http://biotechdispatch.com.au/news/sta-welcomes-approval-of-new-eye-therapy 2019-08-06T09:00:01+10:00 http://biotechdispatch.com.au/news/opthea-in-trading-halt-ahead-of-trial-update 2019-08-06T09:00:01+10:00 http://biotechdispatch.com.au/news/cv-mission-to-back-development-of-medicines-and-therapies 2019-08-01T08:00:01+10:00 http://biotechdispatch.com.au/news/gilead-launches-2020-fellowship-research-grants 2019-08-01T08:00:01+10:00 http://biotechdispatch.com.au/news/new-non-executive-director-for-adalta 2019-08-01T08:00:01+10:00 http://biotechdispatch.com.au/news/telix-announces-new-collaboration-with-global-biopharma 2019-08-01T08:00:01+10:00 http://biotechdispatch.com.au/news/defining-ausbiotechs-role-in-agritech-and-foodtech 2019-08-01T08:00:01+10:00 http://biotechdispatch.com.au/news/australian-company-updates-on-neuroscience-trial 2019-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/awards-open-to-recognise-outstanding-life-science-leaders 2019-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/3d-bioprinter-co-developed-by-unsw-researchers-wins-top-design-a 2019-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/anteo-diagnostics-appoints-new-ceo 2019-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/pfizer-makes-another-transformational-move 2019-07-30T08:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-updates-on-atl1102-trial-1 2019-07-25T09:00:01+10:00 http://biotechdispatch.com.au/news/emeritus-professor-maree-smith-ac-promoting-gender-equality-at-w 2019-07-25T09:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-reports-data-from-pre-clinical-celgro-study 2019-07-25T09:00:01+10:00 http://biotechdispatch.com.au/news/icon-group-study-provides-hope-for-prostate-cancer-patients 2019-07-25T09:00:01+10:00 http://biotechdispatch.com.au/news/first-patient-treated-in-race-oncology-trial 2019-07-25T09:00:01+10:00 http://biotechdispatch.com.au/news/japanese-pharma-moves-to-acquire-local-stem-cell-company 2019-07-23T08:00:01+10:00 http://biotechdispatch.com.au/news/opthea-brings-forward-trial-analysis 2019-07-23T08:00:01+10:00 http://biotechdispatch.com.au/news/case-studies-campaign-launched-local-stories-global-impact 2019-07-23T08:00:01+10:00 http://biotechdispatch.com.au/news/disappointment-for-australian-innovation 2019-07-23T08:00:01+10:00 http://biotechdispatch.com.au/news/new-collaboration-for-zelda-therapeutics-1 2019-07-23T08:00:01+10:00 http://biotechdispatch.com.au/news/breakthrough-designation-for-imagion-breast-cancer-test 2019-07-23T08:00:01+10:00 http://biotechdispatch.com.au/news/jj-innovation-recognises-undergraduates 2019-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/servier-in-new-collaboration-with-melbournes-biocurate 2019-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/immuron-prices-underwritten-public-offering 2019-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-completes-40-million-capital-raise 2019-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/australias-next-antimicrobial-resistance-strategy-2020-and-beyon 2019-07-18T09:00:01+10:00 http://biotechdispatch.com.au/news/imugene-acquires-rights-to-new-oncolytic-virus-technology 2019-07-16T06:00:01+10:00 http://biotechdispatch.com.au/news/botanix-updates-on-cannabidiol-antimicrobial-platform 2019-07-16T06:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-receives-approval-for-new-trial 2019-07-16T06:00:01+10:00 http://biotechdispatch.com.au/news/the-uniqure-experience-highlights-the-commercial-challenge 2019-07-16T06:00:01+10:00 http://biotechdispatch.com.au/news/global-table-conference-programme-released 2019-07-16T06:00:01+10:00 http://biotechdispatch.com.au/news/impressive-stock-market-debut-for-new-perth-based-biopharma 2019-07-11T08:00:01+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-initiates-trial-of-ptx-100 2019-07-11T08:00:01+10:00 http://biotechdispatch.com.au/news/draft-guidelines-released-on-repeal-of-ip-restrictive-trade-prac 2019-07-11T08:00:01+10:00 http://biotechdispatch.com.au/news/next-generation-car-t-could-resolve-key-issue 2019-07-11T08:00:01+10:00 http://biotechdispatch.com.au/news/biotron-updates-on-bit225-009-development 2019-07-11T08:00:01+10:00 http://biotechdispatch.com.au/news/pitchpalace-30-australia-open-for-applications 2019-07-09T08:00:01+10:00 http://biotechdispatch.com.au/news/volpara-signs-to-distribution-agreement 2019-07-09T08:00:01+10:00 http://biotechdispatch.com.au/news/dr-john-bashford-redefining-the-future-for-rare-cancers 2019-07-09T08:00:01+10:00 http://biotechdispatch.com.au/news/osprey-launches-new-podcast-series-for-investors 2019-07-09T08:00:01+10:00 http://biotechdispatch.com.au/news/ellex-reports-four-year-follow-up-data 2019-07-09T08:00:01+10:00 http://biotechdispatch.com.au/news/technology-transfer-expert-appointed-to-uniquest-board 2019-07-04T09:00:01+10:00 http://biotechdispatch.com.au/news/former-sirtex-ceo-pleads-guilty-to-insider-trading 2019-07-04T09:00:01+10:00 http://biotechdispatch.com.au/news/australian-developed-ai-flu-vax-starts-trials-in-the-us 2019-07-04T09:00:01+10:00 http://biotechdispatch.com.au/news/last-call-for-early-bird-registrations-to-the-industry-event-of- 2019-07-04T09:00:01+10:00 http://biotechdispatch.com.au/news/epichem-makes-final-loan-repayment-for-new-laboratory 2019-07-04T09:00:01+10:00 http://biotechdispatch.com.au/news/biointelect-announces-new-collaboration 2019-07-02T09:00:01+10:00 http://biotechdispatch.com.au/news/125-million-fellowships-to-foster-australian-medical-research-ex 2019-07-02T09:00:01+10:00 http://biotechdispatch.com.au/news/the-future-has-arrived-now 2019-07-02T09:00:01+10:00 http://biotechdispatch.com.au/news/approval-for-zeldas-new-clinical-trial 2019-07-02T09:00:01+10:00 http://biotechdispatch.com.au/news/sienna-secures-us-patent-for-cancer-test 2019-07-02T09:00:01+10:00 http://biotechdispatch.com.au/news/publication-of-positive-date-for-admedus-cardiocel 2019-06-27T05:00:01+10:00 http://biotechdispatch.com.au/news/australia-ranked-first-in-attractiveness-of-oecd-countries-for-p 2019-06-27T05:00:01+10:00 http://biotechdispatch.com.au/news/the-cost-of-immunoglobulin-is-on-the-rise 2019-06-27T05:00:01+10:00 http://biotechdispatch.com.au/news/immutep-completes-enrolment-in-new-trial 2019-06-27T05:00:01+10:00 http://biotechdispatch.com.au/news/minister-announces-new-regional-stem-partnerships 2019-06-27T05:00:01+10:00 http://biotechdispatch.com.au/news/join-the-delegation-to-medtech-conference-boston 2019-06-25T05:00:01+10:00 http://biotechdispatch.com.au/news/new-cancer-test-headlines-international-nanomedicine-conference 2019-06-24T06:00:01+10:00 http://biotechdispatch.com.au/news/botanix-presents-new-antimicrobial-data 2019-06-24T05:00:01+10:00 http://biotechdispatch.com.au/news/the-challenge-of-attracting-gene-and-cell-therapy-makers 2019-06-24T05:00:01+10:00 http://biotechdispatch.com.au/news/greg-hunt-will-work-to-ensure-patient-access-to-gene-and-cell-th 2019-06-24T05:00:01+10:00 http://biotechdispatch.com.au/news/profound-change-required-to-integrate-precision-medicines 2019-06-20T11:00:01+10:00 http://biotechdispatch.com.au/news/rdtis-critical-role-emphasised-to-federal-mps-and-senators 2019-06-20T11:00:01+10:00 http://biotechdispatch.com.au/news/medlab-receives-ethics-approval-for-second-the-second-nanabis-tr 2019-06-20T11:00:01+10:00 http://biotechdispatch.com.au/news/divesting-older-technologies-will-be-required 2019-06-20T11:00:01+10:00 http://biotechdispatch.com.au/news/botanix-updates-investors-on-new-btx-1801-data 2019-06-20T11:00:01+10:00 http://biotechdispatch.com.au/news/biomedtech-horizons-grant-round-two-opens 2019-06-18T09:00:01+10:00 http://biotechdispatch.com.au/news/emerging-companies-dominate-new-therapies 2019-06-18T09:00:01+10:00 http://biotechdispatch.com.au/news/anteo-signs-new-agreement-with-lumos-diagnostics 2019-06-18T09:00:01+10:00 http://biotechdispatch.com.au/news/another-trial-site-for-rhythm-biosciences-colostat-trial 2019-06-18T09:00:01+10:00 http://biotechdispatch.com.au/news/bard1-life-sciences-capital-raise-and-board-appointments 2019-06-18T09:00:01+10:00 http://biotechdispatch.com.au/news/gene-technology-an-increasing-focus 2019-06-13T09:00:01+10:00 http://biotechdispatch.com.au/news/global-medtech-and-pharma-firms-engaging-with-australia 2019-06-13T09:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-to-present-new-recell-data 2019-06-13T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-extends-collaboration-with-osaka-university 2019-06-13T09:00:01+10:00 http://biotechdispatch.com.au/news/resapp-receives-1785m-rd-tax-incentive-rebate 2019-06-13T05:00:01+10:00 http://biotechdispatch.com.au/news/canadian-company-to-acquire-creso-pharma 2019-06-11T08:01:01+10:00 http://biotechdispatch.com.au/news/international-council-convenes-to-progress-global-issues-and-nam 2019-06-11T08:00:01+10:00 http://biotechdispatch.com.au/news/proteomics-promarkerd-to-feature-at-major-us-conference 2019-06-11T08:00:01+10:00 http://biotechdispatch.com.au/news/government-invites-new-applications-for-global-connections-fund 2019-06-11T08:00:01+10:00 http://biotechdispatch.com.au/news/new-four-year-pbac-term-for-ausbiotech-board-member 2019-06-11T08:00:01+10:00 http://biotechdispatch.com.au/news/bluebird-bio-secures-eu-approval-but-still-no-australia 2019-06-06T09:00:01+10:00 http://biotechdispatch.com.au/news/new-report-reveals-scale-of-us-industry 2019-06-06T09:00:01+10:00 http://biotechdispatch.com.au/news/invitation-for-australasian-biotechnology-journal-contributions 2019-06-06T09:00:01+10:00 http://biotechdispatch.com.au/news/microba-launches-new-ibd-rd-program 2019-06-06T09:00:01+10:00 http://biotechdispatch.com.au/news/immutep-updates-on-immunotherapy-trial 2019-06-06T09:00:01+10:00 http://biotechdispatch.com.au/news/new-industry-and-health-shadow-ministers 2019-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/uqs-uniquest-in-cancer-partnership-with-pfizer 2019-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/az-inks-new-deal-with-starpharma 2019-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/csl-seeking-applicants-for-125m-fellowships 2019-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/merger-of-two-leading-consultancies 2019-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/2019s-bio-delegation-most-impressive-to-date 2019-06-04T08:00:01+10:00 http://biotechdispatch.com.au/news/bionomics-updates-on-strategic-review 2019-05-30T09:00:01+10:00 http://biotechdispatch.com.au/news/antisense-therapeutics-confirms-phase-2-dmd-trial-fully-enrolled 2019-05-30T09:00:01+10:00 http://biotechdispatch.com.au/news/biomarin-updates-on-haemophilia-gene-therapy 2019-05-30T09:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-confirms-106m-capital-raise 2019-05-30T09:00:01+10:00 http://biotechdispatch.com.au/news/investors-cheer-patrys-in-response-to-trial-update 2019-05-30T09:00:01+10:00 http://biotechdispatch.com.au/news/survey-reveals-apprehension-on-rd-tax-incentive-decision 2019-05-30T09:00:01+10:00 http://biotechdispatch.com.au/news/heavy-hitters-of-medtech-deliver-vibrant-gathering 2019-05-28T10:00:01+10:00 http://biotechdispatch.com.au/news/kim-carr-will-not-nominate-for-shadow-ministry 2019-05-28T10:00:01+10:00 http://biotechdispatch.com.au/news/no-change-for-industry-and-health-portfolios 2019-05-28T10:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-updates-on-dep-irinotecan-human-colon-cancer-model 2019-05-28T10:00:01+10:00 http://biotechdispatch.com.au/news/new-distribution-agreement-for-medlab 2019-05-28T10:00:01+10:00 http://biotechdispatch.com.au/news/monash-secures-federal-funding-for-two-projects 2019-05-23T10:46:01+10:00 http://biotechdispatch.com.au/news/new-ceo-commences-at-auscann 2019-05-23T09:00:01+10:00 http://biotechdispatch.com.au/news/fostering-innovation-in-queensland-2 2019-05-23T09:00:01+10:00 http://biotechdispatch.com.au/news/rhythm-biosciences-secures-secures-key-certification 2019-05-23T09:00:01+10:00 http://biotechdispatch.com.au/news/longas-presents-on-ngs-technology 2019-05-23T09:00:01+10:00 http://biotechdispatch.com.au/news/new-leadership-for-botanix-pharmaceuticals 2019-05-21T12:00:01+10:00 http://biotechdispatch.com.au/news/industry-urges-coalition-to-reassess-cuts-to-rd-tax-incentive 2019-05-21T12:00:01+10:00 http://biotechdispatch.com.au/news/cardiex-updates-on-china-operations 2019-05-21T12:00:01+10:00 http://biotechdispatch.com.au/news/another-fda-approval-for-lbt-innovations-apas-independence 2019-05-21T12:00:01+10:00 http://biotechdispatch.com.au/news/heramed-appoints-leading-clinician-to-advisory-board 2019-05-21T12:00:01+10:00 http://biotechdispatch.com.au/news/csl-appoints-new-operations-leader 2019-05-16T09:27:01+10:00 http://biotechdispatch.com.au/news/race-oncology-launches-trial-in-israel 2019-05-16T09:00:01+10:00 http://biotechdispatch.com.au/news/opthea-completes-final-patient-visit-in-phase-2b-wet-amd-clinica 2019-05-16T09:00:01+10:00 http://biotechdispatch.com.au/news/celebrating-international-clinical-trials-day-2019 2019-05-16T09:00:01+10:00 http://biotechdispatch.com.au/news/longas-launches-and-confirms-new-ceo 2019-05-16T09:00:01+10:00 http://biotechdispatch.com.au/news/ausmedtech-programme-brings-together-over-550-industry-stakehold 2019-05-14T10:00:01+10:00 http://biotechdispatch.com.au/news/medtech-actuator-teams-up-with-jj-innovation 2019-05-14T10:00:01+10:00 http://biotechdispatch.com.au/news/fda-sticks-with-suffix-and-sets-a-high-bar-for-interchangeabilit 2019-05-14T10:00:01+10:00 http://biotechdispatch.com.au/news/bluebird-bio-australia-not-in-current-plan 2019-05-14T10:00:01+10:00 http://biotechdispatch.com.au/news/minister-officially-opens-ausmedtech-2019 2019-05-14T10:00:01+10:00 http://biotechdispatch.com.au/news/industry-key-to-boosting-health-and-medical-research 2019-05-09T12:42:01+10:00 http://biotechdispatch.com.au/news/orthocell-soars-on-trial-result 2019-05-09T09:00:01+10:00 http://biotechdispatch.com.au/news/positive-progress-for-pharmaxis-in-the-us 2019-05-09T09:00:01+10:00 http://biotechdispatch.com.au/news/one-ventures-appoints-us-expertise 2019-05-09T09:00:01+10:00 http://biotechdispatch.com.au/news/groups-unite-in-call-for-political-backing-for-rd 2019-05-09T09:00:01+10:00 http://biotechdispatch.com.au/news/bridgetech-symposium-up-skilling-our-medtech-workforce 2019-05-07T09:02:01+10:00 http://biotechdispatch.com.au/news/thecsiro-has-announced-a-new-5-million-partnership-with-genesisc 2019-05-07T09:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-updates-on-early-phase-dose-study 2019-05-07T09:00:01+10:00 http://biotechdispatch.com.au/news/lundbeck-acquires-us-basedabide-therapeutics 2019-05-07T09:00:01+10:00 http://biotechdispatch.com.au/news/xanadu-trials-disappoints-for-actinogen-medical 2019-05-07T09:00:01+10:00 http://biotechdispatch.com.au/news/new-australian-life-sciences-investment-fund 2019-05-02T08:00:01+10:00 http://biotechdispatch.com.au/news/medtech-featured-in-aprils-australasian-biotechnology-journal 2019-05-02T08:00:01+10:00 http://biotechdispatch.com.au/news/polynovo-gains-access-to-us-government-contracts 2019-05-02T08:00:01+10:00 http://biotechdispatch.com.au/news/new-report-highlights-the-changing-face-of-drug-development 2019-05-02T08:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-submits-application-to-tga 2019-05-02T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-fostering-international-biotech-connections 2019-04-30T10:48:01+10:00 http://biotechdispatch.com.au/news/new-technique-could-help-analysis-of-human-microbiome 2019-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/new-directors-for-regeneus 2019-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/mrff-grant-for-new-lung-initiative 2019-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/nominations-open-for-annual-gsk-research-award-1 2019-04-30T10:00:01+10:00 http://biotechdispatch.com.au/news/new-appointments-to-guide-ellume-growth 2019-04-23T10:00:01+10:00 http://biotechdispatch.com.au/news/health-commitments-keep-coming 2019-04-23T10:00:01+10:00 http://biotechdispatch.com.au/news/positive-trial-results-for-resapp-health 2019-04-23T10:00:01+10:00 http://biotechdispatch.com.au/news/suda-updates-on-regulatory-process 2019-04-23T10:00:01+10:00 http://biotechdispatch.com.au/news/gender-equality-on-track-for-ausmedtech-2019 2019-04-23T10:00:01+10:00 http://biotechdispatch.com.au/news/medlab-clinical-in-new-collaboration-with-chronic-pain-australia 2019-04-18T09:00:01+10:00 http://biotechdispatch.com.au/news/federal-government-repeal-of-the-ip-exemption-for-restrictive-tr 2019-04-18T08:00:01+10:00 http://biotechdispatch.com.au/news/labor-commits-to-early-access-trials 2019-04-18T08:00:01+10:00 http://biotechdispatch.com.au/news/immuron-appoints-ceo-to-board 2019-04-18T08:00:01+10:00 http://biotechdispatch.com.au/news/medibio-teams-up-with-humanitas-university 2019-04-18T08:00:01+10:00 http://biotechdispatch.com.au/news/wait-and-see-rdti-decision-still-on-hold 2019-04-16T08:00:01+10:00 http://biotechdispatch.com.au/news/funding-and-local-manufacturing-for-novartis-car-t-therapy 2019-04-16T08:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-launches-new-implant 2019-04-16T08:00:01+10:00 http://biotechdispatch.com.au/news/mxc-receives-cannepil-import-permit-for-the-uk 2019-04-16T08:00:01+10:00 http://biotechdispatch.com.au/news/resapp-submits-application-to-fda-for-new-mobile-software-applic 2019-04-16T08:00:01+10:00 http://biotechdispatch.com.au/news/recognition-for-ex-ausbiotech-ceo 2019-04-11T08:00:01+10:00 http://biotechdispatch.com.au/news/australias-rd-program-works-but-we-cant-rest-on-our-laurels 2019-04-11T08:00:01+10:00 http://biotechdispatch.com.au/news/new-director-for-factor-therapeutics 2019-04-11T08:00:01+10:00 http://biotechdispatch.com.au/news/facilitating-funding-and-collaboration-for-spin-outsstart-ups 2019-04-11T08:00:01+10:00 http://biotechdispatch.com.au/news/the-new-prana-starts-investor-roadshow 2019-04-11T05:00:01+10:00 http://biotechdispatch.com.au/news/applications-open-for-seqirus-immunisation-grants 2019-04-09T08:00:01+10:00 http://biotechdispatch.com.au/news/labor-extends-cancer-commitment-to-clinical-trials 2019-04-09T08:00:01+10:00 http://biotechdispatch.com.au/news/csiro-discussion-paper-promotes-conversation-on-the-ethics-of-ai 2019-04-09T08:00:01+10:00 http://biotechdispatch.com.au/news/antisense-updates-on-atl1102-study-enrolment 2019-04-09T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-comments-on-medical-device-consultations 2019-04-09T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-budget-delivers-no-surprises 2019-04-04T09:00:01+11:00 http://biotechdispatch.com.au/news/aamri-welcomes-long-term-commitment-to-medical-research 2019-04-04T08:00:01+11:00 http://biotechdispatch.com.au/news/new-european-patent-for-cynatas-stem-cell-technology 2019-04-04T08:00:01+11:00 http://biotechdispatch.com.au/news/actinogen-appoints-new-director 2019-04-04T08:00:01+11:00 http://biotechdispatch.com.au/news/suda-provides-zolpimist-regulatory-update 2019-04-04T08:00:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-commences-mrsa-study 2019-04-02T09:40:01+11:00 http://biotechdispatch.com.au/news/clinical-trials-consultations-progressing 2019-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/ustr-restates-criticism-of-australia-and-nz 2019-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/kazia-therapeutics-presents-cantrixil-data 2019-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/imugene-presents-positive-new-data-on-her-vaxx-cancer-vaccine 2019-04-02T09:00:01+11:00 http://biotechdispatch.com.au/news/kazia-to-present-on-cantrixil-trial 2019-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/race-submits-bisantrene-to-us-fda 2019-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/industry-unites-for-team-australia 2019-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-updates-on-phase-1-monepantel-study 2019-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/flinders-university-to-lead-campaign-to-reduce-liver-disease-dea 2019-03-28T10:00:01+11:00 http://biotechdispatch.com.au/news/nominations-open-for-research-awards 2019-03-26T10:00:01+11:00 http://biotechdispatch.com.au/news/government-announces-new-investment-in-gene-therapy 2019-03-26T10:00:01+11:00 http://biotechdispatch.com.au/news/review-of-national-innovation-metrics 2019-03-26T10:00:01+11:00 http://biotechdispatch.com.au/news/new-australian-collaboration-for-johnson-johnson 2019-03-26T10:00:01+11:00 http://biotechdispatch.com.au/news/biogen-and-eisai-scrap-development-of-alzheimers-therapy 2019-03-26T10:00:01+11:00 http://biotechdispatch.com.au/news/extending-the-promise-of-immunotherapy 2019-03-21T08:00:01+11:00 http://biotechdispatch.com.au/news/gsk-announces-australian-winners-of-research-challenge 2019-03-21T08:00:01+11:00 http://biotechdispatch.com.au/news/international-mou-for-microba 2019-03-21T08:00:01+11:00 http://biotechdispatch.com.au/news/us-company-calls-melbourne-home 2019-03-21T08:00:01+11:00 http://biotechdispatch.com.au/news/changes-mooted-for-accessories-for-active-implantable-medical-de 2019-03-21T08:00:01+11:00 http://biotechdispatch.com.au/news/btf-backs-creation-of-new-perth-based-biotech 2019-03-19T09:00:01+11:00 http://biotechdispatch.com.au/news/csl-renews-stem-partnership-with-national-youth-science-forum 2019-03-19T09:00:01+11:00 http://biotechdispatch.com.au/news/help-shape-the-ausbiotech-2019-programme 2019-03-19T09:00:01+11:00 http://biotechdispatch.com.au/news/2019-bridgetech-program-officially-underway 2019-03-19T09:00:01+11:00 http://biotechdispatch.com.au/news/tga-no-impact-on-medicine-supply-with-no-deal-brexit 2019-03-19T09:00:01+11:00 http://biotechdispatch.com.au/news/government-backs-new-10-year-stem-cell-mission 2019-03-14T09:00:01+11:00 http://biotechdispatch.com.au/news/women-in-life-sciences-empowering-actions 2019-03-14T09:00:01+11:00 http://biotechdispatch.com.au/news/company-moves-us-operation-to-la-trobe 2019-03-14T09:00:01+11:00 http://biotechdispatch.com.au/news/antisense-placement-to-support-further-development-of-atl1102 2019-03-14T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-updates-on-phase-1-monepantel-trial 2019-03-14T09:00:01+11:00 http://biotechdispatch.com.au/news/australias-medical-technology-sector-assemble-for-ausmedtech-201 2019-03-12T10:37:01+11:00 http://biotechdispatch.com.au/news/research-reveals-potential-for-early-alzheimers-test 2019-03-12T10:00:01+11:00 http://biotechdispatch.com.au/news/our-current-concept-of-aging-is-wrong 2019-03-12T10:00:01+11:00 http://biotechdispatch.com.au/news/us-agreement-for-zelda-therapeutics 2019-03-12T10:00:01+11:00 http://biotechdispatch.com.au/news/european-approval-for-key-admedus-products 2019-03-12T10:00:01+11:00 http://biotechdispatch.com.au/news/life-biosciences-moves-to-take-stake-in-prana 2019-03-07T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-on-the-move-this-week 2019-03-07T10:00:01+11:00 http://biotechdispatch.com.au/news/uk-launches-national-genome-health-strategy 2019-03-07T10:00:01+11:00 http://biotechdispatch.com.au/news/immutep-updates-on-efti-keytruda-combination 2019-03-07T10:00:01+11:00 http://biotechdispatch.com.au/news/zelda-confirms-new-australian-patent 2019-03-07T10:00:01+11:00 http://biotechdispatch.com.au/news/catheter-ablation-added-to-prostheses-list 2019-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/adalta-announces-new-uk-collaboration 2019-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/imugene-announces-presentation-on-key-vaxx-and-b-vaxx-cancer-vac 2019-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/medlab-signs-new-deal-with-canadian-company 2019-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/asian-investment-series-abundant-with-activities 2019-03-05T10:00:01+11:00 http://biotechdispatch.com.au/news/new-testing-means-patients-no-longer-defined-by-their-symptoms 2019-02-28T10:00:01+11:00 http://biotechdispatch.com.au/news/clinical-trials-collaborative-forum-third-meeting 2019-02-28T10:00:01+11:00 http://biotechdispatch.com.au/news/cancer-drug-discovery-expert-joins-qeddi-advisory-committee 2019-02-28T10:00:01+11:00 http://biotechdispatch.com.au/news/ide-opens-entries-for-2019-challenge 2019-02-28T10:00:01+11:00 http://biotechdispatch.com.au/news/imugene-announces-her-vaxx-cancer-vaccine-presentation 2019-02-28T10:00:01+11:00 http://biotechdispatch.com.au/news/trial-results-give-hope-on-peanut-allergy 2019-02-26T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-doses-first-patient-in-lox-inhibitor-trial 2019-02-26T09:00:01+11:00 http://biotechdispatch.com.au/news/imagion-biosystems-updates-on-development-milestone 2019-02-26T09:00:01+11:00 http://biotechdispatch.com.au/news/government-announces-new-10-year-mission-for-cardiovascular-heal 2019-02-26T09:00:01+11:00 http://biotechdispatch.com.au/news/keynote-speakers-announced-kate-carnell-and-karen-bevan 2019-02-26T09:00:01+11:00 http://biotechdispatch.com.au/news/rhythm-announces-first-study-site-for-trial-of-new-colorectal-ca 2019-02-21T09:00:01+11:00 http://biotechdispatch.com.au/news/melbourne-based-company-updates-on-pain-trial 2019-02-21T09:00:01+11:00 http://biotechdispatch.com.au/news/boosting-australia-at-biokorea-2019 2019-02-21T09:00:01+11:00 http://biotechdispatch.com.au/news/first-equity-raise-for-hearing-solutions-company-hemideina 2019-02-20T09:00:01+11:00 http://biotechdispatch.com.au/news/fate-of-rd-tax-reform-a-matter-for-election-winner 2019-02-20T09:00:01+11:00 http://biotechdispatch.com.au/news/bionomics-updates-on-additional-data-analysis-of-bnc210-for-ptsd 2019-02-19T09:00:01+11:00 http://biotechdispatch.com.au/news/partnership-to-manage-biomedical-translation-bridge-program 2019-02-19T09:00:01+11:00 http://biotechdispatch.com.au/news/accessing-global-talent-in-australia 2019-02-19T09:00:01+11:00 http://biotechdispatch.com.au/news/new-products-drive-cochlear-growth 2019-02-19T09:00:01+11:00 http://biotechdispatch.com.au/news/creso-confirms-new-canadian-license-for-subsidiary 2019-02-19T09:00:01+11:00 http://biotechdispatch.com.au/news/strong-result-for-csl 2019-02-14T08:00:01+11:00 http://biotechdispatch.com.au/news/nominations-open-for-2019-victorian-manufacturing-hall-of-fame-a 2019-02-14T08:00:01+11:00 http://biotechdispatch.com.au/news/minomic-announces-new-us-agreement-for-micheck 2019-02-14T08:00:01+11:00 http://biotechdispatch.com.au/news/orthocell-releases-results-from-2018-annual-quality-study 2019-02-14T08:00:01+11:00 http://biotechdispatch.com.au/news/new-board-appointment-for-botanix-pharmaceuticals 2019-02-14T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotechs-2019-survey-of-biotech-leaders-closing-soon 2019-02-14T08:00:01+11:00 http://biotechdispatch.com.au/news/government-should-delay-and-reconsider-rd-tax-cut 2019-02-12T10:00:01+11:00 http://biotechdispatch.com.au/news/iawards-recognising-innovation-in-australias-digital-ecosystem 2019-02-12T10:00:01+11:00 http://biotechdispatch.com.au/news/new-32-million-program-to-support-australian-researchers 2019-02-12T10:00:01+11:00 http://biotechdispatch.com.au/news/nucleus-network-welcomes-acquisition-of-q-pharm 2019-02-12T10:00:01+11:00 http://biotechdispatch.com.au/news/australia-and-nz-hold-positions-in-global-ip-index 2019-02-12T10:00:01+11:00 http://biotechdispatch.com.au/news/new-funding-for-perth-based-phenome-centre 2019-02-07T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-medicines-australia-empowering-women-in-life-scie 2019-02-07T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-executes-clinical-trial-agreement 2019-02-07T09:00:01+11:00 http://biotechdispatch.com.au/news/new-study-reveals-mass-failings-on-transplant-research 2019-02-07T09:00:01+11:00 http://biotechdispatch.com.au/news/government-opens-nominations-for-pms-science-prizes 2019-02-07T09:00:01+11:00 http://biotechdispatch.com.au/news/nanosonics-announces-new-senior-appointments 2019-02-05T10:50:01+11:00 http://biotechdispatch.com.au/news/sienna-announces-distribution-partner-for-singapore 2019-02-05T10:00:01+11:00 http://biotechdispatch.com.au/news/qimr-berghofer-sells-clinical-trials-company 2019-02-05T10:00:01+11:00 http://biotechdispatch.com.au/news/regenerative-medicine-industry-showed-burst-of-growth-1 2019-02-05T10:00:01+11:00 http://biotechdispatch.com.au/news/officials-confirm-relief-on-orphan-designation 2019-02-05T10:00:01+11:00 http://biotechdispatch.com.au/news/us-company-launches-australian-clinical-trial 2019-01-31T09:00:01+11:00 http://biotechdispatch.com.au/news/nsw-medical-devices-fund-closing-soon 2019-01-31T09:00:01+11:00 http://biotechdispatch.com.au/news/prana-secures-us-orphan-designation-for-pbt434 2019-01-31T09:00:01+11:00 http://biotechdispatch.com.au/news/medlab-secures-new-pharmacy-distribution-agreement 2019-01-31T09:00:01+11:00 http://biotechdispatch.com.au/news/government-invests-30m-in-new-parkinsons-research 2019-01-31T09:00:01+11:00 http://biotechdispatch.com.au/news/new-leaders-welcomed-to-ausmedtech-national-advisory-group 2019-01-29T10:00:01+11:00 http://biotechdispatch.com.au/news/government-welcomes-more-collaborations 2019-01-29T10:00:01+11:00 http://biotechdispatch.com.au/news/auscann-acquires-rd-facility 2019-01-29T10:00:01+11:00 http://biotechdispatch.com.au/news/opthea-confirms-japanese-patent-for-opt-302 2019-01-29T10:00:01+11:00 http://biotechdispatch.com.au/news/government-reappoints-chair-of-key-advisory-committee 2019-01-29T10:00:01+11:00 http://biotechdispatch.com.au/news/in-2019-the-smart-country-that-is-australia-owes-nothing-to-luck 2019-01-24T09:00:01+11:00 http://biotechdispatch.com.au/news/industry-executive-to-lead-regeneus 2019-01-24T09:00:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-updates-on-atl1102-trial 2019-01-24T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-partners-with-csiro-to-connect-the-sector 2019-01-24T09:00:01+11:00 http://biotechdispatch.com.au/news/australia-hosts-meeting-of-global-leadership-team 2019-01-24T09:00:01+11:00 http://biotechdispatch.com.au/news/registrations-open-for-2019bridgetech-program 2019-01-22T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-seeks-biotech-leaders-views-to-help-shape-2019-advoca 2019-01-22T09:00:01+11:00 http://biotechdispatch.com.au/news/sme-qualification-from-ema-for-medlabs-nanabis 2019-01-22T09:00:01+11:00 http://biotechdispatch.com.au/news/new-canada-supply-agreement-for-creso 2019-01-22T09:00:01+11:00 http://biotechdispatch.com.au/news/sienna-signs-new-distribution-agreement-for-korea 2019-01-22T09:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-support-for-industry-back-digital-health-accelerator 2019-01-17T09:00:01+11:00 http://biotechdispatch.com.au/news/opportunity-to-present-and-partner-in-china 2019-01-17T09:00:01+11:00 http://biotechdispatch.com.au/news/anteo-updates-on-partnership-with-ellume 2019-01-17T09:00:01+11:00 http://biotechdispatch.com.au/news/unsw-tops-latest-crc-p-funding-round 2019-01-17T09:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-updates-on-loxl2-studies 2019-01-17T09:00:01+11:00 http://biotechdispatch.com.au/news/monepantels-principal-metabolite-shows-anti-cancer-activity 2019-01-15T12:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-presents-australia-at-biotech-showcase-2019 2019-01-15T12:00:01+11:00 http://biotechdispatch.com.au/news/walter-and-eliza-hall-institute-launch-key-global-study 2019-01-15T12:00:01+11:00 http://biotechdispatch.com.au/news/government-commits-25m-for-new-drug-discovery-centre 2019-01-15T12:00:01+11:00 http://biotechdispatch.com.au/news/new-collaboration-for-immutep 2019-01-15T12:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnects-dr-dan-grant-a-new-future-for-medical-research-fundi 2018-12-20T08:00:01+11:00 http://biotechdispatch.com.au/news/tga-approves-first-car-t-therapy 2018-12-20T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-in-2018-a-year-in-review 2018-12-20T08:00:01+11:00 http://biotechdispatch.com.au/news/federal-government-announces-new-ageing-research-package 2018-12-20T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-immutep-secures-new-financing-from-us-based-investors-ne 2018-12-20T08:00:01+11:00 http://biotechdispatch.com.au/news/starpharma-licenses-us-rights-to-vivagel-bv 2018-12-20T08:00:01+11:00 http://biotechdispatch.com.au/news/new-members-of-national-science-and-technology-council 2018-12-18T06:00:01+11:00 http://biotechdispatch.com.au/news/researchers-slam-cuts-to-block-grants-program 2018-12-18T06:00:01+11:00 http://biotechdispatch.com.au/news/applicants-open-for-2019-bridge-program 2018-12-18T06:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-comments-on-regulation-of-ivd-companion-diagnostics 2018-12-18T06:00:01+11:00 http://biotechdispatch.com.au/news/labor-to-preserve-rd-tax-incentive 2018-12-18T06:00:01+11:00 http://biotechdispatch.com.au/news/organisations-unite-to-research-ethical-ai 2018-12-18T05:00:01+11:00 http://biotechdispatch.com.au/news/adherium-announces-reorganisation 2018-12-13T10:35:01+11:00 http://biotechdispatch.com.au/news/digital-partnership-for-gsk-consumer-health 2018-12-13T10:00:01+11:00 http://biotechdispatch.com.au/news/new-report-highlights-opportunities-for-digital-health-growth-in 2018-12-13T10:00:01+11:00 http://biotechdispatch.com.au/news/bayer-backing-new-kidney-disease-trial 2018-12-13T10:00:01+11:00 http://biotechdispatch.com.au/news/cellmid-updated-on-japenese-sales 2018-12-13T10:00:01+11:00 http://biotechdispatch.com.au/news/bupa-foundation-recognises-immune-system-researcher 2018-12-11T09:00:01+11:00 http://biotechdispatch.com.au/news/melbourne-company-joins-the-antimicrobial-challenge 2018-12-11T09:00:01+11:00 http://biotechdispatch.com.au/news/development-agreement-for-zelda-and-suda 2018-12-11T09:00:01+11:00 http://biotechdispatch.com.au/news/backing-for-queensland-cardiac-rehabilitation-app 2018-12-11T09:00:01+11:00 http://biotechdispatch.com.au/news/clinical-trials-governance-framework-workshops-announced 2018-12-11T09:00:01+11:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-expands-phase-1-metastatic-breast-cancer-tr 2018-12-06T09:00:01+11:00 http://biotechdispatch.com.au/news/new-blood-test-could-lead-to-earlier-cancer-diagnosis 2018-12-06T09:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-congratulates-mtpconnect-on-new-funding 2018-12-06T09:00:01+11:00 http://biotechdispatch.com.au/news/avita-medical-secures-40m-in-new-placement 2018-12-06T09:00:01+11:00 http://biotechdispatch.com.au/news/perth-company-takes-out-australian-start-up-competition 2018-12-06T09:00:01+11:00 http://biotechdispatch.com.au/news/labor-to-launch-root-and-branch-review-of-research 2018-12-04T10:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-updates-on-monepantel-development 2018-12-04T10:00:01+11:00 http://biotechdispatch.com.au/news/creso-pharma-to-list-in-canada 2018-12-04T10:00:01+11:00 http://biotechdispatch.com.au/news/medlab-expands-into-europe 2018-12-04T10:00:01+11:00 http://biotechdispatch.com.au/news/senate-inquiry-report-delay-welcomed 2018-12-03T10:00:01+11:00 http://biotechdispatch.com.au/news/opthea-raises-133m-through-exercise-of-options3 2018-11-29T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-confirms-new-director 2018-11-29T10:00:01+11:00 http://biotechdispatch.com.au/news/new-leadership-for-rhythm-biosciences 2018-11-29T10:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-announces-positive-data-from-cep-1-study-of-veyonda 2018-11-29T10:00:01+11:00 http://biotechdispatch.com.au/news/immutep-confirms-new-european-patents-for-efti 2018-11-29T10:00:01+11:00 http://biotechdispatch.com.au/news/mixed-result-for-australia-in-new-innovation-report 2018-11-27T10:00:01+11:00 http://biotechdispatch.com.au/news/medical-devices-industry-subject-of-media-scrutiny 2018-11-27T10:00:01+11:00 http://biotechdispatch.com.au/news/zelda-partners-with-st-vincents-hospital-on-opioid-reduction-stu 2018-11-27T10:00:01+11:00 http://biotechdispatch.com.au/news/admedus-appoints-interim-cfo 2018-11-27T10:00:01+11:00 http://biotechdispatch.com.au/news/final-patient-enrolled-in-actinogens-xanadu-trial 2018-11-27T10:00:01+11:00 http://biotechdispatch.com.au/news/queensland-cell-therapy-advances-in-ms-trial 2018-11-22T09:00:01+11:00 http://biotechdispatch.com.au/news/the-consequences-of-rd-tax-change-not-unintended 2018-11-22T09:00:01+11:00 http://biotechdispatch.com.au/news/ausmedtech-calls-for-session-proposals 2018-11-22T09:00:01+11:00 http://biotechdispatch.com.au/news/ivd-australia-becomes-pathology-technology-australia 2018-11-22T09:00:01+11:00 http://biotechdispatch.com.au/news/the-wild-program-launches-with-first-intake-of-20-participants 2018-11-22T09:00:01+11:00 http://biotechdispatch.com.au/news/rd-tax-change-driven-by-budget-bottom-line-and-judgement 2018-11-20T10:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-reports-new-positive-results-for-loxl2-program 2018-11-20T10:00:01+11:00 http://biotechdispatch.com.au/news/cochlear-appoints-experienced-industry-executive-to-its-board 2018-11-20T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-presents-to-senate-inquiry 2018-11-20T10:00:01+11:00 http://biotechdispatch.com.au/news/jj-innovation-seeking-applicants-to-quick-pitch 2018-11-20T10:00:01+11:00 http://biotechdispatch.com.au/news/government-extends-my-health-record-opt-out-period 2018-11-15T12:00:01+11:00 http://biotechdispatch.com.au/news/new-ceo-for-anatara-lifesciences 2018-11-15T12:00:01+11:00 http://biotechdispatch.com.au/news/ip-australia-responds-to-views-on-exposure-draft 2018-11-15T12:00:01+11:00 http://biotechdispatch.com.au/news/single-session-radiation-therapy-moves-one-step-closer 2018-11-15T12:00:01+11:00 http://biotechdispatch.com.au/news/flinders-foundation-announces-funding-for-35-research-projects 2018-11-15T12:00:01+11:00 http://biotechdispatch.com.au/news/major-changes-for-bionomics 2018-11-13T10:00:01+11:00 http://biotechdispatch.com.au/news/new-resources-to-amplify-gains-in-regenerative-medicine 2018-11-13T10:00:01+11:00 http://biotechdispatch.com.au/news/cochlear-invests-21m-in-belgium-based-nyxoah 2018-11-13T10:00:01+11:00 http://biotechdispatch.com.au/news/melanoma-researchers-win-gsk-award-for-research-excellence-1 2018-11-13T10:00:01+11:00 http://biotechdispatch.com.au/news/imugene-advances-her-vaxx-cancer-vaccine 2018-11-13T10:00:01+11:00 http://biotechdispatch.com.au/news/industry-experts-guide-researchers-and-entrepreneurs 2018-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/research-australia-calls-on-senate-to-scrap-rd-tax-changes 2018-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-urges-senate-inquiry-not-to-pass-legislation 2018-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/cellmid-announces-new-us-patent-1 2018-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/invion-announces-new-partnerships 2018-11-08T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-signed-new-alliance-with-mtpconnect 2018-11-06T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-highlights-success-of-national-conference 2018-11-06T10:00:01+11:00 http://biotechdispatch.com.au/news/cochlear-to-appeal-patent-judgement 2018-11-06T10:00:01+11:00 http://biotechdispatch.com.au/news/first-bridgetech-symposium-to-be-held-in-sydney 2018-11-06T10:00:01+11:00 http://biotechdispatch.com.au/news/new-report-highlights-regenerative-medicine-opportunity 2018-11-01T10:00:01+11:00 http://biotechdispatch.com.au/news/recognition-for-dr-anna-lavelle 2018-11-01T10:00:01+11:00 http://biotechdispatch.com.au/news/takeda-announces-cockpi-t-australia-2018-research-grants 2018-11-01T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-confirms-board-line-up-at-agm-1 2018-11-01T10:00:01+11:00 http://biotechdispatch.com.au/news/joint-emerging-company-of-the-year-telix-pharmaceuticals-and-mic 2018-11-01T10:00:01+11:00 http://biotechdispatch.com.au/news/biggest-week-of-the-year-for-biotech 2018-10-30T10:00:01+11:00 http://biotechdispatch.com.au/news/melbourne-based-ctx-signs-new-collaboration-with-pfizer 2018-10-30T10:00:01+11:00 http://biotechdispatch.com.au/news/medlab-initiates-next-stage-of-nanabis-trial 2018-10-30T10:00:01+11:00 http://biotechdispatch.com.au/news/opthea-reports-three-month-data-from-opt-302-trial 2018-10-30T10:00:01+11:00 http://biotechdispatch.com.au/news/industry-seeking-nominations-for-pbac-appointment 2018-10-30T10:00:01+11:00 http://biotechdispatch.com.au/news/nsw-launches-strategy-to-boost-medical-technology-industry 2018-10-25T11:00:01+11:00 http://biotechdispatch.com.au/news/anatara-creates-new-advisory-board 2018-10-25T11:00:01+11:00 http://biotechdispatch.com.au/news/opthea-to-update-on-opt-302-trial 2018-10-25T11:00:01+11:00 http://biotechdispatch.com.au/news/city-of-brisbane-recognises-cook-medical 2018-10-25T10:58:01+11:00 http://biotechdispatch.com.au/news/avita-medical-announces-new-recell-trial 2018-10-25T10:00:01+11:00 http://biotechdispatch.com.au/news/parliament-backs-tpp-legislation 2018-10-23T08:00:01+11:00 http://biotechdispatch.com.au/news/senate-inquiry-for-rd-tax-incentive-bill-1 2018-10-23T08:00:01+11:00 http://biotechdispatch.com.au/news/medtronic-founder-passes-away 2018-10-23T08:00:01+11:00 http://biotechdispatch.com.au/news/new-collaboration-for-kazia-therapeutics 2018-10-23T08:00:01+11:00 http://biotechdispatch.com.au/news/recruitment-to-close-for-actinogen-alzheimers-trial 2018-10-23T08:00:01+11:00 http://biotechdispatch.com.au/news/ms-kalin-stated 2018-10-18T02:00:01+11:00 http://biotechdispatch.com.au/news/new-collaboration-on-medicinal-cannabis-trials 2018-10-18T02:00:01+11:00 http://biotechdispatch.com.au/news/novotech-acquires-australian-cro 2018-10-18T02:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-works-to-increase-diversity-and-inclusion 2018-10-18T02:00:01+11:00 http://biotechdispatch.com.au/news/no-share-split-for-csl 2018-10-18T02:00:01+11:00 http://biotechdispatch.com.au/news/australian-scientists-contribute-to-uk-biobank-project 2018-10-16T11:00:01+11:00 http://biotechdispatch.com.au/news/queensland-export-award-for-cook-medical 2018-10-16T11:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-funds-three-more-projects 2018-10-16T11:00:01+11:00 http://biotechdispatch.com.au/news/new-findings-show-amplified-value-of-a-medical-research-dollar 2018-10-16T11:00:01+11:00 http://biotechdispatch.com.au/news/labor-moves-to-block-trade-related-pbs-changes-1 2018-10-16T11:00:01+11:00 http://biotechdispatch.com.au/news/new-study-of-implantable-cochlear-implant-technology 2018-10-11T08:00:01+11:00 http://biotechdispatch.com.au/news/abbvie-hosts-cancer-moonshot-seminar 2018-10-11T08:00:01+11:00 http://biotechdispatch.com.au/news/academy-of-science-hosts-women-stem-roundtable 2018-10-11T08:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-launches-2018-21-strategic-plan 2018-10-11T08:00:01+11:00 http://biotechdispatch.com.au/news/genesiscare-and-telix-enter-strategic-collaboration-agreement 2018-10-10T08:00:01+11:00 http://biotechdispatch.com.au/news/investors-cheer-new-green-whistle-deal 2018-10-09T08:00:01+11:00 http://biotechdispatch.com.au/news/annual-report-shows-a-year-of-evolution-delivery-and-achievement 2018-10-09T08:00:01+11:00 http://biotechdispatch.com.au/news/biotech-one-of-six-potential-new-crcs 2018-10-09T08:00:01+11:00 http://biotechdispatch.com.au/news/visioneering-technologies-appoints-first-european-distributor 2018-10-09T08:00:01+11:00 http://biotechdispatch.com.au/news/synchrotron-research-to-aid-cancer-detection 2018-10-09T07:00:01+11:00 http://biotechdispatch.com.au/news/new-chair-starts-for-mtpconnect 2018-10-04T10:00:01+10:00 http://biotechdispatch.com.au/news/national-and-global-industry-leaders-to-convene-as-ausbiotech-20 2018-10-04T10:00:01+10:00 http://biotechdispatch.com.au/news/minomic-completes-demerger-of-glytherix 2018-10-04T10:00:01+10:00 http://biotechdispatch.com.au/news/peter-mac-deploys-varian-solution 2018-10-04T10:00:01+10:00 http://biotechdispatch.com.au/news/auscann-releases-cannabinoid-medical-education-resources 2018-10-04T10:00:01+10:00 http://biotechdispatch.com.au/news/canada-backs-pharma-ip-extension 2018-10-02T08:00:01+10:00 http://biotechdispatch.com.au/news/south-australias-gm-moratorium-under-review-2 2018-10-02T08:00:01+10:00 http://biotechdispatch.com.au/news/biotron-reports-positive-results-from-phase-2-bit225-trial 2018-10-02T08:00:01+10:00 http://biotechdispatch.com.au/news/disappointment-for-bionomics-in-ptsd-trial 2018-10-02T08:00:01+10:00 http://biotechdispatch.com.au/news/que-oncology-progresses-q-122-to-phase-2 2018-10-02T08:00:01+10:00 http://biotechdispatch.com.au/news/looming-victorian-election-prompts-joint-statement-on-health 2018-09-27T10:00:01+10:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-zelda-insomnia-trial 2018-09-27T10:00:01+10:00 http://biotechdispatch.com.au/news/recell-study-results-presented-in-the-us 2018-09-27T10:00:01+10:00 http://biotechdispatch.com.au/news/invion-spin-off-cat-selects-chinese-research-partner 2018-09-27T10:00:01+10:00 http://biotechdispatch.com.au/news/dementia-on-the-rise-as-a-leading-cause-of-death-of-all-australi 2018-09-27T09:56:01+10:00 http://biotechdispatch.com.au/news/rd-tax-incentive-bill-enters-the-parliament 2018-09-25T06:00:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-new-collaboration-with-merck-and-pfizer 2018-09-25T06:00:01+10:00 http://biotechdispatch.com.au/news/noxopharm-announces-irak4-advance 2018-09-25T06:00:01+10:00 http://biotechdispatch.com.au/news/unsw-sydney-to-invest-200m-in-new-institutes 2018-09-25T06:00:01+10:00 http://biotechdispatch.com.au/news/invion-updates-on-new-formulation-of-therapy 2018-09-25T06:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-invites-members-to-annual-general-meeting 2018-09-20T08:00:01+10:00 http://biotechdispatch.com.au/news/former-industry-leaders-join-china-incubator 2018-09-20T08:00:01+10:00 http://biotechdispatch.com.au/news/first-new-malaria-treatment-in-two-decades 2018-09-20T08:00:01+10:00 http://biotechdispatch.com.au/news/osprey-partners-with-ge-on-be-kind-to-kidneys-campaign 2018-09-20T08:00:01+10:00 http://biotechdispatch.com.au/news/government-launches-exports-hub-initiative 2018-09-20T08:00:01+10:00 http://biotechdispatch.com.au/news/opthea-initiates-first-australian-patients-in-dme-trial 2018-09-18T10:00:01+10:00 http://biotechdispatch.com.au/news/last-call-for-industry-excellence-awards-nominations 2018-09-18T10:00:01+10:00 http://biotechdispatch.com.au/news/applications-open-for-second-round-of-the-global-innovation-link 2018-09-18T10:00:01+10:00 http://biotechdispatch.com.au/news/csl-behring-welcomes-new-approval 2018-09-18T10:00:01+10:00 http://biotechdispatch.com.au/news/race-signs-agreement-to-facilitate-regulatory-filing 2018-09-18T10:00:01+10:00 http://biotechdispatch.com.au/news/sydney-based-cellmid-announces-positive-trial-result 2018-09-13T10:00:01+10:00 http://biotechdispatch.com.au/news/nine-companies-so-far-benefited-from-csiro-innovation-fund 2018-09-13T10:00:01+10:00 http://biotechdispatch.com.au/news/australia-speaks-on-embracing-health-and-medical-research 2018-09-13T10:00:01+10:00 http://biotechdispatch.com.au/news/burnet-launches-new-quick-development-of-solutions-lab3 2018-09-13T10:00:01+10:00 http://biotechdispatch.com.au/news/unity-on-potential-change-to-orphan-drug-limit 2018-09-13T10:00:01+10:00 http://biotechdispatch.com.au/news/new-collaboration-for-melbournes-monash-1 2018-09-11T08:00:01+10:00 http://biotechdispatch.com.au/news/imagion-biosystems-updates-on-first-in-human-testing 2018-09-11T08:00:01+10:00 http://biotechdispatch.com.au/news/equity-crowd-funding-to-become-more-accessible 2018-09-11T08:00:01+10:00 http://biotechdispatch.com.au/news/osprey-medical-launches-european-commercial-activities 2018-09-11T08:00:01+10:00 http://biotechdispatch.com.au/news/medlab-secures-export-licence 2018-09-11T08:00:01+10:00 http://biotechdispatch.com.au/news/government-extends-term-of-chief-scientist 2018-09-06T08:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-comments-on-ip-and-mrff-consultations-1 2018-09-06T08:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-progresses-new-dep-candidate 2018-09-06T08:00:01+10:00 http://biotechdispatch.com.au/news/optheas-opt-302-trial-to-continue-after-positive-review 2018-09-06T08:00:01+10:00 http://biotechdispatch.com.au/news/factor-therapeutics-updates-on-vf00102-trial 2018-09-06T08:00:01+10:00 http://biotechdispatch.com.au/news/polyactiva-recruits-first-patient-in-new-study 2018-09-04T10:00:01+10:00 http://biotechdispatch.com.au/news/agtech-conference-attracts-record-attendance 2018-09-04T10:00:01+10:00 http://biotechdispatch.com.au/news/us-agree-or-canada-will-be-out 2018-09-04T10:00:01+10:00 http://biotechdispatch.com.au/news/new-ceo-for-dimerix 2018-09-04T09:50:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-ceo-lorraine-chiroiu-on-early-impressions-and-future- 2018-09-03T18:00:01+10:00 http://biotechdispatch.com.au/news/join-csiro-workshop-on-medical-device-cyber-security 2018-08-30T09:38:01+10:00 http://biotechdispatch.com.au/news/us-secures-major-data-protection-victory 2018-08-30T09:00:01+10:00 http://biotechdispatch.com.au/news/immutep-receives-french-rd-tax-credit 2018-08-30T09:00:01+10:00 http://biotechdispatch.com.au/news/medical-developments-international-updates-on-penthrox-in-the-us 2018-08-30T09:00:01+10:00 http://biotechdispatch.com.au/news/cellmid-announces-us-in-store-launch 2018-08-30T09:00:01+10:00 http://biotechdispatch.com.au/news/medlab-announces-new-safety-study 2018-08-28T12:00:01+10:00 http://biotechdispatch.com.au/news/patrys-teams-up-with-walter-and-eliza-hall-institute 2018-08-28T12:00:01+10:00 http://biotechdispatch.com.au/news/lbt-announces-finalisation-of-sa-loan-facility 2018-08-28T12:00:01+10:00 http://biotechdispatch.com.au/news/global-cardiovascular-challenge-offers-50-million-1 2018-08-28T12:00:01+10:00 http://biotechdispatch.com.au/news/new-pm-appoints-new-industry-minister 2018-08-28T12:00:01+10:00 http://biotechdispatch.com.au/news/innovation-and-health-minister-resign 2018-08-23T10:00:01+10:00 http://biotechdispatch.com.au/news/lbt-confirms-first-sale-of-apas-independence 2018-08-23T09:00:01+10:00 http://biotechdispatch.com.au/news/comment-sought-on-the-mrff-priorities 2018-08-23T09:00:01+10:00 http://biotechdispatch.com.au/news/new-immunotherapy-collaboration-between-uwa-and-msd 2018-08-23T09:00:01+10:00 http://biotechdispatch.com.au/news/new-cmo-for-imugene 2018-08-23T09:00:01+10:00 http://biotechdispatch.com.au/news/neuren-receives-initial-payment-from-acadia 2018-08-23T09:00:01+10:00 http://biotechdispatch.com.au/news/telix-files-study-for-kidney-cancer-imaging-in-europe 2018-08-23T09:00:01+10:00 http://biotechdispatch.com.au/news/cgp-shareholders-backs-participation-in-sirtex-acquisition 2018-08-21T10:00:01+10:00 http://biotechdispatch.com.au/news/jj-offering-750000-in-grants-for-solutions-to-lung-cancer 2018-08-21T10:00:01+10:00 http://biotechdispatch.com.au/news/auscann-announces-successful-pilot-study-of-final-dose-cannabino 2018-08-21T10:00:01+10:00 http://biotechdispatch.com.au/news/government-expands-stem-program-seeking-women-ambassadors 2018-08-21T10:00:01+10:00 http://biotechdispatch.com.au/news/medtronic-launches-new-pilot-study 2018-08-21T10:00:01+10:00 http://biotechdispatch.com.au/news/investors-cheer-csl-result-and-outlook 2018-08-16T10:00:01+10:00 http://biotechdispatch.com.au/news/report-released-on-review-of-food-using-new-breeding-techniques 2018-08-16T10:00:01+10:00 http://biotechdispatch.com.au/news/csiro-announces-new-chief-scientist 2018-08-16T10:00:01+10:00 http://biotechdispatch.com.au/news/fda-approval-for-pharmaxis-manufacturing-facility 2018-08-16T10:00:01+10:00 http://biotechdispatch.com.au/news/government-announces-200m-in-new-medical-research-grants 2018-08-16T10:00:01+10:00 http://biotechdispatch.com.au/news/acrux-first-to-file-first-generic-in-the-us 2018-08-14T10:00:01+10:00 http://biotechdispatch.com.au/news/abbvie-investsin-northern-qld-biotech 2018-08-14T10:00:01+10:00 http://biotechdispatch.com.au/news/new-governance-framework-for-clinical-trials-underway 2018-08-14T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-anna-lavelles-new-appointment 2018-08-14T10:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-reports-record-profit-and-500000th-implant-sale 2018-08-14T10:00:01+10:00 http://biotechdispatch.com.au/news/adherium-launches-hailie-in-the-us 2018-08-13T10:00:01+10:00 http://biotechdispatch.com.au/news/ex-roche-executive-to-lead-qimr-spin-out 2018-08-09T08:00:01+10:00 http://biotechdispatch.com.au/news/g-medical-to-spin-off-chinese-subsidiary 2018-08-09T08:00:01+10:00 http://biotechdispatch.com.au/news/recognition-for-actinogen-medical-advisor 2018-08-09T08:00:01+10:00 http://biotechdispatch.com.au/news/csiro-to-research-medical-device-software-and-cybersecurity 2018-08-09T08:00:01+10:00 http://biotechdispatch.com.au/news/biotron-updates-on-proof-of-concept-trial 2018-08-09T08:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-completes-successful-capital-raise 2018-08-07T08:00:01+10:00 http://biotechdispatch.com.au/news/driven-by-the-profound-unmet-needs-of-patients 2018-08-07T08:00:01+10:00 http://biotechdispatch.com.au/news/new-global-rankings-show-little-improvement 2018-08-07T08:00:01+10:00 http://biotechdispatch.com.au/news/queensland-announces-latest-queensland-ignite-ideas-grants 2018-08-07T08:00:01+10:00 http://biotechdispatch.com.au/news/cann-partners-with-idt-on-manufacturing 2018-08-07T08:00:01+10:00 http://biotechdispatch.com.au/news/adalta-backing-long-kayak-for-lungs 2018-08-02T09:00:01+10:00 http://biotechdispatch.com.au/news/search-for-new-antibiotics-from-australias-microbiome 2018-08-02T09:00:01+10:00 http://biotechdispatch.com.au/news/is-the-clinical-trials-definition-fit-for-purpose 2018-08-02T09:00:01+10:00 http://biotechdispatch.com.au/news/cellmid-completes-capital-raise-1 2018-08-02T09:00:01+10:00 http://biotechdispatch.com.au/news/sirtex-shareholders-to-vote-on-acquisition 2018-08-02T09:00:01+10:00 http://biotechdispatch.com.au/news/opthea-starts-phase-2-opt-302-trial 2018-07-31T06:00:01+10:00 http://biotechdispatch.com.au/news/cochlear-completes-final-phase-of-new-brisbane-site 2018-07-31T06:00:01+10:00 http://biotechdispatch.com.au/news/regeneus-reports-on-phase-1-cancer-vaccine-trial 2018-07-31T06:00:01+10:00 http://biotechdispatch.com.au/news/concern-as-eu-strays-on-gene-editing 2018-07-31T06:00:01+10:00 http://biotechdispatch.com.au/news/canadian-company-completes-shipment-to-medlab 2018-07-31T06:00:01+10:00 http://biotechdispatch.com.au/news/new-funding-for-ai-and-cancer-projects 2018-07-26T08:00:01+10:00 http://biotechdispatch.com.au/news/draft-rd-tax-reform-legislation-not-ready-to-pass-1 2018-07-26T08:00:01+10:00 http://biotechdispatch.com.au/news/fda-approval-for-melbourne-based-not-for-profit 2018-07-26T08:00:01+10:00 http://biotechdispatch.com.au/news/opthea-reports-on-opt-302-trial 2018-07-26T08:00:01+10:00 http://biotechdispatch.com.au/news/prescient-secures-new-us-patent-for-ptx-200 2018-07-26T08:00:01+10:00 http://biotechdispatch.com.au/news/new-agreement-with-jj-for-australian-company 2018-07-24T08:00:01+10:00 http://biotechdispatch.com.au/news/minomic-updates-on-miltuximab-trial 2018-07-24T08:00:01+10:00 http://biotechdispatch.com.au/news/ip-measures-open-for-comment 2018-07-24T08:00:01+10:00 http://biotechdispatch.com.au/news/andhealth-announces-2018-cohort 2018-07-24T08:00:01+10:00 http://biotechdispatch.com.au/news/cardiex-reports-on-wave-analysis-technology 2018-07-24T08:00:01+10:00 http://biotechdispatch.com.au/news/wa-scientists-develop-world-new-test-for-early-detection-of-mela 2018-07-19T08:00:01+10:00 http://biotechdispatch.com.au/news/fast-track-for-melbourne-company 2018-07-19T08:00:01+10:00 http://biotechdispatch.com.au/news/rd-tax-reform-to-unfairly-hit-biotech-startups 2018-07-19T08:00:01+10:00 http://biotechdispatch.com.au/news/government-announces-investment-in-genome-sequencing 2018-07-19T08:00:01+10:00 http://biotechdispatch.com.au/news/mesoblast-enters-alliance-with-chinas-tasly 2018-07-19T08:00:01+10:00 http://biotechdispatch.com.au/news/new-bridge-grant-to-nurture-early-stage-ventures 2018-07-17T09:00:01+10:00 http://biotechdispatch.com.au/news/partners-announced-for-bridgetech-program 2018-07-17T09:00:01+10:00 http://biotechdispatch.com.au/news/historic-goods-shed-transformed-into-innovation-hub 2018-07-17T09:00:01+10:00 http://biotechdispatch.com.au/news/world-first-trial-of-medication-for-ice-addiction 2018-07-17T09:00:01+10:00 http://biotechdispatch.com.au/news/shipment-of-additional-adult-flu-vaccines-commences-2 2018-07-17T09:00:01+10:00 http://biotechdispatch.com.au/news/government-hopes-to-strengthen-innovation-links-with-the-us 2018-07-12T10:00:01+10:00 http://biotechdispatch.com.au/news/sbe-australia-invites-expressions-of-interest-from-female-entrep 2018-07-12T10:00:01+10:00 http://biotechdispatch.com.au/news/early-bird-finishes-tomorrow-for-biotech-event-of-the-year-1 2018-07-12T10:00:01+10:00 http://biotechdispatch.com.au/news/new-partnership-for-adherium 2018-07-12T10:00:01+10:00 http://biotechdispatch.com.au/news/new-us-patent-for-regeneus-progenza 2018-07-12T10:00:01+10:00 http://biotechdispatch.com.au/news/wild-womens-stem-leadership-program 2018-07-12T10:00:01+10:00 http://biotechdispatch.com.au/news/benitec-secures-licensing-deal-for-gene-therapy 2018-07-10T09:00:01+10:00 http://biotechdispatch.com.au/news/bionomics-reports-on-trial-progress 2018-07-10T09:00:01+10:00 http://biotechdispatch.com.au/news/tga-seeks-advisory-committee-members 2018-07-10T09:00:01+10:00 http://biotechdispatch.com.au/news/starpharmas-vivagel-bv-advances-to-next-stage-of-fda-review 2018-07-10T09:00:01+10:00 http://biotechdispatch.com.au/news/clinical-trial-gives-hope-to-transplant-patients 2018-07-10T09:00:01+10:00 http://biotechdispatch.com.au/news/takeda-launches-australian-innovation-program 2018-07-05T09:00:01+10:00 http://biotechdispatch.com.au/news/survey-confirms-life-sciences-sector-booming-and-more-buoyant-th 2018-07-05T09:00:01+10:00 http://biotechdispatch.com.au/news/new-director-for-neurotech-international 2018-07-05T09:00:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-launches-western-australian-node 2018-07-05T09:00:01+10:00 http://biotechdispatch.com.au/news/auscann-completes-334-million-capital-raise 2018-07-05T09:00:01+10:00 http://biotechdispatch.com.au/news/new-accreditation-for-pharmausts-epichem 2018-07-03T10:00:01+10:00 http://biotechdispatch.com.au/news/opthea-reached-mid-point-in-recruitment-for-pivotal-opt-302-stud 2018-07-03T10:00:01+10:00 http://biotechdispatch.com.au/news/comment-sought-on-the-rd-tax-incentive-draft-legislation 2018-07-03T10:00:01+10:00 http://biotechdispatch.com.au/news/pro-medicus-signs-deal-with-us-health-network 2018-07-03T10:00:01+10:00 http://biotechdispatch.com.au/news/regeneus-updates-on-progenza-in-japan 2018-07-03T10:00:01+10:00 http://biotechdispatch.com.au/news/government-seeking-feedback-on-rd-tax-reform-legislation 2018-07-02T07:11:01+10:00 http://biotechdispatch.com.au/news/site-found-for-australias-largest-medicinal-cannabis-manufacturi 2018-06-28T11:00:01+10:00 http://biotechdispatch.com.au/news/tga-opens-annual-stakeholder-survey 2018-06-28T11:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-announces-acquisition-of-us-manufacturing-facility 2018-06-28T11:00:01+10:00 http://biotechdispatch.com.au/news/regulator-approves-commercial-release-of-gm-safflower 2018-06-28T11:00:01+10:00 http://biotechdispatch.com.au/news/another-vivagel-bv-for-starpharma 2018-06-28T11:00:01+10:00 http://biotechdispatch.com.au/news/a-disruptive-technology-that-changed-everything 2018-06-26T08:00:01+10:00 http://biotechdispatch.com.au/news/medical-research-future-fund-priorities-under-review 2018-06-26T08:00:01+10:00 http://biotechdispatch.com.au/news/clinuvel-completes-scenesse-fda-filing 2018-06-26T08:00:01+10:00 http://biotechdispatch.com.au/news/when-is-marketing-approval 2018-06-26T08:00:01+10:00 http://biotechdispatch.com.au/news/china-now-the-focus-in-asia 2018-06-26T08:00:01+10:00 http://biotechdispatch.com.au/news/us-healthcare-leader-joins-mesoblast-board 2018-06-21T10:00:01+10:00 http://biotechdispatch.com.au/news/rhythm-biosciences-reports-progress-on-reagent-development 2018-06-21T10:00:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-announces-new-cyp-001-data 2018-06-21T10:00:01+10:00 http://biotechdispatch.com.au/news/data-protection-push-likely-in-australia-eu-fta 2018-06-21T10:00:01+10:00 http://biotechdispatch.com.au/news/the-2018-ausbiotech-and-johnson-johnson-industry-excellence-awar 2018-06-21T10:00:01+10:00 http://biotechdispatch.com.au/news/sirtex-accepts-19bn-takeover-bid 2018-06-19T10:00:01+10:00 http://biotechdispatch.com.au/news/applications-open-for-female-startup-founders-program 2018-06-19T10:00:01+10:00 http://biotechdispatch.com.au/news/positivie-updated-trial-results-for-ortho-ati 2018-06-19T10:00:01+10:00 http://biotechdispatch.com.au/news/new-leadership-for-msd-australia-1 2018-06-19T10:00:01+10:00 http://biotechdispatch.com.au/news/novotech-signs-mou-in-taiwan 2018-06-19T10:00:01+10:00 http://biotechdispatch.com.au/news/recognition-for-gilead-head-of-rd 2018-06-14T09:00:01+10:00 http://biotechdispatch.com.au/news/industry-makes-joint-recommendation-on-medical-device-identifica 2018-06-14T09:00:01+10:00 http://biotechdispatch.com.au/news/capital-raise-for-kiwi-regenerative-tissue-developer 2018-06-14T09:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-new-medicines-australia-boss 2018-06-14T09:00:01+10:00 http://biotechdispatch.com.au/news/bayer-completes-monsanto-acquisition 2018-06-14T09:00:01+10:00 http://biotechdispatch.com.au/news/award-for-walter-and-eliza-hall-institute-researchers 2018-06-14T09:00:01+10:00 http://biotechdispatch.com.au/news/recognition-for-csl-board-member 2018-06-12T10:00:01+10:00 http://biotechdispatch.com.au/news/professor-paul-wood-awarded-order-of-australia 2018-06-12T10:00:01+10:00 http://biotechdispatch.com.au/news/cynata-therapeutics-announces-positive-trial-results 2018-06-12T10:00:01+10:00 http://biotechdispatch.com.au/news/new-investor-in-rhythm-biosciences 2018-06-12T10:00:01+10:00 http://biotechdispatch.com.au/news/auscann-completes-second-harvest-in-chile 2018-06-12T10:00:01+10:00 http://biotechdispatch.com.au/news/btf-backs-creation-of-certa-therapeutics 2018-06-07T10:00:01+10:00 http://biotechdispatch.com.au/news/queensland-off-to-flying-start-at-boston-2018-bio-conference-1 2018-06-07T10:00:01+10:00 http://biotechdispatch.com.au/news/avita-announces-16-million-placement 2018-06-07T10:00:01+10:00 http://biotechdispatch.com.au/news/cann-and-la-trobe-expand-collaboration 2018-06-07T10:00:01+10:00 http://biotechdispatch.com.au/news/four-cases-with-more-to-come 2018-06-07T10:00:01+10:00 http://biotechdispatch.com.au/news/new-manufacturing-agreements-for-adalta 2018-06-05T10:22:01+10:00 http://biotechdispatch.com.au/news/csl-seeking-2019-fellowship-applicants 2018-06-05T10:00:01+10:00 http://biotechdispatch.com.au/news/pitch-perfect-opportunity-closing-soon 2018-06-05T10:00:01+10:00 http://biotechdispatch.com.au/news/product-failure-laid-the-groundwork-for-success 2018-06-05T10:00:01+10:00 http://biotechdispatch.com.au/news/landmark-study-shows-chemo-not-needed-for-most-early-breast-canc 2018-06-05T10:00:01+10:00 http://biotechdispatch.com.au/news/us-global-asset-manager-increases-stake-in-cynata 2018-05-31T10:00:01+10:00 http://biotechdispatch.com.au/news/victoria-attracts-key-conferences 2018-05-31T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-the-third-review-of-the-national-gene-tec 2018-05-31T10:00:01+10:00 http://biotechdispatch.com.au/news/immutep-announces-new-imp321-trial-data 2018-05-31T10:00:01+10:00 http://biotechdispatch.com.au/news/new-collaboration-for-telix-pharmaceuticals 2018-05-31T10:00:01+10:00 http://biotechdispatch.com.au/news/us-company-goes-to-court-over-bid-for-sirtex 2018-05-29T08:00:01+10:00 http://biotechdispatch.com.au/news/tga-approval-for-novitas-tali-train-1 2018-05-29T06:00:01+10:00 http://biotechdispatch.com.au/news/seqirus-announces-practice-nurse-grants 2018-05-29T06:00:01+10:00 http://biotechdispatch.com.au/news/strong-clinical-trials-sector-to-be-drawcard-at-bio 2018-05-29T06:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-announces-monepantel-reformulation 2018-05-29T05:00:01+10:00 http://biotechdispatch.com.au/news/positive-news-for-australian-company-actinogen 2018-05-24T06:00:01+10:00 http://biotechdispatch.com.au/news/new-trial-for-bionomics-bnc210 2018-05-24T06:00:01+10:00 http://biotechdispatch.com.au/news/us-company-decides-not-to-match-sirtex-bid 2018-05-24T06:00:01+10:00 http://biotechdispatch.com.au/news/australian-medtech-sector-invited-to-join-delegation-to-medtech- 2018-05-24T06:00:01+10:00 http://biotechdispatch.com.au/news/bms-updates-study-connect-website 2018-05-24T06:00:01+10:00 http://biotechdispatch.com.au/news/prota-completes-enrolment-of-new-trial 2018-05-24T06:00:01+10:00 http://biotechdispatch.com.au/news/btf-fund-managers-announce-new-investments 2018-05-22T09:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-ceo-departs-to-join-zelda-therapeutics 2018-05-22T09:00:01+10:00 http://biotechdispatch.com.au/news/minomic-announces-trial-completion 2018-05-22T09:00:01+10:00 http://biotechdispatch.com.au/news/bioscience-managers-backs-implantable-monitoring-device 2018-05-22T09:00:01+10:00 http://biotechdispatch.com.au/news/nominations-open-for-annual-gsk-research-award 2018-05-22T09:00:01+10:00 http://biotechdispatch.com.au/news/new-branding-for-adheriums-hailie 2018-05-17T11:26:01+10:00 http://biotechdispatch.com.au/news/anatara-signs-global-deal-with-zoetis 2018-05-17T10:00:01+10:00 http://biotechdispatch.com.au/news/new-awareness-campaign-to-support-clinical-trials 2018-05-17T10:00:01+10:00 http://biotechdispatch.com.au/news/new-investing-guide-builds-understanding-of-life-sciences-sector 2018-05-17T10:00:01+10:00 http://biotechdispatch.com.au/news/oneventures-invests-in-bivacor 2018-05-17T10:00:01+10:00 http://biotechdispatch.com.au/news/medlab-commences-cancer-pain-trial 2018-05-15T11:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-announces-new-trials-for-dmx-200 2018-05-15T11:00:01+10:00 http://biotechdispatch.com.au/news/my-health-record-opt-out-period-confirmed 2018-05-15T11:00:01+10:00 http://biotechdispatch.com.au/news/proposed-intensity-measure-under-the-spotlight 2018-05-15T10:00:01+10:00 http://biotechdispatch.com.au/news/ex-adviser-joins-industry 2018-05-15T08:16:01+10:00 http://biotechdispatch.com.au/news/clinical-trials-gets-well-deserved-support-to-lead-the-world 2018-05-10T13:00:01+10:00 http://biotechdispatch.com.au/news/biotron-announces-capital-raise 2018-05-10T13:00:01+10:00 http://biotechdispatch.com.au/news/more-companies-join-medibio-pilot 2018-05-10T13:00:01+10:00 http://biotechdispatch.com.au/news/admedus-completes-6m-capital-raise 2018-05-10T13:00:01+10:00 http://biotechdispatch.com.au/news/orthocell-secures-distribution-in-another-country 2018-05-10T13:00:01+10:00 http://biotechdispatch.com.au/news/rd-tax-incentive-reform-delivers-positive-news-for-clinical-tria 2018-05-08T20:02:01+10:00 http://biotechdispatch.com.au/news/chinese-company-enters-race-for-sirtex 2018-05-08T10:00:01+10:00 http://biotechdispatch.com.au/news/call-for-australian-health-tech-startups-for-world-best-accelera 2018-05-08T10:00:01+10:00 http://biotechdispatch.com.au/news/sector-welcomes-new-mtpconnect-ceo 2018-05-08T10:00:01+10:00 http://biotechdispatch.com.au/news/fak-to-the-future-innate-breathes-new-life-into-ctx-fak-assets 2018-05-08T10:00:01+10:00 http://biotechdispatch.com.au/news/stakeholders-ready-for-2018-19-budget 2018-05-08T10:00:01+10:00 http://biotechdispatch.com.au/news/g-medical-innovations-launches-primza-online 2018-05-03T10:00:01+10:00 http://biotechdispatch.com.au/news/cellmid-signs-volis-distribution-agreement-in-china 2018-05-03T10:00:01+10:00 http://biotechdispatch.com.au/news/nominations-for-the-2018-research-australia-health-and-medical-r 2018-05-03T10:00:01+10:00 http://biotechdispatch.com.au/news/medibio-announces-ce-marking 2018-05-03T10:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-teams-up-with-mundipharma-on-vivagel-bv 2018-05-03T10:00:01+10:00 http://biotechdispatch.com.au/news/collaboration-backs-medtech-innovation 2018-05-01T10:00:01+10:00 http://biotechdispatch.com.au/news/new-program-for-medtech-innovators 2018-05-01T10:00:01+10:00 http://biotechdispatch.com.au/news/clinical-trials-sector-gathers-to-celebrate-international-day-1 2018-05-01T10:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-submits-final-vivagel-bv-module-to-fda 2018-05-01T10:00:01+10:00 http://biotechdispatch.com.au/news/uwa-and-douglas-partner-on-immunotherapies1 2018-05-01T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-announces-new-ceo 2018-05-01T08:00:01+10:00 http://biotechdispatch.com.au/news/successful-capital-raise-for-microba 2018-04-26T10:00:01+10:00 http://biotechdispatch.com.au/news/attention-turns-to-all-things-medtech 2018-04-26T10:00:01+10:00 http://biotechdispatch.com.au/news/qimr-berghofer-sings-cancer-research-mou-with-dubai 2018-04-26T10:00:01+10:00 http://biotechdispatch.com.au/news/auscann-expands-partnership-with-canopy 2018-04-26T10:00:01+10:00 http://biotechdispatch.com.au/news/shire-accepts-us64bn-proposal-from-takeda 2018-04-26T10:00:01+10:00 http://biotechdispatch.com.au/news/digital-health-industry-accelerator-opens-for-2018-applicants-1 2018-04-24T10:00:01+10:00 http://biotechdispatch.com.au/news/microsoft-backs-development-of-garvans-genetic-index 2018-04-24T10:00:01+10:00 http://biotechdispatch.com.au/news/lbt-innovations-ships-first-instrument-to-germany 2018-04-24T10:00:01+10:00 http://biotechdispatch.com.au/news/immuron-reports-strong-travelan-sales 2018-04-24T10:00:01+10:00 http://biotechdispatch.com.au/news/cannabis-access-appoints-new-medical-director 2018-04-24T10:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-enters-monepantel-agreement-with-elanco 2018-04-19T10:00:01+10:00 http://biotechdispatch.com.au/news/applications-open-for-new-round-of-sector-growth-program 2018-04-19T10:00:01+10:00 http://biotechdispatch.com.au/news/pharmaceutical-leader-joins-qeddi-advisory-committee 2018-04-19T10:00:01+10:00 http://biotechdispatch.com.au/news/industry-welcomes-first-grants-under-biomedtech-horizons-program 2018-04-19T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-advancing-collaboration-in-china 2018-04-19T10:00:01+10:00 http://biotechdispatch.com.au/news/csl-behring-commits-on-world-haemophilia-day 2018-04-17T10:00:01+10:00 http://biotechdispatch.com.au/news/amgen-joins-digital-health-crc 2018-04-17T10:00:01+10:00 http://biotechdispatch.com.au/news/leadership-of-ausmedtech-national-advisory-group-to-change 2018-04-17T10:00:01+10:00 http://biotechdispatch.com.au/news/telix-signs-partnership-with-french-nuclear-medicine-researchers 2018-04-17T10:00:01+10:00 http://biotechdispatch.com.au/news/avita-reports-positive-recell-trial-result 2018-04-17T09:00:01+10:00 http://biotechdispatch.com.au/news/bionomics-progresses-ptsd-trial 2018-04-12T10:00:01+10:00 http://biotechdispatch.com.au/news/btf-fund-manager-invests-in-melbourne-based-company 2018-04-12T10:00:01+10:00 http://biotechdispatch.com.au/news/value-based-healthcare-inevitable 2018-04-12T10:00:01+10:00 http://biotechdispatch.com.au/news/recell-trial-data-presented-in-the-us 2018-04-12T10:00:01+10:00 http://biotechdispatch.com.au/news/is-pre-approval-the-answer-for-rd-tax-incentive 2018-04-12T10:00:01+10:00 http://biotechdispatch.com.au/news/biotron-updates-on-new-hiv-therapy 2018-04-10T10:00:01+10:00 http://biotechdispatch.com.au/news/novartis-acquires-gene-therapy-company-for-us87bn 2018-04-10T10:00:01+10:00 http://biotechdispatch.com.au/news/life-sciences-industry-caught-in-cross-fire-of-rd-tax-overhaul 2018-04-10T10:00:01+10:00 http://biotechdispatch.com.au/news/bridge-program-welcomes-98-new-participants 2018-04-10T10:00:01+10:00 http://biotechdispatch.com.au/news/new-ceo-for-anteo-technologies 2018-04-10T10:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-food-standards-for-new-breeding-technique 2018-04-05T12:00:01+10:00 http://biotechdispatch.com.au/news/cancer-therapeutics-crc-appoints-new-ceo 2018-04-05T12:00:01+10:00 http://biotechdispatch.com.au/news/bayer-backs-emerging-cv-researchers 2018-04-05T12:00:01+10:00 http://biotechdispatch.com.au/news/nhmrc-clinical-trials-centre-partners-to-digitize-cancer-researc 2018-04-05T10:00:01+10:00 http://biotechdispatch.com.au/news/victorian-government-backs-new-cancer-projects 2018-04-05T10:00:01+10:00 http://biotechdispatch.com.au/news/mesoblast-completes-enrolment-in-phase-3-trial 2018-04-03T11:00:01+10:00 http://biotechdispatch.com.au/news/tmcx-to-host-medical-device-accelerator-info-session 2018-04-03T11:00:01+10:00 http://biotechdispatch.com.au/news/cyclopharm-progresses-technegas 2018-04-03T11:00:01+10:00 http://biotechdispatch.com.au/news/psivida-becomes-eyepoint-pharmaceuticals 2018-04-03T11:00:01+10:00 http://biotechdispatch.com.au/news/takeda-in-potential-bid-for-shire 2018-04-03T11:00:01+10:00 http://biotechdispatch.com.au/news/kazia-commences-brain-cancer-study 2018-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/tga-releases-revised-australian-clinical-trial-handbook 2018-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/the-actuator-accelerator-round-2 2018-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/orphan-designation-for-cynatas-cyp-0011 2018-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/sementis-reports-on-innovative-vaccine-technology 2018-03-29T10:00:01+11:00 http://biotechdispatch.com.au/news/telix-submits-master-file-to-fda 2018-03-27T10:00:01+11:00 http://biotechdispatch.com.au/news/sienna-appoints-new-director 2018-03-27T10:00:01+11:00 http://biotechdispatch.com.au/news/asia-investment-series-lauded-huge-success-in-wake-of-new-tech-i 2018-03-27T10:00:01+11:00 http://biotechdispatch.com.au/news/opthea-doses-first-patient-in-new-opt-302-trial 2018-03-27T10:00:01+11:00 http://biotechdispatch.com.au/news/abbvies-kirsten-odoherty-pay-and-leadership-gaps-remain-a-major- 2018-03-27T10:00:01+11:00 http://biotechdispatch.com.au/news/dentons-acquires-leading-life-sciences-law-firm 2018-03-22T10:00:01+11:00 http://biotechdispatch.com.au/news/asx-listing-rules-clampdown-highlights-need-for-vigilance 2018-03-22T10:00:01+11:00 http://biotechdispatch.com.au/news/tga-confirms-provisional-approval-criteria 2018-03-22T10:00:01+11:00 http://biotechdispatch.com.au/news/bard1-life-sciences-announced-new-patent 2018-03-22T10:00:01+11:00 http://biotechdispatch.com.au/news/new-us-collaboration-for-numedico-technologies 2018-03-22T10:00:01+11:00 http://biotechdispatch.com.au/news/a-political-battle-over-stem-visas 2018-03-20T11:00:01+11:00 http://biotechdispatch.com.au/news/technology-transfer-innovators-to-gather-in-brisbane-for-tts-glo 2018-03-20T11:00:01+11:00 http://biotechdispatch.com.au/news/immutep-attracts-new-investment 2018-03-20T11:00:01+11:00 http://biotechdispatch.com.au/news/ide-group-launches-2018-building-better-futures-for-health-chall 2018-03-20T11:00:01+11:00 http://biotechdispatch.com.au/news/avita-launches-government-funded-trial-in-china 2018-03-20T11:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-austrade-collaborate-for-biokorea-2018 2018-03-15T09:00:01+11:00 http://biotechdispatch.com.au/news/us-investors-pursue-immuron 2018-03-15T08:00:01+11:00 http://biotechdispatch.com.au/news/immutep-signs-collaboration-with-msd 2018-03-15T08:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-new-collaboration-with-leading-cancer-research-institu 2018-03-15T08:00:01+11:00 http://biotechdispatch.com.au/news/study-confirms-benefit-of-il-17a-inhibitor 2018-03-15T08:00:01+11:00 http://biotechdispatch.com.au/news/ma-searching-for-new-ceo 2018-03-13T10:00:01+11:00 http://biotechdispatch.com.au/news/noxopharm-reports-cep-1-study-results 2018-03-13T05:00:01+11:00 http://biotechdispatch.com.au/news/melbourne-biomedical-precinct-website-launched 2018-03-13T05:00:01+11:00 http://biotechdispatch.com.au/news/admedus-signs-us-purchasing-agreement 2018-03-13T05:00:01+11:00 http://biotechdispatch.com.au/news/resapp-updates-on-us-study 2018-03-13T05:00:01+11:00 http://biotechdispatch.com.au/news/msd-and-eisai-enter-us58bn-cancer-deal 2018-03-13T05:00:01+11:00 http://biotechdispatch.com.au/news/new-reports-challenges-sa-gm-ban 2018-03-08T12:06:01+11:00 http://biotechdispatch.com.au/news/victorian-aiming-for-more-clinical-trials 2018-03-08T11:00:01+11:00 http://biotechdispatch.com.au/news/vision-for-women-in-life-sciences-marks-international-womens-day 2018-03-08T11:00:01+11:00 http://biotechdispatch.com.au/news/researcher-highlights-bridge-program-opportunity 2018-03-08T11:00:01+11:00 http://biotechdispatch.com.au/news/positive-progenza-trial-data-published 2018-03-08T11:00:01+11:00 http://biotechdispatch.com.au/news/tga-approval-for-new-vti-contact-lens 2018-03-06T11:00:01+11:00 http://biotechdispatch.com.au/news/expanded-collaboration-for-zelda-and-curtin-university 2018-03-06T11:00:01+11:00 http://biotechdispatch.com.au/news/lbt-innovations-placement-raises-7m 2018-03-06T11:00:01+11:00 http://biotechdispatch.com.au/news/bard1-reports-additional-results-from-ovarian-test 2018-03-06T11:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-the-launch-guide-to-life-sciences-investing 2018-03-06T07:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-consultations-on-gene-technology-regulati 2018-03-01T12:00:01+11:00 http://biotechdispatch.com.au/news/positive-data-for-patrys-pat-dx1 2018-03-01T11:00:01+11:00 http://biotechdispatch.com.au/news/us-company-chooses-australia-for-trials 2018-03-01T10:00:01+11:00 http://biotechdispatch.com.au/news/antisense-therapeutics-secures-approval-for-clinical-trial 2018-03-01T10:00:01+11:00 http://biotechdispatch.com.au/news/paradigm-reports-results-of-patient-study 2018-03-01T10:00:01+11:00 http://biotechdispatch.com.au/news/launch-of-australian-health-innovation-showcase 2018-02-27T12:00:01+11:00 http://biotechdispatch.com.au/news/nominations-open-for-pms-prizes-for-science 2018-02-27T12:00:01+11:00 http://biotechdispatch.com.au/news/swiss-launch-for-creso-pharma 2018-02-27T12:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-annual-survey-of-biotech-leaders-closing-soon 2018-02-27T12:00:01+11:00 http://biotechdispatch.com.au/news/fda-grants-orphan-designation-to-kazias-gdc-0084 2018-02-27T10:36:01+11:00 http://biotechdispatch.com.au/news/industry-recognised-by-gender-equality-agency 2018-02-22T10:00:01+11:00 http://biotechdispatch.com.au/news/last-call-for-big-sisters-to-support-women-in-life-sciences 2018-02-22T10:00:01+11:00 http://biotechdispatch.com.au/news/new-research-collaboration-for-uniquest 2018-02-22T10:00:01+11:00 http://biotechdispatch.com.au/news/viralytics-to-be-acquired-for-502-million 2018-02-22T10:00:01+11:00 http://biotechdispatch.com.au/news/stryker-signs-visafe-contract-with-dorsavi 2018-02-22T10:00:01+11:00 http://biotechdispatch.com.au/news/cook-medical-to-expand-brisbane-based-manufacturing-facility 2018-02-20T08:00:01+11:00 http://biotechdispatch.com.au/news/melbourne-briefing-on-medical-countermeasures-program 2018-02-20T08:00:01+11:00 http://biotechdispatch.com.au/news/new-research-shows-promise-of-human-amniotic-cells-for-stroke-pa 2018-02-20T08:00:01+11:00 http://biotechdispatch.com.au/news/sa-government-backs-lbt-innovations 2018-02-20T08:00:01+11:00 http://biotechdispatch.com.au/news/cincera-launches-with-grant-from-mrcf 2018-02-20T08:00:01+11:00 http://biotechdispatch.com.au/news/australia-must-walk-the-talk-on-innovation 2018-02-15T10:00:01+11:00 http://biotechdispatch.com.au/news/biodiem-secures-patents-in-key-markets 2018-02-15T10:00:01+11:00 http://biotechdispatch.com.au/news/csl-boosts-outlook-on-strong-growth 2018-02-15T10:00:01+11:00 http://biotechdispatch.com.au/news/jj-opens-new-partnering-office-1 2018-02-15T10:00:01+11:00 http://biotechdispatch.com.au/news/grant-opportunity-opens 2018-02-15T10:00:01+11:00 http://biotechdispatch.com.au/news/the-medical-technology-industry-to-gather-at-ausmedtech-1 2018-02-13T11:00:01+11:00 http://biotechdispatch.com.au/news/jobs-and-exports-grew-in-2016 2018-02-13T11:00:01+11:00 http://biotechdispatch.com.au/news/leadership-changes-for-mtpconnect 2018-02-13T11:00:01+11:00 http://biotechdispatch.com.au/news/fda-approves-wider-compassionate-access-to-recell 2018-02-13T11:00:01+11:00 http://biotechdispatch.com.au/news/strong-developed-market-growth-for-cochlear 2018-02-13T11:00:01+11:00 http://biotechdispatch.com.au/news/allergan-acquires-australian-company 2018-02-08T12:00:01+11:00 http://biotechdispatch.com.au/news/women-in-life-sciences-to-gather-in-support-of-gender-equity-1 2018-02-08T12:00:01+11:00 http://biotechdispatch.com.au/news/anatara-achieves-a-major-us-fda-milestone-for-detach 2018-02-08T12:00:01+11:00 http://biotechdispatch.com.au/news/cancer-vaccine-shows-early-promise 2018-02-08T12:00:01+11:00 http://biotechdispatch.com.au/news/new-director-for-invitrocue 2018-02-08T12:00:01+11:00 http://biotechdispatch.com.au/news/deal-to-secure-passage-of-tga-bill 2018-02-06T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-says-plan-to-disadvantage-life-sciences-innovation 2018-02-06T10:00:01+11:00 http://biotechdispatch.com.au/news/government-funds-gene-identification-project 2018-02-06T10:00:01+11:00 http://biotechdispatch.com.au/news/regeneus-announces-positive-results-in-sygenus-acne-study 2018-02-06T10:00:01+11:00 http://biotechdispatch.com.au/news/g-medical-china-granted-green-channel 2018-02-06T10:00:01+11:00 http://biotechdispatch.com.au/news/us-based-company-in-16bn-deal-for-sirtex 2018-02-01T10:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-seeks-annual-snapshot-of-biotech-ceos-views 2018-02-01T10:00:01+11:00 http://biotechdispatch.com.au/news/starpharma-announces-new-dep-trial 2018-02-01T10:00:01+11:00 http://biotechdispatch.com.au/news/visioneering-technologies-announces-eu-approval 2018-02-01T10:00:01+11:00 http://biotechdispatch.com.au/news/admedus-launches-adapt-technology-in-india 2018-02-01T10:00:01+11:00 http://biotechdispatch.com.au/news/new-report-features-australias-clinical-trial-advantage 2018-01-30T13:00:01+11:00 http://biotechdispatch.com.au/news/new-research-grants-for-north-australia 2018-01-30T13:00:01+11:00 http://biotechdispatch.com.au/news/pharmaust-reports-progress-on-reformulation 2018-01-30T13:00:01+11:00 http://biotechdispatch.com.au/news/patrys-reports-pre-clinical-data-on-pat-dx1-np 2018-01-30T13:00:01+11:00 http://biotechdispatch.com.au/news/report-recommends-cap-on-rd-tax-incentive-payments 2018-01-30T13:00:01+11:00 http://biotechdispatch.com.au/news/new-position-for-ausbiotech-board-member 2018-01-25T14:00:01+11:00 http://biotechdispatch.com.au/news/ip-provisions-suspended-but-not-scrapped 2018-01-25T14:00:01+11:00 http://biotechdispatch.com.au/news/tga-commences-priority-review-for-medical-devices 2018-01-25T14:00:01+11:00 http://biotechdispatch.com.au/news/suda-completes-acquisition-of-potential-cancer-therapy 2018-01-25T14:00:01+11:00 http://biotechdispatch.com.au/news/rare-cancers-welcomes-research-funding-commitment 2018-01-25T14:00:01+11:00 http://biotechdispatch.com.au/news/medlab-completes-24m-placement 2018-01-25T14:00:01+11:00 http://biotechdispatch.com.au/news/call-for-session-proposals-as-ausbiotech-2018-takes-shape 2018-01-23T14:00:01+11:00 http://biotechdispatch.com.au/news/numedico-appoints-indonesian-distributor-for-clickzip 2018-01-23T14:00:01+11:00 http://biotechdispatch.com.au/news/resmed-announces-second-quarter-results 2018-01-23T14:00:01+11:00 http://biotechdispatch.com.au/news/neuclone-adds-fifth-biosimilar-candidate-to-portfolio 2018-01-23T14:00:01+11:00 http://biotechdispatch.com.au/news/tga-sticks-with-same-names-for-biologics 2018-01-19T14:00:01+11:00 http://biotechdispatch.com.au/news/orphan-designation-for-benitec-gene-therapy 2018-01-18T14:00:01+11:00 http://biotechdispatch.com.au/news/avpma-accepts-review-recommendations 2018-01-18T14:00:01+11:00 http://biotechdispatch.com.au/news/member-representation-continued-over-festive-break 2018-01-18T14:00:01+11:00 http://biotechdispatch.com.au/news/medlab-secures-licence-to-sell-cannabis-products 2018-01-18T14:00:01+11:00 http://biotechdispatch.com.au/news/phosphagenics-secures-137-million-through-placement 2018-01-18T14:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-secures-another-milestone-payment 2018-01-16T14:00:01+11:00 http://biotechdispatch.com.au/news/2018-ushers-in-year-of-confidence-for-australian-biotech 2018-01-16T14:00:01+11:00 http://biotechdispatch.com.au/news/telix-pharmaceuticals-establishes-japanese-subsidiary 2018-01-16T14:00:01+11:00 http://biotechdispatch.com.au/news/fda-approves-clinical-trial-for-qimr-berghofer-developed-immunot 2018-01-16T14:00:01+11:00 http://biotechdispatch.com.au/news/lepu-medical-takes-stake-in-viralytics 2018-01-16T14:00:01+11:00 http://biotechdispatch.com.au/news/medtronic-officially-opens-new-headquarters 2017-12-21T14:00:01+11:00 http://biotechdispatch.com.au/news/new-director-for-visioneering-technologies 2017-12-21T14:00:01+11:00 http://biotechdispatch.com.au/news/michaela-cash-formally-takes-on-innovation-portfolio 2017-12-21T14:00:01+11:00 http://biotechdispatch.com.au/news/8m-in-new-grants-for-cancer-research 2017-12-21T14:00:01+11:00 http://biotechdispatch.com.au/news/2017-the-best-year-yet-for-australian-biotechnology 2017-12-21T02:00:01+11:00 http://biotechdispatch.com.au/news/2017-the-best-year-yet-for-australian-biotechnology-1 2017-12-21T02:00:01+11:00 http://biotechdispatch.com.au/news/opthea-doses-first-patient-in-opt-302-trial 2017-12-19T14:00:01+11:00 http://biotechdispatch.com.au/news/new-appointment-for-pharmaaust-advisory-board 2017-12-19T14:00:01+11:00 http://biotechdispatch.com.au/news/pharmaxis-takes-control-of-promising-loxl2-program 2017-12-19T14:00:01+11:00 http://biotechdispatch.com.au/news/telix-collaboration-with-memorial-sloan-kettering-cancer-center 2017-12-19T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-submit-on-tga-amendment-bill-senate-inquiry-1 2017-12-19T14:00:01+11:00 http://biotechdispatch.com.au/news/former-ceo-returns-as-csl-chair 2017-12-14T14:00:01+11:00 http://biotechdispatch.com.au/news/victoria-opens-call-for-2018-premiers-awards-for-health-and-medi 2017-12-14T14:00:01+11:00 http://biotechdispatch.com.au/news/telix-announces-manufacturing-partnership-for-japan 2017-12-14T14:00:01+11:00 http://biotechdispatch.com.au/news/suda-reveals-new-data-for-anagrelide 2017-12-14T14:00:01+11:00 http://biotechdispatch.com.au/news/phase-2-dog-lymphoma-trial-confirms-monepantel-clinical-benefit 2017-12-14T14:00:01+11:00 http://biotechdispatch.com.au/news/new-chair-for-uniquest 2017-12-14T14:00:01+11:00 http://biotechdispatch.com.au/news/csl-secures-new-plasma-agreement 2017-12-12T14:00:01+11:00 http://biotechdispatch.com.au/news/global-award-for-mesoblast 2017-12-12T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-appoints-new-director-dr-megan-baldwin 2017-12-12T14:00:01+11:00 http://biotechdispatch.com.au/news/ato-cautions-on-tax-transparency-report 2017-12-12T14:00:01+11:00 http://biotechdispatch.com.au/news/australia-must-not-fear-innovation-ferris 2017-12-12T14:00:01+11:00 http://biotechdispatch.com.au/news/australian-companies-down-the-list-on-rd-spend 2017-12-07T14:00:01+11:00 http://biotechdispatch.com.au/news/new-cfo-for-avita-medical 2017-12-07T14:00:01+11:00 http://biotechdispatch.com.au/news/csl-officially-opens-230m-advanced-manufacturing-facility 2017-12-07T14:00:01+11:00 http://biotechdispatch.com.au/news/express-interest-in-trade-delegations-to-us-and-israel-3 2017-12-07T14:00:01+11:00 http://biotechdispatch.com.au/news/government-grant-to-back-development-of-woundvue 2017-12-07T14:00:01+11:00 http://biotechdispatch.com.au/news/florey-medal-for-gene-therapy-innovator 2017-12-07T14:00:01+11:00 http://biotechdispatch.com.au/news/senate-inquiry-into-tga-changes 2017-12-05T14:00:01+11:00 http://biotechdispatch.com.au/news/new-resources-to-protect-ip-in-china 2017-12-05T14:00:01+11:00 http://biotechdispatch.com.au/news/new-tpm-agreement-for-phosphagenics 2017-12-05T14:00:01+11:00 http://biotechdispatch.com.au/news/cellmid-signs-new-agreement-for-evolisr-in-china 2017-12-05T14:00:01+11:00 http://biotechdispatch.com.au/news/csl-secures-rights-to-organ-transplant-rejection-therapy 2017-12-05T14:00:01+11:00 http://biotechdispatch.com.au/news/government-must-curate-not-control 2017-11-30T14:00:01+11:00 http://biotechdispatch.com.au/news/apas-independence-passes-in-situ-evaluation 2017-11-30T14:00:01+11:00 http://biotechdispatch.com.au/news/tga-consults-on-personalised-and-3d-printed-medical-devices 2017-11-30T14:00:01+11:00 http://biotechdispatch.com.au/news/change-needed-for-cancer-patients 2017-11-30T14:00:01+11:00 http://biotechdispatch.com.au/news/winner-of-the-2017-ansto-australian-synchrotron-stephen-wilkins- 2017-11-30T14:00:01+11:00 http://biotechdispatch.com.au/news/disruption-is-the-future-of-drug-development 2017-11-28T14:00:01+11:00 http://biotechdispatch.com.au/news/call-for-new-members-as-ip-expert-panel-expands 2017-11-28T14:00:01+11:00 http://biotechdispatch.com.au/news/suda-acquires-global-rights-to-potential-anti-cancer-therapy 2017-11-28T14:00:01+11:00 http://biotechdispatch.com.au/news/local-approval-for-g-medicals-primza 2017-11-28T14:00:01+11:00 http://biotechdispatch.com.au/news/china-patent-for-q-seras-blood-clotting-technology 2017-11-28T14:00:01+11:00 http://biotechdispatch.com.au/news/eu-approval-for-orthocells-celgro 2017-11-23T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-comments-on-objects-clause-and-inventive-step 2017-11-23T14:00:01+11:00 http://biotechdispatch.com.au/news/new-licensing-deal-for-specialised-therapeutics 2017-11-23T14:00:01+11:00 http://biotechdispatch.com.au/news/starpharma-lodges-fda-submission-for-vivagel-bv 2017-11-23T14:00:01+11:00 http://biotechdispatch.com.au/news/new-website-brings-together-cancer-data 2017-11-23T14:00:01+11:00 http://biotechdispatch.com.au/news/new-cancer-collaboration-for-walter-and-eliza-hall-institute 2017-11-21T14:00:01+11:00 http://biotechdispatch.com.au/news/shareholders-back-name-change-for-prima-biomed 2017-11-21T14:00:01+11:00 http://biotechdispatch.com.au/news/novogen-becomes-kazia-therapeutics 2017-11-21T14:00:01+11:00 http://biotechdispatch.com.au/news/dendright-advances-immunotherapy 2017-11-21T14:00:01+11:00 http://biotechdispatch.com.au/news/farmers-suffer-from-narrow-misguided-anti-science-party-politics 2017-11-21T14:00:01+11:00 http://biotechdispatch.com.au/news/farmers-suffer-from-narrow-misguided-anti-science-party-politics 2017-11-21T14:00:01+11:00 http://biotechdispatch.com.au/news/manufacturing-training-for-pharma-industry-under-review 2017-11-21T14:00:01+11:00 http://biotechdispatch.com.au/news/us-tax-cut-could-hit-advanced-manufacturing 2017-11-16T14:00:01+11:00 http://biotechdispatch.com.au/news/regenerative-medicine-stakes-its-claim-as-emerging-strength 2017-11-16T14:00:01+11:00 http://biotechdispatch.com.au/news/new-collaboration-for-patrys-with-wehi 2017-11-16T14:00:01+11:00 http://biotechdispatch.com.au/news/biotron-announces-hbv-study-outcomes-were-positive 2017-11-16T14:00:01+11:00 http://biotechdispatch.com.au/news/government-confirms-new-apvma-ceo 2017-11-16T14:00:01+11:00 http://biotechdispatch.com.au/news/simply-wrong-or-wilfully-misleading-on-ip 2017-11-14T14:00:01+11:00 http://biotechdispatch.com.au/news/new-ceo-for-trajan 2017-11-14T14:00:01+11:00 http://biotechdispatch.com.au/news/prima-to-present-new-data-on-melanoma-combination 2017-11-14T14:00:01+11:00 http://biotechdispatch.com.au/news/japanese-approval-for-volpara 2017-11-14T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-responds-to-ip-consultations 2017-11-14T14:00:01+11:00 http://biotechdispatch.com.au/news/tga-progresses-provisional-approval-pathway-for-medicines 2017-11-09T14:00:01+11:00 http://biotechdispatch.com.au/news/clarity-completes-site-activation-for-sartate-trial 2017-11-09T14:00:01+11:00 http://biotechdispatch.com.au/news/another-restructure-coming-for-health 2017-11-09T14:00:01+11:00 http://biotechdispatch.com.au/news/new-name-for-quintilesims 2017-11-09T14:00:01+11:00 http://biotechdispatch.com.au/news/immuron-reports-strong-first-quarter-travelan-sales 2017-11-09T14:00:01+11:00 http://biotechdispatch.com.au/news/industry-welcomes-interim-announcement-on-gene-technology-regula 2017-11-07T14:00:01+11:00 http://biotechdispatch.com.au/news/turnbull-and-ardern-back-tpp-11 2017-11-07T14:00:01+11:00 http://biotechdispatch.com.au/news/amgen-veteran-joins-actinogen-1 2017-11-07T14:00:01+11:00 http://biotechdispatch.com.au/news/impedimed-signs-distribution-agreement-with-regional-health-care 2017-11-07T14:00:01+11:00 http://biotechdispatch.com.au/news/prescient-to-resume-clinical-trial-of-ptx-200-in-ovarian-cancer 2017-11-07T14:00:01+11:00 http://biotechdispatch.com.au/news/government-building-mrff-grants 2017-11-02T14:00:01+11:00 http://biotechdispatch.com.au/news/35-million-boost-for-new-medical-breakthroughs 2017-11-02T14:00:01+11:00 http://biotechdispatch.com.au/news/chairs-gather-to-update-on-committees-and-advisory-groups 2017-11-02T14:00:01+11:00 http://biotechdispatch.com.au/news/wa-export-award-for-epichem 2017-11-02T14:00:01+11:00 http://biotechdispatch.com.au/news/new-appointment-for-clarity-pharmaceuticals 2017-11-02T14:00:01+11:00 http://biotechdispatch.com.au/news/another-ip-test-for-australia 2017-10-31T14:00:01+11:00 http://biotechdispatch.com.au/news/flagship-conference-demonstrates-buoyant-life-sciences-sector 2017-10-31T14:00:01+11:00 http://biotechdispatch.com.au/news/new-appointments-for-bioscience-managers 2017-10-31T14:00:01+11:00 http://biotechdispatch.com.au/news/first-investments-from-main-sequence-ventures 2017-10-31T14:00:01+11:00 http://biotechdispatch.com.au/news/lbt-secures-capital-from-autobio-diagnostic 2017-10-31T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-johnson-johnson-innovation-industry-excellent-awa 2017-10-31T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-confirms-board-line-up-at-agm 2017-10-26T14:30:01+11:00 http://biotechdispatch.com.au/news/snapshot-shows-magnitude-of-life-sciences-sector 2017-10-26T14:30:01+11:00 http://biotechdispatch.com.au/news/msd-signs-collaboration-with-uniquest 2017-10-26T14:00:01+11:00 http://biotechdispatch.com.au/news/australia-at-risk-of-falling-behind 2017-10-26T14:00:01+11:00 http://biotechdispatch.com.au/news/tga-approval-for-starpharma-product 2017-10-26T14:00:01+11:00 http://biotechdispatch.com.au/news/mtpconnect-funding-for-ausbiotech 2017-10-26T14:00:01+11:00 http://biotechdispatch.com.au/news/innovation-the-focus-at-healthy-ageing-conference 2017-10-24T14:00:01+11:00 http://biotechdispatch.com.au/news/participants-gather-for-bridge-program-conference 2017-10-24T14:00:01+11:00 http://biotechdispatch.com.au/news/name-change-for-prima-biomed 2017-10-24T14:00:01+11:00 http://biotechdispatch.com.au/news/largest-yet-life-science-investor-event-opens-in-victoria 2017-10-24T14:00:01+11:00 http://biotechdispatch.com.au/news/telix-launches-ipo 2017-10-24T14:00:01+11:00 http://biotechdispatch.com.au/news/trajan-teams-up-with-uniquest 2017-10-24T02:00:01+11:00 http://biotechdispatch.com.au/news/who-officially-scraps-proposed-naming-convention 2017-10-19T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-aligns-with-japanese-industry-body 2017-10-19T14:00:01+11:00 http://biotechdispatch.com.au/news/dorsavi-receives-11m-government-grant 2017-10-19T14:00:01+11:00 http://biotechdispatch.com.au/news/reformulation-project 2017-10-19T14:00:01+11:00 http://biotechdispatch.com.au/news/canadian-patent-for-orthocells-celgro 2017-10-19T14:00:01+11:00 http://biotechdispatch.com.au/news/csl-fellowships-target-cancer-and-cardiovascular-disease 2017-10-17T14:00:01+11:00 http://biotechdispatch.com.au/news/new-name-for-evolving-novogen 2017-10-17T14:00:01+11:00 http://biotechdispatch.com.au/news/us-delegation-in-australia-for-ip-talks 2017-10-17T14:00:01+11:00 http://biotechdispatch.com.au/news/neurotech-completes-4m-placement 2017-10-17T14:00:01+11:00 http://biotechdispatch.com.au/news/agreement-to-provide-greater-certainty-on-prostheses-pricing 2017-10-17T14:00:01+11:00 http://biotechdispatch.com.au/news/avita-launches-169m-capital-raise 2017-10-12T23:00:01+11:00 http://biotechdispatch.com.au/news/new-funding-for-israeli-australian-company 2017-10-12T14:00:01+11:00 http://biotechdispatch.com.au/news/new-us-patent-for-patrys-pat-lm1 2017-10-12T14:00:01+11:00 http://biotechdispatch.com.au/news/process-for-skilled-occupation-lists-takes-shape 2017-10-12T14:00:01+11:00 http://biotechdispatch.com.au/news/grants-to-encourage-women-in-stem 2017-10-12T14:00:01+11:00 http://biotechdispatch.com.au/news/extended-pbac-default-for-biosimilars 2017-10-10T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-agrees-on-up-classification-of-surgical-mesh 2017-10-10T14:00:01+11:00 http://biotechdispatch.com.au/news/new-grant-for-starpharma-and-peer-mac 2017-10-10T14:00:01+11:00 http://biotechdispatch.com.au/news/new-marketing-chief-for-adherium 2017-10-10T14:00:01+11:00 http://biotechdispatch.com.au/news/childhood-pneumonia-researcher-recognised-with-peter-wills-medal 2017-10-10T08:31:01+11:00 http://biotechdispatch.com.au/news/az-celebrates-60-years-in-australia 2017-10-05T14:00:01+11:00 http://biotechdispatch.com.au/news/tga-releases-new-uniform-recall-procedure 2017-10-05T14:00:01+11:00 http://biotechdispatch.com.au/news/new-us-patent-for-phylogicas-phylomers 2017-10-05T14:00:01+11:00 http://biotechdispatch.com.au/news/body-clock-discovery-wins-nobel-prize 2017-10-05T14:00:01+11:00 http://biotechdispatch.com.au/news/polynovo-enters-israel-market 2017-10-05T14:00:01+11:00 http://biotechdispatch.com.au/news/companies-and-university-partner-on-scholarships 2017-10-03T14:00:01+11:00 http://biotechdispatch.com.au/news/ausbiotech-reports-on-year-of-commitment-and-growth 2017-10-03T14:00:01+11:00 http://biotechdispatch.com.au/news/antisense-updates-on-atl1102 2017-10-03T14:00:01+11:00 http://biotechdispatch.com.au/news/will-clones-qualify-for-uptake-drivers 2017-10-03T14:00:01+11:00 http://biotechdispatch.com.au/news/industry-a-big-winner-from-trump-tax-proposal 2017-09-29T06:00:01+10:00 http://biotechdispatch.com.au/news/new-us-mou-for-mtpconnect 2017-09-28T14:00:01+10:00 http://biotechdispatch.com.au/news/ip-australia-consults-on-five-policies 2017-09-28T14:00:01+10:00 http://biotechdispatch.com.au/news/positive-preliminary-findings-for-neurotechs-mente-autism-device 2017-09-28T14:00:01+10:00 http://biotechdispatch.com.au/news/australian-biotech-leads-new-hope-for-influenza-control 2017-09-28T14:00:01+10:00 http://biotechdispatch.com.au/news/new-manufacturing-capacity-for-airxpanders 2017-09-28T14:00:01+10:00 http://biotechdispatch.com.au/news/clinical-trials-system-broken 2017-09-26T14:00:01+10:00 http://biotechdispatch.com.au/news/sienna-appoints-exclusive-distributor-for-denmark-and-sweden 2017-09-26T14:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-reports-positive-phase-1-results 2017-09-26T14:00:01+10:00 http://biotechdispatch.com.au/news/austrades-china-market-desk-arriving-at-ausbiotech 2017-09-26T14:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-and-barda-execute-contract-option 2017-09-26T14:00:01+10:00 http://biotechdispatch.com.au/news/new-mou-for-mtpconnect 2017-09-21T14:00:01+10:00 http://biotechdispatch.com.au/news/digital-health-boosted-as-new-accelerator-reveals-first-cohort 2017-09-21T14:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-reports-on-monepantel-reformulation-project 2017-09-21T14:00:01+10:00 http://biotechdispatch.com.au/news/ferris-australia-falling-behind 2017-09-21T14:00:01+10:00 http://biotechdispatch.com.au/news/partnership-produces-new-dementia-resource 2017-09-21T14:00:01+10:00 http://biotechdispatch.com.au/news/a-new-industry-and-innovation-minister 2017-09-21T08:22:01+10:00 http://biotechdispatch.com.au/news/government-backs-world-first-trial-in-childhood-cancers 2017-09-19T14:00:01+10:00 http://biotechdispatch.com.au/news/new-cfo-for-adherium 2017-09-19T14:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-open-board-election-ballot 2017-09-19T14:00:01+10:00 http://biotechdispatch.com.au/news/new-board-appointments-for-telix 2017-09-19T14:00:01+10:00 http://biotechdispatch.com.au/news/european-clearance-for-g-medicals-prizma 2017-09-19T14:00:01+10:00 http://biotechdispatch.com.au/news/tga-reports-annual-performance-statistics 2017-09-14T14:00:01+10:00 http://biotechdispatch.com.au/news/salary-survey-reveals-the-latest-on-life-sciences-sector 2017-09-14T14:00:01+10:00 http://biotechdispatch.com.au/news/adherium-launches-new-device 2017-09-14T14:00:01+10:00 http://biotechdispatch.com.au/news/searching-for-emerging-entrepreneurs 2017-09-14T14:00:01+10:00 http://biotechdispatch.com.au/news/graeme-clarke-orator-announced 2017-09-14T14:00:01+10:00 http://biotechdispatch.com.au/news/bioscience-managers-selects-three-companies-for-btf-investment 2017-09-12T14:00:01+10:00 http://biotechdispatch.com.au/news/new-chair-for-lifespot-health 2017-09-12T14:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-set-to-trigger-another-milestone 2017-09-12T14:00:01+10:00 http://biotechdispatch.com.au/news/new-patent-for-pharmausts-monepantel 2017-09-12T14:00:01+10:00 http://biotechdispatch.com.au/news/global-valuation-expert-to-host-one-day-course 2017-09-12T14:00:01+10:00 http://biotechdispatch.com.au/news/fda-clearance-for-new-g-medical-smartphone-jacket 2017-09-07T14:00:01+10:00 http://biotechdispatch.com.au/news/new-publication-on-engeneic-trial 2017-09-07T14:00:01+10:00 http://biotechdispatch.com.au/news/new-ipo-guide-for-life-sciences-companies-to-launch 2017-09-07T14:00:01+10:00 http://biotechdispatch.com.au/news/first-patient-recruited-for-new-orthocell-trial 2017-09-07T14:00:01+10:00 http://biotechdispatch.com.au/news/acrux-and-lilly-terminate-axiron-deal 2017-09-07T14:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-secures-patent-portfolio 2017-09-05T14:02:01+10:00 http://biotechdispatch.com.au/news/australian-treatment-centres-working-to-progress-ovarian-cancer- 2017-09-05T14:00:01+10:00 http://biotechdispatch.com.au/news/new-partnership-to-tackle-cancer-and-alzheimers-disease 2017-09-05T14:00:01+10:00 http://biotechdispatch.com.au/news/new-trial-for-imugenes-her-vaxx-immunotherapy 2017-09-05T14:00:01+10:00 http://biotechdispatch.com.au/news/fda-clearance-for-new-adherium-device 2017-09-05T14:00:01+10:00 http://biotechdispatch.com.au/news/tpp-countries-scrap-pharma-ip-provisions 2017-09-05T14:00:01+10:00 http://biotechdispatch.com.au/news/final-days-to-nominate-for-ausbiotech-2017-board-election 2017-09-05T14:00:01+10:00 http://biotechdispatch.com.au/news/jj-innovation-prize-for-clinical-genomics 2017-08-31T14:00:01+10:00 http://biotechdispatch.com.au/news/new-appointment-for-avita-medical 2017-08-31T14:00:01+10:00 http://biotechdispatch.com.au/news/new-edition-of-agricultural-biotechnology-guide-launches 2017-08-31T14:00:01+10:00 http://biotechdispatch.com.au/news/announces-new-collaboration-with-puretech-health 2017-08-31T14:00:01+10:00 http://biotechdispatch.com.au/news/cyanta-no-longer-an-evolving-market 2017-08-31T14:00:01+10:00 http://biotechdispatch.com.au/news/ag-and-food-summit-features-investment-focus 2017-08-29T14:00:01+10:00 http://biotechdispatch.com.au/news/governments-ip-response-the-detail 2017-08-29T14:00:01+10:00 http://biotechdispatch.com.au/news/csl-acquires-gene-therapy-company 2017-08-29T14:00:01+10:00 http://biotechdispatch.com.au/news/new-cfo-for-lbt-innovations 2017-08-29T14:00:01+10:00 http://biotechdispatch.com.au/news/ip-response-a-victory-for-the-sector 2017-08-29T14:00:01+10:00 http://biotechdispatch.com.au/news/new-australian-partnership-for-janssen 2017-08-24T14:00:01+10:00 http://biotechdispatch.com.au/news/qiagen-and-clinical-genomics-partner-on-liquid-biopsies 2017-08-24T14:00:01+10:00 http://biotechdispatch.com.au/news/japan-development-agreement-for-phosphagenics 2017-08-24T14:00:01+10:00 http://biotechdispatch.com.au/news/health-adviser-leaves-turnbull-office 2017-08-24T14:00:01+10:00 http://biotechdispatch.com.au/news/more-to-do-on-skilled-migration-visas 2017-08-24T11:41:01+10:00 http://biotechdispatch.com.au/news/epworth-goes-live-with-velos-research-system 2017-08-22T14:00:01+10:00 http://biotechdispatch.com.au/news/monash-biomedicine-discovery-institute-joins-mrcf 2017-08-22T14:00:01+10:00 http://biotechdispatch.com.au/news/nominations-call-for-industry-excellence-awards 2017-08-22T14:00:01+10:00 http://biotechdispatch.com.au/news/major-milestone-for-adherium 2017-08-22T14:00:01+10:00 http://biotechdispatch.com.au/news/zoetis-exercises-option-for-anataras-detach 2017-08-22T14:00:01+10:00 http://biotechdispatch.com.au/news/new-us-patent-for-gkcs-personal-kinetigraph 2017-08-22T14:00:01+10:00 http://biotechdispatch.com.au/news/msd-partnership-boosts-bionomics 2017-08-17T14:00:01+10:00 http://biotechdispatch.com.au/news/phd-mentoring-program-rolls-out-across-australia 2017-08-17T14:00:01+10:00 http://biotechdispatch.com.au/news/csl-hurt-by-high-expectations 2017-08-17T14:00:01+10:00 http://biotechdispatch.com.au/news/prota-reports-positive-results-from-follow-up-study 2017-08-17T14:00:01+10:00 http://biotechdispatch.com.au/news/response-to-ip-report-moving-closer 2017-08-17T14:00:01+10:00 http://biotechdispatch.com.au/news/winning-one-part-of-the-drug-development-process 2017-08-15T14:00:01+10:00 http://biotechdispatch.com.au/news/perth-based-biotech-resurrects-cancer-therapy 2017-08-15T14:00:01+10:00 http://biotechdispatch.com.au/news/sa-award-for-lbt-innovations 2017-08-15T14:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-board-election-opens-as-members-invited-to-gather-for 2017-08-15T14:00:01+10:00 http://biotechdispatch.com.au/news/opthea-presents-additional-data-from-opt-302-trial 2017-08-15T14:00:01+10:00 http://biotechdispatch.com.au/news/australian-manufacturing-licence-for-auscann 2017-08-10T14:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-and-monash-awarded-stem-business-fellowships 2017-08-10T14:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-to-support-australias-most-prestigious-free-public-sc 2017-08-10T14:00:01+10:00 http://biotechdispatch.com.au/news/immuron-approved-to-commence-new-study 2017-08-10T14:00:01+10:00 http://biotechdispatch.com.au/news/resapp-reports-preliminary-top-line-results-from-smartcough-c-st 2017-08-10T14:00:01+10:00 http://biotechdispatch.com.au/news/positive-trial-results-for-starpharmas-vivagel-bv 2017-08-08T14:00:01+10:00 http://biotechdispatch.com.au/news/call-for-good-news-prosthesis-stories-to-build-support 2017-08-08T14:00:01+10:00 http://biotechdispatch.com.au/news/zelda-therapeutics-extends-research-program-with-new-collaborati 2017-08-08T14:00:01+10:00 http://biotechdispatch.com.au/news/new-study-for-lbts-woundvue-prototype 2017-08-08T14:00:01+10:00 http://biotechdispatch.com.au/news/benitec-advances-opmd-orphan-disease-program 2017-08-08T14:00:01+10:00 http://biotechdispatch.com.au/news/sienna-cancer-diagnostics-debuts-on-asx 2017-08-03T14:00:01+10:00 http://biotechdispatch.com.au/news/trajan-confirms-la-trobe-university-has-joined-astech 2017-08-03T14:00:01+10:00 http://biotechdispatch.com.au/news/tga-unique-identifier-could-undermine-biosimilar-policy 2017-08-03T14:00:01+10:00 http://biotechdispatch.com.au/news/new-directory-to-connect-the-industry-1 2017-08-03T14:00:01+10:00 http://biotechdispatch.com.au/news/tga-medical-devices-sponsor-information-day 2017-08-03T14:00:01+10:00 http://biotechdispatch.com.au/news/leadership-change-at-immuron 2017-08-03T14:00:01+10:00 http://biotechdispatch.com.au/news/new-uk-investment-consultant-for-bioscience-managers 2017-08-01T14:00:01+10:00 http://biotechdispatch.com.au/news/avita-medical-announces-fourth-quarter-results 2017-08-01T14:00:01+10:00 http://biotechdispatch.com.au/news/leading-vcs-to-conduct-roadshow-seeking-local-investment-opportu 2017-08-01T14:00:01+10:00 http://biotechdispatch.com.au/news/new-leadership-for-cochlear 2017-08-01T14:00:01+10:00 http://biotechdispatch.com.au/news/haemalogix-signs-immuno-oncology-deal-with-research-institutes 2017-08-01T14:00:01+10:00 http://biotechdispatch.com.au/news/us325-million-deal-for-walter-and-eliza-hall-institute 2017-07-27T14:04:01+10:00 http://biotechdispatch.com.au/news/mtp-connect-to-lead-australian-delegation-to-the-medtech-confere 2017-07-27T14:03:01+10:00 http://biotechdispatch.com.au/news/creso-pharma-acquires-canadian-counterpart 2017-07-27T14:02:01+10:00 http://biotechdispatch.com.au/news/us-approval-for-cogstates-digital-cognitive-assessment-tool 2017-07-27T14:01:01+10:00 http://biotechdispatch.com.au/news/leaders-out-of-step-with-public-opinion-on-reputation-2 2017-07-27T14:00:01+10:00 http://biotechdispatch.com.au/news/retirement-for-long-serving-lbt-innovations-chair 2017-07-25T14:04:01+10:00 http://biotechdispatch.com.au/news/biotech-capital-announces-btc-capital-as-new-trading-name 2017-07-25T14:03:01+10:00 http://biotechdispatch.com.au/news/adalta-and-la-trobe-awarded-grant-to-identify-novel-i-bodies 2017-07-25T14:02:01+10:00 http://biotechdispatch.com.au/news/americans-want-action-to-protect-innovation 2017-07-25T14:01:01+10:00 http://biotechdispatch.com.au/news/funding-for-national-health-emergency-readiness 2017-07-25T14:00:01+10:00 http://biotechdispatch.com.au/news/ustr-acting-on-trade-agreements-1 2017-07-20T14:00:01+10:00 http://biotechdispatch.com.au/news/new-trial-of-prostate-cancer-breakthrough 2017-07-20T14:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-to-refresh-selected-committees-1 2017-07-20T14:00:01+10:00 http://biotechdispatch.com.au/news/minomic-new-micheck-trial-to-support-us-entry-1 2017-07-20T14:00:01+10:00 http://biotechdispatch.com.au/news/uniquest-seals-long-term-deal-to-tackle-diabetes-and-obesity-1 2017-07-20T14:00:01+10:00 http://biotechdispatch.com.au/news/epat-pain-assessment-app-secures-regulatory-clearance 2017-07-20T14:00:01+10:00 http://biotechdispatch.com.au/news/idt-announces-departure-of-ceo 2017-07-18T14:00:01+10:00 http://biotechdispatch.com.au/news/victorian-pharma-and-medtech-booming 2017-07-18T14:00:01+10:00 http://biotechdispatch.com.au/news/investor-visas-under-review 2017-07-18T14:00:01+10:00 http://biotechdispatch.com.au/news/epichem-records-strong-performance 2017-07-18T14:00:01+10:00 http://biotechdispatch.com.au/news/new-distribution-agreement-for-uscom 2017-07-18T14:00:01+10:00 http://biotechdispatch.com.au/news/industry-nomination-appointed-to-pbac 2017-07-13T14:00:01+10:00 http://biotechdispatch.com.au/news/dimerix-progresses-dmx-200-in-kidney-disease 2017-07-13T14:00:01+10:00 http://biotechdispatch.com.au/news/tga-approval-for-uscoms-pulmonary-function-monitors 2017-07-13T14:00:01+10:00 http://biotechdispatch.com.au/news/victoria-launches-clinical-trials-gateway 2017-07-13T14:00:01+10:00 http://biotechdispatch.com.au/news/az-to-invest-100m-in-australian-manufacturing 2017-07-13T14:00:01+10:00 http://biotechdispatch.com.au/news/trajan-invests-in-cloud-based-platform 2017-07-11T14:00:01+10:00 http://biotechdispatch.com.au/news/sector-cynical-about-rort-claims 2017-07-11T14:00:01+10:00 http://biotechdispatch.com.au/news/another-us-patent-for-optheas-vegfr-3-trap 2017-07-11T14:00:01+10:00 http://biotechdispatch.com.au/news/epat-welcomes-positive-study-result 2017-07-11T14:00:01+10:00 http://biotechdispatch.com.au/news/south-australia-launches-new-vc-fund-for-local-companies 2017-07-11T14:00:01+10:00 http://biotechdispatch.com.au/news/additional-funding-for-research-in-western-sydney 2017-07-06T14:00:01+10:00 http://biotechdispatch.com.au/news/suda-inks-zolpimist-deal-with-teva 2017-07-06T14:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-actively-engaged-in-commercial-negotiations-for-vivag 2017-07-06T14:00:01+10:00 http://biotechdispatch.com.au/news/fda-advice-for-cynata-therapeutics 2017-07-06T14:00:01+10:00 http://biotechdispatch.com.au/news/jj-offers-global-scholarships-for-women-in-stem 2017-07-06T14:00:01+10:00 http://biotechdispatch.com.au/news/australian-biotech-appoints-us-political-heir 2017-07-06T06:00:01+10:00 http://biotechdispatch.com.au/news/sector-welcomes-visa-changes 2017-07-04T14:04:01+10:00 http://biotechdispatch.com.au/news/clarity-completes-capital-raise 2017-07-04T14:03:01+10:00 http://biotechdispatch.com.au/news/minomic-progresses-study-milga-in-other-cancers 2017-07-04T14:02:01+10:00 http://biotechdispatch.com.au/news/more-news-for-sirtex 2017-07-04T14:01:01+10:00 http://biotechdispatch.com.au/news/support-program-for-digital-health-technologies-opens 2017-07-04T14:00:01+10:00 http://biotechdispatch.com.au/news/monash-ivf-group-and-rhs-team-up-on-new-test 2017-06-29T14:04:01+10:00 http://biotechdispatch.com.au/news/new-formulation-planned-for-pharmausts-monepantel 2017-06-29T14:03:01+10:00 http://biotechdispatch.com.au/news/sirtex-confirms-guidance-but-announces-restructure 2017-06-29T14:02:01+10:00 http://biotechdispatch.com.au/news/ag-and-food-summit-to-feature-investorpitching 2017-06-29T14:01:01+10:00 http://biotechdispatch.com.au/news/capital-raise-for-ondek 2017-06-29T14:00:01+10:00 http://biotechdispatch.com.au/news/funding-for-project-looking-to-link-datasets 2017-06-27T14:00:01+10:00 http://biotechdispatch.com.au/news/tsunami-of-change-coming 2017-06-27T14:00:01+10:00 http://biotechdispatch.com.au/news/governor-of-victoria-export-awards-now-open 2017-06-27T14:00:01+10:00 http://biotechdispatch.com.au/news/csiro-marks-one-year-of-data61-operations 2017-06-27T14:00:01+10:00 http://biotechdispatch.com.au/news/australia-set-to-be-targeted-in-trump-global-drug-review 2017-06-27T14:00:01+10:00 http://biotechdispatch.com.au/news/crunch-time-on-working-visa-changes 2017-06-22T14:00:01+10:00 http://biotechdispatch.com.au/news/industry-feedback-requested-on-e-form-and-managing-variations-in 2017-06-22T14:00:01+10:00 http://biotechdispatch.com.au/news/imagion-biosystems-lists-on-asx 2017-06-22T12:37:01+10:00 http://biotechdispatch.com.au/news/sienna-seeks-asx-listing-with-ipo 2017-06-22T08:56:01+10:00 http://biotechdispatch.com.au/news/milestone-payment-for-regeneus 2017-06-22T08:51:01+10:00 http://biotechdispatch.com.au/news/mtpconnect-clinical-trials-add-11bn-to-economy 2017-06-22T02:00:01+10:00 http://biotechdispatch.com.au/news/recce-secures-funding-for-development-of-synthetic-antibiotic 2017-06-20T14:00:01+10:00 http://biotechdispatch.com.au/news/ethics-approval-for-new-meblab-trials 2017-06-20T14:00:01+10:00 http://biotechdispatch.com.au/news/parkinsons-dataset-reveals-variation-across-markets 2017-06-20T14:00:01+10:00 http://biotechdispatch.com.au/news/avita-reports-positive-results-from-new-recell-study 2017-06-20T14:00:01+10:00 http://biotechdispatch.com.au/news/bio-kicks-off-with-qld-announcing-support-for-ausbiotech-2018 2017-06-20T14:00:01+10:00 http://biotechdispatch.com.au/news/starpharma-sells-agrochemicals-business 2017-06-15T14:00:01+10:00 http://biotechdispatch.com.au/news/new-report-sheds-light-on-venture-capital-in-australia 2017-06-15T14:00:01+10:00 http://biotechdispatch.com.au/news/zelda-targets-key-south-american-market 2017-06-15T14:00:01+10:00 http://biotechdispatch.com.au/news/pharmaxis-to-advance-bronchitol-in-the-us 2017-06-15T14:00:01+10:00 http://biotechdispatch.com.au/news/lbt-innovations-appointed-apas-distributor 2017-06-15T06:00:01+10:00 http://biotechdispatch.com.au/news/csl-acquires-strategic-stake-in-chinese-company 2017-06-13T14:00:01+10:00 http://biotechdispatch.com.au/news/biotron-appoints-advisor-for-china-strategy 2017-06-13T14:00:01+10:00 http://biotechdispatch.com.au/news/support-for-smes-to-navigate-tga-regulations 2017-06-13T14:00:01+10:00 http://biotechdispatch.com.au/news/study-results-confirm-efficacy-of-proteomics-test 2017-06-13T14:00:01+10:00 http://biotechdispatch.com.au/news/minister-announces-new-5m-fund 2017-06-13T14:00:01+10:00 http://biotechdispatch.com.au/news/queens-birthday-honours-for-csl-chair-and-leading-health-policy- 2017-06-13T14:00:01+10:00 http://biotechdispatch.com.au/news/investment-for-another-uniquest-spinout 2017-06-08T14:00:01+10:00 http://biotechdispatch.com.au/news/lbt-innovations-appoints-ai-expert-to-board 2017-06-08T14:00:01+10:00 http://biotechdispatch.com.au/news/tga-approval-for-neurotech 2017-06-08T14:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-consults-with-government-to-repair-the-skilled-occupa 2017-06-08T14:00:01+10:00 http://biotechdispatch.com.au/news/mixed-trial-result-for-sirtex 2017-06-08T14:00:01+10:00 http://biotechdispatch.com.au/news/new-board-appointment-for-pharmaxis 2017-06-08T14:00:01+10:00 http://biotechdispatch.com.au/news/sinodinos-cabinet-has-considered-ip-changes 2017-06-06T14:00:01+10:00 http://biotechdispatch.com.au/news/global-kinetics-corporation-and-parkinsons-foundation-announce-f 2017-06-06T14:00:01+10:00 http://biotechdispatch.com.au/news/another-australian-collaboration-for-janssen 2017-06-06T14:00:01+10:00 http://biotechdispatch.com.au/news/mrcf-funding-for-oncores-medical 2017-06-06T14:00:01+10:00 http://biotechdispatch.com.au/news/worlds-most-decorated-olympian-joins-medibio-board 2017-06-06T14:00:01+10:00 http://biotechdispatch.com.au/news/pitch-your-investment-ready-business-at-the-ausag-foodtech-summi 2017-06-06T14:00:01+10:00 http://biotechdispatch.com.au/news/janssen-signs-new-agreement-with-australian-biotech 2017-06-01T14:00:01+10:00 http://biotechdispatch.com.au/news/tga-approval-for-orthocells-cartilage-repair-therapy 2017-06-01T14:00:01+10:00 http://biotechdispatch.com.au/news/new-appointments-for-oneventures 2017-06-01T14:00:01+10:00 http://biotechdispatch.com.au/news/ip-ready-tool-to-help-smes-to-access-high-end-ip-advice-1 2017-06-01T14:00:01+10:00 http://biotechdispatch.com.au/news/major-investor-backs-australian-research 2017-06-01T14:00:01+10:00 http://biotechdispatch.com.au/news/first-investment-from-btf 2017-05-30T14:00:01+10:00 http://biotechdispatch.com.au/news/australian-health-innovators-build-partnerships-with-us-texas-me 2017-05-30T14:00:01+10:00 http://biotechdispatch.com.au/news/first-cohort-of-patients-approach-end-of-therapy-session 2017-05-30T14:00:01+10:00 http://biotechdispatch.com.au/news/visa-changes-a-disaster-for-life-sciences 2017-05-30T14:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-johnson-johnson-industry-excellence-awards-now-op 2017-05-30T14:00:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-and-johnson-johnson-industry-excellence-awards-now-op 2017-05-30T14:00:01+10:00 http://biotechdispatch.com.au/news/doing-better-than-we-think-on-clinical-trials 2017-05-25T14:00:01+10:00 http://biotechdispatch.com.au/news/parliamentary-hold-up-impacts-tga-review-changes 2017-05-25T14:00:01+10:00 http://biotechdispatch.com.au/news/strength-in-clinical-trials-set-to-grow-with-funding-boost 2017-05-25T14:00:01+10:00 http://biotechdispatch.com.au/news/japanese-patent-for-regeneus-progenz 2017-05-25T14:00:01+10:00 http://biotechdispatch.com.au/news/monash-research-sparks-change-in-editorial-policy 2017-05-25T14:00:01+10:00 http://biotechdispatch.com.au/news/pharmaust-reports-preliminary-results-from-monepantel-trial-in-d 2017-05-23T14:00:01+10:00 http://biotechdispatch.com.au/news/digital-health-leads-the-way 2017-05-23T14:00:01+10:00 http://biotechdispatch.com.au/news/mrcf-and-uniseed-invest-in-respiratory-start-up-innavac 2017-05-23T14:00:01+10:00 http://biotechdispatch.com.au/news/avita-board-takes-fees-as-shares 2017-05-23T14:00:01+10:00 http://biotechdispatch.com.au/news/paradigm-welcomes-new-publication 2017-05-23T14:00:01+10:00 http://biotechdispatch.com.au/news/patient-treatment-commences-in-cynata-clinical-trial 2017-05-18T10:39:05+10:00 http://biotechdispatch.com.au/news/specialised-therapeutics-adds-compound-to-portfolio 2017-05-18T10:38:58+10:00 http://biotechdispatch.com.au/news/pharmaust-secures-broad-patent-coverage-for-non-cancer-applicati 2017-05-18T10:38:55+10:00 http://biotechdispatch.com.au/news/actinogen-medical-starts-phase-2-trial-for-alzheimers-therapy 2017-05-18T10:38:52+10:00 http://biotechdispatch.com.au/news/aravax-initiates-trial-of-peanut-allergy-treatment 2017-05-16T13:02:17+10:00 http://biotechdispatch.com.au/news/senate-inquiry-releases-prostheses-list-pricing-report 2017-05-16T13:01:53+10:00 http://biotechdispatch.com.au/news/bi-extends-development-of-pharmaxis-compound 2017-05-16T13:01:42+10:00 http://biotechdispatch.com.au/news/croplife-concern-over-apvma-performance 2017-05-16T13:01:28+10:00 http://biotechdispatch.com.au/news/nominations-for-gsk-award-now-open 2017-05-16T13:01:22+10:00 http://biotechdispatch.com.au/news/research-australia-awards-2 2017-05-16T13:01:15+10:00 http://biotechdispatch.com.au/news/monash-signs-collaboration-with-corvus-pharmaceuticals 2017-05-11T11:26:42+10:00 http://biotechdispatch.com.au/news/recognition-for-idt-australia-at-manufacturing-awards 2017-05-11T11:26:34+10:00 http://biotechdispatch.com.au/news/mtpconnect-welcomes-budget 2017-05-11T11:26:31+10:00 http://biotechdispatch.com.au/news/new-fda-submission-for-use-of-recell-in-mass-casualty-scenario 2017-05-11T11:26:27+10:00 http://biotechdispatch.com.au/news/relief-for-biotech-sector-on-rd-tax-incentive 2017-05-09T20:19:43+10:00 http://biotechdispatch.com.au/news/new-ceo-for-q-pharm 2017-05-09T11:31:55+10:00 http://biotechdispatch.com.au/news/extended-distribution-deal-for-rhinomed 2017-05-09T11:31:50+10:00 http://biotechdispatch.com.au/news/australia-targeted-in-us-trade-review 2017-05-09T11:31:46+10:00 http://biotechdispatch.com.au/news/concern-grown-over-visa-changes 2017-05-09T11:31:43+10:00 http://biotechdispatch.com.au/news/industry-holds-collective-breath-on-budget-announcement 2017-05-08T11:31:01+10:00 http://biotechdispatch.com.au/news/oncosil-appoints-ex-cochlear-ceo-its-chair 2017-05-04T11:47:25+10:00 http://biotechdispatch.com.au/news/tga-seeks-comment-on-low-risk-product-regulation 2017-05-04T11:47:22+10:00 http://biotechdispatch.com.au/news/mtpconnect-funding-call 2017-05-04T11:47:20+10:00 http://biotechdispatch.com.au/news/ex-alcon-executive-appointed-to-visioneering-technologies-board 2017-05-04T11:47:15+10:00 http://biotechdispatch.com.au/news/grants-to-support-collaborations-for-translation 2017-05-04T11:47:10+10:00 http://biotechdispatch.com.au/news/ceo-for-biocurate 2017-05-02T09:50:11+10:00 http://biotechdispatch.com.au/news/us-gives-mixed-message-on-australia 2017-05-02T09:50:08+10:00 http://biotechdispatch.com.au/news/opthea-completes-45m-capital-raise 2017-05-02T09:50:01+10:00 http://biotechdispatch.com.au/news/biotron-says-new-study-backs-bit225-development 2017-05-02T09:49:53+10:00 http://biotechdispatch.com.au/news/survey-shows-biotech-industry-buoyant-but-fearing-imminent-polic 2017-05-01T09:50:04+10:00 http://biotechdispatch.com.au/news/nasal-delivery-of-cannabinoids-to-be-developed-in-second-prevece 2017-04-27T09:22:46+10:00 http://biotechdispatch.com.au/news/budget-key-for-mrff 2017-04-27T09:22:24+10:00 http://biotechdispatch.com.au/news/disappointing-trial-result-for-sirtex 2017-04-27T09:22:21+10:00 http://biotechdispatch.com.au/news/starpharma-triggers-milestone-payment-from-az 2017-04-27T09:22:18+10:00 http://biotechdispatch.com.au/news/calling-australian-exporters-for-international-business-survey 2017-04-26T09:22:27+10:00 http://biotechdispatch.com.au/news/sector-concern-over-scrapping-of-457-visas 2017-04-20T10:15:05+10:00 http://biotechdispatch.com.au/news/medtech-features-in-april-journal 2017-04-20T10:15:01+10:00 http://biotechdispatch.com.au/news/ip-australia-delays-legislation 2017-04-20T10:14:58+10:00 http://biotechdispatch.com.au/news/approval-for-csls-afstyla 2017-04-20T10:14:51+10:00 http://biotechdispatch.com.au/news/immuron-announces-positive-results-of-imm-124e-in-acute-colitis 2017-04-18T11:05:35+10:00 http://biotechdispatch.com.au/news/australia-failing-to-implement-trade-obligations 2017-04-18T11:05:26+10:00 http://biotechdispatch.com.au/news/new-alliance-for-invion 2017-04-18T11:05:23+10:00 http://biotechdispatch.com.au/news/extended-deployment-for-alcidions-patient-flow-solution 2017-04-18T11:05:18+10:00 http://biotechdispatch.com.au/news/peak-bodies-unite-against-threat-to-commercialisation-of-austral 2017-04-18T11:05:01+10:00 http://biotechdispatch.com.au/news/monash-university-rejects-mimotopes-administrative-oversight-cla 2017-04-13T11:53:51+10:00 http://biotechdispatch.com.au/news/asian-investor-series-confirms-strong-investor-interest 2017-04-13T11:53:48+10:00 http://biotechdispatch.com.au/news/idt-reports-better-than-expected-sales-result 2017-04-13T11:53:45+10:00 http://biotechdispatch.com.au/news/applications-open-for-bridge-program 2017-04-13T11:53:41+10:00 http://biotechdispatch.com.au/news/canadian-launch-for-starpharmas-vivagel 2017-04-13T11:53:38+10:00 http://biotechdispatch.com.au/news/new-leadership-for-prota 2017-04-11T11:41:01+10:00 http://biotechdispatch.com.au/news/mimotopes-fights-to-survive-after-administrative-error 2017-04-11T11:40:58+10:00 http://biotechdispatch.com.au/news/mesoblast-progresses-phase-3-trial 2017-04-11T11:40:53+10:00 http://biotechdispatch.com.au/news/new-digital-collaboration-to-back-connected-medical-technologies 2017-04-11T11:40:49+10:00 http://biotechdispatch.com.au/news/government-grant-for-cell-therapies 2017-04-11T11:40:44+10:00 http://biotechdispatch.com.au/news/novogen-halts-anisina-development 2017-04-06T12:17:06+10:00 http://biotechdispatch.com.au/news/ausbiotech-says-rd-tax-incentive-critical-to-2030-innovation-str 2017-04-06T12:16:09+10:00 http://biotechdispatch.com.au/news/oversubscribed-placement-for-botanix 2017-04-06T12:16:02+10:00 http://biotechdispatch.com.au/news/bard1-life-sciences-announces-new-collaboration 2017-04-06T12:15:59+10:00 http://biotechdispatch.com.au/news/opthea-reports-positive-trial-results-for-opt-302 2017-04-06T12:15:56+10:00 http://biotechdispatch.com.au/news/labor-slams-rd-tax-uncertainty 2017-04-04T09:25:50+10:00 http://biotechdispatch.com.au/news/ausbiotech-endorses-changes-for-accessing-unapproved-therapeutic 2017-04-04T09:25:47+10:00 http://biotechdispatch.com.au/news/csiros-releases-blueprint-for-mtp-to-drive-australian-economy 2017-04-04T09:25:41+10:00 http://biotechdispatch.com.au/news/bionic-vision-technologies-raises-funds-to-develop-bionic-eye 2017-04-04T09:25:38+10:00 http://biotechdispatch.com.au/news/australia-free-riding-and-engaged-in-commercial-blackmail 2017-04-03T09:25:44+10:00 http://biotechdispatch.com.au/news/senate-backs-crowd-sourced-funding-bill 2017-03-30T10:19:55+11:00 http://biotechdispatch.com.au/news/neurotech-files-pre-submission-package-with-us-fda 2017-03-30T10:19:52+11:00 http://biotechdispatch.com.au/news/obj-executes-collaboration-agreement-for-bodyguard 2017-03-30T10:19:42+11:00 http://biotechdispatch.com.au/news/vivagel-bv-phase-3-trials-for-prevention-of-bv-completed 2017-03-30T10:19:38+11:00 http://biotechdispatch.com.au/news/croplife-calls-for-action-on-agricultural-red-tape 2017-03-30T10:19:32+11:00 http://biotechdispatch.com.au/news/competition-for-technology-smes-opens-for-2017 2017-03-29T10:19:47+11:00 http://biotechdispatch.com.au/news/consultations-underway-on-australias-innovation-plan-to-2030 2017-03-28T13:20:30+11:00 http://biotechdispatch.com.au/news/womens-luncheon-proves-inspirational 2017-03-28T13:20:26+11:00 http://biotechdispatch.com.au/news/medlab-granted-ethics-approval-for-phase-2a-depression-study 2017-03-28T13:20:19+11:00 http://biotechdispatch.com.au/news/turnbull-government-unveils-national-science-statement 2017-03-23T08:17:11+11:00 http://biotechdispatch.com.au/news/join-the-survey-of-australian-medical-countermeasures 2017-03-23T08:17:07+11:00 http://biotechdispatch.com.au/news/sinodinos-we-have-to-get-better-at-collaboration 2017-03-23T08:17:05+11:00 http://biotechdispatch.com.au/news/neuren-reports-top-line-results-from-phase-2-trial 2017-03-23T08:17:01+11:00 http://biotechdispatch.com.au/news/engeneic-doses-first-patient-in-phase-1-study 2017-03-23T08:16:57+11:00 http://biotechdispatch.com.au/news/clarity-establishes-european-subsidiary 2017-03-21T09:50:50+11:00 http://biotechdispatch.com.au/news/tga-seeks-feedback-on-support-needs-for-smes 2017-03-21T09:50:46+11:00 http://biotechdispatch.com.au/news/opthea-meets-with-european-regulators 2017-03-21T09:50:42+11:00 http://biotechdispatch.com.au/news/tga-reforms-one-step-closer 2017-03-21T09:50:35+11:00 http://biotechdispatch.com.au/news/adalta-continues-collaboration-with-the-alfred-hospital 2017-03-21T09:50:31+11:00 http://biotechdispatch.com.au/news/prima-biomed-confirms-trial-recruitment 2017-03-16T10:04:25+11:00 http://biotechdispatch.com.au/news/nine-submissions-done-and-two-due-by-month-end 2017-03-16T10:04:19+11:00 http://biotechdispatch.com.au/news/capital-raise-for-rhinomed 2017-03-16T10:04:14+11:00 http://biotechdispatch.com.au/news/avita-medical-announces-rd-tax-rebate 2017-03-16T10:04:04+11:00 http://biotechdispatch.com.au/news/psivida-announces-presentation-of-durasert-abstract 2017-03-16T10:04:00+11:00 http://biotechdispatch.com.au/news/key-leadership-changes-for-novogen 2017-03-13T18:24:26+11:00 http://biotechdispatch.com.au/news/senate-inquiry-to-probe-the-complexity-of-prostheses-pricing 2017-03-13T18:24:13+11:00 http://biotechdispatch.com.au/news/rhinomed-updates-on-global-distribution 2017-03-13T18:23:51+11:00 http://biotechdispatch.com.au/news/new-grant-for-proclara-biosciences 2017-03-13T18:22:57+11:00 http://biotechdispatch.com.au/news/food-manufacturing-executive-appointed-to-lead-techinsa 2017-03-13T11:02:20+11:00 http://biotechdispatch.com.au/news/government-grants-first-licence-to-grow-and-harvest-medicinal-ca 2017-03-09T11:51:15+11:00 http://biotechdispatch.com.au/news/opthea-meets-fda-to-discuss-wet-amd-clinical-program 2017-03-09T11:51:07+11:00 http://biotechdispatch.com.au/news/fda-clearance-for-osprey-medicals-dyevert-plus 2017-03-09T11:51:03+11:00 http://biotechdispatch.com.au/news/tga-approval-for-actinogen-medicals-xanadu-trial 2017-03-09T11:51:00+11:00 http://biotechdispatch.com.au/news/submission-to-senate-inquiry-seeks-support-for-tga-bill 2017-03-08T11:51:11+11:00 http://biotechdispatch.com.au/news/medlab-signs-agreement-for-new-study 2017-03-07T11:38:58+11:00 http://biotechdispatch.com.au/news/victoria-launches-new-acceleration-fund-for-medical-research 2017-03-07T11:37:03+11:00 http://biotechdispatch.com.au/news/engeneic-announces-us-orphan-designation-for-edv-nanocell-platfo 2017-03-07T11:36:54+11:00 http://biotechdispatch.com.au/news/another-anti-pd-l1-cancer-therapy-emerging 2017-03-07T11:36:51+11:00 http://biotechdispatch.com.au/news/government-announces-nip-flu-vaccines 2017-03-07T11:36:45+11:00 http://biotechdispatch.com.au/news/us-medical-device-company-to-list-on-asx 2017-03-02T13:05:23+11:00 http://biotechdispatch.com.au/news/annual-survey-of-biotech-ceos-closing-soon 2017-03-02T13:05:19+11:00 http://biotechdispatch.com.au/news/neurotech-signs-new-distribution-partner 2017-03-02T13:05:12+11:00 http://biotechdispatch.com.au/news/new-ceo-for-pharmaust 2017-03-02T13:05:05+11:00 http://biotechdispatch.com.au/news/new-chairman-for-actinogen-medical 2017-03-02T13:04:59+11:00 http://biotechdispatch.com.au/news/peter-mac-joins-bms-global-immuno-oncology-network 2017-02-28T12:14:01+11:00 http://biotechdispatch.com.au/news/tga-approval-for-csl-behring-lung-therapy 2017-02-28T12:13:58+11:00 http://biotechdispatch.com.au/news/new-chairman-for-cynata-therapeutics 2017-02-28T12:13:50+11:00 http://biotechdispatch.com.au/news/innate-ms-trial-on-schedule-for-april-completion 2017-02-28T12:13:47+11:00 http://biotechdispatch.com.au/news/sinodinos-announces-intention-for-womens-advisory-roundtable 2017-02-27T12:13:54+11:00 http://biotechdispatch.com.au/news/wa-labor-commits-to-medical-research-future-fund 2017-02-23T10:46:05+11:00 http://biotechdispatch.com.au/news/uncertainty-on-rd-tax-incentive-causing-harm 2017-02-23T10:46:01+11:00 http://biotechdispatch.com.au/news/company-secures-first-cannabis-licence-as-government-acts-on-spe 2017-02-23T10:45:57+11:00 http://biotechdispatch.com.au/news/polynovo-reports-first-patient-treated-in-us 2017-02-23T10:45:49+11:00 http://biotechdispatch.com.au/news/orthocell-reports-initial-results-from-celgro-trial 2017-02-23T10:45:43+11:00 http://biotechdispatch.com.au/news/victoria-announces-new-grants-for-cancer-research 2017-02-21T07:40:05+11:00 http://biotechdispatch.com.au/news/ausbiotech-suggests-fsanz-amend-cost-recovery-plan 2017-02-21T07:39:51+11:00 http://biotechdispatch.com.au/news/australia-and-nz-sign-innovation-treaty 2017-02-21T07:39:40+11:00 http://biotechdispatch.com.au/news/immuron-completes-trial-recruitment 2017-02-21T07:39:31+11:00 http://biotechdispatch.com.au/news/medical-and-biological-engineering-call-for-abstracts 2017-02-21T07:39:28+11:00 http://biotechdispatch.com.au/news/support-for-innovation-real-or-rhetoric 2017-02-16T12:08:49+11:00 http://biotechdispatch.com.au/news/australian-life-science-companies-to-engage-with-asian-investors 2017-02-16T12:08:44+11:00 http://biotechdispatch.com.au/news/government-announces-appointment-of-cannabis-advisory-council 2017-02-16T12:08:41+11:00 http://biotechdispatch.com.au/news/new-senior-appointment-for-botanix 2017-02-16T12:08:38+11:00 http://biotechdispatch.com.au/news/csl-delivers-exceptionally-strong-performance 2017-02-16T12:08:35+11:00 http://biotechdispatch.com.au/news/mgc-announces-new-medical-cannabis-study 2017-02-16T12:08:32+11:00 http://biotechdispatch.com.au/news/pfizer-to-close-adelaide-biologic-facility 2017-02-14T10:27:13+11:00 http://biotechdispatch.com.au/news/cook-medical-australia-invests-in-new-australian-commercialisati 2017-02-14T10:27:06+11:00 http://biotechdispatch.com.au/news/csl-therapy-shows-potential-in-diabetic-kidney-disease 2017-02-14T10:27:02+11:00 http://biotechdispatch.com.au/news/novogen-secures-3m-grant 2017-02-14T10:27:00+11:00 http://biotechdispatch.com.au/news/tga-bill-to-cut-red-tape-stalls-for-inquiry 2017-02-13T10:27:09+11:00 http://biotechdispatch.com.au/news/ausbiotech-backs-tga-bill-to-cut-red-tape 2017-02-09T11:54:55+11:00 http://biotechdispatch.com.au/news/last-call-for-abstracts-for-international-research-conference-on 2017-02-09T11:54:52+11:00 http://biotechdispatch.com.au/news/bionomics-receives-first-milestone-payment 2017-02-09T11:54:50+11:00 http://biotechdispatch.com.au/news/australia-undermining-proud-tradition-of-ip-led-innovation 2017-02-09T11:54:47+11:00 http://biotechdispatch.com.au/news/ip-change-permanently-adopted 2017-02-09T11:54:44+11:00 http://biotechdispatch.com.au/news/australia-must-do-better-on-innovation 2017-02-09T11:54:41+11:00 http://biotechdispatch.com.au/news/more-grants-for-medical-research 2017-02-06T18:41:05+11:00 http://biotechdispatch.com.au/news/applications-open-for-gcf-priming-grants 2017-02-06T18:40:59+11:00 http://biotechdispatch.com.au/news/botanix-extends-permetrex-license-agreement 2017-02-06T18:40:55+11:00 http://biotechdispatch.com.au/news/immuron-announces-first-patient-enrolled-in-new-phase-2-trial 2017-02-06T18:40:46+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-initiate-clinical-trials-advisory-group 2017-02-05T18:41:02+11:00 http://biotechdispatch.com.au/news/ethics-approval-for-oncosil-pancreatic-cancer-study 2017-02-02T11:03:57+11:00 http://biotechdispatch.com.au/news/ausbiotech-consults-biotech-ceos-on-industry-advocacy 2017-02-02T11:03:52+11:00 http://biotechdispatch.com.au/news/nhmrc-establishes-new-advisory-committees 2017-02-02T11:03:44+11:00 http://biotechdispatch.com.au/news/china-agreement-for-oventus-medical 2017-02-02T11:03:39+11:00 http://biotechdispatch.com.au/news/cyanta-reports-positive-data-from-early-study 2017-02-02T11:03:01+11:00 http://biotechdispatch.com.au/news/first-patient-in-new-prima-trial 2017-01-31T11:18:20+11:00 http://biotechdispatch.com.au/news/senate-inquiry-on-prostheses-pricing-urged-to-consider-implicati 2017-01-31T11:18:17+11:00 http://biotechdispatch.com.au/news/new-board-appointment-for-cogstate 2017-01-31T11:18:11+11:00 http://biotechdispatch.com.au/news/anatara-received-second-payment-from-zoetis 2017-01-31T11:18:08+11:00 http://biotechdispatch.com.au/news/macquarie-database-to-help-uncover-missing-proteins 2017-01-26T08:10:09+11:00 http://biotechdispatch.com.au/news/medical-researcher-named-australian-of-the-year 2017-01-26T08:09:51+11:00 http://biotechdispatch.com.au/news/orthocell-teams-up-with-jj 2017-01-25T19:14:44+11:00 http://biotechdispatch.com.au/news/victoria-launches-40m-training-fund 2017-01-25T19:14:41+11:00 http://biotechdispatch.com.au/news/turnbull-sticks-by-trade-enhancing-agreement 2017-01-25T16:15:01+11:00 http://biotechdispatch.com.au/news/australiaday-celebration-of-the-life-sciences-industry 2017-01-24T19:15:05+11:00 http://biotechdispatch.com.au/news/trump-officially-withdraws-us-from-tpp 2017-01-24T11:33:27+11:00 http://biotechdispatch.com.au/news/immuron-initiates-new-studies-for-imm-124e 2017-01-24T11:33:21+11:00 http://biotechdispatch.com.au/news/csl-inks-collaboration-with-momenta 2017-01-24T11:33:18+11:00 http://biotechdispatch.com.au/news/new-senior-appointment-for-clarity 2017-01-24T11:33:15+11:00 http://biotechdispatch.com.au/news/government-seeks-further-comment-on-productivity-commissions-int 2017-01-23T11:33:24+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-new-ministers 2017-01-19T13:28:17+11:00 http://biotechdispatch.com.au/news/ausbiotech-submits-to-tga-on-medical-device-reform 2017-01-19T13:28:13+11:00 http://biotechdispatch.com.au/news/csl-upgrade-on-strong-sales 2017-01-19T13:28:09+11:00 http://biotechdispatch.com.au/news/regeneus-signs-progenza-collaboration-for-japan 2017-01-19T13:28:06+11:00 http://biotechdispatch.com.au/news/victorian-manufacturing-hall-of-fame 2017-01-19T13:28:03+11:00 http://biotechdispatch.com.au/news/orphan-designation-for-adaltas-idiopathic-pulmonary-disease-ther 2017-01-19T13:28:00+11:00 http://biotechdispatch.com.au/news/new-austrade-ceo 2017-01-17T13:30:49+11:00 http://biotechdispatch.com.au/news/seqirus-announces-new-collaboration-with-zambon 2017-01-17T13:30:39+11:00 http://biotechdispatch.com.au/news/sirtex-looking-for-new-leadership 2017-01-17T13:30:36+11:00 http://biotechdispatch.com.au/news/start-up-support-aimed-to-reduce-stillbirth 2017-01-16T13:30:46+11:00 http://biotechdispatch.com.au/news/medicines-and-medical-research-headline-ley-legacy 2017-01-16T13:30:42+11:00 http://biotechdispatch.com.au/news/mtpconnect-reveals-the-10-year-plan-for-sector 2017-01-12T11:42:27+11:00 http://biotechdispatch.com.au/news/new-years-resolution-for-leadership-in-australian-life-sciences- 2017-01-12T11:42:24+11:00 http://biotechdispatch.com.au/news/vivagel-bv-granted-qidp-and-fast-track-designation-by-us-fda 2017-01-12T11:42:20+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-collaborate-with-texas-medical-centre-on-nfl-start 2017-01-12T11:42:17+11:00 http://biotechdispatch.com.au/news/australian-approval-for-new-leukaemia-drug 2017-01-12T11:42:13+11:00 http://biotechdispatch.com.au/news/china-market-ready-seminars-for-biotech 2016-12-22T11:07:12+11:00 http://biotechdispatch.com.au/news/2016-a-momentous-year-for-australian-biotechnology 2016-12-22T10:53:20+11:00 http://biotechdispatch.com.au/news/productivity-commission-proposes-a-free-ride-for-australia 2016-12-22T10:53:16+11:00 http://biotechdispatch.com.au/news/neurotech-makes-first-shipment-of-mente-autism-devices 2016-12-22T10:53:13+11:00 http://biotechdispatch.com.au/news/us-approval-for-airxpanders-aeroform 2016-12-22T10:53:10+11:00 http://biotechdispatch.com.au/news/ausbiotech-scrap-rd-tax-cap-based-on-myefo 2016-12-20T09:57:27+11:00 http://biotechdispatch.com.au/news/ausbiotech-submits-to-review-of-gene-technology-regulations 2016-12-20T09:57:21+11:00 http://biotechdispatch.com.au/news/myefo-delivers-funding-for-clinical-trials-reform 2016-12-20T09:57:13+11:00 http://biotechdispatch.com.au/news/genentech-extends-agreement-with-phylogica 2016-12-20T09:57:04+11:00 http://biotechdispatch.com.au/news/tga-still-considering-naming-convention 2016-12-15T10:18:52+11:00 http://biotechdispatch.com.au/news/global-gamble-survey-exposes-how-proposed-rd-cap-could-harm-life 2016-12-15T10:18:50+11:00 http://biotechdispatch.com.au/news/biosimilar-options-under-consideration 2016-12-15T10:18:43+11:00 http://biotechdispatch.com.au/news/first-patient-dosed-in-prescient-aml-trial 2016-12-15T10:18:41+11:00 http://biotechdispatch.com.au/news/proteomics-updates-on-promarkerd-2 2016-12-14T10:18:47+11:00 http://biotechdispatch.com.au/news/government-announces-btf-fund-managers 2016-12-13T11:54:37+11:00 http://biotechdispatch.com.au/news/ausbiotech-nominee-appointed-to-the-prostheses-list-advisory-com 2016-12-13T11:54:33+11:00 http://biotechdispatch.com.au/news/cellmid-updates-on-cxbladder-license 2016-12-13T11:54:30+11:00 http://biotechdispatch.com.au/news/uniquest-for-uq-researchers 2016-12-13T11:54:20+11:00 http://biotechdispatch.com.au/news/government-highlights-innovation-policy-but 2016-12-08T06:45:42+11:00 http://biotechdispatch.com.au/news/botanix-announces-positive-trial-data 2016-12-08T06:45:32+11:00 http://biotechdispatch.com.au/news/orthocell-confirms-4m-capital-raise 2016-12-08T06:45:24+11:00 http://biotechdispatch.com.au/news/industry-mentors-critical-for-stem-students-and-graduates 2016-12-07T06:45:38+11:00 http://biotechdispatch.com.au/news/minister-announces-funding-for-largest-australian-clinical-trial 2016-12-06T12:18:52+11:00 http://biotechdispatch.com.au/news/first-stage-of-prostheses-benefit-reform-commences 2016-12-06T12:18:47+11:00 http://biotechdispatch.com.au/news/proteomics-completes-capital-raise 2016-12-06T12:18:41+11:00 http://biotechdispatch.com.au/news/phylogica-collaboration-secures-nhmrc-grant 2016-12-06T12:18:28+11:00 http://biotechdispatch.com.au/news/new-collaboration-for-zelda-therapeutics 2016-12-06T12:18:20+11:00 http://biotechdispatch.com.au/news/growing-the-company-rather-than-protecting-it 2016-12-01T13:19:58+11:00 http://biotechdispatch.com.au/news/imf-report-confirms-rd-incentives-increase-innovation 2016-12-01T13:19:54+11:00 http://biotechdispatch.com.au/news/minomic-announces-oversubscribed-capital-raise 2016-12-01T13:19:51+11:00 http://biotechdispatch.com.au/news/dorsavi-announces-launch-of-myvisafe 2016-12-01T13:19:48+11:00 http://biotechdispatch.com.au/news/anti-cancer-effects-observed-in-initial-zelda-study 2016-12-01T13:19:45+11:00 http://biotechdispatch.com.au/news/the-new-astrazeneca-emerges-in-cambridge 2016-11-29T13:36:03+11:00 http://biotechdispatch.com.au/news/medical-devices-consultations-opened-by-tga 2016-11-29T13:36:00+11:00 http://biotechdispatch.com.au/news/new-licensing-deal-for-starpharma 2016-11-29T13:35:57+11:00 http://biotechdispatch.com.au/news/techinsa-seeking-new-ceo 2016-11-29T13:35:54+11:00 http://biotechdispatch.com.au/news/immuron-receives-1-6m-rd-tax-refund 2016-11-29T13:35:51+11:00 http://biotechdispatch.com.au/news/ramaciotti-medal-for-excellence-awarded-to-breast-cancer-researc 2016-11-24T10:50:38+11:00 http://biotechdispatch.com.au/news/share-your-medtech-story-in-australasian-biotechnology 2016-11-24T10:50:35+11:00 http://biotechdispatch.com.au/news/pkd-australia-and-pkd-foundation-us-partner-to-advance-research 2016-11-24T10:50:30+11:00 http://biotechdispatch.com.au/news/industry-dominates-auspar-use 2016-11-24T10:50:27+11:00 http://biotechdispatch.com.au/news/trump-to-scrap-tpp-on-day-one 2016-11-24T10:50:23+11:00 http://biotechdispatch.com.au/news/innovation-minister-hosts-sector 2016-11-22T11:56:20+11:00 http://biotechdispatch.com.au/news/proposed-cap-on-rd-tax-incentive-will-hamper-clinical-trials 2016-11-22T11:56:15+11:00 http://biotechdispatch.com.au/news/new-quality-control-revealed-in-immune-t-cell-development 2016-11-22T11:56:10+11:00 http://biotechdispatch.com.au/news/national-collaboration-award-for-imnis 2016-11-22T11:56:06+11:00 http://biotechdispatch.com.au/news/senate-backs-inquiry-into-medical-device-pricing 2016-11-22T11:56:01+11:00 http://biotechdispatch.com.au/news/join-australian-delegation-to-ces-2017-digital-health-summit 2016-11-22T11:55:57+11:00 http://biotechdispatch.com.au/news/medical-research-community-recognises-achievement 2016-11-17T09:44:38+11:00 http://biotechdispatch.com.au/news/pharmaxis-signs-collaboration-with-woolcock-institute 2016-11-17T09:44:31+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-host-industry-celebrations-at-year-end 2016-11-16T09:44:34+11:00 http://biotechdispatch.com.au/news/prime-minister-opens-monash-biomedicine-discovery-institute 2016-11-15T10:11:08+11:00 http://biotechdispatch.com.au/news/review-opens-on-gene-technology-regulation 2016-11-15T10:11:04+11:00 http://biotechdispatch.com.au/news/botanix-accelerates-btx-1503-development-with-first-human-study 2016-11-15T10:10:59+11:00 http://biotechdispatch.com.au/news/winners-announced-for-unique-digital-health-program 2016-11-15T10:10:55+11:00 http://biotechdispatch.com.au/news/neurotech-launches-mente-autism 2016-11-15T10:10:51+11:00 http://biotechdispatch.com.au/news/epiaxis-therapeutics-wins-startup-slam-in-germany 2016-11-15T10:10:47+11:00 http://biotechdispatch.com.au/news/research-australia-welcomes-mrff-strategy 2016-11-10T11:39:47+11:00 http://biotechdispatch.com.au/news/new-trials-for-imugenes-her-vaxx 2016-11-10T11:39:39+11:00 http://biotechdispatch.com.au/news/adalta-licenses-alzheimers-disease-specific-shark-antibodies 2016-11-10T11:39:34+11:00 http://biotechdispatch.com.au/news/medlab-secures-cannabis-import-licence 2016-11-10T11:39:28+11:00 http://biotechdispatch.com.au/news/advanced-manufacturing-to-drive-next-gen-biomedical-research 2016-11-09T11:39:43+11:00 http://biotechdispatch.com.au/news/government-announces-global-innovation-strategy 2016-11-08T11:06:21+11:00 http://biotechdispatch.com.au/news/australian-biotech-wins-technology-award-for-global-potential 2016-11-08T11:06:02+11:00 http://biotechdispatch.com.au/news/bionomics-msd-symposium-in-adelaide 2016-11-08T11:05:53+11:00 http://biotechdispatch.com.au/news/antisense-reports-progress-in-ms-trial 2016-11-08T11:05:36+11:00 http://biotechdispatch.com.au/news/invitation-for-medtech-to-mingle 2016-11-08T11:05:06+11:00 http://biotechdispatch.com.au/news/australia-falling-behind-on-innovation 2016-11-03T08:54:48+11:00 http://biotechdispatch.com.au/news/acquisitions-for-novogen 2016-11-03T08:54:41+11:00 http://biotechdispatch.com.au/news/business-group-opposes-ip-extension-for-biologics 2016-11-03T08:54:38+11:00 http://biotechdispatch.com.au/news/new-ip-application-to-acrux 2016-11-03T08:54:33+11:00 http://biotechdispatch.com.au/news/what-makes-a-comparable-overseas-regulator 2016-11-02T08:54:45+11:00 http://biotechdispatch.com.au/news/consultation-underway-on-tga-reforms 2016-11-01T12:51:05+11:00 http://biotechdispatch.com.au/news/ausbiotech-rejects-package-to-further-cut-rd-tax-incentive 2016-11-01T12:50:42+11:00 http://biotechdispatch.com.au/news/funding-for-atomo-hiv-self-test 2016-11-01T12:49:59+11:00 http://biotechdispatch.com.au/news/jj-partners-with-day-of-stem 2016-11-01T12:49:55+11:00 http://biotechdispatch.com.au/news/cellmids-3m-capital-raise 2016-11-01T12:49:51+11:00 http://biotechdispatch.com.au/news/chief-scientist-defends-rd-tax-cap 2016-10-27T13:23:15+11:00 http://biotechdispatch.com.au/news/ausbiotech-cements-plans-to-collaborate 2016-10-27T13:23:03+11:00 http://biotechdispatch.com.au/news/sirtex-delivers-positive-outlook 2016-10-27T13:22:40+11:00 http://biotechdispatch.com.au/news/swisse-partners-with-csiro 2016-10-27T13:18:30+11:00 http://biotechdispatch.com.au/news/ausbiotech-and-johnson-johnson-innovation-industry-excellence-aw 2016-10-25T10:24:44+11:00 http://biotechdispatch.com.au/news/ausbiotech-confirms-future-board-at-agm 2016-10-25T10:24:39+11:00 http://biotechdispatch.com.au/news/new-report-highlights-biotech-potential 2016-10-25T10:24:28+11:00 http://biotechdispatch.com.au/news/ausbiotech-consortium-receives-funding-for-global-investment-edu 2016-10-25T10:24:22+11:00 http://biotechdispatch.com.au/news/no-shortage-of-dance-partners-for-industry 2016-10-24T10:24:33+11:00 http://biotechdispatch.com.au/news/members-unite-in-response-to-rd-tax-incentive-review 2016-10-19T20:23:56+11:00 http://biotechdispatch.com.au/news/genetic-signatures-to-present-results-of-clinical-validation-tri 2016-10-19T20:23:51+11:00 http://biotechdispatch.com.au/news/university-announces-80-million-molecular-and-life-sciences-rese 2016-10-18T20:24:00+11:00 http://biotechdispatch.com.au/news/new-research-centre-in-queensland 2016-10-18T10:54:04+11:00 http://biotechdispatch.com.au/news/ausbiotech-members-to-attend-next-weeks-agm 2016-10-18T10:54:01+11:00 http://biotechdispatch.com.au/news/fda-clearance-for-admedus-vascucel 2016-10-18T10:53:57+11:00 http://biotechdispatch.com.au/news/opthea-claims-rd-tax-incentive 2016-10-18T10:53:51+11:00 http://biotechdispatch.com.au/news/recognition-to-mesoblast 2016-10-18T10:53:48+11:00 http://biotechdispatch.com.au/news/new-therapy-for-specialised-therapeutics-2 2016-10-13T12:20:00+11:00 http://biotechdispatch.com.au/news/industry-heavyweights-amongst-feature-articles-in-biofest-journa 2016-10-13T12:19:57+11:00 http://biotechdispatch.com.au/news/csl-awards-2-5m-in-grants-to-two-australian-researchers 2016-10-13T12:19:54+11:00 http://biotechdispatch.com.au/news/sirtex-announces-new-trial 2016-10-13T12:19:52+11:00 http://biotechdispatch.com.au/news/award-for-resapp 2016-10-13T12:19:47+11:00 http://biotechdispatch.com.au/news/government-considering-new-innovation-fund 2016-10-11T13:12:12+11:00 http://biotechdispatch.com.au/news/biotech-sector-crafts-response-to-rd-tax-incentive-review 2016-10-11T13:12:08+11:00 http://biotechdispatch.com.au/news/fda-approval-for-lbts-apas 2016-10-11T13:12:03+11:00 http://biotechdispatch.com.au/news/new-cancer-therapies-grabbing-headlines 2016-10-11T13:11:59+11:00 http://biotechdispatch.com.au/news/atl1103-higher-dose-study 2016-10-11T13:11:39+11:00 http://biotechdispatch.com.au/news/discovery-could-accelerate-drug-development 2016-10-06T04:06:49+11:00 http://biotechdispatch.com.au/news/last-chance-to-vote-in-ausbiotech-board-election 2016-10-06T04:06:46+11:00 http://biotechdispatch.com.au/news/an-opportunity-to-celebrate-australian-researchers 2016-10-06T04:06:42+11:00 http://biotechdispatch.com.au/news/ministerial-responsibilities-confirmed 2016-10-06T04:06:39+11:00 http://biotechdispatch.com.au/news/bill-ferris-we-have-to-get-better-at-collaboration 2016-10-06T04:06:36+11:00 http://biotechdispatch.com.au/news/cochlear-announces-retirement-of-cfo 2016-10-04T13:02:04+11:00 http://biotechdispatch.com.au/news/sector-to-rally-against-rd-tax-incentive-cap-for-smes 2016-10-04T13:02:00+11:00 http://biotechdispatch.com.au/news/funding-boost-for-australian-healthcare-startups 2016-10-04T13:01:56+11:00 http://biotechdispatch.com.au/news/tga-approval-for-csl-behrings-long-acting-haemophilia-treatment 2016-10-04T13:01:51+11:00 http://biotechdispatch.com.au/news/new-cfo-for-anteo 2016-10-04T13:01:47+11:00 http://biotechdispatch.com.au/news/review-calls-for-reform-of-rd-tax-incentive 2016-09-29T13:38:47+10:00 http://biotechdispatch.com.au/news/ausbiotech-concern-of-2m-rd-tax-cap 2016-09-29T13:38:31+10:00 http://biotechdispatch.com.au/news/apply-for-the-next-jj-quickfire-challenge 2016-09-29T13:30:03+10:00 http://biotechdispatch.com.au/news/tribute-to-dr-chris-holloway 2016-09-29T13:00:35+10:00 http://biotechdispatch.com.au/news/tga-recruiting-for-advisors-and-committees 2016-09-28T13:38:27+10:00 http://biotechdispatch.com.au/news/global-kinetics-announced-fda-clearance-for-kinetigraph 2016-09-27T13:32:30+10:00 http://biotechdispatch.com.au/news/patents-not-the-issue-when-it-comes-to-access 2016-09-27T13:32:13+10:00 http://biotechdispatch.com.au/news/biotech-bodies-united-in-concern-over-un-report 2016-09-26T13:32:21+10:00 http://biotechdispatch.com.au/news/ausbiotech-nominates-for-prostheses-list-advisory 2016-09-22T09:15:05+10:00 http://biotechdispatch.com.au/news/greens-go-hard-against-tpp 2016-09-22T09:14:19+10:00 http://biotechdispatch.com.au/news/uwa-drug-offers-new-hope-to-young-muscular-dystrophy-sufferers 2016-09-21T09:16:24+10:00 http://biotechdispatch.com.au/news/bayer-could-drop-monsanto-name 2016-09-21T09:14:14+10:00 http://biotechdispatch.com.au/news/mtaa-chief-executive-resigns 2016-09-20T07:17:11+10:00 http://biotechdispatch.com.au/news/mtaa-chief-executive-resigns 2016-09-20T07:17:11+10:00 http://biotechdispatch.com.au/news/senate-passes-rd-tax-cut 2016-09-20T07:15:52+10:00 http://biotechdispatch.com.au/news/hacking-their-way-to-healthcare-solutions 2016-09-20T07:14:19+10:00 http://biotechdispatch.com.au/news/dibbsbarker-to-open-melbourne-office 2016-09-20T07:14:06+10:00 http://biotechdispatch.com.au/news/vale-lawrence-bremner 2016-09-19T07:15:08+10:00 http://biotechdispatch.com.au/news/tga-review-government-responses-to-the-key-recommendations 2016-09-15T08:48:28+10:00 http://biotechdispatch.com.au/news/minister-ley-reforms-mean-faster-access 2016-09-15T08:48:25+10:00 http://biotechdispatch.com.au/news/new-company-tackling-chronic-inflammatory-diseases-secures-22m-i 2016-09-15T08:48:17+10:00 http://biotechdispatch.com.au/news/vivagel-condom-receives-regulatory-approval-in-canada 2016-09-15T08:48:12+10:00 http://biotechdispatch.com.au/news/mtpconnect-consults-on-draft-10-year-sector-competitiveness-plan 2016-09-14T08:48:21+10:00 http://biotechdispatch.com.au/news/labor-backs-rd-tax-cut-bill 2016-09-13T10:06:51+10:00 http://biotechdispatch.com.au/news/industry-groups-asked-to-nominate-again 2016-09-13T10:06:45+10:00 http://biotechdispatch.com.au/news/australian-secures-award-grant-from-merck 2016-09-13T10:06:35+10:00 http://biotechdispatch.com.au/news/fda-approves-ind-for-cantrixil-study 2016-09-13T10:06:31+10:00 http://biotechdispatch.com.au/news/industry-excellence-awards-nominations-now-open 2016-09-12T10:06:39+10:00 http://biotechdispatch.com.au/news/turnbull-government-revamps-medical-device-committee 2016-09-08T13:06:29+10:00 http://biotechdispatch.com.au/news/mining-health-data-the-future-boom-not-mining 2016-09-08T13:06:21+10:00 http://biotechdispatch.com.au/news/anatara-completes-target-safety-study 2016-09-08T13:06:18+10:00 http://biotechdispatch.com.au/news/certara-acquires-d3-medicine 2016-09-08T13:06:14+10:00 http://biotechdispatch.com.au/news/australians-back-mrff-investment 2016-09-06T10:37:04+10:00 http://biotechdispatch.com.au/news/century-of-medical-breakthroughs-celebrated-at-melbourne-museum 2016-09-06T10:36:51+10:00 http://biotechdispatch.com.au/news/adherium-expands-international-presence-and-announces-new-appoin 2016-09-06T10:36:47+10:00 http://biotechdispatch.com.au/news/cell-colour-technology-wins-eureka-prize 2016-09-06T10:36:43+10:00 http://biotechdispatch.com.au/news/australias-life-sciences-competitive-advantage-at-risk-from-omni 2016-09-05T10:37:00+10:00 http://biotechdispatch.com.au/news/minomic-launches-first-in-human-trial-of-antibody 2016-09-05T10:36:56+10:00 http://biotechdispatch.com.au/news/day-of-change-as-new-leadership-takes-charge 2016-09-01T10:22:56+10:00 http://biotechdispatch.com.au/news/clarity-secure-belgium-government-grant 2016-09-01T10:22:42+10:00 http://biotechdispatch.com.au/news/how-advanced-manufacturing-will-drive-the-future-of-biotech-phar 2016-09-01T08:22:51+10:00 http://biotechdispatch.com.au/news/coalition-moves-on-rd-tax-cut 2016-09-01T07:22:46+10:00 http://biotechdispatch.com.au/news/mtpconnect-appoints-leadership-group 2016-08-30T10:52:52+10:00 http://biotechdispatch.com.au/news/ausbiotech-commits-to-digital-health 2016-08-30T10:52:48+10:00 http://biotechdispatch.com.au/news/more-money-for-mrff 2016-08-30T10:52:38+10:00 http://biotechdispatch.com.au/news/new-ceo-for-global-kinetics-corporation 2016-08-30T10:52:32+10:00 http://biotechdispatch.com.au/news/brilliant-innovation-policy-but-mixed-messages-a-risk 2016-08-29T10:52:44+10:00 http://biotechdispatch.com.au/news/deakin-partners-with-inspark-science-network 2016-08-25T11:42:08+10:00 http://biotechdispatch.com.au/news/new-advisory-group-launched-to-advance-regenerative-medicine 2016-08-25T11:42:02+10:00 http://biotechdispatch.com.au/news/pfizer-adds-az-antibiotics-business 2016-08-25T11:41:48+10:00 http://biotechdispatch.com.au/news/new-ceo-for-medicines-australia 2016-08-25T11:40:53+10:00 http://biotechdispatch.com.au/news/first-3d-map-of-cell-building-protein-linked-to-cancer 2016-08-23T10:10:23+10:00 http://biotechdispatch.com.au/news/pfizer-wins-battle-for-medivation 2016-08-23T10:10:14+10:00 http://biotechdispatch.com.au/news/abbvie-and-cochlear-make-most-innovative-list 2016-08-23T10:10:09+10:00 http://biotechdispatch.com.au/news/medlab-completes-cannabis-supply-agreement-ahead-of-trial 2016-08-23T10:10:03+10:00 http://biotechdispatch.com.au/news/government-proceeds-with-rd-tax-cut 2016-08-18T11:59:13+10:00 http://biotechdispatch.com.au/news/csl-expecting-strong-growth-ahead 2016-08-18T11:59:10+10:00 http://biotechdispatch.com.au/news/adelaide-biotech-company-reproductive-health-science-to-launch-l 2016-08-18T11:59:04+10:00 http://biotechdispatch.com.au/news/novartis-set-to-award-major-prizes-in-melbourne 2016-08-18T11:59:00+10:00 http://biotechdispatch.com.au/news/final-call-for-posters-for-the-international-biotechnology-sympo 2016-08-17T11:59:07+10:00 http://biotechdispatch.com.au/news/compound-derived-from-australian-rainforest-progresses-in-human- 2016-08-16T12:01:06+10:00 http://biotechdispatch.com.au/news/add-your-tribute-to-thank-dr-lavelle 2016-08-16T12:01:03+10:00 http://biotechdispatch.com.au/news/biogen-backs-student-biotech-showcase 2016-08-16T12:00:59+10:00 http://biotechdispatch.com.au/news/botanix-us-scheduling-decision-for-cannabidiol-supports-approach 2016-08-16T12:00:55+10:00 http://biotechdispatch.com.au/news/ausbiotech-joins-industry-groups-for-pbs-meeting 2016-08-16T12:00:41+10:00 http://biotechdispatch.com.au/news/mtpconnect-signs-mou-with-arcs 2016-08-11T12:50:13+10:00 http://biotechdispatch.com.au/news/roundtables-to-discuss-action-on-clinical-trials 2016-08-11T12:50:00+10:00 http://biotechdispatch.com.au/news/cochlear-breaks-1bn-in-sales 2016-08-11T12:49:47+10:00 http://biotechdispatch.com.au/news/mesoblast-announced-positive-phase-2-ra-results 2016-08-11T12:49:45+10:00 http://biotechdispatch.com.au/news/institute-for-glycomics-signs-another-commercial-deal 2016-08-09T13:34:10+10:00 http://biotechdispatch.com.au/news/jj-backs-health-innovation-competition 2016-08-09T13:34:04+10:00 http://biotechdispatch.com.au/news/obj-signs-new-agreement-with-pg 2016-08-09T13:33:54+10:00 http://biotechdispatch.com.au/news/new-name-and-responsibilities-for-biosa 2016-08-09T13:33:49+10:00 http://biotechdispatch.com.au/news/18-million-to-boost-global-collaboration 2016-08-09T13:33:44+10:00 http://biotechdispatch.com.au/news/biomedical-translation-fund-opens-with-briefings-for-vc-fund-man 2016-08-08T13:34:00+10:00 http://biotechdispatch.com.au/news/fundamental-misunderstanding-on-clinical-trials 2016-08-04T10:10:21+10:00 http://biotechdispatch.com.au/news/botanix-secures-drug-supply 2016-08-04T10:04:24+10:00 http://biotechdispatch.com.au/news/psividia-appoints-new-chief-medical-officer 2016-08-04T10:04:18+10:00 http://biotechdispatch.com.au/news/clinuvel-completes-pre-clinical-study-of-scenesse-combination 2016-08-04T10:04:15+10:00 http://biotechdispatch.com.au/news/minister-announces-details-of-btf 2016-08-03T14:47:44+10:00 http://biotechdispatch.com.au/news/chief-scientist-opens-ausbiotechs-agfood-symposium 2016-08-03T10:04:27+10:00 http://biotechdispatch.com.au/news/tariff-hit-for-clinical-trials 2016-08-02T12:21:43+10:00 http://biotechdispatch.com.au/news/mtpconnect-opens-project-fund-program-applications 2016-08-02T12:21:35+10:00 http://biotechdispatch.com.au/news/cynata-files-application-to-commence-phase-1-clinical-trial 2016-08-02T12:21:21+10:00 http://biotechdispatch.com.au/news/psivida-and-hss-announce-ind-for-sustained-release-implant 2016-08-02T12:21:16+10:00 http://biotechdispatch.com.au/news/mesoblast-presents-24-month-trial-results 2016-08-02T12:21:12+10:00 http://biotechdispatch.com.au/news/artes-and-burnet-institute-to-develop-hepatitis-c-vaccine 2016-07-28T12:36:20+10:00 http://biotechdispatch.com.au/news/artes-and-burnet-institute-to-develop-hepatitis-c-vaccine 2016-07-28T12:36:20+10:00 http://biotechdispatch.com.au/news/draft-report-on-regulation-of-australian-agriculture-welcomed 2016-07-28T12:36:12+10:00 http://biotechdispatch.com.au/news/garvan-launch-first-clinical-whole-genome-sequencing-service 2016-07-28T12:36:05+10:00 http://biotechdispatch.com.au/news/starpharma-inks-new-agreement-with-astrazeneca 2016-07-28T12:35:54+10:00 http://biotechdispatch.com.au/news/hunt-the-changing-face-of-australian-innovation 2016-07-26T10:52:52+10:00 http://biotechdispatch.com.au/news/mtpconnect-releases-draft-competitiveness-plan 2016-07-26T10:52:02+10:00 http://biotechdispatch.com.au/news/kim-carr-reappointed-to-shadow-innovation-portfolio 2016-07-26T10:51:47+10:00 http://biotechdispatch.com.au/news/starpharma-signs-license-for-a-vivagel-in-china 2016-07-26T10:51:41+10:00 http://biotechdispatch.com.au/news/research-consultations-commence-around-australia 2016-07-25T10:51:57+10:00 http://biotechdispatch.com.au/news/dr-samih-nabulsi-takes-the-helm-at-cook-medical-australia 2016-07-21T11:51:39+10:00 http://biotechdispatch.com.au/news/innovation-progress-anticipated-with-new-ministry 2016-07-21T11:51:33+10:00 http://biotechdispatch.com.au/news/strong-asx-debut-for-sleep-disorder-company 2016-07-21T11:50:57+10:00 http://biotechdispatch.com.au/news/changes-for-labor-frontbench 2016-07-21T11:50:53+10:00 http://biotechdispatch.com.au/news/new-guidelines-will-impact-innovation 2016-07-21T11:50:48+10:00 http://biotechdispatch.com.au/news/the-new-turnbull-ministry 2016-07-19T10:20:41+10:00 http://biotechdispatch.com.au/news/dr-lavelle-recognised-with-tributes-and-life-membership 2016-07-19T10:20:37+10:00 http://biotechdispatch.com.au/news/pharmaxis-completes-recruitment-of-phase-3-bronchitol-trial 2016-07-19T10:20:30+10:00 http://biotechdispatch.com.au/news/botanix-pharmaceuticals-lists-on-asx 2016-07-19T10:20:27+10:00 http://biotechdispatch.com.au/news/who-is-greg-hunt 2016-07-18T10:20:34+10:00 http://biotechdispatch.com.au/news/ausbiotech-ceo-hands-over-leadership-after-stellar-contribution 2016-07-15T14:27:34+10:00 http://biotechdispatch.com.au/news/new-investigator-sponsored-study-for-primas-imp321 2016-07-14T11:43:14+10:00 http://biotechdispatch.com.au/news/arcs-extends-reach-with-new-global-partnership 2016-07-14T11:41:10+10:00 http://biotechdispatch.com.au/news/department-announces-new-cmo 2016-07-14T11:39:19+10:00 http://biotechdispatch.com.au/news/ausmedtechs-directory-of-known-china-advisors-to-foster-partners 2016-07-13T11:41:27+10:00 http://biotechdispatch.com.au/news/finalists-announced-for-westpacs-innovation-challenge 2016-07-12T10:30:43+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-resumption-of-innovation-agenda 2016-07-12T10:30:39+10:00 http://biotechdispatch.com.au/news/sirtex-announces-worldwide-full-year-dose-sales-growth-of-16-4 2016-07-12T10:30:18+10:00 http://biotechdispatch.com.au/news/imugene-receives-board-approval-for-study 2016-07-12T10:30:13+10:00 http://biotechdispatch.com.au/news/orthocell-receives-ethics-approval-for-pivotal-ortho-atitm-tendo 2016-07-12T10:30:08+10:00 http://biotechdispatch.com.au/news/nanosonics-appoints-new-non-executive-director 2016-07-07T10:00:22+10:00 http://biotechdispatch.com.au/news/final-call-for-entries-in-2016-medtech-and-pharma-award 2016-07-07T10:00:03+10:00 http://biotechdispatch.com.au/news/immuron-rights-issue-raises-5-33m 2016-07-07T09:59:50+10:00 http://biotechdispatch.com.au/news/dorsavi-updates-on-us-operations 2016-07-07T09:59:19+10:00 http://biotechdispatch.com.au/news/queensland-seeks-input-on-biomedical-and-life-sciences-10-year-r 2016-07-05T12:40:59+10:00 http://biotechdispatch.com.au/news/new-10m-biopharmaceutical-initiative-in-queensland 2016-07-05T12:40:55+10:00 http://biotechdispatch.com.au/news/new-sirflox-analysis-shows-benefit-of-sir-spheres-y-90-resin-mic 2016-07-05T12:40:49+10:00 http://biotechdispatch.com.au/news/pfizer-donation-to-east-timor 2016-07-05T12:40:45+10:00 http://biotechdispatch.com.au/news/research-australia-calls-for-award-nominations 2016-06-30T11:45:23+10:00 http://biotechdispatch.com.au/news/ausmedtech-to-launch-directory-of-known-china-advisors 2016-06-30T11:44:31+10:00 http://biotechdispatch.com.au/news/bionomics-initiates-new-bnc201-trial 2016-06-30T11:43:23+10:00 http://biotechdispatch.com.au/news/universal-biosensors-appoints-new-director 2016-06-30T11:43:18+10:00 http://biotechdispatch.com.au/news/resapp-updates-on-us-study-program 2016-06-30T11:43:12+10:00 http://biotechdispatch.com.au/news/looking-for-political-commitment-on-mrff 2016-06-28T12:42:40+10:00 http://biotechdispatch.com.au/news/avita-medical-receives-barda-extension-deal 2016-06-28T10:10:08+10:00 http://biotechdispatch.com.au/news/atl1103-for-acromegaly-granted-orphan-status-in-europe 2016-06-28T10:09:49+10:00 http://biotechdispatch.com.au/news/government-advice-confirmed-trade-reality 2016-06-23T13:23:38+10:00 http://biotechdispatch.com.au/news/tga-provides-guidance-on-annual-charge-exemption 2016-06-23T13:23:26+10:00 http://biotechdispatch.com.au/news/new-patent-for-neurens-trofinetide 2016-06-23T13:23:08+10:00 http://biotechdispatch.com.au/news/prima-biomed-announces-first-data-from-aipac-study 2016-06-23T13:22:38+10:00 http://biotechdispatch.com.au/news/antara-updates-on-trial 2016-06-23T13:22:24+10:00 http://biotechdispatch.com.au/news/minister-stumbles-over-rd-tax-incentive 2016-06-21T12:56:03+10:00 http://biotechdispatch.com.au/news/ausbiotech-appears-at-ip-hearing 2016-06-21T12:55:54+10:00 http://biotechdispatch.com.au/news/cynata-prepares-for-phase-1-clinical-trial 2016-06-21T12:55:49+10:00 http://biotechdispatch.com.au/news/resapp-announces-positive-preliminary-results-from-adult-clinica 2016-06-21T12:55:45+10:00 http://biotechdispatch.com.au/news/worldview-2016-ranks-australia-in-top-five-for-third-year 2016-06-16T10:41:16+10:00 http://biotechdispatch.com.au/news/shire-local-leadership-confirmed 2016-06-16T10:41:03+10:00 http://biotechdispatch.com.au/news/uscom-agreement-with-ciic-shanghai 2016-06-16T10:41:00+10:00 http://biotechdispatch.com.au/news/winners-of-jj-innovation-quickfire-challenge 2016-06-15T10:41:20+10:00 http://biotechdispatch.com.au/news/labor-scraps-opposition-to-rd-tax-cut 2016-06-14T11:21:44+10:00 http://biotechdispatch.com.au/news/comments-supportive-of-tgas-clinical-evidence-guidelines 2016-06-14T11:21:39+10:00 http://biotechdispatch.com.au/news/queens-birthday-award-recognises-gender-equity-champion 2016-06-14T11:21:35+10:00 http://biotechdispatch.com.au/news/queens-birthday-honours-for-key-figures 2016-06-14T11:21:31+10:00 http://biotechdispatch.com.au/news/sanofi-pasteur-calls-for-bright-ideas 2016-06-14T11:21:27+10:00 http://biotechdispatch.com.au/news/ausbiotech-urges-extension-of-btf 2016-06-09T12:09:18+10:00 http://biotechdispatch.com.au/news/ausbiotech-at-odds-with-recommendations-in-ip-draft-report 2016-06-09T12:09:14+10:00 http://biotechdispatch.com.au/news/european-and-australian-organisations-sign-international-super-c 2016-06-09T12:08:57+10:00 http://biotechdispatch.com.au/news/2016-australian-technologies-competition-open-for-entries 2016-06-09T12:08:46+10:00 http://biotechdispatch.com.au/news/bluechilli-and-westpac-team-up-for-40000-innovation-challenge 2016-06-09T12:08:40+10:00 http://biotechdispatch.com.au/news/uscom-completes-2m-capital-raise 2016-06-09T12:08:36+10:00 http://biotechdispatch.com.au/news/new-report-proposes-mrff-priorities 2016-06-07T12:19:01+10:00 http://biotechdispatch.com.au/news/seqirus-donates-flu-vax-to-fiji 2016-06-07T12:18:46+10:00 http://biotechdispatch.com.au/news/tga-moves-to-increase-transparency 2016-06-07T12:18:42+10:00 http://biotechdispatch.com.au/news/asx-consults-on-changed-requirements-for-admission 2016-06-06T12:18:56+10:00 http://biotechdispatch.com.au/news/new-leadership-for-pfizer-australia 2016-06-06T12:18:52+10:00 http://biotechdispatch.com.au/news/university-collaboration-launched-to-discover-new-medicines 2016-06-02T13:11:34+10:00 http://biotechdispatch.com.au/news/medical-research-future-fund-makes-public-call-for-submissions 2016-06-02T13:11:23+10:00 http://biotechdispatch.com.au/news/researcher-wins-funding-from-bill-melinda-gates-foundation 2016-06-02T13:10:41+10:00 http://biotechdispatch.com.au/news/aamri-announces-new-director-of-strategy-and-operations 2016-06-02T13:10:36+10:00 http://biotechdispatch.com.au/news/clinical-study-to-evaluate-regenercell-for-diabetic-foot-ulcer-t 2016-06-02T13:10:30+10:00 http://biotechdispatch.com.au/news/applications-open-for-csl-fellowship 2016-06-01T13:11:13+10:00 http://biotechdispatch.com.au/news/biotechnology-front-and-centre-of-australias-economic-transition 2016-05-31T12:24:47+10:00 http://biotechdispatch.com.au/news/tga-releases-performance-snapshot 2016-05-31T12:12:16+10:00 http://biotechdispatch.com.au/news/ellex-announces-results-of-interim-review-of-trial 2016-05-31T12:12:11+10:00 http://biotechdispatch.com.au/news/coalition-targets-childhood-cancers 2016-05-31T12:10:20+10:00 http://biotechdispatch.com.au/news/industry-response-to-productivity-commissions-ip-report 2016-05-30T12:12:30+10:00 http://biotechdispatch.com.au/news/australia-must-do-more-to-build-true-innovation-eco-system 2016-05-30T12:12:26+10:00 http://biotechdispatch.com.au/news/lbt-will-continue-to-grow-and-prosper-says-retiring-ceo 2016-05-26T12:59:33+10:00 http://biotechdispatch.com.au/news/type-1-diabetes-innovation-awards 2016-05-26T09:36:00+10:00 http://biotechdispatch.com.au/news/curve-secures-spot-in-map-startup-accelerator 2016-05-26T09:35:56+10:00 http://biotechdispatch.com.au/news/recruitment-milestone-for-immuron-nash-study 2016-05-26T09:00:09+10:00 http://biotechdispatch.com.au/news/a-match-made-in-heaven 2016-05-25T09:36:06+10:00 http://biotechdispatch.com.au/news/ausbiotechs-asian-investment-series-strengthens-interest-in-the- 2016-05-25T09:36:03+10:00 http://biotechdispatch.com.au/news/greens-back-support-for-collaborations-and-commercialisation 2016-05-24T11:08:27+10:00 http://biotechdispatch.com.au/news/clarity-pharmaceuticals-completes-2m-capital-raise 2016-05-24T11:08:17+10:00 http://biotechdispatch.com.au/news/coalition-announces-7m-for-clinical-trials 2016-05-24T11:07:54+10:00 http://biotechdispatch.com.au/news/new-directory-to-connect-the-industry 2016-05-23T11:08:24+10:00 http://biotechdispatch.com.au/news/industry-investment-in-rd-continues-to-grow 2016-05-19T12:14:39+10:00 http://biotechdispatch.com.au/news/australia-demonstrates-leadership-on-international-clinical-tria 2016-05-19T12:14:35+10:00 http://biotechdispatch.com.au/news/phosphagenics-expands-agreement-with-themis-medicare 2016-05-19T12:14:31+10:00 http://biotechdispatch.com.au/news/clinuvel-updates-on-eu-access 2016-05-19T12:14:27+10:00 http://biotechdispatch.com.au/news/prescient-therapeutics-completes-capital-raise 2016-05-19T12:14:23+10:00 http://biotechdispatch.com.au/news/sirtex-appoints-new-ceo-of-americas-operation 2016-05-17T13:48:21+10:00 http://biotechdispatch.com.au/news/educating-shareholders-on-biotech-investing 2016-05-17T13:48:15+10:00 http://biotechdispatch.com.au/news/minister-anticipates-clinical-trials-announcement 2016-05-17T13:48:11+10:00 http://biotechdispatch.com.au/news/prima-biomed-signs-license-deal-for-cvac 2016-05-17T13:48:07+10:00 http://biotechdispatch.com.au/news/labor-announces-advanced-manufacturing-plan 2016-05-17T13:48:03+10:00 http://biotechdispatch.com.au/news/mtpconnect-looking-for-leaders 2016-05-17T13:45:24+10:00 http://biotechdispatch.com.au/news/invitrocue-expands-3d-cell-based-platform 2016-05-12T13:39:34+10:00 http://biotechdispatch.com.au/news/orphan-drug-designation-for-atl1103-in-acromegaly 2016-05-12T13:39:23+10:00 http://biotechdispatch.com.au/news/european-approval-for-csls-idelvion 2016-05-12T13:39:18+10:00 http://biotechdispatch.com.au/news/mvp-updates-on-fda-delays 2016-05-12T13:39:14+10:00 http://biotechdispatch.com.au/news/student-volunteer-program-now-open-for-biofest-2016 2016-05-11T13:39:28+10:00 http://biotechdispatch.com.au/news/adelaide-welcomes-medical-technology-sector 2016-05-10T10:53:32+10:00 http://biotechdispatch.com.au/news/new-product-agreements-for-obj 2016-05-10T10:53:20+10:00 http://biotechdispatch.com.au/news/consultations-continue-despite-caretaker 2016-05-09T10:53:28+10:00 http://biotechdispatch.com.au/news/treasury-should-consider-new-innovation-incentives 2016-05-05T11:58:13+10:00 http://biotechdispatch.com.au/news/start-up-tax-breaks-passes-senate 2016-05-05T11:58:05+10:00 http://biotechdispatch.com.au/news/vivagel-active-against-zika-virus 2016-05-05T11:57:48+10:00 http://biotechdispatch.com.au/news/opthea-doses-patient-in-new-study 2016-05-05T11:57:39+10:00 http://biotechdispatch.com.au/news/budget-passes-with-no-mention-of-rd-tax-incentive 2016-05-05T11:57:29+10:00 http://biotechdispatch.com.au/news/regulatory-reform-features-in-federal-budget 2016-05-04T11:57:56+10:00 http://biotechdispatch.com.au/news/all-eyes-on-tonights-budget 2016-05-03T11:30:04+10:00 http://biotechdispatch.com.au/news/on-q-recruitment-salary-and-job-satisfaction-survey 2016-05-03T11:29:49+10:00 http://biotechdispatch.com.au/news/the-medical-technology-industry-to-gather-at-ausmedtech-2 2016-05-03T11:28:47+10:00 http://biotechdispatch.com.au/news/japanese-patients-for-primas-imp321 2016-05-03T11:28:32+10:00 http://biotechdispatch.com.au/news/another-impractical-report-on-ip 2016-05-03T11:28:16+10:00 http://biotechdispatch.com.au/news/uniseed-co-leads-investment-round-in-probiotics-drink-perkii 2016-04-28T12:34:49+10:00 http://biotechdispatch.com.au/news/final-call-for-abstracts-for-the-international-biotechnology-sym 2016-04-28T12:34:45+10:00 http://biotechdispatch.com.au/news/dimerix-requests-pre-ind-meeting-with-fda 2016-04-28T12:34:41+10:00 http://biotechdispatch.com.au/news/resmed-profit-falls-on-higher-rd-spend 2016-04-28T12:34:36+10:00 http://biotechdispatch.com.au/news/leadership-and-strategy-change-for-simavita 2016-04-28T12:34:31+10:00 http://biotechdispatch.com.au/news/focus-groups-to-test-new-supply-chain-index 2016-04-26T13:26:21+10:00 http://biotechdispatch.com.au/news/csl-marks-official-centenary 2016-04-26T13:26:17+10:00 http://biotechdispatch.com.au/news/neuren-updates-on-results-of-phase-2-trofinetide-trial 2016-04-26T13:26:11+10:00 http://biotechdispatch.com.au/news/volpara-to-list-on-asx-after-successful-ipo 2016-04-26T13:26:07+10:00 http://biotechdispatch.com.au/news/prana-presents-at-world-orphan-drug-congress 2016-04-25T13:26:25+10:00 http://biotechdispatch.com.au/news/time-expires-on-rd-tax-cut-but-concern-remains 2016-04-21T11:52:02+10:00 http://biotechdispatch.com.au/news/ferris-collaboration-performance-not-good-enough 2016-04-21T11:51:58+10:00 http://biotechdispatch.com.au/news/labor-accuses-government-of-tpp-backdown-on-biologics 2016-04-21T11:51:47+10:00 http://biotechdispatch.com.au/news/csl-announces-rd-support-program 2016-04-19T10:11:50+10:00 http://biotechdispatch.com.au/news/annual-ip-report-shows-growth 2016-04-19T10:11:44+10:00 http://biotechdispatch.com.au/news/viralytics-reports-data-from-three-studies 2016-04-19T10:11:37+10:00 http://biotechdispatch.com.au/news/low-ranking-for-australia-in-new-innovation-report 2016-04-19T10:11:32+10:00 http://biotechdispatch.com.au/news/treasury-confirms-mrff-funding-hole 2016-04-14T11:15:50+10:00 http://biotechdispatch.com.au/news/msac-reform-update-notes-new-form-and-guidelines 2016-04-14T11:15:40+10:00 http://biotechdispatch.com.au/news/fdt-approvals-idt-brain-cancer-drug 2016-04-14T11:15:35+10:00 http://biotechdispatch.com.au/news/resirt-study-completes-patient-recruitment 2016-04-14T11:15:27+10:00 http://biotechdispatch.com.au/news/admedus-expands-distribution-partnership-with-coroneo 2016-04-12T12:49:14+10:00 http://biotechdispatch.com.au/news/new-chair-for-cryosite 2016-04-12T12:49:10+10:00 http://biotechdispatch.com.au/news/new-chair-for-phylogica 2016-04-12T12:49:06+10:00 http://biotechdispatch.com.au/news/new-digital-marketplace-showcases-public-sector-ip 2016-04-11T12:49:34+10:00 http://biotechdispatch.com.au/news/policy-oversight-of-btf-stays-with-health 2016-04-10T12:19:04+10:00 http://biotechdispatch.com.au/news/speculation-of-new-targets-as-pfizer-scraps-allergan-takeover 2016-04-10T11:18:28+10:00 http://biotechdispatch.com.au/news/critics-confused-over-proposed-innovation-tax-incentive 2016-04-07T13:18:52+10:00 http://biotechdispatch.com.au/news/clinical-trials-community-welcomes-mrff-board 2016-04-07T13:18:45+10:00 http://biotechdispatch.com.au/news/patrys-drug-candidate-highlighted-in-journal 2016-04-07T13:18:23+10:00 http://biotechdispatch.com.au/news/adherium-established-european-operation 2016-04-04T20:53:13+10:00 http://biotechdispatch.com.au/news/bionomics-initiates-trial-of-bnc101 2016-04-04T20:53:07+10:00 http://biotechdispatch.com.au/news/positive-trial-results-for-starpharmas-dep-cabazitaxel 2016-04-04T20:53:03+10:00 http://biotechdispatch.com.au/news/biointelect-acquired-by-biotech-capital 2016-04-04T20:52:58+10:00 http://biotechdispatch.com.au/news/university-and-industry-endeavours-converge-at-the-tech-transfer 2016-04-03T20:53:17+10:00 http://biotechdispatch.com.au/news/the-drug-development-odd-couple 2016-03-22T13:04:50+11:00 http://biotechdispatch.com.au/news/bone-medical-acquires-us-company 2016-03-22T13:04:47+11:00 http://biotechdispatch.com.au/news/support-to-fast-track-breakthrough-technologies 2016-03-17T13:42:58+11:00 http://biotechdispatch.com.au/news/government-opens-applications-for-new-landing-pad 2016-03-17T13:42:47+11:00 http://biotechdispatch.com.au/news/new-distribution-agreement-for-3d-medical 2016-03-17T13:42:44+11:00 http://biotechdispatch.com.au/news/viralytics-reports-positive-data-from-cavatak-trial 2016-03-15T13:03:11+11:00 http://biotechdispatch.com.au/news/resapp-reports-positive-meeting-with-fda 2016-03-15T13:02:16+11:00 http://biotechdispatch.com.au/news/new-clinical-trial-shows-value-of-extract-in-reducing-cv-risks 2016-03-15T13:02:08+11:00 http://biotechdispatch.com.au/news/biotech-dominates-list-of-top-25-rd-spin-offs 2016-03-15T12:59:02+11:00 http://biotechdispatch.com.au/news/attendees-applaud-inaugural-nsw-women-in-life-sciences-luncheon 2016-03-14T13:02:26+11:00 http://biotechdispatch.com.au/news/pyne-abbvie-backed-therapy-evidence-of-success 2016-03-10T13:17:08+11:00 http://biotechdispatch.com.au/news/positive-study-result-for-benitecs-hbv-therapy 2016-03-10T13:17:01+11:00 http://biotechdispatch.com.au/news/proteomics-updates-on-promarkerd 2016-03-10T13:16:57+11:00 http://biotechdispatch.com.au/news/imugene-manufacturing-on-track 2016-03-10T13:16:53+11:00 http://biotechdispatch.com.au/news/sirtex-completes-recruitment-for-soramic-study 2016-03-10T13:16:49+11:00 http://biotechdispatch.com.au/news/new-leadership-for-novo-nordisk-australia 2016-03-10T13:16:46+11:00 http://biotechdispatch.com.au/news/ausbiotech-showcase-to-attract-investment-from-asia 2016-03-09T13:17:04+11:00 http://biotechdispatch.com.au/news/csl-announces-new-translation-hub-for-melbourne 2016-03-08T10:44:24+11:00 http://biotechdispatch.com.au/news/ausbiotech-joins-with-industry-and-research-organisations-to-sup 2016-03-08T10:44:21+11:00 http://biotechdispatch.com.au/news/clinical-genomics-wins-approval-in-china-for-insure-fit 2016-03-08T10:44:17+11:00 http://biotechdispatch.com.au/news/new-agreement-for-specialized-therapeutics-and-mundipharma 2016-03-08T10:44:14+11:00 http://biotechdispatch.com.au/news/ausbiotech-urges-review-to-protect-rd-tax-incentives-integrity 2016-03-03T13:05:02+11:00 http://biotechdispatch.com.au/news/paradigm-initiates-second-trial-site-for-zilosul 2016-03-03T13:03:15+11:00 http://biotechdispatch.com.au/news/resapp-records-strong-performance-in-paediatric-clinical-study 2016-03-03T13:02:44+11:00 http://biotechdispatch.com.au/news/auscann-welcomes-new-cannabis-law 2016-03-01T13:01:40+11:00 http://biotechdispatch.com.au/news/greens-want-cultural-change-on-innovation 2016-03-01T13:01:36+11:00 http://biotechdispatch.com.au/news/join-ausmedtech-and-australia-week-in-china 2016-03-01T09:01:47+11:00 http://biotechdispatch.com.au/news/biointelect-taking-innovation-from-science-to-market 2016-02-25T13:37:37+11:00 http://biotechdispatch.com.au/news/biointelect-taking-innovation-from-science-to-market 2016-02-25T13:37:37+11:00 http://biotechdispatch.com.au/news/ausmedtech-early-bird-registration-closing-this-friday 2016-02-25T13:36:50+11:00 http://biotechdispatch.com.au/news/aubiotech-recommends-changes-to-tax-incentives 2016-02-25T13:36:45+11:00 http://biotechdispatch.com.au/news/sirtex-reports-46-9-per-cent-profit-jump 2016-02-25T13:36:28+11:00 http://biotechdispatch.com.au/news/obj-reports-trial-and-consumer-research-results 2016-02-25T13:36:19+11:00 http://biotechdispatch.com.au/news/labor-still-cautious-on-tpp 2016-02-25T13:36:04+11:00 http://biotechdispatch.com.au/news/resmed-acquires-us-cloud-software-company 2016-02-23T09:43:23+11:00 http://biotechdispatch.com.au/news/gsk-brings-researchers-in-house 2016-02-23T09:43:20+11:00 http://biotechdispatch.com.au/news/immuron-initiates-pre-clinical-colitis-development-program 2016-02-23T09:43:15+11:00 http://biotechdispatch.com.au/news/even-more-australian-biotechnology-success-stories 2016-02-22T09:43:27+11:00 http://biotechdispatch.com.au/news/ausbiotech-in-joint-submission-on-tax-incentives-role-in-austral 2016-02-18T09:03:27+11:00 http://biotechdispatch.com.au/news/biotron-compound-to-be-tested-for-zika 2016-02-18T09:02:06+11:00 http://biotechdispatch.com.au/news/mesoblast-updates-on-financial-and-operational-results 2016-02-18T09:02:00+11:00 http://biotechdispatch.com.au/news/cynata-announces-rd-tax-incentive-refund 2016-02-18T09:01:56+11:00 http://biotechdispatch.com.au/news/new-patent-for-atcor-medical-in-japan 2016-02-18T09:01:48+11:00 http://biotechdispatch.com.au/news/us-partnership-for-global-kinetics 2016-02-18T09:01:43+11:00 http://biotechdispatch.com.au/news/immuron-raises-1-7m-in-funding 2016-02-18T09:01:37+11:00 http://biotechdispatch.com.au/news/consultation-on-start-up-tax-incentive-opens-for-quick-comment 2016-02-17T09:02:11+11:00 http://biotechdispatch.com.au/news/a-strong-start-for-csl-in-its-centenary-year 2016-02-16T10:14:33+11:00 http://biotechdispatch.com.au/news/rd-tax-review-releases-issues-paper 2016-02-16T10:14:17+11:00 http://biotechdispatch.com.au/news/new-ceo-for-prescient-therapeutics 2016-02-16T10:14:13+11:00 http://biotechdispatch.com.au/news/fda-grants-additional-organ-designation-to-clinuvel-therapy 2016-02-16T10:14:06+11:00 http://biotechdispatch.com.au/news/psivida-progressing-market-access-for-medidur 2016-02-11T11:37:37+11:00 http://biotechdispatch.com.au/news/ferris-time-to-focus-on-the-d-in-rd 2016-02-11T11:36:48+11:00 http://biotechdispatch.com.au/news/actinogen-announced-rd-tax-payment 2016-02-11T11:36:32+11:00 http://biotechdispatch.com.au/news/impedimed-raises-75m 2016-02-11T11:00:34+11:00 http://biotechdispatch.com.au/news/bill-ferris-briefs-on-biomedical-translation-fund 2016-02-11T10:44:23+11:00 http://biotechdispatch.com.au/news/mvp-acquires-asthma-device-maker 2016-02-09T13:44:28+11:00 http://biotechdispatch.com.au/news/novogen-appoints-new-chairman 2016-02-09T13:44:19+11:00 http://biotechdispatch.com.au/news/medibio-partners-with-swinburne-university 2016-02-09T13:44:14+11:00 http://biotechdispatch.com.au/news/fda-clearance-for-expanded-dyevert-system-claims 2016-02-09T13:44:08+11:00 http://biotechdispatch.com.au/news/21-million-deal-for-australian-cancer-discovery 2016-02-04T13:03:48+11:00 http://biotechdispatch.com.au/news/add-your-story-to-the-30-success-stories 2016-02-04T13:03:36+11:00 http://biotechdispatch.com.au/news/progen-rejoins-asx-as-tbd-diagnostics 2016-02-04T13:03:26+11:00 http://biotechdispatch.com.au/news/new-therapy-for-specialised-therapeutics 2016-02-04T13:03:21+11:00 http://biotechdispatch.com.au/news/new-report-confirms-impact-of-rd-tax-cut 2016-02-04T13:00:32+11:00 http://biotechdispatch.com.au/news/minister-opens-applications-for-crccrc-p-funding 2016-02-02T10:43:14+11:00 http://biotechdispatch.com.au/news/first-statement-from-new-chief-scientist 2016-02-02T10:28:45+11:00 http://biotechdispatch.com.au/news/another-30-million-for-advanced-manufacturing 2016-02-02T09:00:50+11:00 http://biotechdispatch.com.au/news/new-novogen-ceo-writes-to-shareholders 2016-02-02T08:55:21+11:00 http://biotechdispatch.com.au/news/registrations-open-for-international-biofest-2016 2016-02-01T10:04:43+11:00 http://biotechdispatch.com.au/news/ceo-industry-survey-significant-in-year-of-innovation 2016-01-28T11:01:16+11:00 http://biotechdispatch.com.au/news/polynovo-appoints-new-non-executive-director 2016-01-28T11:01:12+11:00 http://biotechdispatch.com.au/news/us-biotech-establishes-australian-presence 2016-01-28T11:01:08+11:00 http://biotechdispatch.com.au/news/admedus-signds-distribution-agreement-with-canadian-company 2016-01-28T11:01:03+11:00 http://biotechdispatch.com.au/news/prima-biomed-initiates-phase-1-melanoma-trial 2016-01-28T11:00:59+11:00 http://biotechdispatch.com.au/news/new-study-backs-uscom-technology 2016-01-21T16:54:11+11:00 http://biotechdispatch.com.au/news/starpharma-completes-capital-raise 2016-01-21T16:46:06+11:00 http://biotechdispatch.com.au/news/imugene-extends-partnership-with-the-medical-university-of-vienn 2016-01-21T16:43:03+11:00 http://biotechdispatch.com.au/news/cancer-medicines-making-headlines-again 2016-01-21T16:39:40+11:00 http://biotechdispatch.com.au/news/orthocell-presents-new-data-at-international-hip-conference 2016-01-21T16:38:08+11:00 http://biotechdispatch.com.au/news/ausbiotech-to-host-women-in-life-sciences-luncheon-in-nsw 2016-01-20T16:49:49+11:00 http://biotechdispatch.com.au/news/government-announces-community-awareness-campaign 2016-01-14T13:01:38+11:00 http://biotechdispatch.com.au/news/us-approval-for-polynovo 2016-01-14T13:00:28+11:00 http://biotechdispatch.com.au/news/a-new-year-a-30th-birthday-a-biofest-and-good-news-rolling-in-al 2016-01-14T12:59:44+11:00 http://biotechdispatch.com.au/news/psivida-closes-17-8-million-offering 2016-01-14T12:59:33+11:00 http://biotechdispatch.com.au/news/orthocells-cell-factory-granted-patent-in-us 2016-01-14T12:59:21+11:00 http://biotechdispatch.com.au/news/government-releases-new-crc-guidelines 2015-12-22T09:40:37+11:00 http://biotechdispatch.com.au/news/admedus-raises-us5-million-from-us-investor 2015-12-22T09:39:33+11:00 http://biotechdispatch.com.au/news/genetic-technologies-announces-publication-of-new-study 2015-12-22T09:39:29+11:00 http://biotechdispatch.com.au/news/gsk-vaccine-manufacturing-boost 2015-12-17T09:13:35+11:00 http://biotechdispatch.com.au/news/ip-australia-issues-revised-examination-practice-after-high-cour 2015-12-17T09:13:30+11:00 http://biotechdispatch.com.au/news/rd-returns-challenged-by-high-costs 2015-12-17T09:13:26+11:00 http://biotechdispatch.com.au/news/rd-tax-claims-set-to-rise 2015-12-17T09:13:22+11:00 http://biotechdispatch.com.au/news/more-detail-on-translation-fund 2015-12-17T09:13:16+11:00 http://biotechdispatch.com.au/news/more-positive-new-for-pharmaxis 2015-12-17T09:13:09+11:00 http://biotechdispatch.com.au/news/flinders-named-key-node-for-national-med-tech-growth-centre 2015-12-15T12:45:25+11:00 http://biotechdispatch.com.au/news/dimerix-granted-orphan-designation-for-lead-drug-candidate 2015-12-15T09:43:47+11:00 http://biotechdispatch.com.au/news/viralytics-raises-28-million-through-placement 2015-12-15T09:41:44+11:00 http://biotechdispatch.com.au/news/new-fund-will-help-grow-the-sector 2015-12-15T09:41:41+11:00 http://biotechdispatch.com.au/news/minister-discusses-innovation-in-israel 2015-12-15T09:41:36+11:00 http://biotechdispatch.com.au/news/jj-exec-to-lead-private-health-funds 2015-12-15T09:41:32+11:00 http://biotechdispatch.com.au/news/innovation-reforms-not-funded-from-new-rd-tax-cuts 2015-12-10T10:41:48+11:00 http://biotechdispatch.com.au/news/novogen-appoints-new-ceo 2015-12-10T10:38:43+11:00 http://biotechdispatch.com.au/news/phylogica-announces-positive-study-results 2015-12-10T10:38:40+11:00 http://biotechdispatch.com.au/news/viralytics-reports-2-9-million-from-rd-tax-incentive 2015-12-10T10:38:36+11:00 http://biotechdispatch.com.au/news/call-for-posters-for-the-international-biotechnology-symposium-2 2015-12-09T10:39:11+11:00 http://biotechdispatch.com.au/news/australia-must-create-the-best-eco-system 2015-12-08T10:45:21+11:00 http://biotechdispatch.com.au/news/commercialisation-the-first-step-for-mrff 2015-12-08T10:44:13+11:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-innovations-new-place-firmly-on-australias-a 2015-12-08T10:43:40+11:00 http://biotechdispatch.com.au/news/new-innovation-cabinet-sub-committee 2015-12-08T10:43:00+11:00 http://biotechdispatch.com.au/news/hudson-building-a-biotech-hub-following-nexvet-success 2015-12-08T10:42:50+11:00 http://biotechdispatch.com.au/news/new-government-report-highlights-benefit-or-rd-tax-incentive 2015-12-03T11:24:29+11:00 http://biotechdispatch.com.au/news/incarda-therapeutics-announces-australian-operation 2015-12-03T11:24:24+11:00 http://biotechdispatch.com.au/news/msac-opens-public-consultation-on-reforms 2015-12-03T11:24:20+11:00 http://biotechdispatch.com.au/news/circadian-board-changes-and-renewal 2015-12-03T11:24:14+11:00 http://biotechdispatch.com.au/news/csiro-collaboration-delivers-for-kayban 2015-12-03T11:24:09+11:00 http://biotechdispatch.com.au/news/ausbiotech-cautions-on-rd-tax-change 2015-12-01T07:31:31+11:00 http://biotechdispatch.com.au/news/ausbiotech-submits-to-productivity-commissions-ip-inquiry 2015-12-01T07:31:25+11:00 http://biotechdispatch.com.au/news/oncosil-announces-rd-tax-refund 2015-12-01T07:31:04+11:00 http://biotechdispatch.com.au/news/fda-approves-genetically-modified-salmon 2015-12-01T07:30:57+11:00 http://biotechdispatch.com.au/news/trajan-announces-new-business-unit 2015-12-01T07:30:45+11:00 http://biotechdispatch.com.au/news/entrepreneurship-the-focus-of-new-innovation-report 2015-11-26T07:48:48+11:00 http://biotechdispatch.com.au/news/lucy-turnbull-sticks-with-prima-biomed 2015-11-26T07:48:38+11:00 http://biotechdispatch.com.au/news/new-trial-for-isonea-home-monitoring-device 2015-11-26T07:48:27+11:00 http://biotechdispatch.com.au/news/paradigm-therapy-approved-for-clinical-trial 2015-11-24T07:36:52+11:00 http://biotechdispatch.com.au/news/minister-launches-new-ip-platform 2015-11-24T07:36:07+11:00 http://biotechdispatch.com.au/news/csl-subsidiary-launches-first-product-under-new-name 2015-11-24T07:36:02+11:00 http://biotechdispatch.com.au/news/pfizer-to-merge-with-allergan 2015-11-24T07:35:45+11:00 http://biotechdispatch.com.au/news/policyhack-outcomes-back-ausbiotech-patent-box 2015-11-19T13:21:45+11:00 http://biotechdispatch.com.au/news/ausbiotech-members-in-top-100-manufacturers 2015-11-19T12:58:08+11:00 http://biotechdispatch.com.au/news/research-australia-awards 2015-11-19T12:18:39+11:00 http://biotechdispatch.com.au/news/starpharmas-targeted-dep-outperforms-other-treatments-in-ovarian 2015-11-19T11:29:23+11:00 http://biotechdispatch.com.au/news/prime-biomed-initiates-new-trial-for-imp321 2015-11-19T11:29:15+11:00 http://biotechdispatch.com.au/news/idt-completes-capital-raise-to-fund-expandsion 2015-11-19T11:29:04+11:00 http://biotechdispatch.com.au/news/technology-industry-sectors-not-one-size-fits-all 2015-11-18T13:00:31+11:00 http://biotechdispatch.com.au/news/apply-for-the-advance-queensland-jj-innovation-quick-fire-challe 2015-11-17T13:13:43+11:00 http://biotechdispatch.com.au/news/mesoblast-nasdaq-debut 2015-11-17T13:13:33+11:00 http://biotechdispatch.com.au/news/we-only-get-a-certain-number-of-neurons 2015-11-17T11:07:31+11:00 http://biotechdispatch.com.au/news/patent-box-report-too-limited-to-be-helpful 2015-11-16T13:13:51+11:00 http://biotechdispatch.com.au/news/make-no-mistake-its-8-years-on-data-exclusivity-says-ustr 2015-11-12T12:14:55+11:00 http://biotechdispatch.com.au/news/starpharma-banks-3-4m-from-rd-tax-incentive 2015-11-12T12:13:51+11:00 http://biotechdispatch.com.au/news/phosphagenics-announces-rd-tax-incentive-refund 2015-11-12T12:13:46+11:00 http://biotechdispatch.com.au/news/new-australian-patent-for-regeneus-stem-cell-technology 2015-11-12T12:13:41+11:00 http://biotechdispatch.com.au/news/new-preclinical-studies-on-anisina-dosing-regimen 2015-11-12T12:13:36+11:00 http://biotechdispatch.com.au/news/viralytics-enters-immunotherapy-deal-with-msd 2015-11-10T10:30:05+11:00 http://biotechdispatch.com.au/news/record-low-nhmrc-success-rate-a-concern 2015-11-10T10:29:48+11:00 http://biotechdispatch.com.au/news/immuron-commences-nash-companion-diagnostic-collaboration-with-o 2015-11-10T10:29:43+11:00 http://biotechdispatch.com.au/news/european-label-expansion-for-cardiocel 2015-11-10T10:29:37+11:00 http://biotechdispatch.com.au/news/last-chance-to-express-interest-in-china-ausmedtech-mission 2015-11-09T10:29:59+11:00 http://biotechdispatch.com.au/news/immune-therapies-reshaping-standard-of-care 2015-11-05T09:35:44+11:00 http://biotechdispatch.com.au/news/bionomics-to-present-pre-clinical-data-on-bnc105 2015-11-05T09:35:16+11:00 http://biotechdispatch.com.au/news/proteomics-targets-key-asian-markets-and-biosimilars 2015-11-05T09:35:07+11:00 http://biotechdispatch.com.au/news/medical-device-regulation-discussed-at-tgas-sponsor-day 2015-11-04T09:35:38+11:00 http://biotechdispatch.com.au/news/starpharma-to-present-at-bio-europe 2015-11-03T09:35:21+11:00 http://biotechdispatch.com.au/news/regeneus-partners-with-leading-animal-health-company-on-stem-cel 2015-11-03T08:07:14+11:00 http://biotechdispatch.com.au/news/ogtr-to-review-application-for-gm-trial 2015-11-03T08:06:53+11:00 http://biotechdispatch.com.au/news/invion-announces-full-enrolment-in-nih-funded-asthma-study 2015-11-03T08:06:45+11:00 http://biotechdispatch.com.au/news/ausbiotech-submission-to-ip-australia-consultation-on-gene-paten 2015-11-02T08:07:01+11:00 http://biotechdispatch.com.au/news/minomic-announces-first-in-human-trial-of-novel-cancer-imaging-a 2015-10-29T12:25:30+11:00 http://biotechdispatch.com.au/news/ausbiotech-makes-four-nominations-to-pbac 2015-10-29T12:25:23+11:00 http://biotechdispatch.com.au/news/positive-results-for-orthocell-tendon-treatment 2015-10-29T12:25:13+11:00 http://biotechdispatch.com.au/news/key-us-patent-for-mesoblast-treatment 2015-10-29T12:25:06+11:00 http://biotechdispatch.com.au/news/circadian-regains-rights-to-vegfr-3-antibody 2015-10-28T11:40:57+11:00 http://biotechdispatch.com.au/news/pm-announces-new-chief-scientist 2015-10-27T11:41:11+11:00 http://biotechdispatch.com.au/news/resmed-reports-revenue-boost 2015-10-27T11:40:52+11:00 http://biotechdispatch.com.au/news/first-patient-safely-treated-in-regeneus-cancer-vaccine-trial 2015-10-27T11:40:48+11:00 http://biotechdispatch.com.au/news/ausbiotech-pleased-after-first-meeting-with-wyatt-roy 2015-10-25T11:41:00+11:00 http://biotechdispatch.com.au/news/new-laws-to-allow-crowdfunding-for-australian-business 2015-10-22T11:54:30+11:00 http://biotechdispatch.com.au/news/ip-australia-consults-on-high-court-decision 2015-10-22T11:54:26+11:00 http://biotechdispatch.com.au/news/another-senior-appointment-for-oncosil-medical 2015-10-22T11:54:22+11:00 http://biotechdispatch.com.au/news/phosphagenics-signs-development-agreement-for-its-tpmoxymorphone 2015-10-22T11:54:18+11:00 http://biotechdispatch.com.au/news/pm-announces-2015-science-prizes 2015-10-22T11:54:14+11:00 http://biotechdispatch.com.au/news/researchers-and-celebrities-get-behind-mrff 2015-10-20T10:52:26+11:00 http://biotechdispatch.com.au/news/labor-announces-first-roundtable-of-the-innovation-investment-pa 2015-10-20T10:50:58+11:00 http://biotechdispatch.com.au/news/mesoblast-and-celgene-extend-agreement 2015-10-20T10:50:51+11:00 http://biotechdispatch.com.au/news/cochlear-urges-government-to-life-rd-tax-cap 2015-10-20T10:50:16+11:00 http://biotechdispatch.com.au/news/australias-next-generation-of-biotech-researchers-recognised-in- 2015-10-19T10:51:05+11:00 http://biotechdispatch.com.au/news/csl-announces-1-billion-share-buyback 2015-10-15T12:54:31+11:00 http://biotechdispatch.com.au/news/government-confirms-rd-tax-cut-still-going-ahead 2015-10-15T12:54:24+11:00 http://biotechdispatch.com.au/news/leadership-change-for-prescient 2015-10-15T12:54:20+11:00 http://biotechdispatch.com.au/news/orthocell-presents-study-data-at-key-conferences 2015-10-15T12:54:16+11:00 http://biotechdispatch.com.au/news/qld-biobeers-and-bubbles-24-november 2015-10-15T09:12:42+11:00 http://biotechdispatch.com.au/news/call-for-appropriate-nominations-for-pbac 2015-10-14T12:54:27+11:00 http://biotechdispatch.com.au/news/tpp-requires-market-protection-period-for-biologics 2015-10-13T12:02:24+11:00 http://biotechdispatch.com.au/news/lbt-announces-retirement-of-ceo 2015-10-13T12:02:15+11:00 http://biotechdispatch.com.au/news/labor-scrap-rd-tax-cut-if-youre-serious-about-innovation 2015-10-13T12:02:10+11:00 http://biotechdispatch.com.au/news/phosphagenics-restructures-following-strategic-review 2015-10-13T12:02:05+11:00 http://biotechdispatch.com.au/news/ip-australia-should-avoid-over-reach-on-gene-patent-decision 2015-10-08T10:15:14+11:00 http://biotechdispatch.com.au/news/merck-extends-collaboration-and-acquires-stake-in-bionomics 2015-10-08T10:14:57+11:00 http://biotechdispatch.com.au/news/benitec-secures-manufacturing-agreement 2015-10-08T10:14:54+11:00 http://biotechdispatch.com.au/news/countries-agree-historic-tpp 2015-10-06T10:09:26+11:00 http://biotechdispatch.com.au/news/australia-a-second-tier-biotech-country 2015-10-06T10:09:09+11:00 http://biotechdispatch.com.au/news/admedus-announces-new-collaboration-on-stem-cell-therapy 2015-10-06T10:08:47+11:00 http://biotechdispatch.com.au/news/invion-progresses-development-of-respiratory-drug 2015-10-06T10:08:37+11:00 http://biotechdispatch.com.au/news/nash-retains-tga 2015-10-01T12:41:48+10:00 http://biotechdispatch.com.au/news/zita-peach-joins-4dx-as-non-executive-director 2015-10-01T12:40:56+10:00 http://biotechdispatch.com.au/news/biotron-announces-interim-trial-results 2015-10-01T12:40:45+10:00 http://biotechdispatch.com.au/news/trial-shows-most-benefit-in-patients-with-advanced-heart-failure 2015-10-01T12:40:41+10:00 http://biotechdispatch.com.au/news/investors-drawn-to-melbourne-for-world-leading-biotech-investmen 2015-10-01T10:08:58+10:00 http://biotechdispatch.com.au/news/dr-anna-lavelle-on-ten-years-at-ausbiotech 2015-09-29T08:42:37+10:00 http://biotechdispatch.com.au/news/policy-stability-essential-says-pharmaxis-ceo 2015-09-29T08:41:17+10:00 http://biotechdispatch.com.au/news/new-hope-in-tpp-talks 2015-09-29T08:41:10+10:00 http://biotechdispatch.com.au/news/chinese-fda-gives-approval-to-start-laiv-vaccine-trials 2015-09-29T08:41:04+10:00 http://biotechdispatch.com.au/news/ausbiotech-suggests-improvements-to-innovation-patent-system 2015-09-28T08:42:30+10:00 http://biotechdispatch.com.au/news/annual-report-2015-ausbiotech-supporting-biotech-as-industry-of- 2015-09-24T08:59:31+10:00 http://biotechdispatch.com.au/news/jj-encouraged-by-turnbull 2015-09-24T08:58:37+10:00 http://biotechdispatch.com.au/news/eu-marketing-approval-granted-for-vivagel-bv 2015-09-24T08:58:36+10:00 http://biotechdispatch.com.au/news/nhmrc-recognises-top-medical-researchers 2015-09-24T08:58:20+10:00 http://biotechdispatch.com.au/news/admedus-initiates-clinical-study-in-reconstructing-heart-valves 2015-09-24T08:58:14+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-turnbull-ministry 2015-09-22T11:58:15+10:00 http://biotechdispatch.com.au/news/ausbiotech-to-nominate-pbac-member-2 2015-09-22T11:58:09+10:00 http://biotechdispatch.com.au/news/new-ministers-welcome-appointments 2015-09-22T11:57:59+10:00 http://biotechdispatch.com.au/news/pharmaxis-announces-positive-phase-1-results-for-pxs%e2%80%90472 2015-09-22T11:57:54+10:00 http://biotechdispatch.com.au/news/september-journal-profiles-national-conference-and-advanced-manu 2015-09-21T11:59:03+10:00 http://biotechdispatch.com.au/news/malcolm-turnbull-announces-new-ministry-with-innovation-at-the-c 2015-09-20T16:02:14+10:00 http://biotechdispatch.com.au/news/benitec-initiaties-fourth-site-in-hep-c-trial 2015-09-17T12:46:56+10:00 http://biotechdispatch.com.au/news/bionomics-reports-positive-data-from-phase-1-study-of-bnc210 2015-09-17T12:45:32+10:00 http://biotechdispatch.com.au/news/engeneic-to-initiate-phase-1-clinical-trial-in-glioma 2015-09-17T12:42:48+10:00 http://biotechdispatch.com.au/news/viralytics-rewards-leadership 2015-09-17T12:35:13+10:00 http://biotechdispatch.com.au/news/ausbiotech-hopes-new-leadership-accelerates-tax-reform 2015-09-15T12:25:40+10:00 http://biotechdispatch.com.au/news/grants-for-australian-biotech-companies 2015-09-15T12:25:23+10:00 http://biotechdispatch.com.au/news/sun-biomedical-progresses-trial-of-dmx-200 2015-09-15T12:25:16+10:00 http://biotechdispatch.com.au/news/new-gp-partnership-for-rhinomed 2015-09-15T12:25:10+10:00 http://biotechdispatch.com.au/news/us-agreement-for-cyclopharm 2015-09-15T12:25:03+10:00 http://biotechdispatch.com.au/news/orthocells-cell-factory-validated-for-bone-regeneration 2015-09-15T12:24:55+10:00 http://biotechdispatch.com.au/news/government-launches-ip-toolkit-for-collaboration 2015-09-14T12:25:30+10:00 http://biotechdispatch.com.au/news/strong-year-for-psivida 2015-09-10T12:45:39+10:00 http://biotechdispatch.com.au/news/nominate-an-industry-leader-in-the-annual-biotech-excellence-awa 2015-09-10T12:45:32+10:00 http://biotechdispatch.com.au/news/140m-expansion-for-melbournes-bio21-medical-research-centre 2015-09-10T12:45:26+10:00 http://biotechdispatch.com.au/news/industry-minister-marks-two-years-since-the-election 2015-09-10T12:45:21+10:00 http://biotechdispatch.com.au/news/antisense-announces-dosing-commenced-in-atl1103-study 2015-09-10T12:45:13+10:00 http://biotechdispatch.com.au/news/oncosil-fast-track-review-for-ce-mark-confirmed-for-october 2015-09-10T12:45:05+10:00 http://biotechdispatch.com.au/news/starpharma-inks-deal-with-astrazeneca 2015-09-08T12:46:39+10:00 http://biotechdispatch.com.au/news/national-and-global-industry-leaders-to-convene-at-ausbiotech-20 2015-09-08T12:46:36+10:00 http://biotechdispatch.com.au/news/australia-putting-tpp-at-risk 2015-09-08T12:46:32+10:00 http://biotechdispatch.com.au/news/csl-standing-firm-on-pay-offer 2015-09-08T12:46:24+10:00 http://biotechdispatch.com.au/news/imugene-announces-successful-capital-raise 2015-09-08T12:46:15+10:00 http://biotechdispatch.com.au/news/global-recognition-for-prescient-chief-scientific-officer 2015-09-03T06:41:32+10:00 http://biotechdispatch.com.au/news/medibio-announces-3-1m-capital-raise 2015-09-03T06:41:18+10:00 http://biotechdispatch.com.au/news/immuron-seeks-better-access-to-us-investors 2015-09-03T06:41:01+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-court-decision 2015-09-02T06:42:07+10:00 http://biotechdispatch.com.au/news/bionomics-set-to-initiate-trial-of-cancer-stem-cell-therapy-foll 2015-09-01T10:22:02+10:00 http://biotechdispatch.com.au/news/regeneus-delivers-business-update 2015-09-01T10:21:45+10:00 http://biotechdispatch.com.au/news/new-leadership-era-for-cochlear-starts-today 2015-09-01T10:21:39+10:00 http://biotechdispatch.com.au/news/prescient-confirms-new-patents-covering-ptx-200 2015-09-01T10:21:35+10:00 http://biotechdispatch.com.au/news/wuxi-toxicology-services-a-global-nonclinical-safety-center-in-c 2015-08-28T10:24:21+10:00 http://biotechdispatch.com.au/news/ausbiotech-response-to-review-of-medicines-and-medical-devices-r 2015-08-28T10:22:50+10:00 http://biotechdispatch.com.au/news/suda-acquires-full-control-of-artimist 2015-08-27T06:38:30+10:00 http://biotechdispatch.com.au/news/ausbiotech-seeking-part-time-cfo 2015-08-27T06:38:26+10:00 http://biotechdispatch.com.au/news/growing-revenue-for-dorsavi 2015-08-27T06:38:21+10:00 http://biotechdispatch.com.au/news/prescient-issues-ptx-200-update 2015-08-27T06:38:16+10:00 http://biotechdispatch.com.au/news/ausbiotech-members-on-list-of-most-innovative 2015-08-25T11:45:18+10:00 http://biotechdispatch.com.au/news/immuron-appoints-new-ceo-2 2015-08-25T11:45:08+10:00 http://biotechdispatch.com.au/news/engeneic-initiates-phase-1-study-in-solid-tumours 2015-08-25T11:44:56+10:00 http://biotechdispatch.com.au/news/benitec-closes-us-ipo 2015-08-25T11:44:50+10:00 http://biotechdispatch.com.au/news/whos-who-of-global-agri-biotech-to-gather-in-melbourne 2015-08-24T11:45:15+10:00 http://biotechdispatch.com.au/news/clarity-and-the-university-of-melbourne-receive-arc-linkage-gran 2015-08-24T11:45:02+10:00 http://biotechdispatch.com.au/news/first-report-of-innovation-inquiry-backs-biotech 2015-08-21T11:33:39+10:00 http://biotechdispatch.com.au/news/abbvie-student-poster-awards-supporting-the-next-generation-of-b 2015-08-21T11:00:09+10:00 http://biotechdispatch.com.au/news/another-ip-review 2015-08-20T12:08:19+10:00 http://biotechdispatch.com.au/news/benitec-announces-us-ipo-pricing 2015-08-20T12:07:39+10:00 http://biotechdispatch.com.au/news/dorsavi-signs-nfl-champions-to-viperform 2015-08-20T12:07:35+10:00 http://biotechdispatch.com.au/news/political-leaders-speak-in-support-of-innovation 2015-08-18T12:02:12+10:00 http://biotechdispatch.com.au/news/higher-rd-spend-impacts-mesoblast-result 2015-08-18T12:01:51+10:00 http://biotechdispatch.com.au/news/prima-to-receive-milestone-payment-from-novartis 2015-08-18T12:01:44+10:00 http://biotechdispatch.com.au/news/medibio-reports-on-us-interest 2015-08-18T12:01:38+10:00 http://biotechdispatch.com.au/news/views-sought-on-abolishing-the-innovation-patent-system-and-alte 2015-08-17T12:01:57+10:00 http://biotechdispatch.com.au/news/robb-stands-ground-on-tpp 2015-08-13T11:23:04+10:00 http://biotechdispatch.com.au/news/immunoglobulin-sales-boost-csl 2015-08-13T11:22:55+10:00 http://biotechdispatch.com.au/news/victoria-wants-biotech 2015-08-13T11:22:52+10:00 http://biotechdispatch.com.au/news/sirtex-profit-up-69 2015-08-13T11:22:47+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-parliamentary-approval-of-mrff 2015-08-12T11:22:59+10:00 http://biotechdispatch.com.au/news/inquiry-backs-mrff 2015-08-11T10:10:47+10:00 http://biotechdispatch.com.au/news/growing-china-an-opportunity-for-australian-companies 2015-08-11T10:10:43+10:00 http://biotechdispatch.com.au/news/adherium-confirms-35m-ipo 2015-08-11T10:10:33+10:00 http://biotechdispatch.com.au/news/new-appointment-for-clinical-genomics 2015-08-11T10:10:29+10:00 http://biotechdispatch.com.au/news/cochlear-disappoints-despite-record-sales 2015-08-11T10:09:50+10:00 http://biotechdispatch.com.au/news/debate-over-definition-of-a-biologic 2015-08-11T10:08:02+10:00 http://biotechdispatch.com.au/news/david-thodey-appointed-to-chair-csiro-board 2015-08-06T11:10:34+10:00 http://biotechdispatch.com.au/news/pharmaxis-signs-deal-for-loxl2-inhibitor 2015-08-06T11:07:50+10:00 http://biotechdispatch.com.au/news/positive-fda-response-for-suda 2015-08-06T11:07:43+10:00 http://biotechdispatch.com.au/news/government-consults-on-regulations-for-crowd-sourced-funding 2015-08-05T11:11:18+10:00 http://biotechdispatch.com.au/news/groups-unite-in-support-of-innovation 2015-08-04T13:20:57+10:00 http://biotechdispatch.com.au/news/australia-in-trade-fantasy-world 2015-08-04T13:20:40+10:00 http://biotechdispatch.com.au/news/bionomics-appoints-us-based-chief-business-officer 2015-08-04T13:20:31+10:00 http://biotechdispatch.com.au/news/csl-completes-flu-vax-acquisition 2015-08-04T13:20:25+10:00 http://biotechdispatch.com.au/news/victoria-appoints-new-innovation-minister 2015-08-04T13:19:48+10:00 http://biotechdispatch.com.au/news/ausbiotech-submits-a-proposal-for-an-incentive-for-investment-pr 2015-08-03T13:21:07+10:00 http://biotechdispatch.com.au/news/novogen-to-review-and-re-prioritise-programs 2015-07-30T12:56:27+10:00 http://biotechdispatch.com.au/news/australia-not-moving-on-tpp 2015-07-30T12:18:34+10:00 http://biotechdispatch.com.au/news/minister-highlights-health-and-medical-research-success 2015-07-30T12:17:18+10:00 http://biotechdispatch.com.au/news/cellmid-completes-capital-raise 2015-07-30T12:17:09+10:00 http://biotechdispatch.com.au/news/nsw-government-grants-medlab-licence-for-medical-cannabas-resear 2015-07-30T12:17:04+10:00 http://biotechdispatch.com.au/news/annual-biotech-excellence-awards-open-for-nominations 2015-07-29T18:07:44+10:00 http://biotechdispatch.com.au/news/fda-to-review-new-csl-haemophilia-product 2015-07-28T12:43:09+10:00 http://biotechdispatch.com.au/news/suda-granted-us-patent 2015-07-28T12:42:55+10:00 http://biotechdispatch.com.au/news/immuron-appoints-chief-operating-and-scientific-officer 2015-07-28T12:42:50+10:00 http://biotechdispatch.com.au/news/iain-ross-rejoins-novogen 2015-07-23T10:23:07+10:00 http://biotechdispatch.com.au/news/mesoblast-type-2-diabetes-trial-results-published-in-diabetes-ca 2015-07-23T10:22:56+10:00 http://biotechdispatch.com.au/news/encouraging-investment-in-pre-revenue-companies 2015-07-22T10:23:11+10:00 http://biotechdispatch.com.au/news/orthocell-pipeline-cartilage-product-validated-in-publication 2015-07-21T13:31:25+10:00 http://biotechdispatch.com.au/news/world-renowned-ivf-pioneer-prof-alan-trounson-to-headline-ausbio 2015-07-21T13:31:16+10:00 http://biotechdispatch.com.au/news/biosimilars-forum-moving-closer 2015-07-21T13:31:08+10:00 http://biotechdispatch.com.au/news/novogens-anisina-granted-orphan-drug-statues-for-neuroblastoma 2015-07-21T13:31:00+10:00 http://biotechdispatch.com.au/news/protagonist-raises-40m-for-development 2015-07-21T13:30:53+10:00 http://biotechdispatch.com.au/news/engeneic-recognised-with-innovation-award 2015-07-21T13:30:43+10:00 http://biotechdispatch.com.au/news/mesoblast-phase-2-heart-failure-results-published 2015-07-16T10:15:57+10:00 http://biotechdispatch.com.au/news/australia-in-the-biotechnology-age 2015-07-15T10:16:14+10:00 http://biotechdispatch.com.au/news/positive-developments-for-ip-law-firm 2015-07-15T10:16:03+10:00 http://biotechdispatch.com.au/news/asia-pacific-expansion-continues-for-clinical-genomics 2015-07-15T10:15:33+10:00 http://biotechdispatch.com.au/news/queensland-targets-innovation-in-budget 2015-07-14T10:23:58+10:00 http://biotechdispatch.com.au/news/grant-for-biodiem-and-griffith-university 2015-07-14T10:23:35+10:00 http://biotechdispatch.com.au/news/next-stop-hawaii-for-tpp 2015-07-14T10:23:29+10:00 http://biotechdispatch.com.au/news/psivida-announces-positive-trial-results 2015-07-14T10:23:22+10:00 http://biotechdispatch.com.au/news/qut-transfers-ip-to-tissue-therapies 2015-07-14T10:23:19+10:00 http://biotechdispatch.com.au/news/positive-trial-results-for-novogens-anisina 2015-07-14T10:00:03+10:00 http://biotechdispatch.com.au/news/another-commercialisation-review 2015-07-09T10:02:05+10:00 http://biotechdispatch.com.au/news/australias-capability-in-clinical-trials-featured-in-new-report 2015-07-09T10:02:02+10:00 http://biotechdispatch.com.au/news/cellmid-appoints-dr-bryce-vissel-to-scientific-advisory-board 2015-07-09T10:01:59+10:00 http://biotechdispatch.com.au/news/phosphagenics-founder-steps-down 2015-07-09T10:01:48+10:00 http://biotechdispatch.com.au/news/dorsavi-signs-nfl-teams-to-use-viperform 2015-07-09T10:01:44+10:00 http://biotechdispatch.com.au/news/vale-alastair-lucas-ao 2015-07-07T12:31:19+10:00 http://biotechdispatch.com.au/news/ausbiotech-july-journal-features-clinical-trials 2015-07-07T12:31:14+10:00 http://biotechdispatch.com.au/news/tour-de-france-leader-adopts-australian-developed-breathing-aid 2015-07-07T12:31:11+10:00 http://biotechdispatch.com.au/news/department-convenes-biosimilar-consultation-meeting 2015-07-07T12:31:05+10:00 http://biotechdispatch.com.au/news/labor-wants-ip-trade-review 2015-07-07T12:31:00+10:00 http://biotechdispatch.com.au/news/acrux-and-lilly-allege-axiron-patent-infringement 2015-07-07T12:30:55+10:00 http://biotechdispatch.com.au/news/university-of-adelaide-announces-rd-agreement-with-az 2015-07-02T12:31:14+10:00 http://biotechdispatch.com.au/news/sirtex-announces-positive-sirflox-sub-analysis 2015-07-02T12:31:09+10:00 http://biotechdispatch.com.au/news/new-directory-to-promote-australian-medtech-companies-in-china 2015-07-02T12:30:26+10:00 http://biotechdispatch.com.au/news/immuron-advances-trial-recruitment 2015-07-02T12:30:00+10:00 http://biotechdispatch.com.au/news/polynovo-announces-publication-of-more-clinical-evidence 2015-07-02T12:29:55+10:00 http://biotechdispatch.com.au/news/parliament-backs-share-scheme-changes 2015-06-30T13:14:10+10:00 http://biotechdispatch.com.au/news/join-ausbiotechs-comment-on-the-mrff 2015-06-30T13:12:24+10:00 http://biotechdispatch.com.au/news/cellmid-announces-new-us-patent 2015-06-30T13:12:00+10:00 http://biotechdispatch.com.au/news/tga-review-recommends-major-changes 2015-06-25T10:54:14+10:00 http://biotechdispatch.com.au/news/senate-recommends-more-consultation-on-biosimilars 2015-06-25T10:43:16+10:00 http://biotechdispatch.com.au/news/another-step-forward-for-tpp 2015-06-25T10:43:08+10:00 http://biotechdispatch.com.au/news/trust-us-on-biosimilars-not-good-enough-says-ex-chf-chair 2015-06-25T10:43:04+10:00 http://biotechdispatch.com.au/news/novogens-anisina-on-track-to-enter-clinic-in-2016 2015-06-25T10:43:01+10:00 http://biotechdispatch.com.au/news/ministers-convene-health-industry-forum 2015-06-25T10:42:57+10:00 http://biotechdispatch.com.au/news/pharma-and-biotech-companies-warned-on-cyber-threat 2015-06-24T10:43:12+10:00 http://biotechdispatch.com.au/news/government-provides-more-detail-on-mrff 2015-06-23T11:44:13+10:00 http://biotechdispatch.com.au/news/benitec-announces-collaboration-with-uk-based-reneuron-and-us-li 2015-06-23T11:43:43+10:00 http://biotechdispatch.com.au/news/automated-processes-to-help-ip-users 2015-06-23T11:43:25+10:00 http://biotechdispatch.com.au/news/prana-receives-6-8-million-rd-tax-incentive-refund 2015-06-23T11:43:14+10:00 http://biotechdispatch.com.au/news/a-new-home-for-biotech-and-pharma-recruitment 2015-06-23T11:43:04+10:00 http://biotechdispatch.com.au/news/clinical-trials-ready-initiative-open-for-consultation 2015-06-22T11:44:03+10:00 http://biotechdispatch.com.au/news/frazier-australia-could-be-a-dominant-power-in-medicines 2015-06-18T12:45:54+10:00 http://biotechdispatch.com.au/news/government-promotes-benefit-of-new-fta 2015-06-18T12:45:37+10:00 http://biotechdispatch.com.au/news/worldview-edition-2015-to-launch-at-the-bio-international-conven 2015-06-17T12:45:43+10:00 http://biotechdispatch.com.au/news/stick-to-the-evidence-on-biosimilars-says-ausbiotech 2015-06-16T12:12:29+10:00 http://biotechdispatch.com.au/news/csl-lower-tax-to-attract-investment 2015-06-16T12:12:24+10:00 http://biotechdispatch.com.au/news/health-summit-to-explore-opportunities-for-china-australia-engag 2015-06-16T12:12:17+10:00 http://biotechdispatch.com.au/news/uniquest-announces-new-collaboration-with-janssen 2015-06-16T12:12:13+10:00 http://biotechdispatch.com.au/news/positive-trial-news-for-engeneic 2015-06-16T12:12:06+10:00 http://biotechdispatch.com.au/news/bionomics-files-new-patent-for-bnc105 2015-06-16T12:12:02+10:00 http://biotechdispatch.com.au/news/clinical-trial-using-dorsavi-sensors-demonstrates-reduction-in-b 2015-06-11T13:12:11+10:00 http://biotechdispatch.com.au/news/scrap-innovation-patent-system 2015-06-11T13:12:04+10:00 http://biotechdispatch.com.au/news/stem-mentoring-program-launches-victorian-pilot 2015-06-11T13:11:51+10:00 http://biotechdispatch.com.au/news/fda-reactivates-prescients-ind-for-ptx-100-breast-cancer-trial 2015-06-11T13:11:35+10:00 http://biotechdispatch.com.au/news/minomic-appointed-clinical-advisory-panel 2015-06-11T13:11:24+10:00 http://biotechdispatch.com.au/news/government-confirms-formation-of-new-industry-forum 2015-06-09T12:33:40+10:00 http://biotechdispatch.com.au/news/mesoblast-announces-rd-tax-payment-and-results-of-diabetes-trial 2015-06-09T12:33:33+10:00 http://biotechdispatch.com.au/news/searching-for-australias-next-chief-scientist 2015-06-09T12:33:28+10:00 http://biotechdispatch.com.au/news/novogen-says-studies-confirm-trxe-crosses-blood-brain-barrier 2015-06-09T12:33:24+10:00 http://biotechdispatch.com.au/news/admedus-updates-on-hsv-2-vaccine-programme 2015-06-09T12:33:21+10:00 http://biotechdispatch.com.au/news/plan-now-to-bring-the-team-to-ausbiotech-2015 2015-06-08T12:33:36+10:00 http://biotechdispatch.com.au/news/labor-concern-over-mrff 2015-06-04T13:24:21+10:00 http://biotechdispatch.com.au/news/23-4-million-for-accelerating-commercialisation 2015-06-04T13:24:16+10:00 http://biotechdispatch.com.au/news/tga-seeking-volunteers-for-pharmacovigilance-inspection-program 2015-06-04T13:24:11+10:00 http://biotechdispatch.com.au/news/micheck-development-on-track 2015-06-04T13:24:06+10:00 http://biotechdispatch.com.au/news/cellmid-signs-taiwan-distribution-agreement 2015-06-04T13:24:02+10:00 http://biotechdispatch.com.au/news/oncosil-on-track-for-eu-approval 2015-06-04T13:23:52+10:00 http://biotechdispatch.com.au/news/greens-remain-opposed-to-rd-tax-cut 2015-06-02T12:30:48+10:00 http://biotechdispatch.com.au/news/boost-for-food-and-agriculture-growth-centre 2015-06-02T12:30:42+10:00 http://biotechdispatch.com.au/news/ausbiotech-submits-to-tax-review 2015-06-02T12:30:35+10:00 http://biotechdispatch.com.au/news/minomic-bowel-cancer-test-presented-at-global-conference 2015-06-02T12:30:19+10:00 http://biotechdispatch.com.au/news/prima-adds-further-ip-to-lead-candidate 2015-06-02T12:30:09+10:00 http://biotechdispatch.com.au/news/eu-confirms-orphan-designation-for-pranas-pbt2 2015-06-02T12:30:05+10:00 http://biotechdispatch.com.au/news/ausbiotech-disappointed-as-rd-tax-incentives-1-5-cut-returns-to- 2015-05-28T09:53:34+10:00 http://biotechdispatch.com.au/news/focus-on-translation-says-mp 2015-05-28T09:53:29+10:00 http://biotechdispatch.com.au/news/ministers-announce-commercialisation-strategy 2015-05-28T09:53:22+10:00 http://biotechdispatch.com.au/news/government-says-yes-to-biosimilar-substitution 2015-05-28T09:53:11+10:00 http://biotechdispatch.com.au/news/benitec-enters-new-manufacturing-agreement 2015-05-26T13:13:09+10:00 http://biotechdispatch.com.au/news/contribute-to-the-federal-discussion-on-tax-reform 2015-05-26T13:12:53+10:00 http://biotechdispatch.com.au/news/premier-takes-innovation-portfolio 2015-05-26T13:12:37+10:00 http://biotechdispatch.com.au/news/orthocell-presents-data-at-stem-cell-and-regenerative-medicine-c 2015-05-26T13:12:21+10:00 http://biotechdispatch.com.au/news/administration-for-qrxpharma 2015-05-26T13:12:06+10:00 http://biotechdispatch.com.au/news/40m-for-innovative-manufacturing 2015-05-25T13:13:12+10:00 http://biotechdispatch.com.au/news/governments-announces-50m-for-advanced-manufacturing 2015-05-21T12:28:10+10:00 http://biotechdispatch.com.au/news/government-launches-new-clinical-trials-website 2015-05-21T12:28:04+10:00 http://biotechdispatch.com.au/news/consultations-on-medtech-and-pharma-industry-growth-centre-comme 2015-05-21T12:27:54+10:00 http://biotechdispatch.com.au/news/tpp-trigger-moves-closer 2015-05-21T12:27:42+10:00 http://biotechdispatch.com.au/news/opposition-to-rd-tax-cut 2015-05-19T12:06:01+10:00 http://biotechdispatch.com.au/news/new-frameworks-for-investor-visas-to-encourage-early-stage-inves 2015-05-19T12:05:56+10:00 http://biotechdispatch.com.au/news/prima-biomed-looking-for-cvac-partner 2015-05-19T12:05:50+10:00 http://biotechdispatch.com.au/news/pharmaxis-soars-on-bi-deal 2015-05-19T12:05:41+10:00 http://biotechdispatch.com.au/news/mesoblast-to-present-trial-results-at-ada-meeting 2015-05-19T12:05:33+10:00 http://biotechdispatch.com.au/news/rhinomed-to-present-at-bio 2015-05-19T12:05:25+10:00 http://biotechdispatch.com.au/news/labor-wants-higher-rd-spending 2015-05-15T13:37:32+10:00 http://biotechdispatch.com.au/news/phosphagenics-updates-on-patch-program 2015-05-14T11:46:58+10:00 http://biotechdispatch.com.au/news/federal-budget-delivers-little-for-biotechbut-theres-a-couple-of 2015-05-14T11:34:24+10:00 http://biotechdispatch.com.au/news/disappointment-for-resmed 2015-05-14T11:34:09+10:00 http://biotechdispatch.com.au/news/psivida-announces-agreements-with-global-pharma-company 2015-05-14T11:33:55+10:00 http://biotechdispatch.com.au/news/ausbiotech-welcomes-labor-support-for-innovation 2015-05-13T12:30:35+10:00 http://biotechdispatch.com.au/news/research-sector-welcomes-mrff-commitment 2015-05-13T06:25:57+10:00 http://biotechdispatch.com.au/news/budget-2015-16-wrap 2015-05-13T06:24:01+10:00 http://biotechdispatch.com.au/news/tax-reform-urgent-as-biotechs-reluctantly-prepare-to-leave-home 2015-05-12T11:56:27+10:00 http://biotechdispatch.com.au/news/more-positive-results-for-novogen 2015-05-12T10:57:32+10:00 http://biotechdispatch.com.au/news/medibio-processes-first-participant-for-depression-test-study 2015-05-12T10:56:05+10:00 http://biotechdispatch.com.au/news/medibio-processes-first-participant-for-depression-test-study 2015-05-12T10:56:05+10:00 http://biotechdispatch.com.au/news/macfarlane-translation-is-the-platform 2015-05-12T10:55:39+10:00 http://biotechdispatch.com.au/news/psivida-reports-third-quarter-results 2015-05-12T10:55:16+10:00 http://biotechdispatch.com.au/news/polynovo-announces-ce-mark-clinical-trial-for-btm 2015-05-12T10:55:11+10:00 http://biotechdispatch.com.au/news/victoria-targets-sector-with-200m-fund 2015-05-07T10:02:26+10:00 http://biotechdispatch.com.au/news/labor-urges-budget-focus-on-innovation 2015-05-07T10:02:12+10:00 http://biotechdispatch.com.au/news/new-china-guide-to-support-australian-medtech-companies 2015-05-07T10:01:58+10:00 http://biotechdispatch.com.au/news/tpp-almost-done 2015-05-07T10:01:40+10:00 http://biotechdispatch.com.au/news/circadian-presents-new-data 2015-05-07T10:00:56+10:00 http://biotechdispatch.com.au/news/global-disbelief-over-biosimilar-substitution 2015-05-05T12:50:30+10:00 http://biotechdispatch.com.au/news/victorian-companies-invited-to-express-interest-in-bio-delegatio 2015-05-05T12:50:23+10:00 http://biotechdispatch.com.au/news/adelaide-to-host-ausmedtech-in-2016 2015-05-05T12:50:14+10:00 http://biotechdispatch.com.au/news/starpharma-announces-extension-to-collaboration-with-astrazeneca 2015-05-05T12:49:57+10:00 http://biotechdispatch.com.au/news/benitec-contemplates-us-listing 2015-05-05T12:49:49+10:00 http://biotechdispatch.com.au/news/innate-joins-ms-outcome-assessment-consortium 2015-05-05T12:49:43+10:00 http://biotechdispatch.com.au/news/new-guide-for-medtech-engaging-in-china 2015-04-30T10:44:39+10:00 http://biotechdispatch.com.au/news/jj-give-us-reason-to-believe 2015-04-30T06:41:29+10:00 http://biotechdispatch.com.au/news/victoria-announces-bio-travel-grants 2015-04-30T06:38:39+10:00 http://biotechdispatch.com.au/news/astrazeneca-and-uniquest-announce-open-innovation-research-colla 2015-04-30T06:30:16+10:00 http://biotechdispatch.com.au/news/benitec-biopharma-expands-hcv-trial 2015-04-30T06:30:12+10:00 http://biotechdispatch.com.au/news/medtech-gather-in-melbourne 2015-04-28T12:51:29+10:00 http://biotechdispatch.com.au/news/budget-speculation-begins 2015-04-28T12:51:21+10:00 http://biotechdispatch.com.au/news/in-the-dark-on-rd-tax-change-impact 2015-04-28T12:51:16+10:00 http://biotechdispatch.com.au/news/pbt2-recommended-for-orphan-designation-in-europe 2015-04-28T12:51:10+10:00 http://biotechdispatch.com.au/news/prescient-appoints-new-cmo 2015-04-28T12:51:05+10:00 http://biotechdispatch.com.au/news/minister-confirms-mrff-is-progressing 2015-04-27T12:51:25+10:00 http://biotechdispatch.com.au/news/time-to-back-innovation 2015-04-23T12:30:44+10:00 http://biotechdispatch.com.au/news/cantrixil-receives-orphan-drug-designation-from-fda 2015-04-23T12:30:29+10:00 http://biotechdispatch.com.au/news/gordon-naylor-to-lead-csls-global-flu-vaccine-business 2015-04-23T12:29:52+10:00 http://biotechdispatch.com.au/news/regeneus-secures-ethics-approval-for-progenza-human-trial 2015-04-22T12:30:57+10:00 http://biotechdispatch.com.au/news/the-medical-technology-industry-to-gather-at-ausmedtech 2015-04-22T12:30:50+10:00 http://biotechdispatch.com.au/news/admedus-appoints-distributor-for-middle-east-and-north-africa 2015-04-22T12:30:19+10:00 http://biotechdispatch.com.au/news/super-funds-back-200m-venture-capital-fund 2015-04-21T12:21:03+10:00 http://biotechdispatch.com.au/news/new-australian-ip-report 2015-04-21T12:20:57+10:00 http://biotechdispatch.com.au/news/labor-concern-over-crcs 2015-04-21T12:20:45+10:00 http://biotechdispatch.com.au/news/novogen-moves-to-fund-growth 2015-04-21T12:20:37+10:00 http://biotechdispatch.com.au/news/biotron-announces-1-7m-rd-refund 2015-04-21T12:18:54+10:00 http://biotechdispatch.com.au/news/key-trends-in-healthcare-digitalisation-decentralisation-and-dem 2015-04-16T11:39:36+10:00 http://biotechdispatch.com.au/news/positive-results-for-cellmids-hair-loss-product 2015-04-16T11:38:27+10:00 http://biotechdispatch.com.au/news/psivida-confirms-another-approval-for-iluvien 2015-04-16T11:38:20+10:00 http://biotechdispatch.com.au/news/institute-director-recognised-as-a-champion-of-gender-equality 2015-04-16T11:38:13+10:00 http://biotechdispatch.com.au/news/analytica-commences-recruitment-for-pericoach-trial 2015-04-16T11:38:03+10:00 http://biotechdispatch.com.au/news/billson-defends-share-scheme-reforms 2015-04-14T12:22:31+10:00 http://biotechdispatch.com.au/news/pm-hosts-second-meeting-of-science-council 2015-04-14T12:20:26+10:00 http://biotechdispatch.com.au/news/anteo-announces-partnership-with-uq 2015-04-14T12:20:20+10:00 http://biotechdispatch.com.au/news/phosphagenics-announced-new-board-appointments 2015-04-14T12:20:14+10:00 http://biotechdispatch.com.au/news/call-for-submissions-on-clinical-trial-cost-list 2015-04-09T13:22:57+10:00 http://biotechdispatch.com.au/news/novogen-soars-on-positive-melanoma-study 2015-04-09T13:22:26+10:00 http://biotechdispatch.com.au/news/bandt-welcomes-senate-support-on-rd 2015-04-09T13:22:15+10:00 http://biotechdispatch.com.au/news/industry-launches-five-year-strategic-plan 2015-04-07T12:38:00+10:00 http://biotechdispatch.com.au/news/labor-welcomes-piwg-backflip 2015-04-07T12:37:56+10:00 http://biotechdispatch.com.au/news/aim-incentive-website-launched-to-support-bid-for-tax-relief 2015-04-07T12:37:50+10:00 http://biotechdispatch.com.au/news/phylogica-announced-agreement-with-uk-biotech 2015-04-07T12:37:45+10:00 http://biotechdispatch.com.au/news/regeneus-achieves-key-stem-cell-manufacturing-milestone-for-clin 2015-04-07T12:37:38+10:00 http://biotechdispatch.com.au/news/competition-review-questions-intellectual-property 2015-04-02T11:58:50+11:00 http://biotechdispatch.com.au/news/anderson-some-institutions-too-dependent-on-nhmrc 2015-04-02T11:57:51+11:00 http://biotechdispatch.com.au/news/strong-asx-debut-for-genetic-signatures 2015-04-02T11:57:46+11:00 http://biotechdispatch.com.au/news/immuron-appoints-new-ceo 2015-04-02T11:57:40+11:00 http://biotechdispatch.com.au/news/join-the-register-of-australian-biotech-and-medtech-success-stor 2015-04-02T11:57:33+11:00 http://biotechdispatch.com.au/news/ausmedtech-to-put-digital-health-under-the-microscope 2015-03-31T12:46:28+11:00 http://biotechdispatch.com.au/news/austrade-seeking-input-on-clinical-trial-capability-report 2015-03-31T12:46:23+11:00 http://biotechdispatch.com.au/news/trajan-and-university-of-tasmania-secure-top-postdoctoral-fellow 2015-03-31T12:46:13+11:00 http://biotechdispatch.com.au/news/cook-and-anteo-team-up-on-mixgo-technology 2015-03-31T12:46:08+11:00 http://biotechdispatch.com.au/news/ley-announces-15-2-million-in-commercialisation-grants 2015-03-26T11:03:23+11:00 http://biotechdispatch.com.au/news/ausbiotech-registrations-closing-soon-for-rd-tax-incentive-claim 2015-03-26T11:03:15+11:00 http://biotechdispatch.com.au/news/suda-updates-on-business-development-activities 2015-03-26T11:02:52+11:00 http://biotechdispatch.com.au/news/lbt-granted-first-us-patent-for-apas-technology 2015-03-26T11:02:39+11:00 http://biotechdispatch.com.au/news/ip-still-central-to-tpp-talks 2015-03-24T10:55:23+11:00 http://biotechdispatch.com.au/news/ausbiotech-views-sought-on-collection-of-rd-spend-when-applying- 2015-03-24T10:55:21+11:00 http://biotechdispatch.com.au/news/actinogen-provides-update-on-xanamem-for-alzheimers-disease 2015-03-24T10:55:14+11:00 http://biotechdispatch.com.au/news/govt-appoints-growth-centre-chair 2015-03-19T13:29:41+11:00 http://biotechdispatch.com.au/news/bandt-outraged-over-rd-cuts 2015-03-19T11:29:53+11:00 http://biotechdispatch.com.au/news/ausbiotech-march-journal-features-digital-health-and-ausmedtech 2015-03-19T11:29:48+11:00 http://biotechdispatch.com.au/news/robb-anti-ip-push-just-a-pre-meditated-scare-campaign 2015-03-19T11:29:41+11:00 http://biotechdispatch.com.au/news/25-million-for-research-to-prepare-australia-for-genomics-revolu 2015-03-19T11:29:29+11:00 http://biotechdispatch.com.au/news/sa-strengthens-tech-ties-with-china 2015-03-19T11:29:18+11:00 http://biotechdispatch.com.au/news/disappointment-for-sirtex 2015-03-17T11:56:27+11:00 http://biotechdispatch.com.au/news/ausbiotech-open-letter-to-parliament-urges-strong-ip-protections 2015-03-17T11:56:12+11:00 http://biotechdispatch.com.au/news/resmed-announces-new-heart-failure-data 2015-03-17T11:55:53+11:00 http://biotechdispatch.com.au/news/first-sales-of-genetic-signatures-respiratory-virus-detection-ki 2015-03-17T11:54:55+11:00 http://biotechdispatch.com.au/news/ausbiotech-emdg-provides-critical-support-for-biotech 2015-03-12T11:28:50+11:00 http://biotechdispatch.com.au/news/nsw-govt-announces-14m-for-cancer-research 2015-03-12T11:27:43+11:00 http://biotechdispatch.com.au/news/researchers-want-certainty-on-infrastructure-funding 2015-03-10T11:32:20+11:00 http://biotechdispatch.com.au/news/new-service-linking-research-to-media 2015-03-10T11:32:09+11:00 http://biotechdispatch.com.au/news/ausbiotech-feds-seeking-to-streamline-ip-red-tape-for-small-busi 2015-03-10T11:32:03+11:00 http://biotechdispatch.com.au/news/viralytics-highlights-immunotherapy-progress 2015-03-10T11:31:58+11:00 http://biotechdispatch.com.au/news/progenza-moves-into-human-trials 2015-03-10T11:31:44+11:00 http://biotechdispatch.com.au/news/us-recognition-for-atcor-medicals-sphygmocor-technology 2015-03-10T11:31:33+11:00 http://biotechdispatch.com.au/news/anteo-secures-distribution-partner-for-japan 2015-03-10T11:00:24+11:00 http://biotechdispatch.com.au/news/acrux-updates-on-testosterone 2015-03-05T09:56:34+11:00 http://biotechdispatch.com.au/news/greens-rd-backdown-not-enough 2015-03-05T09:56:29+11:00 http://biotechdispatch.com.au/news/ausbiotech-free-listing-for-medtech-companies-on-bi-lingual-dire 2015-03-05T09:56:25+11:00 http://biotechdispatch.com.au/news/tpp-ip-fiction 2015-03-05T09:56:20+11:00 http://biotechdispatch.com.au/news/chair-still-empty 2015-03-05T09:56:13+11:00 http://biotechdispatch.com.au/news/action-group-welcomes-commitment-on-mrff 2015-03-05T09:56:06+11:00 http://biotechdispatch.com.au/news/igr-innovation-is-key 2015-03-05T09:55:09+11:00 http://biotechdispatch.com.au/news/sa-initiative-delivers-patent-boost 2015-03-05T09:50:14+11:00 http://biotechdispatch.com.au/news/mrff-uncertainty-as-govt-scraps-co-pay 2015-03-03T13:45:05+11:00 http://biotechdispatch.com.au/news/lavelle-problems-with-emerging-policy-barriers 2015-03-02T23:27:02+11:00 http://biotechdispatch.com.au/news/research-infrastructure-funding-under-threat 2015-03-02T22:53:30+11:00 http://biotechdispatch.com.au/news/more-criticism-of-government-over-rd-tax-change 2015-03-02T22:46:02+11:00 http://biotechdispatch.com.au/news/pup-to-abstain-from-voting-why-now 2015-03-02T22:45:23+11:00 http://biotechdispatch.com.au/news/recognition-for-commercialisation 2015-03-02T22:43:32+11:00 http://biotechdispatch.com.au/news/us-investors-get-better-access-to-bionomics 2015-03-02T22:42:45+11:00 http://biotechdispatch.com.au/news/phosphagenics-looks-to-divest-bioelixia-brands 2015-03-02T22:34:13+11:00 http://biotechdispatch.com.au/news/investigators-link-novartis-would-be-cardio-blockbuster-to-alzhe 2015-02-23T14:26:55+11:00 http://biotechdispatch.com.au/news/ausbiotech-comments-on-draft-ip-toolkit-for-research-collaborati 2015-02-23T14:26:25+11:00 http://biotechdispatch.com.au/news/annual-survey-of-australias-biotech-industry-closing-soon 2015-02-23T14:25:55+11:00 http://biotechdispatch.com.au/news/valve-replaced-while-heart-still-beating-in-pioneering-procedure 2015-02-23T14:23:15+11:00 http://biotechdispatch.com.au/news/professor-anne-kelso-named-new-ceo-of-the-national-health-and-me 2015-02-23T14:21:47+11:00 http://biotechdispatch.com.au/news/ausbiotech-government-actions-not-matching-rhetoric 2015-02-23T14:21:03+11:00